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Abstract 
S.pneumoniae is the leading cause of bacterial pneumonia and meningitis. 
Pneumonia alone has been estimated to kill more children under the age of five 
than that caused by AIDS, malaria and tuberculosis combined. The current 
vaccines which are used to prevent pneumococcal infection only protect against 
a small number of the 90+ serotypes currently identified. Current issues which 
may prevent the long term use of these vaccines is capsular switching, a 
phenomenon observed where some strains are able to escape the vaccine 
through switching their capsule genes. Further serotype replacement has been 
shown to occur since the introduction of the PCV7 vaccine, where serotypes not 
protected against by the vaccine have caused a higher incidence of invasive 
pneumococcal disease compared to the pre vaccine era. One strategy to avoid 
this is via the use of a multi-component protein based vaccine which is serotype 
independent. 
The pneumococcus is normally found as a harmless commensal yet can also 
cause invasive disease as stated above, the pneumococcus is also the leading 
cause of otitis media. The ability for the pathogen to occupy a number of 
different niches and evade host defences is attributed to its large cache of 
virulence factors, including numerous cell surface adhesins. The ability of the 
bacteria to regulate genes required for adaptation to a specified niche is vital 
for survival. In this study a number of signalling systems that are able to 
modulate gene expression (specifically virulence factors) to facilitate adaptation 
to varying environmental conditions are assessed to determine the genes they 
regulate. Further key environmental signals are evaluated to determine the 
effect they have on regulation of important cell surface adhesins. 
The main systems used to modulate global expression changes are two-
component signal transduction systems (TCS). 13 TCS and one orphan response 
regulator are encoded in the pneumococcal genome. Little information is 
available with regards to the importance of each system, whether each system 
regulates its own separate collection of genes and the extent to which cross 
regulation may occur between these systems. This study used whole genome 
expression analysis data obtained through microarray analysis of single and 
double TCS mutants to assess the potential cross regulation of two chosen 
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systems. A number of the systems have also been shown to regulate the same 
islet, which encodes a pilus. Measuring expression of the islet itself enabled the 
role of the systems shown to regulate the islet to be assessed for potential 
interactions between the systems and whether a hierarchy exists. 
The pneumococcus is highly genetically variable due to its ability to become 
naturally competent, taking up DNA from the environment and recombining it 
into its genomic DNA to aid genetic variation and survival. The new era of whole 
genome sequencing has begun to shed light on just how variable this pathogen 
is. Although a number of TCS have been shown to regulate pilus expression, with 
the use of whole genome sequencing of two closely related strains (one contains 
reduced pili expression levels) a number of other factors have also been 
identified which have been shown to alter pilus expression, this includes a 
serine/ threonine protein kinase, pyruvate oxidase and lactate oxidase. Further 
the pneumococcus has been shown to respond to exogenously added hydrogen 
peroxide which increases pilus expression levels. Levels of hydrogen peroxide 
may act as a key environmental cue to signal to the bacterium that they are 
present in the nasopharynx and require increased levels of cell surface adhesins. 
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1.1 Streptococcus pneumoniae 
Streptococcus pneumoniae is a gram positive diplococcus that was first isolated 
simultaneously by George Sternberg and Louis Pasteur in 1881 (Sternberg, 1881, 
Pasteur, 1881). In the majority of instances this organism is found as a coloniser 
in the nasopharynx of children and adults but can also cause invasive disease. 
S.pneumoniae can cause a number of diseases but is most commonly associated 
with causing pneumonia, septicaemia, meningitis and otitis media, with the 
highest disease burden seen in young children, the elderly and the 
immunocompromised. 
The pneumococcus has a polysaccharide capsule, which is an important virulence 
factor and is also used as a classification system assigning each isolate into a 
serogroup. Over 90 pneumococcal capsular types (serotype) have currently been 
discovered, with serotype specific antibodies produced against each 
(Henrichsen, 1995, Park et al., 2007, van Dam et al., 1990, Bratcher et al., 
2010). Some serotypes induce the production of antibodies that are cross 
reactive to other serotypes due to similar capsule structure and some strains 
express no capsule and are known as non typables (Smart, 1986). S.pneumoniae 
can be further phenotypically identified in a number of ways, though production 
of alpha haemolysis on blood agar, bile solubility and optochin sensitivity. Yet 
these tests do not necessarily distinguish this pathogen from other viridans group 
streptococci with some S.pneumoniae strains observed that are optochin 
resistant and bile insoluble (Kontiainen & Sivonen, 1987, Phillips et al., 1987, 
Fenoll et al., 1990). For more reliable classification multi locus sequence typing 
(MLST) is used which allows characterisation of pneumococcal isolates based on 
the sequence of seven housekeeping genes (aroE, gki, gdh, xpt, recP, spi and 
ddl), with variation in the alleles of these genes in different isolates used to 
assign a sequence type (ST), which can then be used as a gauge of relatedness to 
other isolates, there are currently over 4000 different ST identified (Enright & 
Spratt, 1998).  
1.1.1 Disease burden 
In 2000 there were roughly 14.5 million cases of invasive pneumococcal disease 
(IPD) encompassing meningitis, septicaemia and pneumonia (O’Brien et al., 
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2009). S.pneumoniae is the leading cause of bacterial pneumonia and meningitis 
worldwide. Pneumococcal infections account for 11% of all child deaths between 
the age of 0-5 years old, which equates to roughly 800,000 deaths per year 
(Bryce et al., 2005). S.pneumoniae is the leading cause of bacterial pneumonia. 
WHO statistics state deaths from pneumonia equate to more deaths than that 
caused by tuberculosis, malaria and AIDS combined. Over 90% of deaths from 
pneumococcal infection occur in the developing world, with the highest burden 
present in Africa and Asia (O’Brien et al., 2009). The burden of pneumococcal 
disease is thought to be greatly underestimated due to less equipped diagnostics 
facilities in the developing world, inaccessibility of hospitals and potentially 
some deaths being attributed to alternative causes such as HIV or influenza, 
where pneumococci cause a secondary bacterial infection which is often the 
cause of death. 
Although there are over 90 serotypes only a small proportion contribute to the 
majority of IPD cases, with the most common disease causing serotypes globally 
including serotypes 1, 5, 6A, 6B, 14, 19F and 23F prior to the introduction of the 
first pneumococcal conjugate vaccine (PCV7) in 2000, discussed further in 
section 1.4 (Johnson et al., 2010). Serotypes 1, 5 and 14 accounted for 30% of all 
cases of IPD in 20 of the poorest countries (Johnson et al., 2010). The major 
disease causing serotypes often vary between different countries making it hard 
to produce a vaccine that gives global protection. Introduction of PCV7 in 2000 
gave protection against 49-82% of IPD causing serotypes with the greatest 
protection observed in Europe and North America where the disease burden in 
generally low comparatively to the developing world (WHO, 2012). Introduction 
of PCV10 and PCV13 however protects against roughly 70% of IPD causing 
serotypes globally (WHO, 2012). 
1.2 Pneumococcal carriage 
In most instances pneumococcal carriage in the nasopharynx does not lead to 
invasive disease. Yet the high instance of IPD is thought to be due to the high 
carriage rate of the pathogen, with 40% of children and 10% of adults colonised 
in the developed world, which can increase to 90% in the developing world 
(Regev-yochay et al., 2004, Austrian, 1986, Obaro & Adegbola, 2002). In 
children, carriage can occur from birth and may occur with more than one 
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serotype at once (Obaro & Adegbola, 2002). Carriage rates decrease over time 
with children thought to act as the main reservoir due to their high carriage rate 
(Gray et al., 1980, Bogaert et al., 2004, Leiberman et al., 1999). Vaccination of 
children promotes herd protection by removing the reservoir from which the 
elderly and at risk groups acquire pneumococcal carriage (Isaacman et al., 2008, 
O’Brien & Dagan, 2003).  
Although colonisation is assumed to be required for progression to invasive 
disease some strains vary in their ability to cause disease with some serotypes 
more readily associated with carriage including serotype 6B, 9V, 19F and 23F. 
Whereas some were found more commonly in disease including serotypes 1, 4, 
14 and 18C (Brueggemann et al., 2003). Carriage of one serotype can occur for a 
number of months. However this is not always the case and serotype 1 although 
causing a high incidence of invasive disease is almost never detected in carriage 
studies (Brueggemann et al., 2003, Brueggemann & Spratt, 2003), except in 
some indigenous Australian communities (Smith-Vaughan et al., 2009). 
Other serotypes are opportunistic pathogens with invasive disease only occurring 
if the host is immunocompromised. One main factor predisposing to IPD is 
influenza infection with pneumococcal infection often occurring secondary to 
the viral infection. S.pneumoniae in this instance is often the cause of death 
(Short et al., 2012). The majority of deaths during the 1918 influenza pandemic 
were due to pneumococcal infection rather than the virus itself. This was also 
observed in 2009 where 29% of deaths caused by H1N1 showed signs of secondary 
bacterial infection (Morens et al., 2009, Chien et al., 2009). This is also the case 
for HIV infected patients with roughly 100,000 of the 800,000 IPD disease 
associated deaths In 2000 occurring in HIV positive children (Amdahl et al., 1995, 
O’Brien et al., 2009). This is also a problem in the developed world with 
immunosuppressed patients such as the elderly or cancer patients etc.  
1.3 Pneumococcal disease 
1.3.1 Pneumonia 
S.pneumoniae is also termed the pneumococcus due to its ability to cause 
pneumonia, with S.pneumoniae being the commonest cause of community 
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acquired pneumonia accounting for 30-50% of hospitalisations due to pneumonia 
infections in Europe and America (WHO, 2012). Of the 800,000 deaths caused by 
IPD observed in 2000, 90% of these were caused by pneumococcal pneumonia 
(O’Brien et al., 2009). Pneumonia can often be treated with antibiotics, which 
upon their introduction has reduced the mortality rate of pneumococcal 
pneumonia from 60% to 9%, however antibiotic treatment in developing 
countries is still often unavailable (Flippin et al., 1951). 
As mentioned already certain factors increase the risk of developing 
pneumococcal pneumonia such as immunosuppression which may be caused by 
influenza infection, HIV infection, cancer, diabetes, smoking, alcoholism etc 
(Bogaert et al., 2004, Amdahl et al., 1995, Herrero & Olivas, 2012). A large scale 
study has been done investigating the bacterial genes essential for lung infection 
using a murine model of pneumonia (Hava & Camilli, 2002). Included in these 
genes are a number of key virulence factors including PhtD, Ply, PspA, CbpA, a 
number of transcription regulators including that of the pilus islet (RlrA) and a 
number of TCS (two component signal transduction system) response regulators 
(RR) including RR01, RR07, RR09 and the histidine kinase (HK) of TCS12 (Hava & 
Camilli, 2002).  
1.3.2 Bacteraemia 
Bacteraemia is characterised by bacteria being present in the normally sterile 
blood stream, during pneumococcal pneumonia over 50% of patients are found to 
have pneumococci in the blood, thought to occur via direct transmission from 
the alveoli to the blood stream (Musher et al., 2000). Mortality rates caused by 
pneumococcal septicaemia can be high with up to 20% mortality in the 
developing world, with the rate highest in children under 2 years of age. Even in 
the developing world where antibiotics are prescribed as prophylaxis there still 
remains a high mortality rate due to pneumococcal septicaemia, which can 
range from 15-20% in adults and 30-40% in the elderly (WHO, 2012). 
Studies into bacterial genes potentially important during bacteraemia have been 
performed looking at the gene expression changes of bacteria isolated from the 
blood of mice with septicaemia compared to growth in broth (Orihuela, Radin, 
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et al., 2004). This included up regulation of PspA and a number of choline 
binding proteins and up regulation of RR02 and RR10. 
1.3.3 Meningitis 
Meningitis can be caused by a number of bacteria however pneumococcal 
infection accounts for up to 37% of adult meningitis (Durand et al., 1993).This 
often occurs post bacteraemia or can also occur directly through the olfactory 
nerve from carriage bypassing pneumonia and bacteraemia (van Ginkel et al., 
2003). Meningitis is often preceded by pneumonia and otitis media with 18% and 
30% of meningitis sufferers having previously had one of these infections 
respectively (Østergaard et al., 2005). Meningitis is caused by the presence of 
bacteria in the cerebrospinal fluid and the meningeal covering of the brain, 
which leads to inflammation and swelling of the meninges. High morality rates 
are associated with meningitis which can be up to 50% in the developing world. 
As high as 58% of meningitis survivors suffer some form of neurological sequelae 
ranging from hearing loss, seizures to brain damage (Goetghebuer et al., 2000).  
Studies have been performed into the genes that are important for bacterial 
replication during meningitis using a rat model of meningitis (Molzen et al., 
2011). However none of the genes found to be important for this represent the 
key adhesins or TCS regulators other than that of the capsule. A number of ABC 
transporters were also shown to be important here which may be required due 
to the limited nutrients available in the CSF (Molzen et al., 2011). However, 
studies looking at the expression changes in a rabbit meningitis model relative to 
growth in broth show some virulence factors may be important during meningitis 
but perhaps non essential (Orihuela et al., 2004). Again although none of the 
well studied cell surface adhesins were differentially regulated in this study a 
down regulation of TCS03 and virulence factors SpxB, Ply and LytA was observed 
(Orihuela et al., 2004). 
1.3.4 Acute otitis media (AOM) 
Acute otitis media also known as earache is the most common form of 
pneumococcal infection, where pneumococci are present in the middle ear 
(Hausdorff et al., 2002). Although a generally mild infection the sheer number of 
Chapter 1 
 
25 
cases cause a huge burden on the health services worldwide. In American alone 
7 million cases are reported each year with a cost of treatment estimated to be 
around $5 billion (Bondy et al., 2000). Roughly 10% of AOM cases result in 
relapse and require further treatment (Sox et al., 2008). Introduction of PCV7 
has helped reduce the AOM cases as roughly 60-70% and 40-50% of the serotypes 
responsible for disease in children aged 6 months- 5 years old and of 0-6 months 
old are included in the vaccine respectively (Hausdorff et al., 2002). However 
further studies have indicated that although there has been a reduction in AOM 
cases caused by vaccine serotypes there has been no overall reduction in the 
total number of cases. Post PCV7 introduction Increasing numbers of AOM cases 
have been caused by non vaccine types, Haemophilus Influenzae and Moraxella 
catarrhalis (see review Dagan, 2004). 
Again studies have been performed into assessing the genes required for AOM 
using a chinchilla ear infection model, a number of virulence factors were shown 
to be essential for ear infection including PspA, CbpA, PhtE, SrtD (pilin sortase), 
RlrA (pilus transcription regulator) and HK06 and RR10 (Chen et al., 2008). 
1.3.5 Other 
Some of the less commonly associated diseases caused by the pneumococcus 
includes endocarditis, empyema, brain abscesses and haemolytic uraemic 
syndrome, which are often found as complications of pneumonia and meningitis 
(Lindberg & Fangel, 1999, Gigliotti et al., 1981, “Proceedings of the Society,” 
1929, Shayegani et al., 1982, Fincher, 1945, Byington et al., 2002). 
1.4 Vaccines 
1.4.1 Current vaccines in use 
All current vaccines on the market target the pneumococcal polysaccharide 
capsule. As there are over 90 different serotypes all the vaccines include only a 
small number of these which are found to cause the highest incidence of disease 
(Henrichsen, 1995, van Dam et al., 1990, Bratcher et al., 2010, Park et al., 
2007). Three vaccines are currently in the market PPSV23 (23-valent 
polysaccharide vaccine), PCV10 (10-valent polysaccharide conjugate vaccine) 
and PCV13 (13-valent polysaccharide conjugate vaccine) with one being phased 
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out PCV7 (7-valent polysaccharide conjugate vaccine). For information about 
vaccines below see review (Pittet & Posfay-Barbe, 2012). 
1.4.1.1 PPSV23 
PPSV23 (Pneumovax 23) was the first pneumococcal vaccine available (1983, 
Merck), which includes serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 
14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F. This vaccine consists of the 
capsular polysaccharide from each of the above serotypes and is currently used 
in the elderly and in some at risk groups and children over 2 years of age. 
However the vaccine is poorly immunogenic in children where a large incidence 
of disease occurs and this vaccine is therefore not used in the developing world. 
1.4.1.2 PCV (pneumococcal conjugate vaccine) 
Later came the pneumococcal polysaccharide conjugate vaccines which couple 
the capsular polysaccharide to that of a carrier protein used to elicit better 
immunity in children under the age of 2, as polysaccharide alone is poorly 
immunogenic in this at risk group.  
The first manufactured conjugate vaccine in use was PCV7 (Prevnar 7), made 
available in 2000 (Wyeth), which includes the polysaccharide from serotypes 4, 
6B, 9V, 14, 18C, 19F, 23F conjugated to a diphtheria toxoid. However although 
this vaccine has made a huge impact on the incidence of IPD as stated earlier 
the serotypes covered by this vaccine are more common in Europe and America 
where disease burden is much lower than that of the developing world. Due to 
this PCV7 is currently being phased out and replaced by PCV10 and PCV13, which 
protect against roughly 70% of all serotypes causing the highest incidence of IPD 
globally. 
PCV10 (Synflorix) was next to be made available in 2009 (GlaxoSmithKline), 
which again contains the capsular polysaccharide of 10 serotypes conjugated to 
a carrier protein. This includes serotypes 1, 4, 5, 6B, 7F, 9V, 14 and 23F 
conjugated to protein D (outer membrane protein of H.influenzae), serotype 19F 
conjugated to a diphtheria toxoid and serotype 18C conjugated to a tetanus 
toxoid. 
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Finally PCV13 (Prevnar 13) made available in 2010 (Pfizer), which contains the 
capsule polysaccharide of serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F 
and 23F conjugated to a non-toxic diphtheria carrier protein, CRM 197.  
These conjugate vaccines are currently only used in children and have shown to 
provide good protection from IPD, with a reduction in overall IPD observed by 
roughly 70%-90%, and 20% reduction in AOM cases caused by vaccine types in the 
years following PCV7 introduction (Bennett et al., 2003, Grijalva et al., 2006, 
Hennessy et al., 2005). Childhood vaccination with these vaccines has also shown 
benefits to the incidence of IPD in the elderly and immunocompromised as 
childhood vaccination removed the reservoir for adult infection (Isaacman et al., 
2008, O’Brien & Dagan, 2003). Nevertheless the cost of these vaccine are high 
which limits their use in the developing world and due to this only a small 
number of serotypes are included in the vaccine, because of this and the reasons 
stated below these vaccines may be limited in their long term efficiency. 
1.4.2 Serotype replacement 
One phenomenon which will limit the long term use of the conjugate vaccines is 
serotype replacement, which has been studied since the introduction of PCV7. 
This has indicated that although the serotypes that cause the highest incidence 
of IPD have been removed, and the overall incidence of IPD dropped since PCV7 
introduction there has been an increase in the incidence of IPD caused by non-
vaccine serotypes. In America between 1998-2004 incidence of invasive disease 
caused by non vaccine serotypes increased post PCV7 vaccination in both 
children under 5 and adults. This increase was mainly due to serotypes 3, 15, 
19A, 22F and 33F (Hicks et al., 2007), with the main disease causing serotype 
being 19A. In Alaska alone studies showed an increase in IPD in children under 2 
by 140%-180% caused by non vaccine serotypes from the pre vaccine era to 2004. 
Of this increase around 30% was caused by serotype 19A (Singleton et al., 2007, 
Kellner et al., 2009). Although overall the IPD disease still remained lower in 
2004 than in the pre vaccine era. Worryingly an increase in serotype 19A in AOM 
cases have also been observed post PCV7 introduction which is a multidrug 
resistant strain (Pichichero & Casey, 2007). Whether the post vaccine IPD 
incidence will rise to that of the pre vaccine incidence due to non-vaccine 
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serotypes remains to be seen. Some of the serotypes causing IPD in the PCV7 era 
are now protected against in the new vaccine compositions (PCV10/PCV13). 
1.4.3 Capsular switching 
Another phenomenon that may hinder the effectiveness of all the current 
pneumococcal vaccines is capsular switching. Due to the pneumococcus being 
naturally competent it is able to take up DNA out of the environment and 
recombine it into its own, switching genes with other strains. The ability of the 
pneumococcus to do this with the genes of the capsule locus means that strains 
protected against by the vaccines are able to change their capsule for that of 
one not protected against by the vaccine and therefore evade death. This has 
occurred in a number of antibiotic resistant strains including serotype 9V clones 
becoming serotype 14 and identification of 19F, 23F and 19A serotypes of the 
same clone, with evidence indicating this may be a frequent occurrence in the 
pneumococcus (Coffey et al., 1998, Coffey et al., 1999, Croucher et al., 2011). 
1.4.4 New vaccine development 
New efforts are focusing on development of a multi-component protein based 
vaccines, which will be immunogenic in children under 2 years of age. In most 
instances a single protein would not give protection as a number of the key 
virulence factors are only present in a proportion of strains including the 
pneumococcal pilus, PsrP etc. Using more than one protein also reduces the 
likelihood of the pneumococcus being able to evade the vaccine by removing this 
factor as they can do for the capsule (Blomberg et al., 2009). Current proposed 
vaccines include use of a RrgB (pilus backbone protein) fusion protein joining the 
three different variants of this pilin (Harfouche et al., 2012). StkP a serine/ 
threonine protein kinase, PcsB a murine hydrolase and a number of other surface 
associated virulence factors including PspA, CbpA, PhtD and the toxin 
pneumolysin are all included in multi-component protein based vaccine currently 
under investigation (Olafsdottir et al., 2012, Denoël et al., 2011, Ogunniyi et al., 
2007, Xin et al., 2009, Cao et al., 2007, Douce et al., 2010).  
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1.5 Genetic variation 
S.pneumoniae is one of the viridans group streptococci that is naturally 
competent. Streptococcus oralis and Streptococcus mitis can also become 
naturally competent (Håvarstein et al., 1997). This enables the bacteria to take 
up DNA out of the environment and recombine it into its genome, which can be 
used to acquire new genes which may be beneficial for survival or repair of 
genes made non functional via spontaneous mutations etc (Johnsborg, et al., 
2008, Steinmoen, et al., 2002).  
1.5.1 Development of natural competence 
The development of natural competence is controlled by TCS12 also known as 
ComDE. ComDE is one of the TCS that the extracellular stimulus is known, this 
TCS is activated by a small peptide known as CSP which is encoded by comC 
located directly upstream of the genes encoding the TCS (Havarstein et al., 
1995, Havarstein et al., 1996, Pestova et al., 1996). Activation of the TCS via 
binding of CSP leads to the regulation of two distinct sets of genes known as the 
early and late competence induced genes. The early competence induced genes 
include ComC/D/E as upon activation of ComDE a positive feedback occurs 
positively regulating the expression of all three gene, which increases the level 
of CSP and the TCS which are activated (Ween et al.,1999, Peterson et al., 
2004). Other early competence genes include ComA/B which are required for the 
maturation and export of pre-CSP. ComX is also an early competence gene which 
is an alternative sigma factor and is required for induction of expression of the 
late competence genes, which include genes required for the uptake and 
processing of DNA for recombination into the transformants (Lee & Morrison, 
1999, Luo, Li, & Morrison, 2003, Luo & Morrison, 2003). The ability of the 
pneumococcus to do this is the main reason for such high genetic variability, 
some of the studies elucidating this are discussed below. 
1.5.2 Regions of diversity (ROD) 
A number of studies have been performed looking into the regions that are 
diverse between different strains. Using comparative genome hybridisation, 
large scale studies have been performed looking at regions between strains of 
the same ST and serotype that are divergent. This kind of analysis would detect 
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large chunks of DNA that are missing/ present in certain strains but would not 
reveal whether the genes contain small changes such as SNPs or indels.  
The current methods used to assign pneumococci into groups that show high 
similarity is based on their serotype (capsule genes) and sequence type (based 
on 7 housekeeping genes), which has been described above. However recent 
studies have indicated that although these genes may be identical the rest of the 
genome may not with strains of the same ST and serotype varying greatly in their 
ability to cause disease (Silva et al., 2006, Sandgren et al., 2005). A total of 25 
ROD were observed by Silva et al., 2006 between the 14 strains assessed. In this 
study three serotype 14 strains ST124 which were all isolated from the blood of 
infected patients in 2000/2001 in Scotland showed a number of variable genes 
between the three strains and each strain also showed varied levels of 
bacteraemia after 6 hours post infection (Silva et al., 2006). Obert et al (2006) 
analysed a total of 72 strains for RODs that may be associated with virulence, 
with comparison performed between 42 strains taken from patients with invasive 
disease and 30 from non invasive disease. The accessory genome in this study 
equated to 27% of the genome, 153 genes were found to be associated with 
invasive disease and 176 with non invasive disease causing strains (Obert et al., 
2006). Further analysis of some of the ROD identified in this study was 
performed in Embry et al., 2007. Another larger scale study was done using a 
similar technique assessing the variable regions (accessory regions) between 47 
different strains of varying serotype and ST (some shared the same ST and 
serotype), which were taken in some instances from different origins of infection 
(Blomberg et al., 2009). A total of 41 accessory regions were identified 
containing 95 genes, roughly 34% of the genome was shown to contain genes that 
are non essential and therefore vary between different strains (Blomberg et al., 
2009). 
Some smaller scale studies have also been performed focusing on the 
distribution of the known virulence factors in different pneumococcal strains. A 
study looking a the presence of virulence factors in strains causing community 
acquired pneumonia in Japan indicated eno, pavA, piuA, cbpA and cbpG were in 
all strains and therefore may be important for this disease. Whereas other 
virulence factors were variable among strains including hly, piaA, rlrA, psrP, 
nanC and pspA (Imai et al., 2010). Along with the presence of virulence factors 
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assessed in different pneumococcal isolates this has also been performed looking 
at their presence in other viridans group streptococci, specifically S.oralis, 
S.mitis and Streptococcus pseudopneumoniae (Johnston et al., 2010). 
Interestingly a large number of the key pneumococcal virulence factors are also 
found in these species including NanA, NanB, PhtA,B,D, a large cache of choline 
binding proteins, penicillin binding protein and some of the regulatory genes 
including TCS05 and TCS12. However again their presence seem to vary 
depending on the strain (Johnston et al., 2010). This indicated DNA is also 
swapped between different streptococci.  
1.5.3 Whole genome sequencing 
Another way to assess genome diversity between different isolates is by the use 
of whole genome sequencing, which has revolutionised the ability to assess 
genetic variability and evolution of bacteria pathogens. The progress in 
technology and reduced cost of genome sequencing has made it accessible to the 
wider scientific community and permits larger scale studies to be performed 
enabling comparison of the whole genome of a number of different strains. The 
use of whole genome sequencing not only allows identification of large ROD 
between strains but also small changes such as SNPs and indels can be identified. 
This technology has been applied to include large scale genome comparisons to 
assess the conservation of genes between different strains which can be used to 
identify potential vaccine candidates, this approach has been used in 
Streptococcus agalactiae assessing the genes conserved in this pathogen and 
within other related streptococci (Tettelin et al., 2005). These studies have also 
linked genomic factors to invasive disease, for instance the association of a 
mutation in a transcription regulator in Staphylococcus aureus was shown to be 
key in progression from carriage to disease (Young et al., 2012). Similarly in 
Neisseria meningitidis the presence of a prophage was linked to the strains 
ability to cause meningitis (Bille et al., 2005). This technology was also used to 
assess the genotype of the Escherichia coli strain which caused an outbreak in 
Germany in summer 2011, the genome sequencing of this strain showed this 
strain has acquired a prophage which carried a shiga toxin responsible for its 
increased virulence (Rasko et al., 2012). Whole genome sequenceing has also 
been used to follow the evolution of a bacterium over time, which was 
performed on Vibrio cholerae strains isolated during a pandemic outbreak 
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(Mutreja et al., 2011). This technology has also proven to be useful in assessing 
the origin of infection of some bacterial pathogens such as that observed for 
Mycobacterium leprae which was found in wild Armadillos and was identified as 
a zoonotic source of human infection (Truman et al., 2011). This technology has 
also been used for metagenomic studies assessing the bacteria and viral flora 
that Is present in different host (human) niches (Lysholm et al., 2012, Nelson et 
al., 2010). Finally this technology will also pave the way for the potential for 
discovery of new microbial and viral species which are currently not identified as 
they cannot be cultured by standard methods (Hongoh & Toyoda, 2011). 
A large number of pneumococcal genome sequences are now available. The first 
pneumococcal genome sequences were made available in 2001 which was that of 
a serotype 4 strain (TIGR4), this was shortly followed by serotype 2 strain (R6), 
and then another serotype 2 strain (D39) in 2007 (Tettelin et al., 2001, Hoskins 
et al., 2001, Lanie et al., 2007). Findings from multiple genome comparisons 
have further confirmed the high genetic variability between different 
pneumococcal strains with genomes ranging from 2000-2200 kb, number of 
predicted coding sequences ranging between 2200-2800 and variations in the 
percentage of the core genome ranging from 21-33% deduced from comparing 
the genomes of 17 strains with different ST and serotype (Hiller et al., 2007). A 
further large scale study was performed comparing the whole genome sequence 
of 240 isolates of the PMEN1 serotype 23F multidrug resistant clone taken from 
Europe, South Africa, America and Asia between 1984-2008, to assess over time 
how the strain had evolved. This study further validates the genome plasticity of 
the pneumococcus, with multiple recombination events observed over a short 
period of time with some allowing development of antibiotic resistance and 
capsular switching to enable vaccine escape (Croucher et al., 2011).  
1.5.4 Phase variation 
Genetic variation can also be observed in the pneumococcus within the same 
bacterial population. In a single population of pneumococci there are often two 
colony types present, encompassing opaque and transparent phenotypes, this 
phenomenon can also be observed in other bacteria (Weiser, 1993, Weiser et al., 
1994). The two colony types can be distinguished between one another using a 
light microscope (Weiser, 1993, Weiser et al., 1994, Weiser et al., 1996). Both 
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phenotypes vary in a number of different ways with both showing different 
surface protein profiles, different membrane fatty acid compositions, different 
capsule levels, different teichoic acid levels, different bacteriocin activity and 
both also vary in the in vivo niche in which they are able to survive (Aricha et 
al., 2004, Overweg et al., 2000, Benisty et al., 2010, , Kim et al., 1998, Kim et 
al., 1999, Weiser et al., 1996, Dawid et al., 2009). Studies into what causes the 
difference between the two phenotypes have shown that mutations in a number 
of genes can lead to a switch from transparent to an opaque phenotype, 
including genes involved in glycerol metabolism, mutations in the capsule genes 
and mutations in pyruvate oxidase (McEllistrem et al., 2007, Saluja & Jeffrey, 
1995, Ramos-Montañez et al., 2008). 
1.6 Virulence factors (VF) 
1.6.1 Overview 
The pneumococcus contains a large number of VF which are important for its 
survival, which aid in adherence to host cells and help evade the host defences. 
An overview of the most important are shown in Figure 1-1. In large scale 
virulence screens a large number of genes are classed as virulence factors yet 
are not present on the cell surface or secreted and therefore are unlikely to 
interact directly with host factors. In this instance deletion of these genes may 
have a knock on effect to the expression of cell surface VF or alter the fitness of 
the cell through altered metabolism/ make required nutrients unavailable (Hava 
& Camilli, 2002). Below only the virulence factors found on the cells surface of 
the bacteria or secreted will be discussed in more detail with regards to their 
role in virulence. 
Protein VF present on the cell wall are initially targeted for secretion by the GSP 
(general secretion pathway), with the majority containing the typical cell wall 
targeting signal peptide, once secreted the VF can be retained in the cell wall 
via three mechanisms, see review Pérez-Dorado et al., 2012. LPXTG anchored 
proteins are covalently attached to the cell wall/ peptidoglycan via specific 
sortase enzymes, this includes the pneumococcal pilus, which contains three 
dedicated sortases for its attachment/ assembly, other LPXTG anchored surface 
proteins are attached via the house keeping sortase (SrtA) (Kharat & Tomasz, 
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2003, Paterson & Mitchell, 2006). The second class are retained in the cell wall 
via non-covalent attachment known as choline binding proteins of which most 
have a C-terminal choline binding domain which interacts with 
phosphorylcholine moiety in teichoic acid (TA) or lipoteichoic acid (LTA). The 
pneumococcus contains a large number of these proteins (19 TIGR4/ 13 D39) of 
which some will be discussed in more detail later (Tettelin et al., 2001, Lanie et 
al., 2007). The final group include proteins retained at the cell wall through 
weak interactions with lipids. 
 
Figure 1-1: Pneumococcal virulence factors 
Schematic diagram modified from (Mitchell, 2003) showing some of the known 
pneumococcal virulence factors and their function during pathogenesis. 
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1.6.2 Capsule 
The capsule is perhaps thought to be the most important virulence factor as 
strains with no capsule are avirulent, and vaccination with capsular 
polysaccharide can protect from IPD (Watson & Musher, 1990,  Brown et al., 
1983, MacLeod,. 1945). As described previously there are over 90 different 
capsule types currently known, due to the large number they cannot all be 
included in a vaccine (Henrichsen, 1995, van Dam et al., 1990, Bratcher et al., 
2010, Park et al., 2007). The genes which are required for capsule synthesis are 
always found to lie between dexB and aliA genes with the size of the intervening 
region varying between them depending on the serotype (Bentley et al., 2006, 
Jiang et al., 2006). The first four genes of the capsule are almost always 
conserved (cpsA-D), adjacent to these genes are varying numbers of 
glycosyltransferases which create the serotype specific capsule (Bentley et al., 
2006). Other genes present here are also involved in transport of the 
oligosaccharide repeat units to the cell surface and their polymerisation (Wzy 
polymerase/ Wzx flippase). Finally genes at the end of the locus are involved in 
synthesis of sugar precursors (Bentley et al., 2006, Morona et al., 2000, Kong et 
al., 2005).  
Little is know about regulation of the capsule yet it has been associated with 
phase variation as described above, with opaque variants having increase 
capsule levels and are more virulent during invasive disease and transparent 
variants having less capsule and are better able to colonise the nasopharynx 
(Kim & Weiser, 1998, Weiser et al., 1994). Further confirmation the capsule 
plays an important role in IPD is shown by the fact In vivo the capsule is up 
regulated (Ogunniyi et al., 2002). The importance of the capsule during IPD fits 
in with the role of the capsule in preventing phagocytosis via blocking 
complement deposition/ antibody binding, preventing being snared in neutrophil 
extracellular traps, it provides some resistance to antibiotic mediated cell lysis 
and reduces pneumococcal mucus mediated clearance, all features which would 
aid survival in the host (Wartha et al., 2007, Abeyta et al., 2003, Fernebro et 
al., 2004, Nelson et al., 2007, Hardy et al., 2000, Hyams et al., 2010). Further 
studies have linked expression of capsule genes to regulation of carbon 
catabolism with mutants in RegM (transcription regulator) showing reduced 
capsule expression (Giammarinaro & Paton, 2002).  
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Although virulence has been linked to the amount of capsule, more recent 
findings clearly show other factors are also important for virulence as strains of 
the same serotype can vary greatly in their disease causing potential, some of 
these other factors are described below (MacLeod & Krauss, 1950, Briles et al., 
1992, Harvey et al., 2011). 
1.6.3 Pneumolysin (Ply) 
Ply is a pore forming toxin which is included in the family of cholesterol 
dependant cytolysins (CDCs) found in a number of bacteria, see review Gilbert, 
2010. These toxins are able to form pores in the host cell membranes by binding 
cholesterol and inserting into the membrane forming large pores lysing the host 
cell (Tilley et al., 2005). Since its initial discovery a large number of studies 
have been performed assessing the role of Ply in virulence and how it get outside 
the cell. Ply unlike other CDC does not contain a signal sequence targeting it for 
secretion and is thought to be released during autolysis, caused by autolysin 
(LytA) which is described below (Guiral et al., 2005). However more recent 
studies have suggested that Ply is secreted and this function lies within the gene 
located upstream of Ply, yet this is still widely contested (Price et al., 2012). In 
the pneumococcus Ply has been well characterised as an important virulence 
factor and is associated with increased inflammation during meningitis and 
increased virulence in a pneumonia and bacteraemia model of infection (Rubins 
et al., 1996,  Jounblat et al., 2003, Berry et al., 1995, Alexander et al., 1998, 
Alcantara et al., 1999). Ply is generally conserved between strains with only 
small nucleotide changes between serotypes, however some strain that remain 
virulent have a non haemolytic Ply (Kirkham et al., 2006, Jefferies et al., 2007). 
Interestingly Ply has also been characterised to be a potential anti-virulence 
factor with low haemolytic variants giving a selective advantage for growth 
during bacteraemia and higher bacterial numbers are tolerated in the blood 
(Harvey et al., 2011, Benton & Everson, 1995). Some well characterised 
functions of Ply include induction of phagocyte respiratory burst plus cytokine 
release, CD4+ T-cell activation, activation of the classical complement pathway, 
cell lysis via pore formation inducing inflammation etc (McNeela et al., 2010, 
Kadioglu et al., 2004, Mitchell et al., 1991, for an overview see Marriott et al., 
2008). 
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1.6.4 Pilus 
More information will be given on the pneumococcal pilus as this will be a major 
focus within this thesis. 
Pili or fimbriae were first identified in 1949 in gram negative pathogens 
(Anderson, 1949). Pili in gram negative pathogens can be categorised into four 
groups: pili assembled by the chaperone usher pathway, pili assembled by the 
alternative chaperone usher pathway, Type IV pili and pili assembled by the 
nucleation/precipitation. Pili have been shown to play roles in biofilm 
formation, twitching motility, host cell invasion/ adherence, DNA transfer and 
phage binding (see review Proft & Baker, 2009). Pili in gram negative bacteria 
will not be discussed further unless comparisons made to gram positive pili. Pili 
in gram positive pathogens were discovered much later than gram negative pili, 
where in 1968 surface rods were observed on the cell surface of 
Corynebacterium renale via electron microscopy (Yanagaw et al., 1968). 
However a better understanding of the assembly, structure and importance of 
pili to virulence was not assessed till some time later, with interest in these 
structures initiated by Schneewind and colleagues (Ton-That & Schneewind, 
2003, Ton-That, et al., 2004, Ton-That et al., 2004, Budzik & Schneewind, 
2006). 
Since the initial discovery many gram positive species have been shown to 
contain surface exposed pili, two types have been indentified: short thin rods 
(Streptococcus salivarius/ S.oralis) and longer flexible pili (S.pneumoniae/ 
S.agalactiae/ Streptococcus pyogenes) (Pauline et al., 1984, Komiyama & 
Gibbons, 1984,  Barocchi et al., 2006). Long flexible gram positive pili have been 
shown to be composed of a long backbone reaching around 3µm beyond the cell, 
which is composed of the major pilin covalently linked to itself. Linkage of the 
pilins it catalysed by the sortase enzymes (transpeptidase reaction) encoded on 
the same genetic islet as the pilins (Ton-That & Schneewind, 2003). Minor pilins 
may also be encoded on the islet which can be present along the backbone or at 
the tip and often act as adhesins for host cells (Ton-That & Schneewind, 2003). 
Some streptococci contain more than one pilus, this includes 9 in S.pyogenes 
(FCT 1-9), 3 in S.agalactiae, 4 in Streptococcus suis and two in S.pneumoniae 
(Jacques et al., 1990, also see review Kreikemeyer et al., 2011). Between the 
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different pilus islets there are variations with regards to the number of pilins 
(range 2-3), number of sortase enzymes (1-5) and whether a positive 
transcription regulator is encoded on the islet (Kreikemeyer et al., 2011). The 
islets themselves are thought to have arisen from the same ancestor and 
diverged depending on the pathogen. Some islets also include a small signal 
peptidase gene, which is thought to act as a chaperone for the pilin proteins. 
Regulation of these operons is often complex and involves a number of 
transcription regulators and in the pneumococcus a number of two-component 
signal transduction systems (TCS) have also been shown to alter pilus expression 
(Haas et al., 2004, Hemsley et al., 2003, Hendriksen et al., 2007, Rosch et al., 
2008, Song et al., 2009, Sebert et al., 2002). . Regulation of pili has also been 
linked to certain physiological conditions, which may give a clearer idea of the 
importance of these adhesins in virulence/ survival. For instance in S.pyogenes 
pili regulation has been linked to changes in pH with increase levels of pili 
observed at pH 6.4 than at higher pH which is thought to be representative of 
the environment on the skin (low pH), enabling the bacteria to colonise (Manetti 
et al., 2010). Links in S.pyogenes have also been made to pili being regulated 
upon variations in hydrogen peroxide levels, with wild type (WT) strains showing 
increased expression of pili genes upon treatment with hydrogen peroxide, 
which may represent being present in and aerobic environment such as in the 
throat where colonisation is important (Grifantini et al., 2011).  
There are currently two islets identified in the pneumococcus which encode pili, 
PI-1 (pilus islet 1) and PI-2 (pilus islet 2) (Bagnoli et al., 2008, Hava & Camilli, 
2002). Both will be described here however the focus will be on PI-1 encoded 
pilus as this has been more widely studied and is the pilus that is studied further 
in this thesis. 
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Figure 1-2: Genome organisation of islets encoding pili in the pneumococcus 
Schematic diagram modified from Bagnoli et al., 2008, representing the genome organisation of pilus islet 1 (A) and pilus islet 2 (B) present in some 
pneumococcal strains. (A) Gene names are present above the gene, dark blue arrows represent the pilins, red arrows the sortase enzymes, pink arrow the 
transcription regulator, green arrows the flanking insertion sequences and in pale blue genes not related to the functioning of the islet. (B) Gene names are 
present above the gene, dark blue arrows represent the pilins, red arrows the sortase enzymes and orange arrow signal peptidase like gene. Star next to 
the gene name means it contains a frameshift in all strains or some strains and is therefore non functional. 
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1.6.4.1 Pilus islet 1 (PI-1) 
Genes encoded on PI-1 (Figure 1-2) were first identified during a large scale 
virulence screen, which identified some of the pilus islet genes to be important 
in a pneumonia and colonisation model of infection (Hava & Camilli, 2002). One 
of these genes rlrA the positive transcription regulator of the operon was shown 
to have homology to the RofA and Nra transcription regulators in S.pyogenes 
(Fogg et al., 1994, Podbielski et al., 1999). Identified downstream of rlrA is 6 
genes, three that encode pilins designated rrgA, rrgB and rrgC and three that 
encode sortase enzymes designated srtB, srtC and srtD, and all 7 genes are 
flanked by IS1167 elements (Figure 1-2). Since this initial study a large effort has 
been put into characterising this islet as to assess its role in virulence, 
epidemiology, structure, regulation and its potential as a vaccine candidate. 
Epidemiological studies into the presence of the pilus islet in pneumococcal 
strains have shown that this islet is only present in a small proportion of strains 
depending on the study. The most encompassing study looking at the presence of 
the pilus in strains over the world found the PI-1 islet to be in 30% of strains 
(Moschioni et al., 2008). Whereas other studies looking at strains taken from one 
region have found a prevalence of around 21% of strains PI-1 positive in USA and 
35% positive from strains isolated from the Thailand/ Burma 2011 (Basset et al., 
2007, Turner et al., 2011). Basset et al., 2007 also assessed the levels of PI-1 pili 
positive strains prior to and after the introduction of PCV7, which showed a 
reduction in PI-1 positive strains from 40% to 21% post PCV7 introduction, this is 
not surprising as the PI-1 islet has been found to be more highly associated with 
serotypes present in the current vaccines (Basset et al., 2007). However the 
association of the PI-1 islet correlated better to the ST of the strain rather that 
the serotype, which has been observed in a number of studies (Basset et al., 
2007, Moschioni et al., 2008, Moschioni et al., 2010). 
Although PI-1 has been found to be more highly associated with vaccine 
serotypes no link has been made between strains being pili positive and causing 
invasive disease (Basset et al., 2007). Studies looking at the transmission of pili 
positive strains from mother to child showed that the pilus was also not 
associated with strains with increased carriage durations and increased 
transmission rates (Turner et al., 2011). However it has been hypothesised the 
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pilus must confer some selective advantage as re-emergence of the PI-1 islet in 
non vaccine serotypes has been observed in Massachusetts (Regev-Yochay et al., 
2010). The presence of the P1-1 islet in antibiotic resistant strains has also been 
observed in a number of studies but why this would be the case is unknown 
(Moschioni et al., 2010, Regev-Yochay et al., 2010). Carriage of strains that are 
PI-1 positive also seems to inversely correlate to carriage of S.aureus, suggesting 
these strains may confer an advantage during colonisation (Regev-Yochay et al., 
2009). However the PI-1 islet has been found to be more associated with strains 
causing AOM confirmed via in vivo studies using a chinchilla model where RlrA 
and SrtD have been found to be vital for middle ear infection (Vainio et al., 
2011, Chen et al., 2008). 
Studies into the genetic variation within the pilus islet have found three 
different variants of the islet exist classed clade I, II and III. Within the clades 
there is high sequence similarity between all the genes. However between the 
different clades there can be large variation in % homology (Moschioni et al., 
2008). The most conserved gene between the clades is rlrA, which shows 100% 
identity in all three followed by the three sortase enzymes which share 93-99% 
homology. The three pilins show the most sequence diversity between the three 
clades with 97-99% diversity between rrgC, 84-99% diversity of rrgA and 49-67% 
diversity observed in rrgB. The highest diversity being observed in rrgB is 
thought to be due to the fact that this pilin being the pilus backbone protein is 
likely more accessible by the host immune system and therefore the islet has 
undergone positive selection to escape this (Muzzi et al., 2008).  
Three structures of the PI-1 encoded pilus have currently been proposed, the 
first put forward in 2008 was that the main pilus shaft was composed of two RrgB 
profilaments arranged in a coiled-coil structure which contained along the length 
RrgA and RrgC minor pilins acting as the adhesins (Hilleringmann et al., 2008). A 
revised structure was published in 2009 by the same group which showed only a 
single RrgB backbone shaft and RrgA at the tip of the pilus acting as the adhesin 
and RrgC at the bottom anchoring the pilus to the cell wall (Hilleringmann et al., 
2009). Two years later a further structure was published based on careful 
assessment of the role of the sortase enzymes in attachment of the pilins to 
themselves/ each other (El Mortaji et al., 2012). Being the most recent structure 
this is diagrammatically represented below (Figure 1-3) with the current known 
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roles of the sortase enzymes. Time will tell whether other revisions will be made 
to this model. This model retains that RrgC acts as the anchor attaching the RrgB 
shaft to the cell wall/ peptidoglycan, this attachment although not designated 
to any of the three sortases currently is independent of the house keeping 
sortase (SrtA), which is not required for pilus assembly (LeMieux et al., 2008). A 
certain amount of redundancy occurs within the three sortase enzymes encoded 
on PI-1 so this function will likely lie with one of these (LeMieux et al., 2008). 
This model also retains that the backbone is composed of RrgB monomers and 
that RrgA is found at the tip and acts as an adhesin. One of the main variation 
within this structure is that RrgA is also able to polymerize forming long 
branches of RrgA adhesins coming from the tip of the pilus and also at varying 
positions along the RrgB shaft, which has been shown to be catalysed by SrtC. 
SrtC also catalyses the association of RrgB to RrgA whereas SrtD catalyses the 
integration of RrgA into the pilus shaft (El Mortaji et al., 2012).  
 
Figure 1-3: Structure of P1-1 encoded pilus 
Schematic diagram of pilus structure modified from (El Mortaji et al., 2012). Purple triangle 
represent RrgC, Blue RrgB and pink RrgA, boxed is the proposed function of each sortase 
enzyme with regards to their ability to polymerise the different pilins. 
Chapter 1 
 
43 
RrgA has long been recognised to act as the main adhesin which is present at the 
tip of the pilus, studies in a RrgA knockout have shown a clear reduced 
adherence to A549 cell lines (respiratory epithelium) and upon its over 
expression increased adherence (Nelson et al., 2007). Interestingly upon deletion 
of RrgB and RrgC adhesion was similar to that of the WT suggesting only RrgA is 
important, yet RrgA mutants still produced full length pili. In vivo analysis in a 
murine colonisation model further confirmed the importance of RrgA in 
adherence but not RrgB and RrgC (Nelson et al., 2007). The crystal structure of 
RrgA has been solved which gives a further indication what the pilus may bind to 
on host cells (El Mortaji et al., 2012). RrgA was found to have four flexible 
domains, which may enable it to bind to a number of host components. One 
domains shares high homology to a eukaryotic like integrin I domain which are 
important receptors involved in attachment of the cells to the extracellular 
matrix molecules (ECM). RrgAs core structure shares high homology to other 
streptococcal adhesins such as in S.pyogenes which have been shown to have 
collagen binding capabilities, which is what RrgA is hypothesised to bind to, 
which is a highly abundant ECM protein (El Mortaji et al., 2012, Kreikemeyer et 
al., 2005).  
A large number of studies have been performed into the role of the PI-1 encoded 
pilus in virulence, using the typical adherence assays and mouse models of 
infection. Yet as described above to date there is no evidence the pilus is more 
highly associated with strains that cause a higher incidence of disease or more 
severe disease. Upon its initial discovery all genes encoded on the PI-1 islet were 
assessed for their potential role in virulence in a murine model of infection 
assessing their ability to compete with their parent strain (Hava & Camilli, 
2002). RrgA and SrtD were shown to be important for pneumonia. During 
colonisation RrgA and SrtB to a lesser extent were shown to be important. 
Strangely deletion of SrtC and RrgC led to a hypercolonisation phenotype 
relative to the parent strain, which was not assessed further. Later studies 
placing the whole pilus islet into a non piliated strain (D39) showed the pilus aids 
adherence as an increased adherence of this strain to A549 cells was observed 
and gave a competitive advantage in vivo, conversely deletion of this islet from 
a piliated strains showed a reduced adherence and was out competed by the WT 
strain in a colonisation, pneumonia and bacteraemia model of infection 
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(Barocchi et al., 2006, Maisey et al., 2009). A similar study to this deleting the 
whole pilus islet in a TIGR4 strains rendered the strain practically avirulent when 
given via the intratracheal route of infection, which is not observed when given 
via an alternative route (Rosch et al., 2008). Due to this it was hypothesised the 
pilus may help protect the bacteria from killing by macrophages and neutrophils 
found in high numbers in the lung (Rosch et al., 2008). The pilus was also shown 
to stimulate the host immune system with higher TNF-! levels observed in 
piliated strains (Barocchi et al., 2006). This has led to the idea that the pilins 
could be used as a component of a protein based vaccine, with further studies 
showing that all three PI-1 encoded pilins are immunogenic upon vaccination of 
mice and that this is able to protect the mice from normally lethal challenge 
(Gianfaldoni et al., 2007). Although there is variability between the sequence of 
the major pilin RrgB this has been overcome by creating a fusion protein 
consisting of the three varying RrgB clades, of which each can protect against 
clade specific RrgB (Harfouche et al., 2012, Moschioni et al., 2012). The 
pneumococcal pilus has also been linked to a potential involvement in biofilm 
formation which is not surprising as promoting biofilm formation is a key role of 
pili in other pathogenic streptococci (Sanchez et al., 2010, Munoz-Elias et al., 
2008, Manetti et al., 2007).  
Studies have also been performed into how the pneumococcal pilus is regulated 
which have elucidated a large number of factors that seem to alter pilus 
expression. Initial studies assessed the role of RlrA in pilus regulation which is 
encoded on the islet itself. Upon deletion of rlrA the expression of all the pilins 
and sortases is reduced suggesting RlrA positively regulates all the genes in the 
operon (Hava et al., 2003). RlrA was shown to bind directly to four promoters in 
the operon, which includes its own suggesting it positively regulates itself, it 
also binds upstream of rrgA, upstream of rrgB and upstream of srtB. 
Interestingly four RlrA promoter binding regions were observed between rlrA–
rrgA, two upstream of rlrA and two upstream of rrgA, with one thought to 
perhaps compete with "70 RNA polymerase binding, however this has not been 
further confirmed (Hava et al., 2003). No putative "70  binding sites were 
observed upstream of genes rrgA, rrgB and srtB which led to the idea an 
alternative sigma factor may regulate these genes but again this has not been 
further assessed (Hava et al., 2003). Since this initial discovery a number of 
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other transcription regulators have been shown to alter pilus regulation such as 
MgrA which has been shown to act as a repressor of the pilus islet (Hemsley et 
al., 2003). To date six TCS have also been shown to alter expression of the pilus 
islet genes, this includes TCS03, TCS06, TCS08, TCS09 and TCS10 which all act as 
repressors of the islet shown by the fact that deletion caused an increase in pilus 
gene expression, and TCS05 acts as a positive regulator as its deletion reduced 
pilus expression (Rosch et al., 2008, Hendriksen et al., 2007, Haas et al., 2004, 
Song et al., 2009, Sebert et al., 2002). Both RR03 and RR06 have been shown to 
bind directly to the rlrA promoter region (Rosch et al., 2008). However this has 
not been assessed for the other four RR and they may also act directly at the 
rlrA promoter or alternatively regulate another factor which affects pilus 
regulation (Rosch et al., 2008). Pilus regulation has also been linked to the 
ability to regulate manganese levels as deletion of mntE (encoding a manganese 
efflux pump) or of psaR (encoding a manganese dependant regulator) an 
increase in pilus expression is observed (Hendriksen et al., 2009, Rosch et al., 
2008, Rosch et al., 2009, Johnston et al., 2006). Pilus regulation is also linked to 
regulation of the divalent cation zinc through MerR which has been shown to 
regulate transport of this ion, as deletion of merR causes an increase in pilus 
expression (Rosch et al., 2008, Kloosterman et al., 2007). A summary of the 
transcription regulators currently known to alter expression of the genes 
encoded on PI-1 (directly or indirectly) can be seen in Figure 1-4. 
 
Figure 1-4: Summary of the transcription regulators known to alter pilus expression in the 
pneumococcus. 
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Diagram summarises the role of a number of pneumococcal transcription regulators with 
regards to their ability to alter pilus expression. 
 
More recent findings have shown that within a growing bacterial population two 
populations exist, cells that are pili positive and cells that are pili negative. With 
a TIGR4 strains showing roughly 30% of cells pili positive (Basset et al., 2011, De 
Angelis et al., 2011). This has been shown in part to be regulated by the levels 
of RrgA, which can bind directly to RlrA, which prevents it from positively 
regulating itself and other genes present on the islet. Deletion of rrgA leads to 
almost all cells becoming pili positive (Basset et al., 2011, Basset et al., 2012). 
This bistable regulation of the pilus at the population level is also observed in 
S.pyogenes which has been shown to modulate the level of pilus expressed 
within the population depending on the temperature at which the bacteria are 
grown, thought to mimic conditions present during superficial skin infections 
(30°C) or systemic infection (37°C) (Nakata et al., 2009). However little is 
currently know about exactly how this phenomenon is modulated. 
It is important for bacteria to be able to adapt to changing environments 
quickly. Heterogeneity within a bacterial population is often modulated through 
two-component signal transduction systems, some examples in the 
pneumococcus include natural competence development (as discussed in section 
1.7.1.1.12). Where some bacterial cells become naturally competent and can 
take up DNA from the environment to aid genetic variation and therefore 
survival. Another TCS has also been shown to aid in protecting a proportion of 
the bacterial population from autolysis, which are the bacterial population 
though to lyse to create a DNA pool for the naturally competent population (as 
discussed in section 1.7.1.1.12).  
As already stated a number of these TCS in the pneumococcus also regulate the 
pilus, it is currently unknown if these modulate the pilus at the population level 
though (as described above). If this was the case its likely that these systems 
detect an external stimulus that signals being in a certain niche within the host 
and modulates the levels of pilus required at the population level accordingly. 
Assuming that the pilus is present on the surface of more cells when found in an 
environment where adhesion is required (e.g. nasopharynx). This seemed to be 
the case for GAS regulation of the pilus which showed higher expression levels at 
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the population level when grown at lower temperatures, thought to mimic being 
present on the skin where adherence is important (Nakata et al., 2009). It was 
hypothesised that regulation at this level may allow some bacteria within the 
population to avoid detection by the immune system as the pilus is 
immunogenic. This may enable survival of some of the population as is observed 
during natural competence development and autolysis. 
Heterogeneity can also be modulated through genome changes such as that 
observed for phase variants, which has been linked to SNPs etc in a number of 
pneumococcal genes (section 1.5.4). Changes at this level if beneficial to the 
bacterium would be positively selected for and spread through the population. 
1.6.4.2 Pilus islet 2 (PI-2) 
In 2008 a second pilus islet was identified in serotype 1 strain INV104 through 
analysis of its genome sequence, this islet showed high similarity to that of an 
islet encoding a pilus in S.pyogenes (Bagnoli et al., 2008, Mora et al., 2005). 
Further studies into this islet confirmed this was also the case in S.pneumoniae 
with this 6.6kb islet encoding 5 genes pitA, pitB, sipA, srtG1 and srtG2 (Figure 
1-2). Further analysis revealed in all strain pitA contained a premature stop 
codon and in all but 1 strain srtG2 is also non functional, yet their non 
functionality did not seem to effect pilus polymerisation and only pitB, sipA and 
srtG1 were required for pilus polymerisation (Bagnoli et al., 2008). PitB was 
confirmed to be the only pilin and made up the whole length of the pilus, which 
was polymerised via SrtG1. The role of SipA is still unknown but it is required for 
polymerisation, and thought to encode a small peptidase (Bagnoli et al., 2008). 
Homologues of this gene in S.pyogenes pili islets are thought to potentially act 
as a chaperone to the pilin (Zahner & Scott, 2008). 
Presence of P1-2 has been associated with serotypes 1, 2 7F, 11A, 19A, 19F 
however again its presence is more closely related to the ST of the strain 
(Bagnoli et al., 2008, Zähner et al., 2010). ST127 has been shown to encode both 
P1-1 and P1-2 however this does not seem to be common. Again like P1-1, P1-2 
is not present in all strains with roughly 16% of strains containing this pilus islet, 
this is lower in AOM causing strains dropping to 7% (Moschioni et al., 2010, 
Bagnoli et al., 2008). This islet is also not associated with strains causing IPD yet 
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has been shown to aid in adherence to a number of cell lines including A549, 
Detroit 562 (nasopharyngeal epithelium), 16 HBE 14O- (bronchial epithelium) and 
Hep-2C (laryngeal epithelium) cell lines, which all showed a reduced adherence 
using a PI-2 mutant (Bagnoli et al., 2008). Little information is available about 
the structure of the PI-2 encoded pilus apart from data indicating PitB contains 
intramolecular isopeptide bonds stabilising them (Zähner et al., 2011). Even less 
is known about the regulation of this islet which encodes no transcription 
regulator unlike PI-1 and no studies have currently been performed to assess any 
other potential transcription regulator that may regulate this operon.  
1.6.5 Pneumococcal serine rich repeat protein (PsrP) 
PsrP is a very large cell surface protein present in the pneumococcus, this gene 
is encoded on a large islet spanning 37kb which consists of itself a large 4777 aa 
(amino acid) protein, 10 glycosyltransferase (function to glycosylate PsrP) and 7 
genes thought to encode a sec translocase system (Obert et al., 2006). PsrP 
itself gained its name from its protein structure which contains two serine rich 
repeat regions (SRR1/ SRR2), SRR1 is short and contains only 8 repeats however 
SRR2 contains 539 SRR2 repeats (Rose et al., 2008). This protein is covalently 
attached to the cell surface via its LPXTG motif like the pilus and is present in 
roughly 50% of strains (Munoz-Almagro et al., 2010). Strains containing PsrP 
positively correlates with strains causing IPD (Munoz-Almagro et al., 2010). PsrP 
is able to bind directly to keratin 10 on lung cells and aid adherence 
(Shivshankar et al., 2009), and knockouts show a reduced virulence in a mouse 
model of infection (Munoz-Almagro et al., 2010, Obert et al., 2006). Further 
study has also indicated PsrP to play a role in intra strain adhesion and biofilm 
formation (Sanchez et al., 2010). This protein is also a potential vaccine 
candidate as it is immunogenic and can protect mice from lethal challenge (Rose 
et al., 2008). 
1.6.6 Neuraminidase 
One of the other well studied cell surface proteins is neuraminidase (NanA) 
present in 100% of strains, its role is still under scrutiny however is thought to 
act by enzymatically cleaving sialic acid off the surface of host cells revealing 
receptors for bacterial adherence and modifying competing bacterial cell 
Chapter 1 
 
49 
surface glycoproteins (Bergmann & Hammerschmidt, 2006, Pettigrew et al., 
2006). More recently another role of NanA was proposed where it aids adherence 
to brain endothelial cells and can cause cytokine release followed by bacterial 
uptake (Banerjee et al., 2011, Uchiyama et al., 2009). Studies have shown 
varying roles of NanA in virulence, initial virulence screens implied no role for 
NanA in virulence using a intraperitoneal (I.P) and intranasal (I.N) route of 
infection yet later studies implied a role in nasopharyngeal colonisation and 
spread to the lungs and blood in a mouse model of infection (Berry & Paton, 
2000, Manco et al., 2006). The pneumococcus also contains two further 
neuraminidases, NanB and NanC but these have been less well characterised, 
they are present in 96% and 51% of strains respectively (Pettigrew et al., 2006). 
NanB unlike NanA does not contain the C-terminal cell wall anchoring domain so 
is not retained at the cell surface, however is thought to play a similar role in 
virulence as NanA (Manco et al., 2006, Lock et al., 1988). More recently NanB 
has been hypothesised to play a role in obtaining nutrients and NanC is thought 
to regulate NanA function (Xu et al., 2011) 
1.6.7 Choline binding proteins (CBPs) 
CBPs attach to the cell wall through non covalent attachments via interactions 
through their C-terminal choline binding domains (CBDs) to phosphorylcholine 
residues present in LTA and TA (Gosink et al., 2000, Yother & White, 1994). 
Although the CBD are generally highly conserved (roughly 20aa) between CBPs 
the N-terminal regions are highly diverse, and in the pneumococcus CBPs have a 
number of different functions, including adhesins and autolytic enzymes, and 
the number of CBPs varies between the strains with roughly 10-15 in 
S.pneumoniae (Bergmann & Hammerschmidt, 2006). The same CBP can also vary 
in its structure between different strains (Brooks-Walter et al., 1999, 
Hollingshead et al., 2000). Some of these CBPs also have homologues in other 
closely related streptococci which may act as a pool for acquisition of variants 
enabling escape from the immune system (Johnston et al., 2010). Some of the 
key CBPs are described below.  
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1.6.7.1 Adhesins? 
One well studies CBP is CbpA (PspC/ SpsA) which is known to act as an adhesin 
present on the surface of the pneumococcus, CbpA is highly variable and can be 
sorted into two clades (Brooks-Walter et al., 1999). Some variants attach to the 
cell wall not through interactions with phosphorylcholine but via LPXTG 
anchoring. This variant known as Hic shares homology to a group B streptococcal 
protein (Jarva et al., 2004, Janulczyk et al., 2000). This CBP has been shown to 
be important for virulence via knockouts showing a reduced ability to bind to 
epithelial cells, reduced nasopharyngeal colonisation and reduced survival in a 
mouse pneumonia and sepsis model (Rosenow et al., 1997, Iannelli et al., 2004, 
Quin et al., 2005, Quin et al., 2007). It functions in part through binding of 
polymeric immunoglobulin receptor, which transports secretory IgA, perturbing 
this function (Hammerschmidt et al., 2000, Zhang et al., 2000). CbpA is also able 
to bind factor H, which is important for activation of the alternative 
complement pathway leading to bacterial opsonophagocytosis (Dave et al., 2004, 
Cheng et al., 2000, Janulczyk et al., 2000, Quin et al., 2005, Quin et al., 2007) 
PspA is another well studied CBP found on the pneumococcal cell surface, again 
this protein is highly structurally variable and can be divided into three families 
and further split into six clades (Hollingshead et al., 2000). Like CbpA this 
protein is able to evade host defences via preventing complement deposition on 
the bacterial cell surface by inhibiting activation of the classical and alternative 
complement pathway (Ren et al., 2003, Ren et al., 2004a, Ren et al., 2004b, 
Ochs et al., 2009, Tu et al., 1999). PspA is also able to bind lactoferrin, a host 
iron transport protein, and is thought to help protect from apolactoferrin 
bactericidal activity (Shaper et al., 2004, Hakansson et al., 2001). With regards 
to virulence the data is conflicting but it may be required for in vitro growth 
(McDaniel et al., 1987, Ren et al., 2004a, Berry & Paton, 2000, Orihuela et al., 
2004, Hava & Camilli, 2002). PspA however is immunogenic and is a component 
in a number of protein based vaccine studies (Nguyen et al., 2011, Xin et al., 
2009, Yamamoto et al., 1997) 
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1.6.7.2 Hydrolytic enzymes 
The pneumococcus contains a number of cell wall hydrolytic enzymes of which 
the most well known are LytA/B/C. LytA has been shown to function as a N-
acetylmuramoyl-L-alanine amidase cleaving N-acetylmuramoyl-L-alanine 
moieties bond of pneumococcal peptidoglycan (Howard, et al., 1974, Tomasz et 
al., 1988). Its main activity has been shown to cause bacterial cell autolysis but 
may also contribute to cell wall turnover and growth. Why autolysis is 
physiologically important is still debated, one function is though to be to release 
Ply which is a VF, however this is now contested. Another suggestion is that the 
lysed cells provide DNA for recombination into surviving bacterial cells to aid 
genetic variation and survival (Steinmoen et al., 2002, Guiral et al., 2005). 
Studies into its role in virulence show conflicting information with some strains 
showing mutants are as virulent as WT however some show deficiencies in 
virulence (Berry et al., 1989, Tomasz et al., 1988, Hirst et al., 2008, Canvin et 
al., 1995, Berry & Paton, 2000, Orihuela et al., 2004). LytB functions during cell 
division localising to the cell septum, mutants in this gene are unable to properly 
separate and form long chains (Garcia et al., 1999, Rudner & Jarvis, 1999). LytCs 
function is less well characterised and shows little phenotype change unless 
deleted alongside LytA. However both LytB and LytC have been shown to be 
important during colonisation (Gosink, et al., 2000). 
On top of the CBPs discussed above a number of other choline binding proteins 
exist with varying functions, briefly this included CbpJ and CbpI of which their 
function is currently unknown (Paterson et al., 2006). CbpF is thought to 
modulate in some way LytC function (another CBP) (Molina et al., 2007, Molina 
et al., 2009). CbpD plays a role in competence induced cell lysis and has been 
characterised as another hydrolytic enzyme (Steinmoen et al., 2003, Guiral et 
al., 2005, Kausmally et al., 2005). CbpE is also thought to act as a cell wall 
hydrolase also known as lytD and Pce, and has been shown to play a role in 
virulence (Höltje & Tomasz, 1974, De las Rivas et al., 2001, Vollmer & Tomasz, 
2001). PcpA is important for virulence in a mouse model of infection and is 
immunogenic (Glover et al., 2008, Hava & Camilli, 2002). 
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1.6.8 Lipoproteins 
PsaA is one of the many pneumococcal cell surface lipoproteins currently 
identified, with 40-50 known, some with roles in virulence (Overweg et al., 
2000,  Hermans et al., 2006). PsaA will be the only example discussed here. PsaA 
has been shown to be important in pneumococcal adherence to mammalian cells 
in vitro, and antibodies raised against this protein prevent adherence (Briles et 
al., 2000, Romero-steiner et al., 2003, Romero-Steiner et al., 2006, Berry & 
Paton, 2000). Recent studies have indicated it binds directly to E-cadherin 
present on surface of nasopharyngeal cells (Anderton et al., 2007), and can also 
aid in cell invasion (Rajam et al., 2008). Yet its role as an adhesin is contested 
as structural analysis implies that this surface protein would not protrude 
beyond the cell wall. Deletion mutants of this gene are avirulent in a mouse 
model of colonisation, pneumonia and septicaemia (McAllister et al., 2004, 
Tseng et al., 2002, Lawrence et al., 1998). PsaA has been further characterised 
as a component of an ABC transporter specific for manganese yet can also bind 
Zinc, the PsaA component acts as the metal ion binding component (Dintilhac et 
al., 1997, McAllister et al., 2004, Lawrence et al., 1998), and has also been 
shown to play a role in resistance to oxidative stress (Johnston et al., 2004, 
Tseng et al., 2002).The other ABC transporter components include PsaB and 
PsaC, which also show a reduced adherence upon their deletion (Johnston et al., 
2004). The final member of the operon is PsaD which is characterised as a 
putative thiol peroxidase, showing homology to an E.coli thiol peroxidase (Cha & 
Kim, 1996, Novak et al., 1998). This gene is also thought to play a role in 
resistance to oxidative stress as deletion mutants of this gene are hypersensitive 
to hydrogen peroxide (Johnston et al., 2004, Tseng et al., 2002). 
1.6.9 Other  
Pneumococcal adherence and virulence factor A (PavA) is found on the 
pneumococcal cell surface even though it contains no signal sequence or 
membrane anchoring motif (Holmes et al., 2001). One of its main functions has 
been shown to be binding of fibronectin which is found in the ECM surrounding 
host cells, of which It is though to contribute to 50% of the cells fibronectin 
binding capability (Holmes et al., 2001). A role in virulence has been assigned to 
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this protein with mutants showing a reduced virulence in a sepsis and meningitis 
model (Holmes et al., 2001, Pracht et al., 2005). 
1.6.10 Hydrogen peroxide 
The ability of the pneumococcus to produce high concentrations of hydrogen 
peroxide (H2O2) is used to its advantage, whereas in other bacteria H2O2 is 
produced merely as a by-product of aerobic metabolism and is degraded quickly 
via enzymes such as catalase etc to prevent toxic effects to the cell. In the 
pneumococcus H2O2 is produced as a by-product of the enzymatic reaction 
catalysed by SpxB (pyruvate oxidase), which converts pyruvate to acetyl 
phosphate during aerobic metabolism. SpxB produces over 90% of the total 
cellular H2O2 which can equate to 0.5-2mM (Spellerberg et al., 1996, Pericone et 
al., 2003). A small amount of H2O2 is also produced by LctO (lactate oxidase), 
which also functions under aerobic conditions converting lactate to pyruvate, 
which can then be processed by SpxB (Taniai et al., 2008). 
Little is known about the role of LctO in virulence but SpxB has long been 
recognised as a very important virulence factor, partly through production of 
H2O2 and through energy production as this is the main pathway used during 
aerobic metabolism to obtain ATP. ATP is produced by conversion of acetyl 
phosphate (product of SpxB reaction) to acetate via acetate kinase (Pericone et 
al., 2003). The use of H2O2 alone has been shown to be important for killing off 
competition in the nasopharynx due to the high levels produced (Pericone et al., 
2000). Bactericidal effects caused by H2O2 levels produced from the 
pneumococcus are high enough to kill other upper respiratory tract pathogens 
including H.influenzae and N.meningitidis (Pericone et al., 2000, Regev-Yochay 
et al., 2006). In a mouse model of infection spxB mutants are unable to colonise 
the nasopharynx and replicate in the blood and lungs in a mouse model. Analysis 
of in vivo gene expression also indicates spxB expression is higher in the 
nasopharynx therefore clearly plays an important role here (Spellerberg et al., 
1996, Orihuela et al., 2004, LeMessurier et al., 2006). 
Interestingly deletion of SpxB causes the loss of tolerance of the pneumococcus 
to H2O2 and therefore SpxB plays a currently unknown function in protecting 
itself from endogenously produced H2O2 (Regev-Yochay et al., 2007). This 
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phenomenon is thought to be in part due to the reduced ATP levels produced 
upon SpxB deletion which may be required to repair the damage caused by the 
H2O2. This can be backed up as upon deletion of acetate kinase (enzyme 
catalysing the last step in ATP production) spontaneous mutations are observed 
in SpxB (Ramos-Montañez et al., 2010). SpxB is also one of the genes important 
for phase variation as its deletion results in only opaque variants being observed, 
discussed above (Overweg et al., 2000, Ramos-Montañez et al., 2008). 
Hydrogen peroxide has recently been shown to directly oxidise a protein 
involved in fatty acid biosynthesis (FabF), which is important in regulating the 
level of membrane fatty acid saturation (Benisty et al., 2010)). 
1.7 Gene regulation 
To be able to adapt to different environmental conditions and stresses genes 
required in different niches need to be tightly regulated to enable survival, this 
includes regulation of cell surface adhesins and other virulence factors. For this 
a number of different signalling systems and signalling molecules are available in 
bacteria to enable this to happen, some of which are discussed below. 
1.7.1 Two component signal transduction systems (TCS) 
TCS are one of the major signalling systems utilised in bacteria to respond to 
changing environmental conditions, see review Stock et al, 1989. These systems 
are present in almost all bacterial species (bar Mycoplasma species) and can also 
be found in some lower eukaryotes. A prototypical TCS consists of two proteins: 
a membrane bound HK (histidine kinase) and a cytoplasmic RR (response 
regulator). The HK contains a N-terminal sensor domain, which responds to 
certain environmental changes, this domain is often extracellular and is followed 
by a C-terminal kinase domain, which is located within the cell. The second 
protein in a TCS pairs is the RR which is found in the cytoplasm, this protein 
contains a N-terminal receiver domain followed by a C-terminal output domain 
(often DNA binding function) (Stock et al, 1989). Upon recognition of an external 
stimulus by the HK which functions as a dimer, the HK is autophosphorylated in 
trans on a conserved histidine residue, the phosphoryl group is provided through 
ATP hydrolysis via the ATPase activity of the HK (Stock et al, 1989). Post 
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autophosphorylation the phosphate is transferred to a conserved aspartate 
residue on the receiver domain of the RR, which triggers a conformational 
change in the protein, usually modulating its DNA binding activity. This mode of 
action is diagrammatically depicted in Figure 1-5. 
 
Figure 1-5:Schematic diagram of TCS signal transduction 
Diagram modified from Paterson et al., 2006 representing prototypical TCS gene regulation. 
Upon recognition of specified extracellular stimulus the membrane associated HK is 
autophosphorylated. The phosphoryl group is subsequently transferred to its cognate RR 
which undergoes a conformational change enabling it to bind its DNA targets. 
 
HK and RR pairs are usually found in the genome adjacent to each other, in some 
cases the open reading frames overlap, and they are normally transcribed 
together (Lange et al., 1999). The numbers of TCS present in a single species 
varies with none found in Mycoplasma species, 13 in S.pneumoniae, roughly 30 in 
E.coli and B.subtilis, 63 in Pseudomonas aeruginosa and over 100 in Myxococcus 
xanthus (Rodrigue et al., 2000, Jung et al., 2012). Orphan RR have also been 
identified in a number of species, which have no cognate HK (Wang et al., 2009). 
The external stimulus recognised by the HK can range from recognition of short 
peptides, temperature changes, pH changes, recognition of metal ions, 
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antibiotics and recognition of oxygen etc, in many cases the external stimulus 
has not been identified (Perry et al., 2011). These TCS have been shown to act 
as global gene regulators regulating large caches of genes important for survival 
and often regulate genes required for virulence. More recently TCS have also 
been shown to regulate a number of small RNA (sRNA) molecules in a number of 
pathogens, which have been shown to regulate virulence. 
The description of the TCS functioning described above is somewhat simplified 
and other factors have more recently been shown to interact with these 
systems. This includes phosphorylation of some RR on an alternative threonine 
residue by a serine/threonine protein kinase, which has been observed in the 
pneumococcus (this is discussed further below) (Agarwal et al., 2012,  Ulijasz et 
al.,2009). Phosphorylation of orphan response regulators can also occur through 
a HK of a non cognate TCS pair (Wang et al., 2009). In some bacteria HK have 
also been shown to form heterodimers with HK of different TCS pairs, preventing 
signalling (Vincent et al., 2010). However in vivo cross talk between HK and RR 
of different TCS pairs does not occur to enable tight regulation of genes (Boll & 
Hendrixson, 2011). TCS have also been shown to regulate genes in both their 
phosphorylated and non phosphorylated forms, with different caches of genes 
regulated in both forms (Standish et al. , 2007). 
1.7.1.1 TCS in S.pneumoniae 
S.pneumoniae contains 13 TCS pairs and one orphan response regulator (Throup 
et al., 2000, Lange et al., 1999), summarised in Table 1-1. The RR of each TCS 
pair have been grouped based on their amino acid sequence identity to each 
other and RR of different species, the receiver domain of the RR share high 
homology to each other however the output domain (DNA binding domain) varies 
considerably due to their different DNA targets (Lange et al., 1999). The first 
family is classed the OmpR family which includes RR01, RR02, RR04, RR05, RR06, 
RR08, RR10 and ORR, the second family classed AraC contains RR07 and RR09, 
the third family is called LuxR and contains RR03 and RR11 and finally the fourth 
family classed AgrA contains RR12 and RR13 (Lange et al., 1999, Throup et al., 
2000).  
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These large scale studies for initial identification of all TCS in S.pneumoniae also 
showed a large number of these systems play some role in virulence (Throup et 
al., 2000). Interestingly the initial studies into their role in virulence performed 
by Lange et al., 1999 showed no difference in virulence of the RR knockouts 
compared to their parent strain in a mouse model of bacteraemia, except for 
RR02 and RR13 which could not be deleted and RR07 which could not be deleted 
in a virulent strain (Lange et al., 1999). This was contrary to the later study 
conducted by Throup et al., 2000 which showed a role in virulence of RR01, 
RR04, RR05, RR06, RR07, RR08, RR13 and ORR using a mouse model of 
pneumonia, with deletion mutants of the RR being attenuated compared to the 
WT (Throup et al., 2000). In this study RR07 and RR13 could be deleted however 
this is not the case for RR02 which has been shown to be the only vital RR in 
S.pneumoniae, which shares homology to the indispensible RR of B.subtilis, 
S.aureus etc (Fabret & Hoch, 1998, Martin et al., 1999). However HK02 can be 
deleted in the pneumococcus (Throup et al., 2000). Since these studies a large 
amount of effort has been put into assessing what genes each of these systems 
regulate. Some features which have added to the complexity of these studies it 
that they seem to regulate genes in a strain dependant manner, and therefore 
their role in virulence is also strain dependant (Lange et al., 1999, Blue & 
Mitchell, 2003, Hendriksen et al., 2007, Mccluskey et al., 2004). This may be 
why RR07, RR13 could not be deleted in the initial study (Lange et al., 1999). 
What is known currently about each of the TCS and genes they regulate will be 
described below. 
TCS Gene number 
(TIGR4) 
Alternative 
nomenclature 
Role in 
virulence? 
Virulence references 
TCS01 HK SP_1632 
RR SP_1633 
480 Yes (Throup et al., 2000) (Hava & 
Camilli, 2002) 
TCS02 HK SP_1226 
RR SP_1227 
YycFG, MicAB, 
VicRK, WalRK ,492 
Yes (Throup et al., 2000) (Lange et 
al., 1999) 
TCS03 HK SP_0386 
RR SP_0387 
LiaSR, 474 Yes (Rosch et al., 2008) 
TCS04 HK SP_2083 
RR SP_2082 
PnpRS, 481 Yes (Throup et al., 2000) (Mccluskey 
et al., 2004) 
TCS05 HK SP_0799 
RR SP_0798 
CiaRH, 494 Yes (Throup et al., 2000), (Hava & 
Camilli, 2002) (Sebert et al., 
2002) (Ibrahim et al., 2004) 
TCS06 HK SP_2192 
RR SP_2193 
CbpSR, 478 Yes (Throup et al., 2000) 
TCS07 HK SP_0157 
RR SP_0156 
539 Yes (Throup et al., 2000) (Lange et 
al., 1999) (Hava & Camilli, 2002) 
(Lau et al., 2001) 
TCS08 HK SP_0082 
RR SP_0083 
484 Yes (Throup et al., 2000) 
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TCS09 HK SP_0662 
RR SP_0661 
ZmpSR, 488 Yes (Hava & Camilli, 2002) 
(Hendriksen et al., 2007) (Blue & 
Mitchell, 2003) 
TCS10 HK SP_0604 
RR SP_0603 
VncRS, 491 No  
TCS11 HK SP_2001 
RR SP_2000 
479 No  
TCS12 HK SP_2236 
RR SP_2235 
ComDE, 498 Yes (Hava & Camilli, 2002) 
TCS13 HK SP_0527 
RR SP_0526 
BlpRH, SpiR1/2, 
SpiRH, 486 
Yes (Throup et al., 2000) (Lange et 
al., 1999) (Dawid et al., 2007) 
ORR RR SP_0376 RitR, 489 Yes (Throup et al., 2000) (Ulijasz et 
al., 2004) 
Table 1-1: Pneumococcal TCS 
Summary of all the current known pneumococcal TCS, information is provided with regards 
to their role in virulence and alternative names used in the literature. 
 
1.7.1.1.1 TCS01 
TCS01 is one of the systems to date that no information is available for with 
regards to what genes it regulates. However it has clearly been shown to play a 
role in virulence in the initial large scale screens (Throup et al., 2000), and a 
later screen has shown this gene is essential for lung infection (Hava & Camilli, 
2002). 
1.7.1.1.2 TCS02 
TCS02 is the only TCS in the pneumococcus which cannot be deleted and is 
essential (Throup et al., 2000, Lange et al., 1999). Homologues of this system 
are present in a large number of other gram positive pathogen where it is also 
essential (Fabret & Hoch, 1998, Liu et al., 2008, Dubrac & Msadek, 2004, 
Senadheera et al., 2005). Interestingly only the RR is essential in the 
pneumococcus rather than both the HK and RR seen in other pathogens (Throup 
et al., 2000, Martin et al., 1999, Fabret & Hoch, 1998). Due to its requirement it 
has made studies into the genes regulated by TCS02 hard to assess and 
mechanisms used to do this have included over expressing RR02 or reducing its 
expression (Ng et al., 2003, Mohedano et al., 2005). The genes regulated by this 
system were shown to include gene involved in peptidoglycan biosynthesis, fatty 
acid biosynthesis, cell division and some cell surface virulence factors, including 
PspA and PcsB which have been shown to be directly regulate by RR02 through 
binding in its phosphorylated form to their upstream promoter regions (Ng et al., 
2003, Ng et l., 2005, Mohedano et al., 2005). PcsB which is positively regulated 
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by this system is essential and upon its over expression RR02 can be deleted (Ng 
et al., 2003, Ng et al., 2004). This peptidoglycan hydrolase has been shown to be 
important for peptidoglycan biosynthesis and localises to the cell septum where 
it interacts with the cell division proteins (Sham et al., 2011). Mutants 
constructed altering the expression of pcsB or rr02 show clear defects in their 
ability to divide properly (Ng et al., 2004). HK02 has been shown to localise 
throughout the cell periphery (Wayne et al., 2010), contrary to the localisation 
of WalK to the cell septum in B.subtilis (Fukushima et al., 2009). The external 
stimulus of TCS02 is currently unknown but due to the genes regulated by the 
system it is thought to respond to change in the cell wall peptidoglycan 
responding to the presence of certain precursors etc (see review Dubrac et al., 
2008). 
1.7.1.1.3 TCS03 
TCS03 was not shown to play a role in virulence in the initial virulence screens 
but later studies have implicated it in playing a role in virulence. Deletion of 
HK03 in a serotype 4 strain (TIGR4) causes a significant increase in survival of 
infected mice (I.N) compared to the WT (Rosch et al., 2008). This correlated to 
a significant decrease in the number of bacteria present in the nasopharynx and 
blood of infected mice 24 hours post infection (Rosch et al., 2008). Within this 
study one of the genes shown to be regulated by this system was that of the 
pneumococcal pilus, with RR03 shown to bind directly to the rlrA promoter 
(Rosch et al., 2008). RR03 was also shown to be up regulated in the CSF of 
infected rabbits, using a meningitis model of infection (Orihuela et al., 2004). 
More recent studies have further characterised the role of TCS03 with regards to 
its function in the pneumococcus. This TCS has been shown to be important in 
helping protect the bacterial cell during autolysis/ fratricide (Eldholm et al., 
2010). As described above the pneumococcus is naturally competent, during 
competence some of the population autolyse to provide DNA for genetic 
variation etc, which is caused by a number of hydrolytic enzymes (LytA, CbpD, 
LytC) (Johnsborg, et al., 2008, Steinmoen, et al., 2002). Activity of these 
enzymes induces cell envelope stress which triggers activation of TCS03. To 
protect the bacteria from lysis this system regulates a number of genes which 
are important to prevent this occurring (Eldholm et al., 2010). This phenomenon 
is backed by earlier studies which show TCS03 is expressed to a higher level in 
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competent cells rather than non competent cells, protecting this population 
(Dagkessamanskaia et al., 2004). TCS03 has also been shown to be up regulated 
when bacterial cells are subjected to vancomycin, which would also cause cell 
envelope stress, activating this system (Haas et al., 2005). 
1.7.1.1.4 TCS04 
Initial studies into the role in virulence of RR04 were conflicting, although the 
Lange study showed no attenuation during a bacteraemia model of infection it 
did show a clear growth defect in vitro (Lange et al., 1999), later studies by 
Throup et al., 2000 identified this as an important virulence factor required 
during a pneumonia model of infection (Throup et al., 2000). Later studies 
looking at the role of this TCS in virulence suggested it plays a strain specific 
role in virulence, with attenuation during a pneumonia and bacteraemia model 
of infection only observed in a serotype 4 TIGR4 strain (Not serotype 2/3) 
(Mccluskey et al., 2004). Gene expression analysis was also performed in this 
study to characterise the genes regulated by this system, which was shown to 
also be strain specific. In the serotype 2 background (D39) genes regulated by 
this system included TCS05 and a serine protease HtrA (Mccluskey et al., 2004). 
In a serotype 3 background (0100993) genes regulated included RR08 and a 
number of PTS (phosphotransferase system) genes (Mccluskey et al., 2004). In 
the serotype 4 strain (TIGR4) some of the genes regulated included that of a 
manganese ABC transporter made up of PsaA, PsaB and PsaC, which is down 
regulated upon deletion of RR04 (Mccluskey et al., 2004). This ABC transporter 
has been shown to play a role in virulence in the pneumococcus (Dintilhac et al., 
1997, Berry & Paton, 1996, Ogunniyi et al., 2000, Marra et al., 2002). 
Homologues of this system in other bacteria have been shown to respond to 
divalent cations, which is hypothesised to be the external stimulus that activates 
this system (Groisman, 2001). 
1.7.1.1.5 TCS05 
TCS05 was the first characterised TCS in the pneumococcus (Guenzi et al., 
1994). This system is also called CiaRH (competence induction and altered 
cefotaxime susceptibility) after some of the phenotypes observed upon its 
deletion (Guenzi et al., 1994, Guenzi & Hakenbeck, 1995). This TCS has 
therefore been associated with repressing competence, protecting the cell from 
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#-lactam antibiotics and protecting the cell for autolysis (Guenzi & Hakenbeck, 
1995, Giammarinaro et al., 1999, Lange et al., 1999, Dagkessamanskaia et al., 
2004, Zähner et al., 2002, Mascher et al., 2006, Echenique et al., 2000). The 
genes regulated by this system have been well characterised which include 
repression of the genes required for competence development and positive 
regulation of HtrA (High temperature requirement protein A) (Mascher et al., 
2003, Sebert et al., 2002). Further the genes directly regulated through binding 
of RR05 to the upstream promoter have been identified (Halfmann et al., 2007), 
which has been shown to include a number of sRNA molecules and is the first 
study in the pneumococcus showing sRNAs regulated by a TCS (Halfmann et al., 
2007). Homologues of this system in other streptococci have been shown to also 
regulate sRNAs suggesting they may play an important role in survival as they are 
conserved (Marx et al., 2010). One other factor shown to be differentially 
regulated by this system is the pneumococcal pilus which upon deletion of this 
TCS is down regulated (Sebert et al., 2002), however this has not been further 
validated by any other methods and the pilus was not found to be directly 
regulated via RR05 (Halfmann et al., 2007). 
This system has been clearly shown to play a role in virulence through the initial 
screens and later studies, which show a clear role of the genes regulated by this 
system in aiding colonisation and systemic infection (Marra et al., 2002, Throup 
et al., 2000, Sebert et al., 2002). Upon contact of bacterial cells with Detroit 
562 cells this system is up regulated (Orihuela et al., 2004). The reduced 
virulence phenotype observed in a RR05 deletion mutant has been shown to be 
due to the reduced expression of HtrA, as deletion RR05 and HtrA show similar 
virulence phenotypes and over expression of HtrA in a RR05 mutant restores 
virulence (Ibrahim et al., 2004). HtrA has also been shown to post 
transcriptionally regulate bacteriocin activity, linking this system to that of 
TCS13 also (Dawid et al., 2009), and is the factor which modulates competence 
induction (Sebert et al., 2005). Upon deletion of a global gene regulator (serine/ 
threonine protein kinase) this system is down regulated suggesting this TCS may 
also be controlled by an alternative kinase (Saskova et al., 2007). This system is 
also down regulated in a RR04 mutant suggesting this system may regulate TCS05 
(Mccluskey et al., 2004). 
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1.7.1.1.6 TCS06 
TCS06 was one of the systems shown to be important for virulence (Throup et 
al., 2000), further studies have validated this with a decrease adherence 
observed to Detroit 562 and A549 cells upon deletion of either the HK or RR in a 
serotype 2 strain (D39) (Standish et al., 2005). Interestingly these strains when 
assessed in a mouse model of infection (I.N) showed in some instances opposite 
effects of the HK and RR mutants. In the RR mutant bacteria counts in the lung, 
blood and nasopharynx were statistically higher than the WT (Standish et al., 
2005). TCS06 has also been linked to biofilm formation as a mutant in HK06 
shows a reduced biofilm formation. Two virulence factors that are regulated by 
TCS06 including RlrA/ RrgA (pilus proteins) and CbpA showed a similar reduction 
in biofilm formation when containing transposon insertions (Muñoz-Elías et al., 
2008). 
This system has also been designated CbpS/R as the important adhesin CbpA 
(PspC) is located directly upstream of this TCS and regulates this genes (Standish 
et al., 2005). RR06 is able to bind directly to the promoter upstream of CbpA, 
which has been shown to occurs when RR06 is in its non phosphorylated form 
(Standish et al., 2005, Standish et al., 2007). Interestingly although this TCS 
contain a cognate HK it is also phosphorylated on a threonine residue by a 
serine/ threonine protein kinase, which has been shown to modulate its affinity 
for binding to the CbpA promoter region (Agarwal et al., 2012). Other genes 
have also been shown to be regulated by this systems this includes the virulence 
factors PspA which is repressed upon over expression of RR06 in D39. This 
repression has been shown to occur when RR06 is in its phosphorylated form 
(Standish et al., 2007). Another virulence factor regulated by this TCS is the 
pneumococcal pilus which is up regulated upon deletion of HK06, the RR has 
been shown to bind directly to the rlrA promoter region (Rosch et al., 2008). 
1.7.1.1.7 TCS07 
TCS07 is another system that has not been characterised with regards to the 
genes it regulates. This TCS however has been shown to play a role in virulence 
(Throup et al., 2000, Hava & Camilli, 2002, Lau et al., 2001). 
1.7.1.1.8 TCS08 
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TCS08 was also one of the TCS shown to play a role in virulence in the initial 
screens performed (Throup et al., 2000). Although this has not been further 
validated in a mouse model of infection deletion of TCS08 has been shown to 
affect the ability to adhere to A549 cells (Song et al., 2009). TCS08 has also 
been linked to phase variation with the two variant showing different virulence 
capabilities as described above, RR08 is down regulated in opaque variant 
compared to transparent (Trappetti et al., 2011). Studies have also been 
performed into the genes that are regulated by this TCS with initial studies in a 
serotype 2 stain (R6) showing this TCS regulates solely a number of genes 
important for cellobiose metabolism including a PTS (Mckessar & Hakenbeck, 
2007). Deletion of TCS08 renders the mutants unable to utilise this as a carbon 
source. However it is unlikely that the pneumococcus would come across 
cellobiose in the host and it is thought these systems recognise structural 
analogues of cellobiose (#-glucosides) which may be derived from the breakdown 
of host ECM proteins (see review King, 2010). Studies of the role of this TCS in a 
serotype 4 strain TIGR4 showed a different collection of genes to be regulated 
by this system, which again may suggest this system acts in a strain dependant 
manner (Song et al., 2009). Included was that of genes encoded on the pilus 
islet, which were up regulated upon deletion of RR08 (Song et al., 2009). 
1.7.1.1.9 TCS09 
In the initial virulence screen TCS09 was not shown to play a role in virulence 
however further studies suggested RR09 was essential during pneumonia (Throup 
et al., 2000, Hava & Camilli, 2002). Further characterisation of its role in 
virulence showed like RR04 it played a strain specific role in virulence (Blue & 
Mitchell, 2003). Deletion of RR09 in a serotype 2 (D39) background rendered the 
strain avirulent when administered via the I.P, I.N and Intravenous (I.V) route in 
a mouse model of infection (Blue & Mitchell, 2003). Conversely deletion of RR09 
in a serotype 4 (TIGR4) and serotype 3 (0100993) background strains rendered 
them attenuated via the I.N route of administration only, this was attributed to 
the inability of the strains to disseminate into the blood rather than an inability 
to grow in the lungs (Blue & Mitchell, 2003). Evaluation of the genes regulated 
by these systems showed this system also regulates genes in a strain dependant 
manner as only 7 genes were found to be commonly regulated by this TCS in D39 
and TIGR4, from the 102 and 80 found to be differentially regulated respectively 
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(Hendriksen et al., 2007). Genes regulated by RR09 in TIGR4 included that of the 
pilus islet genes, which were up regulated upon its deletion, PspA was down 
regulated upon its deletion. In D39 the genes encoding TCS12 were up regulated 
upon RR09 deletion, the serine protease HtrA was down regulated as well as a 
number of PTS encoding genes (Hendriksen et al., 2007). 
1.7.1.1.10 TCS10 
TCS10 has not been shown to play a role in virulence in the large scale screens 
(Lange et al., 1999, Throup et al., 2000). HK10 was shown to be up regulated 
upon contact with Detroit 562 cells and in the blood of infected mice (Orihuela 
et al., 2004). Early studies into the role of this system indicated it played a role 
in vancomycin tolerance as it lies directly downstream of genes shown to be 
important for this function, and may also play a role in autolysis (Novak et al., 
1999, Novak et al., 2000). However this has been revised and TCS10 was shown 
to not regulate the upstream genes important for vancomycin tolerance (Haas et 
al., 2004, Robertson et al., 2002). Upon deletion of RR10 an up regulation of 
some of the genes present on the pilus islet was observed, however this was not 
confirmed via any other methods (Haas et al., 2004). HK10 was one of the genes 
found to be down regulated upon deletion of the ORR and therefore may be 
regulated by this system (Ulijasz et al., 2004). 
1.7.1.1.11 TCS11 
TCS11 is one of the least well studied TCS. Currently no genes have been 
indentified that are regulated by this TCS. This system was also not identified to 
play a role in virulence in any of the large scale virulence screens so it may not 
regulate genes important for virulence. However this system has been found to 
be up regulated when cells are subjected to vancomycin stress (Haas et al., 
2005). Upon deletion of ORR this TCS was down regulated which may imply this 
system is also regulated by the ORR (Ulijasz et al., 2004). 
1.7.1.1.12 TCS12 
Early studies have suggested TCS12 to play a role in virulence showing HK12 is 
essential during pneumonia (Hava & Camilli, 2002), further studies have 
validated its role in virulence  where peptide inhibitors able to block TCS12 
activation cause an increased survival in infected mice (Zhu & Lau, 2011), 
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conversely alternative studies have suggested a fitness advantage upon deletion 
of TCS12 (Kowalko & Sebert, 2008). With regards to the function of this system 
this is one of the most well characterised. This system is known to function to 
allow natural competence development, allowing DNA uptake from the 
environment to allow horizontal gene transfer and genetic variation (Johnsborg, 
et al., 2008, Steinmoen, et al., 2002), which is discussed in section 1.5.1. Briefly 
this system has a know activation stimulus which is that of a small peptide 
named CSP encoded on a gene located upstream of the TCS (Havarstein et al., 
1996, Havarstein et al., 1995, Pestova et al., 1996). Genes regulated by this 
system include those important for DNA uptake and processing to allow 
recombination as well as positively regulating itself (Peterson et al., 2004). 
Some of the genes regulated by this system include some virulence factors (cell 
wall hydrolyses, LytA/ CbpD) which are important for inducing fratricide in a 
population of cells (Guiral et al., 2005, Kausmally et al., 2005), this phenomenon 
is also linked to TCS03 as described in section 1.7.1.1.3. 
This system has also been linked to the function of TCS05, which is known to 
repress competence (Dagkessamanskaia et al., 2004, Guenzi et al., 1994, 
Giammarinaro et al., 1999, Sebert et al., 2005), and plays an important role in 
autolysis which is important during competence for fratricide, discussed above. 
This system is also highly up regulated in a serine/ threonine protein kinase 
mutant, however a reduced expression of TCS05 is also observed in this mutant 
and therefore this may be due to a knock on effect of this, as TCS05 represses 
TCS12 expression (Saskova et al., 2007). RR12 and RR13 are the only two 
members of the AgrA family and both are activated in response to small 
peptides. This may not be surprising as they have been shown to converge in 
some instances on the same promoter and regulate the same gene (Knutsen et 
al., 2004). A number of the genes regulated by TCS13 have also been shown to 
be induced upon early competence development (Peterson et al., 2004). 
1.7.1.1.13 TCS13 
TCS13 was initially thought to be essential as knockouts of the system could not 
be obtained (Lange et al., 1999), although this was found not to be the case this 
TCS has been shown to play a role in virulence (Throup et al., 2000, Dawid et 
al., 2007). This TCS is most similar in aa sequence to TCS12 and is similar in that 
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it is activated by a small peptide encoded by blpC located directly downstream 
of the blpR/blpH encoded TCS (De Saizieu et al., 2000). Directly downstream of 
blpC there are also two genes blpA/ blpB which encode an ABC transporter 
required for BlpC export, which is homologous to the ComA/comB export system 
required for transport of CSP (De Saizieu et al., 2000). Recent studies of strains 
that do not contain a functional BlpA are unable to transport BlpC, however the 
system can still be activated by exogenously produced BlpC if other bacteria in 
the population are able to export BlpC (Son et al., 2011). Genes regulated by 
this system include a number of bacteriocin genes and immunity peptides which 
have been shown to be important for inter and intrastrain competition, 
important during colonisation where it has to compete to occupy this niche 
(Dawid et al., 2007, De Saizieu et al., 2000, Lux et al., 2007). The operons 
containing the genes regulated by this system are highly diverse with regards to 
the number of genes present which affects their ability to kill off other 
colonisers, with some strain more equipped to do so (Lux et al., 2007). As 
described above due to the similarity of TCS12 and TCS13 they are able to 
converge to regulate the same gene in some instances (Knutsen et al., 2004). 
This system has also been linked to TCS05 which regulates HtrA a serine 
protease, this protease has been shown to be able to post transcriptionally 
regulate bacteriocin activity in phase variants (Dawid et al., 2009). Transparent 
phase variant have been shown to have no bacteriocin activity yet opaque do, 
with both showing similar transcript levels, upon deletion of TCS05 or HtrA in 
transparent variants bacteriocin activity is restored (Dawid et al., 2009). 
1.7.1.1.14 ORR 
The orphan response regulator is found in the pneumococcal genome without a 
cognate HK (Throup et al., 2000). This RR was also found to be important for 
virulence in the large screens, which was further validated in a later study which 
showed it was important in a lung model of infection (Ulijasz et al., 2004). This 
study also assessed the genes regulated by this system, which included RR10 and 
RR11 of other TCS pairs. Other genes regulated by this system included genes 
required for iron uptake and led to the proposed name of RitR (repressor of iron 
transport) for this system, as it suppresses a number of genes important for iron 
transport (Ulijasz et al., 2004). ORR has also been shown to play a role in 
resistance to oxidative stress through the genes it regulates. The typical 
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aspartate phosphorylation site in RR is missing in this ORR, which is replaced by 
an asparagine residue. However ORR has been shown to be phosphorylated on its 
DNA binding domain (normally occurs on the receiver domain) by a serine/ 
threonine protein kinase, and this is removed by its cognate phosphatase (Ulijasz 
et al.,2009). Further to add to the complexity the cognate phosphatase of the 
kinase can bind directly through a protein-protein interaction with the DNA 
binding domain of ORR which alters its ability to bind to its promoter regions, 
the phosphatase does not bind to the DNA or compete with ORR binding (Ulijasz 
et al.,2009). This protein complex can be broken down via the kinase but how it 
does this is still unknown (Ulijasz et al.,2009). Other orphan response regulators 
in other bacteria have been shown to be phosphorylated through HK of a non 
cognate TCS pair but to date this has not been observed for ORR (Wang et al., 
2009). 
1.7.2 Serine/ threonine protein kinases 
The use of ESTPK (Eukaryotic-like serine threonine protein kinases) as global 
gene regulator in prokaryotes is currently being elucidated. It was previously 
thought that the mode of signal transduction in bacteria was distinct from that 
in eukaryotes with TCS as described above acting to regulate gene expression 
changes required for adaptation to environmental changes. Whereas in 
eukaryotes signalling normally occurs via signalling cascades made up of 
serine/threonine and tyrosine kinases and their cognate phosphatase. The recent 
discovery of ESTPK in a large number of bacteria has revised this role, which 
share roughly 35% sequence identity to their eukaryotic homologues (see review 
Burnside & Rajagopal, 2012). In prokaryotes these kinases typically consist of a 
N-terminal kinase domain and C-terminal PASTA (Penicillin binding protein and 
serine/threonine kinase associated domain) domains, which can range in number 
from 1-5. S.pneumoniae StkP contains four PASTA domains, S.agalactiae Stk1, 
S.pyogenes SP-STK, S.mutans PknB and S.aureus Stk1 contain three PASTA 
domains and E.faecalis PrkC contains five PASTA domains (see review Burnside & 
Rajagopal, 2012). The PASTA domains are extracellular domains and are thought 
to act to recognise a certain extracellular stimuli. In most instances the stimulus 
is unknown but PASTA domains function to bind unlinked peptidoglycan in PBPs 
(penicillin binding proteins) and this is also the case for PrkC in B.subtilis (Shah 
et al., 2010, Gordon et al. 2000, Maurer et al. 2012). The PASTA domains of StkP 
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in S.pneumoniae have been shown to bind to synthetic peptidoglycan which 
activates the kinase, this is also observed upon incubation with the #-lactam 
ampicillin which binds to the PASTA domains (Maestro et al. 2010, Beilharz et al. 
2012). 
ESTPK are often found adjacent to a STP (protein phosphatase) which function in 
unison with the kinase to dephosphorylate proteins phosphorylated by the kinase 
(Ulijasz et al. 2009). In most bacterial species only a single ESTPK and STP pair 
have found, some exceptions to this are M.tuberculosis which contains 11 ESTPK 
yet only PknB contains extracellular PASTA domains (see review Av-gay & 
Everett, 2000). Some S.aureus strains also contain two ESTKP (Didier et al., 
2010). 
Unlike TCS ESTPK do not contain a DNA binding domain to directly modulate 
gene expression and alter gene expression in a number of other ways discussed 
below. These kinases have however been shown to alter the expression of large 
caches of genes in a number of bacteria this includes S.pneumoniae, S.aureus, 
S.pyogenes and S.mutans (Banu et al., 2010, Bugrysheva et al., 2011, Donat et 
al., 2009, Burnside et al., 2010, Saskova et al., 2007).  
One mode of action through which ESTPK regulate large numbers of genes is via 
phosphorylating RR of TCS pairs, which in turn effects their DNA binding to gene 
targets. Some examples of this include the CovR/S TCS in S.agalactiae. CovR RR 
is normally phosphorylated on an aspartate residue which increased its affinity 
for its DNA targets (Lin et al., 2011, Lamy et al., 2004, Jiang et al., 2005). 
However Stk1 is able to phosphorylate CovR on a threonine residue which 
reduced its affinity for its DNA targets (Lin et al., 2011). In S.pyogenes its CovR 
homologue is also phosphorylated by its ESTPK (ST-STK) on a threonine residue 
(Agarwal et al., 2011), ST-STK also phosphorylates another RR in S.pyogenes that 
of WalR of the WalR/K TCS (Agarwal et al., 2011). This phenomenon is also 
observed in the pneumococcus as its ESTPK (StkP) phosphorylates the orphan 
response regulator known as RitR (Ulijasz et al. 2009), and also RR06 is 
phosphorylated on a threonine residue which increased its binding affinity to its 
DNA target (Agarwal et al. 2012). ESTPK also regulate other transcription 
regulators which modulate gene expression changes. This includes SarA from 
S.aureus which has over 100 known gene targets (Chien et al., 1999, Cheung et 
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al., 2008), which upon phosphorylation by Stk1 on a threonine residue increases 
its binding to its DNA targets four fold (Didier et al., 2010). EmbR transcription 
regulator in M.tuberculosis is also a target of PknH (ESTPK) which again 
enhances its ability to bind to promoter DNA (Sharma et al., 2006b), 
interestingly EmbR can also be phosphorylated by alternative kinases in 
M.tuberculosis including PknA and PknB (Sharma et al., 2006a, Sharma et al., 
2006b). 
ESTPK can also act to regulate gene expression through modification of histone 
proteins. These proteins upon DNA binding can modify the DNA structure and 
stop other regulatory proteins from binding (see review Dorman & Deighan, 
2003). In E.coli DNA binding like histone proteins can effect expression of 8% Of 
the genes in the genome (Oberto et al., 2009). In S.pyogenes SP-STK is able to 
phosphorylate a histone protein, which is thought to contribute to regulation of 
certain virulence factors (Jin & Pancholi, 2006), this phenomenon is also 
observed in S.aureus (Burnside et al., 2010).  
Another hypothesised function of ESTPK with regards to transcription regulation 
is via phosphorylating RNA or DNA polymerase. In L.monocytogenes PrkA (ESTPK) 
has been shown to interact with the alpha subunit of DNA polymerase and the 
alpha and beta subunit of RNA polymerase, but how this may alter genes 
expression in this bacterium is unknown (Lima et al., 2011). Initial studies into 
the protein targets of StkP in the pneumococcus also indicated it was able to 
phosphorylate RNA polymerase however further studies were unable to validate 
this (Novakova et al., 2005, Novakova et al., 2010). 
Finally ESTPK can alter translation through phosphorylation of elongation factors 
which play a vital role in protein biosynthesis. Phosphorylation of elongation 
factors has been observed in a number of bacteria including L.monocytogenes, 
B.subtilis and M.tuberculosis (Absalon et al., 2009, Sajid et al., 2011, Lima et 
al., 2011, Archambaud et al., 2005, Shah & Dworkin, 2010). In M.tuberculosis 
this causes an overall decrease in protein synthesis which can lead to dormancy 
(Sajid et al., 2011), in B.subtilis this phenomenon regulates spore germination 
(Shah & Dworkin, 2010, Shah et al., 2010). 
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With regards to their role in virulence ESTPK regulate a number of virulence 
factors in different bacterial species. In S.agalactiae deletion of the kinase and 
phosphatase lead to a reduction in virulence of 25-100 fold in a neonatal rat 
sepsis model, perhaps due to Stk1s positive regulation of its toxin #-hemolysin 
(Rajagopal et al., 2003, Rajagopal et al., 2008). Toxins are also regulated by SP-
STK in S.pyogenes (Jin & Pancholi, 2006) and by Stk1 in S.aureus, which play a 
role in virulence (Burnside et al., 2010, Débarbouillé et al., 2009, Donat et al., 
2009, Tamber et al., 2010). In S.mutans deletion of PknB leads to production of 
weaker biofilms and increased sensitivity to cellular stresses (oxidative/ 
osmotic/ pH) (Banu et al., 2010, Hussain et al., 2006, Zhu & Kreth, 2011). In the 
pneumococcus deletion of StkP leads to increased sensitivity to oxidative stress 
and heat, a reduction in transformation efficiency and reduced virulence in a 
mouse model of infection (Echenique et al. 2004, Saskova et al. 2007). Further 
PknB in M.tuberculosis is essential (Fernandez et al., 2006, Kang et al., 2005, 
Sassetti et al., 2003). 
1.7.3 Small RNAs 
The role of sRNA (small RNAs) in gene regulation in bacteria is currently at the 
forefront of research. New technology has enabled better identification of these 
small regulators for instance by tiling array and RNA-seq analysis and a number 
of internet prediction tools exist, enabling large scale studies to be performed 
(Rieder et al, 2012, Sharma & Vogel, 2001, Livny & Waldor, 2007). sRNA can 
function in a number of ways to alter gene expression/ translation, which are 
described below.  
One mode of sRNA regulation is through cis-encoded 5’UTR of mRNA, these 
sequences found upstream of the ATG start codon can function to prevent 
translation via blocking the ability of the ribosomes to bind. In a number of 
pathogens these 5’UTR act as thermometers where at certain temperatures this 
region is in a closed structure, preventing ribosome binding as it has formed a 
secondary structure, however upon increased temperature or vice versa the 
secondary structure is removed and translation initiation occurs (Giuliodori et 
al., 2010). The first discovered was that of lcrF mRNA in Yersinia pestis encoding 
a transcription activator (Hoe & Goguen, 1993, Bohme et al., 2012), further 
examples include prfA mRNA in L.monocytogenes which at temperatures below 
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37°C translation of the genes is blocked yet above these temperature translation 
can occur, PrfA is a transcription factor and regulates a number of genes 
involved in virulence (Johansson et al., 2002). These sRNA can also be regulated 
via binding of small metal ions or change in structure due to altered pH (see 
review Breaker, 2012). One example includes gpbA mRNA in V.cholerae which 
functions as a cell surface adhesin, this gene is regulated via the binding of 
cyclic diguanosine monophosphate (Kirn et al., 2005, Sudarsan et al., 2008). 
A large number of sRNA act through base pairing to the mRNA it regulates. These 
sRNA are either cis-antisense RNA which means they are encoded on the 
opposite strand to the gene that is being regulated and is transcribed alongside 
it. However trans encoded sRNA also exist which are transcribed from a region 
that is not linked to the gene it regulates. These elements are not likely to be 
perfect repeats of the mRNA it binds to and therefore form weaker interactions 
(Thomason & Storz, 2011). Again these sRNA have been linked to roles in 
virulence, both M.tuberculosis and Salmonella typhimurium contain cis-
antisense RNAs which can modulate virulence (Lee & Groisman, 2011, Padalon-
brauch et al., 2008, Gong et al., 2011, Arnvig & Young, 2012, Arnvig & Young, 
2009). This is also the case for trans-acting RNA, some examples of these factors 
modulating virulence can be seen in S.aureus, S.pyogenes, L.monocytogenes, 
S.typhimurium etc (Klenk et al., 2005, Toledo-Arana et al., 2009, Chevalier et 
al., 2010, Morfeldt et al., 1995, Padalon-brauch et al., 2008, Roberts & Scott, 
2007). 
Some trans-acting sRNAs require Hfq proteins, which function as sRNA binding 
proteins and act as a chaperone for the sRNA. These Hfq dependant sRNA have 
been well characterised in gram negative pathogens and are highly abundant, 
constituting the largest group of post transcriptional regulators (Sobrero & 
Valverde, 2012). Hfq proteins have currently not been identified in pathogenic 
streptococci so will not be discussed further here.  
sRNA can also function through direct binding to proteins which modulates their 
function, some examples of this activity include binding of sRNA to RNAP (RNA 
polymerase) in E.coli which can modulate the cache of genes the RNAP 
recognises (Cavanagh et al., 2012, Wassarman & Storz, 2000). These also 
function via modulating the activity of other RNA binding proteins which again 
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have clearly been shown to modulate virulence in a number of bacterial species 
(Fortune et al., 2006, Lenz et al., 2004, Rasis & Segal, 2009, Brencic et al., 
2010). 
As stated above a number of these sRNA are regulated by TCS further adding to 
the complexity of signalling networks. Conversely sRNA have also been shown to 
positively regulate TCS, for example translation is prevented of the PhoP/Q TCS 
in E.coli via base paring of the micA sRNA to phoP/Q mRNA (Coornaert et al., 
2011). This type of regulation is also seen in other TCS which form a feedback 
loop with the sRNA, with the TCS being controlled by and controls the sRNA 
(Guillier & Gottesman, 2008, Tu et al., 2010). 
Until recently in the pneumococcus only a small number of regulatory RNAs had 
been discovered (Kumar et al., 2010, Halfmann et al., 2007, Tsui et al., 2010), 
and little work had been done to assess the role of these sRNA in virulence. As 
described above one of the TCS was shown to regulate five sRNA with two found 
to be important for autolysis (Halfmann et al., 2007). The most recent studies 
have identified further sRNA in the pneumococcus with a total of 88-89 
identified (Mann et al., 2012, Acebo et al., 2012), the large number would 
suggest these like in other bacteria may play a key role in virulence gene 
regulation. Upon deletion of a number of these sRNA a number showed clear 
alterations in virulence, 26 were identified to be important for colonisation, 18 
were important during bacteraemia and 28 were important for lung infection 
(Mann et al., 2012), this is currently the most comprehensive study into the role 
of sRNAs in virulence in the pneumococcus and gives an insight into the genes 
that are regulated by these sRNAs. 
1.7.4 Other 
Other transcription regulators have been shown to also play key role in gene 
regulation and virulence in S.pneumoniae. A large number were found to be 
important in the large virulence screens (Hava & Camilli, 2002). Some of the 
better studied regulators are summarised in Table 1-2:, however due to their 
large numbers will not be discussed here in further detail. 
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Transcription 
regulator 
Function Role in virulence 
PsaR Manganese uptake/ virulence factor 
regulation 
(Hendriksen et al., 
2009) 
(Johnston et al., 
2006) 
CodY Amino acid metabolism/ iron uptake/ 
carbon metabolism. 
(Hendriksen et al., 
2008a) 
GlnR Glutamate and Glutamine metabolism. (Hendriksen et al., 
2008) 
RegR Competence regulation/ virulence factor 
regulation 
(Chapuy-regaud et 
al., 2003) 
Rgg Resistance to oxidative stress (Bortoni et al., 
2009) 
Table 1-2: pneumococcal transcription regulators 
Some example of pneumococcal transcription regulators which are important for virulence 
or regulate genes that are biologically important.  
 
Other modes of regulation occur which have not been well studied in the 
pneumococcus, examples include protein to protein interactions such as that of 
the pilus islet transcription regulation RlrA and adhesin RrgA, which can 
modulate expression levels of the islet (Basset et al., 2011, Basset et al., 2012). 
Post transcriptional regulation of bacteriocin activity is also modulated by HtrA 
in opacity variants perhaps through its protease activity (Dawid et al., 2009). 
Hydrogen peroxide has also been shown to be able to modulate fatty acid 
biosynthesis through oxidising FabF (Benisty et al., 2010). 
1.8 Aims of this study 
The aim of this study was to evaluate some of the key regulatory pathways used 
in the pneumococcus to modulate gene expression changes to environmental 
cues.  
This includes assessing the role of two-component signal transduction systems in 
virulence gene regulation. A number of the systems have been shown to regulate 
each other and their functions are often intertwined, with some systems shown 
to regulate the same genes. Therefore we wished to evaluate whether these 
systems are able to compensate for the deletion of another and whether a 
hierarchy exists between the systems. Analysis of this was performed using 
microarrays to assess the whole genome expression changes in single and double 
TCS mutants. 
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The serine/ threonine protein kinase is another signalling system used in the 
pneumococcus to modulate gene expression changes. We therefore also wanted 
to evaluate this system with regards to the genes it regulates. This kinase 
contain four extracellular sensing domains which are thought to recognise the 
extracellular stimulus, therefore the function of the kinase when one of these 
domains was deleted was also evaluated to assess how this affected its ability to 
modulate gene expression changes. 
Often for the above systems the environmental cue is not known. So a final aim 
was to assess the effect key environmental changes may have on expression of 
cell surface virulence factors. This includes looking at the role hydrogen 
peroxide plays in modulating cell surface constituents.  
  
 
 
 
 
 
 
 
 
2 Materials and Methods 
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2.1 Bacterial growth conditions and storage 
S.pneumoniae were grown on BAB (Blood agar base, Oxoid, UK) supplemented 
with 5% Horse blood (E&O laboratories) at 37°C. Throughout BAB will refer to 
that supplemented with 5% horse blood. Purity of culture was checked by placing 
an optochin disc (Mast diagnostics, UK) on the area streaked with S.pneumoniae 
prior to incubation. For S.pneumoniae strains requiring media supplemented 
with antibiotics, concentrations used can be found in Table 2-1.  For liquid 
culture and culture storage a single S.pneumoniae colony was inoculated into 
BHI broth (Brain heart infusion broth, Oxoid, UK) and grown statically to mid log 
(OD600nm 0.6), 15% sterile glycerol was added and 1ml culture aliquotes stored at 
-80°C (Aaberge et al. 1995). For strains grown anaerobically strains were grown 
in BHI broth in an anaerobic cabinet. All S.pneumoniae strains used in this study 
are shown in Table 2-2. 
E.coli strains were grown from a single colony on LB agar (Luria Bertani agar, 
Sigma- Aldrich, UK) or in LB (Luria broth, Sigma-Aldrich, UK) (unless otherwise 
stated) containing the appropriate antibiotic (Table 2-1) at 37°C with shaking 
200rpm. For storage cultures were centrifuged at 4000g for 5 minutes (4K15 
centrifuge, Sigma-Aldrich, UK) and resuspended in LB supplemented with 10% 
glycerol. 1ml aliquots were stored at -80°C. E.coli strains and plasmids used in 
this study can be found in Table 2-4 and Table 2-3 respectively. 
Antibiotic Stock concentration Working 
concentration 
E.coli 
Working 
concentration 
S.pneumoniae 
Ampicillin 100mg/ml 100!g/ml N/A 
Kanamycin 100mg/ml 100!g/ml 400µg/ml 
Chloramphenicol 10mg/ml N/A 10µg/ml 
Spectinomycin 100mg/ml N/A 200µg/ml 
Erythromycin 10mg/ml 1mg/ml 1µg/ml 
Table 2-1: Antibiotic stock and working concentrations used throughout the study. 
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Strain name Parent 
strain 
Description Resistance  
T4NO1 
 
 Serotype 4 TIGR4. Taken one passage from 
strains used in Aaberge et al., 1995. T4NO1 
genome sequence in Tettelin et al. 2001. 
N/A 
T4JH  Serotype 4 TIGR4. N/A 
Xen35  Serotype 4 TIGR4 strain containing luxA-E in 
SP_1914. (Francis et al., 2001, Orihuela et al. 
2003) 
KanR 
T4"stkP T4NO1 Serotype 4 TIGR4 strain containing a transposon 
insertion in stkP (SP_1732). 
SpecR 
T4"spxB T4NO1 Serotype 4 TIGR4 strain containing a transposon 
insertion in spxB (SP_0730). 
SpecR 
T4"lctO T4NO1 Serotype 4 TIGR4 strain with lctO  (SP_0715) 
deleted. 
KanR 
T4"spxB"lctO T4NO1 Serotype 4 TIGR4 strain containing a transposon 
insertion in spxB (SP_0730) and lctO  (SP_0715) 
deleted. 
SpecR/ KanR 
T4"rr06 T4JH Serotype 4 TIGR4 strain with rr06  (SP_2193) 
deleted. 
SpecR 
T4"rr08 T4JH Serotype 4 TIGR4 strain with rr08  (SP_0083) 
deleted. 
ChlorR 
T4"rr09 T4JH Serotype 4 TIGR4 strain with rr09 (SP_0661) 
deleted. (Throup et al. 2000, Hendriksen et al. 
2007) 
EryR 
T4"rr086 T4JH Serotype 4 TIGR4 strain with rr08 and rr06  
(SP_0083/SP_2193) respectively deleted. 
ChlorR/ 
SpecR 
T4"rr096 T4JH Serotype 4 TIGR4 strain with rr08 and rr06  
(SP_0083/ SP_2193) respectively deleted. 
EryR/ SpecR 
T4"rr098 T4JH Serotype 4 TIGR4 strain with rr09 and rr08 
(SP_0661/ SP_0083) respectively deleted. 
EryR/ ChlorR 
T4"rr0986 T4JH Serotype 4 TIGR4 strain with rr09, rr08 and rr06 
(SP_0661/ SP_0083/ SP_2193) respectively 
deleted. 
EryR/ ChlorR/ 
SpecR 
T4"stkP!ST T4NO1 Serotype 4 TIGR4 strain containing a transposon 
insertion in stkP (SP_1732). WT gene with P2 
promoter inserted in SP_1886. 
SpecR/ 
ChlorR 
T4"stkP!XST T4NO1 Serotype 4 TIGR4 strain containing a transposon 
insertion in stkP (SP_1732). Xen35 stkP gene with 
P2 promoter inserted in SP_1886. 
SpecR/ 
ChlorR 
T4P1 T4NO1 Serotype 4 TIGR4 strain with lux genes inserted KanR 
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in SP_1886 under the control of promoter P1. 
T4P2 T4NO1 Serotype 4 TIGR4 strain with lux genes inserted 
in SP_1886 under the control of promoter P2. 
KanR 
T4P3 T4NO1 Serotype 4 TIGR4 strain with lux genes inserted 
in SP_1886 under the control of promoter P3. 
KanR 
T4P4 T4NO1 Serotype 4 TIGR4 strain with lux genes inserted 
in SP_1886 under the control of promoter P4. 
KanR 
T4P19 T4NO1 Serotype 4 TIGR4 strain with lux genes inserted 
in SP_1886 under the control of promoter P19. 
KanR 
Xen35"19 Xen35 Serotype 4 TIGR4 strain containing luxA-E in 
SP_1914. also contains a transposon insertion 
upstream of SP_1915. 
SpecR /KanR 
T4"rrgB T4NO1 Serotype 4 TIGR4 strain with rrgB  (SP_0463) 
deleted. 
KanR 
T4"rlrA T4NO1 Serotype 4 TIGR4 strain with rlrA (SP_0461) 
deleted. 
KanR 
Table 2-2: Names of all S.pneumoniae strains used in this study. 
Table of all S.pneumoniae strains used in this study with their antibiotic profiles. All strains 
unless a reference is given were constructed by the author. T4!rr098 and T4!rr08 were 
constructed by Kanika Kapoor under the supervision of the author. 
 
Plasmid 
name 
Description Resistance Origin 
pCEP2 Plasmid containing 2Kb pneumococcal 
DNA flanking either side (allows 
integration into genome) of a MIP 
(Maltose inducible promoter). 
*AmpR / 
KanR 
(Guiral et al. 2006) 
pCEP2 lux lux genes cloned under the control of 
a maltose inducible promoter. 
*AmpR/ 
KanR 
Generated in TJM lab by 
author Jenny Herbert 
pC2LSD pCEP2 lux plasmid containing a StuI 
restriction site upstream of MIP to 
allow promoter swapping. 
*AmpR/ 
KanR 
Generated in TJM lab by 
author Jenny Herbert 
PCP1 pC2LSD plasmid containing promoter 
P1 in place of the MIP. 
*AmpR/ 
KanR 
Generated in TJM lab by 
author Jenny Herbert 
PCP2 pC2LSD plasmid containing promoter 
P2 in place of the MIP. 
*AmpR/ 
KanR 
Generated in TJM lab by 
author Jenny Herbert 
PCP3 pC2LSD plasmid containing promoter 
P3 in place of the MIP. 
*AmpR/ 
KanR 
Generated in TJM lab by 
author Jenny Herbert 
PCP4 pC2LSD plasmid containing promoter 
P4 in place of the MIP. 
*AmpR/ 
KanR 
Generated in TJM lab by 
author Jenny Herbert 
PCP19 pC2LSD plasmid containing promoter *AmpR/ Generated in TJM lab by 
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P19 in place of the MIP. KanR author Jenny Herbert 
PCP2 ST PCP2 plasmid containing stkP in place 
of the lux genes and ChlorR in place of 
the KanR. 
*AmpR/ 
ChlorR 
Generated in TJM lab by 
author Jenny Herbert 
PCP2 XST PCP2 plasmid containing Xen35 stkP in 
place of the lux genes and ChlorR in 
place of the KanR. 
*AmpR 
/ChlorR 
Generated in TJM lab by 
author Jenny Herbert 
pET-33b Protein expression vector. *KanR N/A 
pET-33bRrgB rrgB gene encoding aa 40-600 cloned 
into pET-33b. 
*KanR Generated in TJM lab by 
author Jenny Herbert 
pR410 Plasmid with KanR cassette flanked by 
IR recognised by MarC9 transposase. 
*AmpR/ 
KanR 
(Prudhomme et al. 
2007) 
pR412 Plasmid with SpecR cassette flanked 
by IR recognised by MarC9 
transposase. 
*AmpR/ 
SpecR 
(Prudhomme et al. 
2007) 
pET-
29bMarC9 
marC9 hyperactive transposase cloned 
into pET-29b. 
*KanR (Lampe et al. 1999) 
Table 2-3: List of plasmids used in this study. 
Table of plasmids used in this study and their parent plasmid origins. * Indicates antibiotic 
added to media for selection in E.coli. 
 
Strain Genotype 
XL1-Blue™  recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´ proAB lacIqZ#M15 Tn10 (Tetr)]. 
BL21(DE3) F– ompT gal dcm lon hsdSB(rB
- mB
-) $(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) 
Stellar™ F–, endA1, supE44, thi-1, recA1, relA1, gyrA96, 
phoA, !80d lacZ" M15, " (lacZYA - argF) U169, " 
(mrr - hsdRMS - mcrBC), "mcrA, #– 
Table 2-4: Genotype of E.coli strains used in this study. 
 
2.1.1 Viable counting of S.pneumoniae frozen glycerol stocks  
At least 24 hours post freezing a vial per strain was thawed at 37°C for 3 
minutes. Mixed well and 20!l removed and serial 10 fold dilutions made in 180!l 
phosphate buffered saline (PBS, Sigma-Aldrich, UK) in a 96 well round bottom 
plate (Miles & Misra 1931), creating dilutions of 10-1 to 10-6. A BAB plate was 
divided into six sections and for each dilution 3x 20 !l was spotted onto 1 
section. Plates were allowed to dry and incubated overnight at 37°C in a candle 
jar. Colonies from each spot were counted and the dilution factor picked which 
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contained roughly 20-100 colonies per spot. From this the CFU/ml (colony 
forming units/ml) can be calculated see Equation 2-1. 
 
Equation 2-1: Equation used to calculate the CFU/ml of S.pneumoniae glycerol stocks. 
 
2.2 Cloning 
2.2.1 Restriction digest 
All restriction enzymes were sourced from NEB (New England Biolabs, UK) and 
used as per manufacturers instructions.  
2.2.2 Polymerase chain reaction (PCR) 
Throughout the study PCR performed for cloning or for sequencing was 
performed using high fidelity DNA polymerase Phusion" (NEB, UK), conditions 
Table 2-6. All other PCRs such as for confirming transformation were performed 
using GoTaq" DNA polymerase (Promega, UK), conditions Table 2-5. For both a 
55°C annealing temperature was kept constant unless otherwise stated. 72°C 
extension time was calculated using the expected PCR product size. For all PCR 
10mM dNTPs and 10mM forward and reverse primers solution were used. All PCRs 
were run in a Flexigene thermal cycler (Bibby Scientific, UK). 
Temperature Time Cycle number 
95°C 2 minutes 1 cycle 
95°C 30 seconds 
55°C 30 seconds 
72°C 1 minute/ Kb 
 
30 cycles 
72°C 5 minutes 1 cycle 
Hold 4°C   
Table 2-5: Program information used when performing PCR with GoTaq"  DNA polymerase. 
Number of colonies spot 1 + spot 2 + spot 3 =  N 
 
N / Divide by Three = A (Average of three spots) 
 
A x 50 =  A50 (gives number/ml) 
 
A50 x dilution factor = CFU/ml 
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Temperature Time Cycle number 
98°C 30 seconds 1 cycle 
98°C 10 seconds 
55°C 30 seconds 
72°C 20 seconds/ Kb 
 
30 cycles 
72°C 5 minutes 1 cycle 
Hold 4°C   
Table 2-6: Program information used when performing PCR with Phusion"  DNA 
polymerase. 
 
2.2.3 Colony PCR 
To screen for S.pneumoniae transformants single colonies were first streaked 
onto a BAB plate and grown for 12 hours to obtain more growth.  Using a pipette 
tip a sweep of bacterial growth was resuspended in 10µl of PCR grade water and 
placed in the microwave (800W microwave) for 2 minutes to lyse the bacterial 
cells. For PCR 1µl from the 10µl is added to a 50µl reaction replacing the 
genomic DNA. 
2.2.4 Agarose gel electrophoresis 
All DNA gels used were at 0.8% (UltraPure™ agarose, Life Technologies, UK) 
unless otherwise stated, containing SYBR"Safe DNA gel stain (Life Technologies, 
UK). Agarose was dissolved and run in 1xTAE buffer (Tris-Acetate EDTA) at 100V 
for 20 minutes. All DNA samples were run alongside 1Kb Plus DNA ladder (Life 
Technologies, UK) to gauge size. Gels were visualized using the UVPro gel doc 
system (UVTech). 
2.2.5 PCR purification/ gel extraction 
PCR purification and gel extraction were performed using the Wizard® SV gel 
and PCR clean up system (Promega) as per the manufacturers guidelines. 
2.2.6 Plasmid purification 
For Plasmid purification E.coli strains were grown in 5ml LB broth overnight, 
centrifuged at 4000g for 5 minutes (4K15 centrifuge, Sigma-Aldrich, UK) to pellet 
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cells and supernatant decanted. The bacterial pellet was processed using the 
QIAprep spin miniprep kit (QIAGEN) as per manufacturers guidelines. 
2.2.7 Ligation 
For ligation the plasmid backbone and PCR product was mixed at a ratio of 2:1 
(Vector (100ng): insert) calculated using the infusion molar ratio calculator 
(http://www.clontech.com/US/Support/xxclt_onlineToolsLoad.jsp?citemId=http
://bioinfo.clontech.com/infusion/molarRatio.do&section=16260&xxheight=750). 
2µl of T4 DNA ligase reaction buffer (10x), 1µl T4 DNA ligase (NEB, UK) were 
added and the reaction made to 20µl with PCR grade water. The reaction was 
incubated for 3 hours at room temperature and then stored at -20°C or 
immediately transformed into XL1-Blue™ chemically competent E.coli.  
2.2.8 In-Fusion cloning 
In-Fusion cloning was used when restriction sites were not available for ligation. 
For In-Fusion cloning plasmid backbone and PCR products were mixed at a ratio 
of 2:1 (Vector (100ng): insert) (In-Fusion molar ratio calculator), to this 2µl of 5x 
In-Fusion HD enzyme Premix (In-Fusion" HD cloning kit, Clontech, USA) was 
added and reaction made to 10µl with PCR grade water. Reaction mix was 
incubated for 15 minutes at 50°C and stored at -20°C until required. 
Transformation was performed into Stellar" competent E.coli cells as per the 
manufacturers guide. 
2.2.9 Transformation into E.coli 
Transformation into E.coli was performed using 50µl of competent cells (Stellar, 
XL1-Blue and BL21(DE3)) as per the manufacturers guide. Purified plasmids were 
transformed using 3-5µl (roughly 100ng/µl) and a volume of 5µl-10µl was used 
for transformation of In-Fusion and ligation reactions. 
2.2.10 Transformation into S.pneumoniae 
Pneumococcal strains to be transformed were grown in 10ml BHI supplemented 
with 1mM CaCl2 until OD600nm 0.07-0.12 was reached. 1ml aliquots were removed 
into sterile 1.5ml eppendorfs and 100ng/ml of competence stimulating peptide 
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(CSP-2) added. Tubes were incubated at 37°C for 15 minutes and then roughly 
1ug of DNA added, samples were then incubated at 37°C for 75 minutes. Samples 
were plated onto BAB containing the appropriate antibiotic to select for the 
transformants. Plates were incubated overnight in a candle jar at 37°C. 
2.2.11 Sequencing 
PCR samples were purified using the Wizard® SV gel and PCR clean up system 
(Promega) and Plasmids using the QIAprep miniprep kit. Samples were sent to 
Source Bioscience, Nottingham, UK for sequencing. Sample and primers were 
supplied at the concentrations required by the company.  
2.2.12 gDNA extraction 
S.pneumoniae strains were grown in 20ml BHI at 37°C to OD600nm 0.6. The culture 
was centrifuged at 4000g for 10 minutes to pellet the cells (4K15 centrifuge), 
the supernatant was removed and pellets froze at -20°C or processed 
immediately. To begin extraction the pellet was resusended in 1ml lysis buffer 
(10mM Tris, 100mM EDTA, 0.5% SDS) and incubated for 1 hour at 37°C.  
Subsequently 20!g/ml proteinase K (Life technologies, UK) was added and 
incubated for 3 hours at 50°C. 20!g/ml RNase A (Life technologies, UK) was then 
added and incubated for 30 minutes at 37°C followed by the addition of an equal 
volume of phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma-Aldrich, UK), and 
samples inverted to mix. Samples were centrifuged at 13,000g for 3 minutes 
(113 centrifuge, Sigma-Aldrich, UK), the upper phase was transferred to a fresh 
tube and to this 0.2 volumes of 10M ammonium acetate (Sigma-Aldrich, UK) 
followed by 600!l of absolute ethanol were added. Tubes were inverted and DNA 
precipitation should be observed, the precipitate was then removed using a 
sterile 200!l pipette tip into a fresh tube. If DNA precipitate cannot be seen 
tubes were centrifuged for 30 minutes at 13,000g (1K15 centrifuge, Sigma-
Aldrich, UK), and the supernatant removed leaving the pellet. DNA pellets were 
air dried at room temperature for 20 minutes and then resuspended in 200!l PCR 
grade water, resuspension was aided by heating at 65°C if required. 
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2.3 Construction of gene knockouts using in vitro 
mariner mutagenesis 
A transposon based mutagenesis method was used for construction of T4"stkP 
and T4"spxB. This method was used as it requires only amplification of the PCR 
product in to which you wish the transposon to insert into. Four plasmidS are 
available for use with this system containing different antibiotic resistance 
cassettes, pR408 Erythromycin, pR410 kanamycin, pR412 spectinomycin, pEMCAT 
chloramphenicol. Each plasmid contains the antibiotic resistance cassette 
flanked by two inverted repeats that are recognized by the MarC9 transposase (a 
hyperactive form of the Himar1 transposase) (Lampe et al., 1996, Lampe et al., 
1999). After incubation of the chosen plasmid, PCR product and transposase 
enzyme the antibiotic resistance cassette flanked by inverted repeats is excised 
from the plasmid and is able to insert into the PCR product at random TA di-
nucleotide repeats. Creating PCR products with insertions at different positions 
along their length, this is transformed into S.pneumoniae giving a pool of 
mutants. Directionality of transposon can be assessed using primer MP128 and 
position along the PCR product length assessed using primer MP127. See Figure 
2-1 and Table 2-9. 
 
Figure 2-1: Schematic diagram representing the key steps during in vitro mariner 
mutagenesis. 
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2.3.1 Transposase purification 
2.3.1.1 Protein expression 
pET-29bMarC9 plasmid was isolated and transformed into BL21(DE3) cells as 
described in materials and methods 2.2.9. An overnight starter culture was 
prepared inoculating a single colony into 10ml LB media and grown at 37°C. 5ml 
of the starter culture was inoculated into 500ml 2xYTmedia (Sigma-Aldrich, UK) 
and grown to OD600nm 0.6 at 160rpm, 37°C. IPTG (Isopropyl %-D-
thiogalactopyranoside, Melford, UK) was subsequently added to a final 
concentration of 1mM and culture grown for a further 2 hours under the same 
conditions. Sample was centrifuged at 5000g at 4°C for 20 minutes (4K15 
centrifuge) and resuspended in 5ml resuspension buffer (Table 2-7), 1ml aliquots 
made and stored at -80°C until purification. 
2.3.1.2 Purification 
One of the 1ml aliquots was thawed and 10µl of 25mg/ml lysozyme (Fluka, 
Sigma-Aldrich, UK) solution added, and incubated at room temperature for 5 
minutes, followed by 1ml of lysis buffer (Table 2-7) and incubated at room 
temperature for 15 minutes. 60µl of 1mg/ml DNase 1 from bovine pancreas 
(Sigma-Aldrich, UK) and 10mM MgCl2 was added and incubated at room 
temperature for 20 minutes. The sample was centrifuged at 12,000g for 2 
minutes at 4°C (1K15 centrifuge) and supernatant discarded. Pellet was washed 
once in 1ml washing buffer (Table 2-7) and centrifuged at 12,000g for 2 minutes 
at 4°C (1K15 centrifuge), supernatant discarded. Pellet was subsequently washed 
twice with 1ml 6M Urea (Fisher Scientific, UK) centrifuged at 12,000g for 2 
minutes at 4°C (1K15 centrifuge) and supernatant discarded. Pellet was 
resuspended in 500µl of column buffer (Table 2-7) centrifuged at 12,000g for 2 
minutes at 4°C (1K15 centrifuge) and supernatant collected. 
A HiTrap™ DEAE FF 5ml column (GE Healthcare, Fisher Scientific, UK) was 
equilibrated with column buffer, 500µl of sample supernatant was loaded onto 
the column at 4°C, followed immediately by 8ml of column buffer. Samples were 
collected manually in 500µl fractions and run on a SDS gel (Figure 2-2) to 
confirm protein presence. Fractions 1-3 were pooled, dialysed in dialysis buffer 
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(Table 2-7) at 4°C while stirring, changing dialysis buffer twice in 8-12 hours. 
Sample was centrifuged at 12,000g 4°C for 2 minutes (1K15 centrifuge) and 
supernatant collected (remove any precipitate). Remaining sample was then 
mixed with an equal volume of 100% glycerol and stored at -80°C. 
Buffer Composition 
Resuspension buffer 20mM Tris-HCl pH 7.6, 25% sucrose, 2mM MgCl2, 1mM DTT, 
1mM Benzamidine 
Lysis Buffer 20mM Tris-HCl pH 7.6, 4mM EDTA, 200mM NaCl, 1% 
Deoxycholic acid, 1% NP-40, 1mM DTT, 1mM Benzamidine, 
0.6mM PMSF (Phenylmethylsulfonyl fluoride) 
Washing buffer 0.5% NP-40, 1mM EDTA 
Column buffer 20mM Tris-HCl pH 7.6, 4M Guanidine/ HCl, 50mM NaCl, 5mM 
DTT, 1mM Benzamidine, 1mM PMSF 
Dialysis buffer 50mM Tris-HCl pH 7.6, 100mM NaCl, 10mM MgCl2, 1mM DTT 
Table 2-7: Buffers used during MarC9 purification. 
 
 
Figure 2-2: Coomassie stained gel of transposase (MarC9) elution fractions. 
Boxed are the three fractions containing the 46kDa transposase MarC9, three fractions were 
pooled and used in later experiments. Left is size in kDa of bands from the SeeBlue"  Plus2 
pre-stained ladder. 
 
2.3.2 Transposase reaction conditions 
Initially the chosen pR plamid was purified using the QIAprep miniprep kit 
(QIAGEN). The desired PCR product amplified and cleaned using the Wizard® SV 
gel and PCR clean up system (Promega). The reaction mixture consisted of 1µg 
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of PCR product, 10µl 2x transposition buffer (Table 2-8), 1µg plasmid DNA, 0.5µl 
transposase and made to 20µl with PCR grade water.  
Buffer Composition 
Transposition buffer 10% glycerol, 2mM DTT, 25mM Hepes pH 7.9, 250µg/ml 
BSA, 100mM NaCl, 10mM MgCl2 
Prepared fresh each time 
Table 2-8: Composition of transposition buffer used in transposase reactions. 
 
The reaction mix was incubated for 6 hours at 30°C, cleaned using the Wizard® 
SV gel and PCR clean up system (Promega) (eluted in 100µl PCR grade water), 
and heated for 10 minutes at 75°C to inactivate the transposase. To the elute 
10µl 10x T4 DNA reaction buffer, 1.5µl 2mM dNTPS, 2µl T4 DNA polymerase 
(3U/µl) (NEB, UK) and 0.5µl 10mg/ml BSA was added and incubated at 16°C for 
30 minutes followed by 75°C for 10 minutes to inactivated the enzyme.  Finally 
2µl of 1mM NAD+ (#-Nicotinamide adenine dinucleotide, NEB, UK) and 4µl E.coli 
DNA ligase (NEB, UK) were added, incubated at 16°C overnight and then stored 
at 4°C until transformation.  
The whole reaction mix was subsequently transformed into an un-encapsulated 
TIGR4 strain due to its increased transformation efficiency as described in 
materials and methods 2.2.10. Transformants were screened using the original 
primers used for amplification of the PCR product (Table 2-9), which would show 
a band size or roughly 1.2kb larger due to transposon insertion. MP127 primers 
were also used in combination with the original primers to show positioning 
within the PCR fragment and MP128 was used for sequencing to assess 
directionality of insertion. 
Once sequencing was confirmed the original primers were used to amplify the 
larger fragment from the un-encapsulated TIGR4 strain. This was then 
transformed into encapsulated T4NO1 creating T4"stkP and T4"spxB, for both of 
which the pR412 plasmid was used giving spectinomycin resistance.  
Also included in Table 2-9 are primers 1917F and 1915R. Transposase reaction 
was also performed on this PCR product and a resulting mutant constructed with 
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the transposon inserting 20 nucleotides upstream of SP_1915. This insertion was 
moved from the unencapsulated T4 strain into Xen35 to assess the insertions 
affects on bioluminescence expression, resulting strain X35"19. This mutant was 
also constructed using plasmid pR412. 
Gene Gene 
number 
Primer 
name 
DNA sequence 5’-3’ size (bp) 
stkP SP_1732 StkPF FL ATGATCCAAATCGGCAAGA 1980 
  StkPR TTAAGGAGTAGCTGAAGTTG  
spxB SP_0730 spxB F ATGACTCAAGGGAAAATTACTG 1776 
  spxB R TTATTTAATTGCGCGTGATTG  
  1917F GATGCAGGAAATACGTCGCTT 1157 
  1915R TTACCTCATGTTTCTTAGATTTTC  
  MP127 CCGGGGACTTATCAGCCAACC  
  MP128 TACTAGCGACGCCATCTATGTG  
Table 2-9: Primers used for construction and confirmation of transposase mutants. 
 
 
Figure 2-3: Example of PCR confirmation of transposon insertion 
In this example a transposon was inserted into stkP. PCR was performed using stkP primer 
pair in Table 2-9. stkP is roughly 2Kb in size and with transposon insertion !stkP is roughly 
3.2Kb as seen on gel. Numbers on left indicate size of bands in the 1Kb+ ladder. 
 
2.4 Construction of gene knockouts using splice overlap 
PCR 
A number of gene knockouts were also constructed by splice overlap PCR, this 
included T4"lctO, T4"rrgB, T4"rlrA, T4"rr08, T4"rr06. For splice overlap PCR 
primers were designed containing approx 20bp of gene specific nucleotides and 
roughly 15bp corresponding to the gene the PCR product is to be joined to. For 
each gene knockout three primer pairs were required, one to amplify the 
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upstream region of the gene to be removed, one for the downstream region and 
one to amplify an antibiotic resistance cassette to replace the gene. For each 
gene knockout the whole gene was removed unless there was any overlap with 
another open reading frame, in this instance a small number of nucleotides 
would remain so as to not perturb the function of surrounding genes. For 
T4"lctO, T4"rrgB and T4"rlrA lctO/ rrgB and rlrA were replaced with a 
kanamycin resistance cassette amplified from the plasmid pR410. For T4"rr08 
rr08 was replaced with a chloramphenicol resistance cassette amplified from the 
strain T4"pspC. For T4"rr06 rr06 was replaced with a spectinomycin resistance 
cassette amplified from the plasmid pR412. Some observations upon growth of 
mutants in BHI indicated the StkP mutants, T4"rr098, SpxB mutants and Xen35 
all seemed to grow slower than the parent strains. Further microscopy indicated 
StkP mutants had an altered morphology showing increased chain length and 
altered septation, which was also observed in Xen35. Mutants containing the 
rr09 deletion also seemed so show smaller colony morphology. 
2.4.1 Construction of single gene knockouts 
Each PCR fragment was amplified individually and PCR purified using the 
Wizard® SV gel and PCR clean up system (Promega). To join the three fragments 
together 1µl of each fragment was added to a PCR reaction using the outermost 
primers indicated by a * in Table 2-10, PCR was performed using an extension 
time that would amplify the correct size band to join all three fragments 
together. Resulting PCR products were run on a 0.8% agarose gel (UltraPure™ 
agarose, Life Technologies, UK) and the band of the correct size gel extracted 
using the Wizard® SV gel and PCR clean up system (Promega). Fragments were 
then transformed into the desired S.pneumoniae strain as described in materials 
and methods 2.2.10, using the correct antibiotic for selection. Transformants 
were screened for using PCR and then sequencing.  
 
Figure 2-4: Example of PCR confirmation of splice overlap PCR gene knockouts 
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In these examples from left to right rrgB, lctO and rr06, the whole gene was replaced by an 
antibiotic resistance cassette. PCR was performed using primer pairs in Table 2-10. Sizes 
corresponding to the expected WT and ! band are shown in Table 2-10. Numbers on left 
indicate size of bands in the 1Kb+ ladder. 
 
Gene 
removing 
Gene 
number 
Primer name DNA sequence 5’-3’ size 
(bp) 
lctO  SP_0715 SP_0715 UPF* TTCGACCAATTCAAGGTTGAGGC 768 
WT- 2.7Kb  SP_0715 UPR ATCCCCAGCTTGAAACTGTCCTCCTCGATT
AAG 
 
"lctO- 2.3Kb  KAN0715 F AGGAGGACAGTTTCAAGCTGGGGATCCGT
TTGA 
795 
  KAN0715 R GGCAATCTGTTTTACTAAAACAATTCATCC
AGTAA 
 
  SP_0715 DWNF GAATTGTTTTAGTAAAACAGATTGCCTCC
ACTG 
766 
  SP_0715 DWNR* AGCTACGCAGGCACCCAGC  
rrgB SP_0463 0462F-25C* CAAGATGGTACTATAACG 1350 
WT- 4.1Kb  0462 R TCCCCAGCTTGGATTTCTCCTTATTCATATC  
"rrgB- 2.9Kb  KANGB-F AGGAGAAATCCAAGCTGGGGATCCGTTTG 795 
  KANGB-R CCTTTCTCTCTTACCTAAAACAATTCATCC
AGTAA 
 
  0464F ATGAATTGTTTTAGGTAAGAGAGAAAGGA
GCCATT 
807 
  0464 R-34R* TTCTGATTGACAACCGTAATCG  
rlrA SP_0461 0460F* ACGTCTGTTATCAAGAATGGTC 834 
WT- 3.2Kb  0460R TGAATTGTTTTAGGTTCATCGTACTGTCT
ACACA 
 
"rlrA- 2.4Kb  KANRL-F TTCGGTAACTCAAGCTGGGGATCCGTTTGA 795 
  KANRL-R GTACGATGAACCTAAAACAATTCATCCAGT  
  0462F ATCCCCAGCTTGAGTTACCGAATCTTAGTTGC 804 
  0462RT-R* CTTCTGTCAAGGTGTATGTCC  
rr06 SP_2193 36O* CTTTAGTGGCAAGTTTGGCTG 878 
WT – 2.1Kb  2194 R N 
GTTCTAGAGCGGTCTCTCCCTTTCTACTA
CCAG 
 
"rr06 – 2.6Kb  Spec06F-N 
TAGAAAGGGAGAGACCGCTCTAGAACTAG
TGGATCC 
1150 
  Spec06R-N 
GGATTTTTTATCATCAATTTTTTTATAATT
TTTTTAATC  
  2192 F N 
TAAAAAAATTGATGATAAAAAATCCTAAAT
TAT 546 
  36P* TTGCATTTTACTAGTCACTTC  
rr08 SP_0083 14Y* ACGATGGCAGGTGAAAACA 356 
WT – 1.45Kb  0082R CAAACAAATTTTTCAG ATCTGTCTCTCCTTTGATAAAA  
"rr08 – 1.6Kb  Chlor08F CAAAGGAGAGACAGAT 
CTGAAAAATTTGTTTGATTTTT 
850 
  Chlor08R ACTTTTTAGTTTCATTTATAAAAGCCAGTC
ATTAGGC 
 
  0084F GACTGGCTTTTATAAATGAAACTAAAAAG 385 
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TTATATTTTGG 
  14Z* GCGACAACTGGGCAATCATCAA  
rr09 SP_0661 R9F* GCGGAGCCGAGTAGGAGATTCTCACC  
WT- 1.5Kb  R9R* TGTAGAAATGACCTGACCAG  
"rr09 – 1.7Kb     
Table 2-10: Primers used for construction of splice overlap PCR gene knockouts. 
Primers and related information used to construct all splice overlap PCR gene knockouts. * 
Indicates primers used for splice overlap PCR. Blue nucleotides indicate region of the 
primer specific to the gene being amplified. !rr09 was not constructed in this study and 
therefore primers stated above are used to amplify and confirm the insertion only. 
 
2.4.2 Construction of double/ triple gene knockouts 
Construction of Double and triple mutants were performed via amplification of 
the " PCR products using the splice overlap primers from the parent strain. 
These were transformed into the desired recipient strain and screened for 
recombination using PCR. 
2.5 Construction of a new bioluminescent strain 
To test the potential metabolic burden of high expression of the lux genes 
(required for bioluminescence) luxA-E were put under the control of different 
strength promoters. For this pCEP2 plasmid was used as it allows chromosomal 
integration of genes cloned into SP_1886 (contained within the plasmid) (Guiral 
et al. 2006). This plasmid contains a maltose inducible promoter with a multiple 
cloning site downstream. Flanking either side of this is 2Kb of pneumococcal DNA 
(SP_1885 and SP_1887) allowing upon transformation integration into the 
pneumococcal genome, the plasmid is unable to replicate in the pneumococcus 
and therefore favors recombination. As to not perturb the function of any of the 
surrounding genes the region containing the maltose inducible promoter 
recombines out a small part of SP_1886, a IS1167 element containing a 
frameshift and is therefore already non functional.  
2.5.1 Cloning lux genes into pCEP2 
Initial cloning steps consisted of cloning the lux genes (luxA-E) into plasmid 
pCEP2 (Figure 2-5) at restriction sites NcoI and BamHI. The lux genes were 
amplified from Xen35 using primers in Table 2-11. Plasmid and lux genes were 
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digested with NcoI and BamHI and subsequently ligated together as described in 
materials and methods 2.2.7. Correct insertion was confirmed by PCR and 
sequencing resulting in the plasmid pCEP2 lux (Figure 2-6). This construct 
contains the lux genes under the control of a maltose inducible promoter 
however when transferred into TIGR4 no bioluminescence was visualized (data 
not shown) implying the promoter was not strong enough to drive expression of 
luxA-E.  
 
Figure 2-5: Plasmid map of pCEP2  
Plasmid map was visulaised in CLC Genomics Workbench 4.5.1. 
 
Primer name DNA sequence 5’-3’ size 
(bp) 
PcepluxF TGCTACCATGGAATTTGGAAACTTTTTGC 5606 
PcepluxR CAAACGGATCCTTAACTATCAAACGCTTCGGTT  
Table 2-11: Primers used for amplification of the lux genes for cloning into pCEP2. 
Primers and related information used for amplification of the lux genes from Xen35 for 
cloning into pCEP2. Light blue and pink region indicates BamHI and NcoI restriction site 
respectively. 
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Figure 2-6: Plasmid map of pCEP2lux. 
Plasmid map of pCEP2lux constructed from plasmid pCEP2 (Figure 2-5) in CLC Genomics 
Workbench 4.5.1. pCEP2lux contains the lux genes from Xen35 between restriction sites 
NcoI and BamHI, constructed using primers in Table 2-11. 
 
2.5.2 Creating a StuI site in pCEP2 lux 
Due to this we wished to remove the maltose inducible promoter and replace it 
for a stronger one. Therefore a StuI restriction site was engineered upstream of 
the maltose inducible promoter allowing complete excision via restriction digest 
with NcoI and StuI. Site directed mutagenesis was performed to create a StuI 
site in pCEP2lux using primers in Table 2-13, with PCR conditions in Table 2-12. 
SDM was performed using 100ng of starting plasmids using high fidelity DNA 
polymerase Phusion" (NEB, UK). Once run 40µl of the reaction was digested with 
DpnI enzyme as per the manufacturers guide at 37°C for 3 hours. The reaction 
was then stored at -20°C until transformed. Transformation was performed into 
XL1-Blue™ competent E.coli and transformants selected for on 100µg/ml 
ampicillin and confirmed by sequencing and restriction digest. Creating plasmid 
pC2LSD. 
Temperature Time Cycle number 
98°C 30 seconds 1 cycle 
98°C 10 seconds 
55°C 30 seconds 
68°C 4.5 minutes 
 
18 cycles 
68°C 10 minutes 1 cycle 
Hold 4°C   
Table 2-12: PCR program conditions used for site directed mutagenesis on pCEP2lux. 
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Primer name DNA sequence 5’-3’ Size (bp) 
Puc18 LSD F GTTCCGAAAACCAAAGGCCTTGCGCTTGATAAGTTTG 12,431 
Puc18 LSD R CAAGGCTTTTGGTTTCCGGAACGCGAACTATTCAAAC  
Table 2-13: Primers used for Site directed mutagenesis on pCEP2lux.  
Primers used for Site directed mutagenesis on pCEP2lux plasmid to create a StuI restriction 
site. Blue indicates the StuI restriction site, and red the nucleotide that is to be altered in the 
pCEP2lux plasmid to create the StuI site (A>C/ T>G). 
 
 
Figure 2-7: Plasmid map of pC2LSD. 
Plasmid map of pC2LSD constructed from plasmid pCEP2lux (Figure 2-6) in CLC Genomics 
Workbench 4.5.1. pC2LSD has had a single nucleotide change creating a StuI restriction site 
using primers in Table 2-13.  
 
2.5.3 Replacing the maltose inducible promoter 
To decide what strong promoters to use RNA-seq data was used to identify genes 
with high expression (RNA-seq data performed by Dr Jiangtao Ma and Dr Andrea 
Mitchell). Genes with the highest expression (RPKM) values were identified and 
the upstream region assessed for the likelihood of a promoter being present. 
Expression of surrounding genes was also taken into consideration as they may 
be expressed as part of an operon. Finally sequence regions upstream of chosen 
genes were further assessed for the presence of promoter sequences using 
BPROM-softberry program that detects potential sigma70 promoter recognition 
sites: 
(http://linux1.softberry.com/berry.phtml?topic=bprom&group=programs&subgro
up=gfindb). All regions selected contained a potential sigma70 binding site and 
as a control the program was run using the region containing the maltose 
inducible promoter from pCEP2, which also contained a binding site.  
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For promoter cloning pC2LSD was digested using restriction enzymes StuI and 
NcoI removing the maltose inducible promoter. Promoters were amplified from 
TIGR4 using primers in Table 2-14, and products PCR purified, digested with 
restriction enzymes StuI and NcoI and then PCR purified again for cloning. Vector 
and insert were ligated together as described in materials and methods 2.2.7, 
and then transformed into XL1-Blue cells. Transformants were selected for on 
100µg/ml ampicillin and confirmed by PCR and sequencing. Plasmids constructed 
were pC2LSD P1/P2/P3/ P4 and P19.  
 
 
Figure 2-8: Plasmid map of pC2LSD P2 
Plasmid map of pC2LSD P2 constructed from plasmid pC2LSD (Figure 2-7) in CLC 
Genomics Workbench 4.5.1. pC2LSD contains the P2 promoter amplified from T4 and 
cloned between restriction sites StuI and NcoI constructed using primers in Table 2-14. 
Other promoter plasmids are identical to pC2LSD P2 with variations only between StuI and 
NcoI restriction sites. 
 
All plasmids were isolated and transformed into T4NO1, selected for on 
100µg/ml kanamycin, and integration into the genome confirmed by PCR using 
primer amiFF T4G (Table 2-15) and the corresponding promoter reverse primer. 
Gene 
number 
Primer name DNA sequence 5’-3’ size 
(bp) 
5’ SP_1489 P1 F GCTAGGCCTGTGGATGGATAATGCTGA 206 
 P1 R TAGCCATGGTTGAGTAAAAGCCTCCAAT  
5’ SP_2012 P2 F CTAGGCCTTAAGGGATTCCTTGGTTTAC 176 
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 P2 R TAGCCATGGTAGTGATTTCCTCCTTATG  
5’ SP_1128 P3 F GCTAGGCCTGAAAACAGTATATCATAAA 163 
 P3 R TAGCCATGGTTTTTACTCTCCTTATGAG  
5’ SP_0232 P4 F TAGGCCTAGCGTTTTTCACACTTGC 116 
 P4 R GCCATGGGCAAAAGCACCTCCATAA  
5’ SP_1915 P19 F TAGGCCTCATGTAAGTTAAGCTAGTC 140 
 P19 R GCCATGGATCTCCTTTCTGACTCTA  
Table 2-14: Primers used for cloning different S.pneumoniae promoters into pC2LSD. 
Primers and related information used for cloning different S.pneumoniae promoters into 
pC2LSD. Blue nucleotides indicate region of the primer specific to the gene being amplified. 
 
2.6 Complementation of gene knockouts 
Complementation of the stkP gene in T4"stkP was performed to assess the 
functionality of the Xen35 stkP allele, which contains a deletion of one of the 
extracelleular sensing domins (PASTA domains) in the C-terminal of the protein. 
To do this stkP was amplified from T4NO1 and Xen35 and cloned into the plasmid 
pC2LSD P2. This put the different stkP alleles under the control of the strong P2 
promoter. The kanamycin resistance cassette was also removed from the pC2LSD 
P2 plasmid and replaced with a chloramphenicol resistance cassette to allow 
transformation into Xen35 (KanR) and T4"stkP.  
 
Figure 2-9: Plasmid map of pCP2 ST and pCP2 XST. 
Plasmid map of pCP2 ST (A) and pCP2 XST (B) created in CLC Genomics workbench 4.5.1. 
Constructed from cloning T4 stkP and Xen35 stkP into plasmid pC2LSD P2 respectively 
along with a chloramphenicol resistance cassette using primers in Table 2-15. 
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pC2LSD P2 plasmid was isolated using the Wizard® SV gel and PCR clean up 
system (Promega) and then restriction digested with NcoI and EcoRV. The digest 
was run on an agarose gel and the required band gel extracted. PCR was 
performed to amplify the two stkP alleles from T4NO1 and Xen35 and the 
chloramphenicol resistant cassette was amplified from T4"rr08. Initially the stkP 
alleles were joined via splice overlap PCR to the chloramphenicol resistance 
cassette (Primers Table 2-15). The correct size band was gel extracted and this 
used for cloning into pC2LSD P2. For cloning In-Fusion cloning technology was 
used (In-Fusion" HD cloning kit, Clontech, USA), see materials and methods 
2.2.8. Transformants were selected for on 100µg/ml ampicillin and confirmed by 
PCR and sequencing. From this plasmids pCP2 ST and pCP2 XST were isolated 
using the QIAprep spin miniprep kit (QIAGEN). Plasmids were subsequently 
transformed into T4"stkP and transformants selected for on 10µg/ml 
chloramphenicol and confirmed by PCR, using primer amiFF T4G to confirm 
integration into the genome (primer binds outside of the plasmids). Creating 
strains T4"stkP!ST and T4"stkP!XST containing the T4 stkP allele and Xen35 
stkP allele respectively between genes SP_1885/SP_1887. No positive 
transformants were obtained when transforming these plasmids into Xen35. 
Gene Gene 
number 
Primer name DNA sequence 5’-3’ size (bp) 
stkP SP_1732 STKP COMP F* CACTACCATGGATGATCCAAATCGGCAAG 
1980 (T4) 
1764 (X35) 
  STKP COMP R TTTCAGGGATCCTTAAGGAGTAGCTGAAGTTG  
  CHLOR ST C F CCTTAAGGATCCCTGAAAAATTTGTTTGATTT 850 
  
CHLOR COMP 
R* CTTCCCCGATATCTTATAAAAGCCAGTCATTAG  
amiF SP_1886 amiFF T4G AGGATGAAGAAGAACGTAAAG  
Table 2-15: Primers used for cloning of two stkP alleles into plasmid pC2LSD P2. 
Primers and other related information used for the cloning of two stkP alleles into plasmid 
pC2LSD P2 for T4!stkP complementation. * indicates primers used for splice overlap PCR. 
Blue nucleotides indicate region of the primer specific to the gene being amplified. 
 
No complemented strains were constructed for any of the other gene knockouts 
due to time limitiations therefore phenotypic observations seen in the knockout 
strains would need to be further confirmed to ensure this is not due to 
accumulation of mutations at other regions within the genome.  
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2.7 Whole genome sequencing (WGS) 
Whole genome sequencing was performed on strains Xen35, T4NO1, T4JH and 
T4P2. Genomic DNA extraction was performed by Dr Andrea Mitchell. 
Pre sequencing DNA was fragmented using a Bioruptor sonicator and processed 
using a TruSeq DNA library preparation kit (Illumina, USA). Quality and quantity 
was checked using the bioanalyser and Kapa library quantification kits (KAPA 
Biosystems, UK) respectively. Samples were loaded onto the flow cells at 12pM 
on the Illumina Cluster station and sequenced using the IlluminaGA$$ (Xen35) or 
IlluminaGA$$x (T4NO1, T4JH and T4P2). Pre sequencing preparation was 
performed by Mrs Julie Galbraith at the Glasgow Polyomics Facility. 
Post sequencing processing was performed by Dr Pawel Herzyk. 
Data analysis was performed in CLC Genomics Workbench 4.5.1 (CLC bio). Xen35 
genome sequence was reference assembled to T4 genome sequence available at 
NCBI (NC_003028), followed by SNP and Indel analysis. A De Novo assembly was 
also performed assembling the reads against themselves to give an indication if 
regions of low coverage are too divergent from the reference to assemble or are 
deletions. Preliminary assemblies, SNP and Indel testing were performed by Dr 
Andrea Mitchell.  
Only prelimnary genome sequence data is available for T4NO1, T4JH and T4P2. 
Where genome sequence data was reference assembled to T4 genome sequence 
available at NCBI (NC_003028), followed by SNP and Indel analysis. Analysis was 
performed by Dr Andrea Mitchell. None of the genome changes have been 
further validated. 
A number of changes detected in Xen35 were confirmed via PCR followed by 
sequencing using primers in Table 2-16. 
Gene 
number 
Primer 
name 
DNA sequence 5’-3’ size 
(bp) 
Changes 
confirmed 
SP_1732 StkPF AAGAAGGAACGAAAATCAAT 716 40/ 41 
 StkPR TTAAGGAGTAGCTGAAGTTG   
SP_1915 1915F ATGAAGTTACGAATTGAGATTG 447 125-142 
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 1915R TTACCTCATGTTTCTTAGATTTTC   
SP_201 201F GAGGAGACAAATACGGAAG 302 2 
 201R CAAGATATTGATTTGGTTATTT   
SP_1908 1908F ATGTATAATAAAGTTATCTTGATTGG 396 47-59 
 1908R TTAAAATGGCAATTCTTCCTC   
SP_1909 1909F ATGGCAAAAAATGTTGTGAT 762 62-67 
 1909R TTATTTTTTATGAACCATGAAACC   
SP_1910 1910F AAAAGGAAACAATGATTTTTACAT 639 68-106 
 1910R  TTAGGCAGTCCAGTGTTTCGC   
SP_1911 1911F ATGATACAGCCAGCAAGTTT 336 107-116 
 1911R CATTGTTTCCTTTTTCTCCTAT   
SP_1927 1927F AGTAAAAACTGGACTATAACTTATT 459 189-195 
 1927R ACCAGAATCATTCGCTAAT   
SP_1928 1928F ATGAAGGCTCAAGCGATT 473 196-208 
 1928R GTTGTGAATGGATAAATATATCAT   
SP_1935 1935F GTGAAGAAGAGTTCAGTCAG 396 236-240 
 1935R GTTATTTTCTAAAAGTTGTTCAG   
0885-0886 0885-0886F CTATCGGATTAAGGAAATTAAC 505 16 
 0885-0886R ATATCTTCCCTTTTCTTTAGTT   
1029-1030 1029-1030F CATTTTTATATTTAAAGGAGCG 557 19 
 1029-1030R TTCATTCAATCTTACATTGAT   
1199-1200 1199-1200F GCTATAAGTATAACACTATATGAAA 426 26-29 
 1199-1200R AGTTATCAGAAATGCCTTTC   
1717-1718 1717-1718F TTTCACCTCCGAAATTTCT 391 36-39 
 1717-1718R AACAATTCAGGATTAAAAATAG   
1777-1778 1777-1778F GAGAAAATTGACAACCGCTA 546 44 
 1777-1778R AATTGAAACTCAAAAAGCC   
1851-1852 1851-1852F AGATAACCACCAAACCACT 404 45 
 1851-1852R ACGGATAAAGAAAAAGCCC   
2105-2106 2105-2106F TAAGGCTGAGGACAGTAAAAAC 396 243 
 2105-2106R GCTTGCTGACTACGAAGAC   
SP_0927 0927F ATGAACATTCAACAATTACGC 880 18 
 0927R CTTGCATGACTTCTACGAA   
0482-0483 0482F GAATTGCCAATGGTGTATCTGT 515 6/7 
 0483R GTGTTTCATACCGGAAAGAGA   
1912-1913 1913R AGATGCTTCGCAATACCTAC 946 117-120 
 1911R As above   
1928-1929 1928F As above 838 209-214 
 1929R AAGCAGAAGTGTACTATTCTAG   
 1918F CCTGACCTTTGAAGTTTTCA 1601 152-167 
 1920R TAGATGGGTTTTAATTTAAC   
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Table 2-16: Primers used for confirmation of genome sequence changes seen in Xen35.  
Primers and other related information used for confirmation of genome sequence changes 
seen in Xen35. Changes confirmed refer to the table of Xen35 whole genome changes seen 
in appendix III. 
 
2.8 RNA WORK 
2.8.1 RNA extraction 
For RNA extraction 10ml S.pneumoniae cultures were grown to mid log (OD600nm 
0.6) in BHI, centrifuged at 4000g for 5 minutes (4K15 centrifuge, Sigma-Aldrich, 
UK), supernatant decanted and pellets froze in liquid nitrogen and stored at -
80°C until extraction. For each strain three cultures were grown at the same 
time in the same broth to reduce variability. Therefore three RNA extractions 
were performed per strain giving three biological replicas. 
To begin extraction the bacterial pellet was resuspended in 200µl lysis buffer 
(lysozyme from chicken egg white 15mg/ml (Sigma-Aldrich, UK), 1mM EDTA 
(0.5M EDTA pH8.0), 10mM Tris (1M Tris HCl, Ambion, Life Technologies, UK)) 
made in nuclease free water (Ambion, Life Technologies, UK), and incubated at 
room temperature for 15 minutes, vortexing (rotamixer, Hook and Tucker 
instruments, UK) every 2 minutes. All buffers used throughout are from the 
RNeasy mini RNA purification kit (Qiagen, UK) unless otherwise stated. Samples 
were transferred to 1.5ml eppendorfs and 700µl RLT buffer added to each and 
vortexed for 10 seconds. Samples were then transferred into a 1.5ml eppendorf 
containing 25-50mg of 100µm glass beads (Sigma-Aldrich, UK) and cells lysed 
using a Hybaid Ribolyser (Hybaid, UK) at speed 4 for 4x 20 seconds. Samples 
were centrifuged briefly for 10 seconds at 13,000g (1K15 centrifuge, Sigma-
Aldrich, UK) and supernatant removed into a 1.5ml eppendorf. 500µl of 100% 
ethanol (Fisher Scientific, UK) was added and mixed without vortexing. 700µl of 
sample was added to an RNeasy column and centrifuged for 30 seconds at 
13,000g, flow through discarded and the remaining volume of sample applied to 
the column and centrifuged for 30 seconds at 13,000g, flow through discarded. 
350µl of RW1 buffer was added to the column and centrifuged for 5 minutes at 
13,000g. 80µl of RNase-free DNase 1 (27.3 Kunitz units) (Qiagen, UK) was 
pippetted directly onto the column membrane and incubated at room 
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temperature for 15 minutes. 700µl of RW1 buffer was added to the column and 
centrifuged for 30 seconds at 13,000g discarding flow through. 500µl of RPE 
buffer was added to the column and centrifuged for 30 seconds at 13,000g, flow 
through discarded, a further 500µl of RPE buffer was added and centrifuged for 
2 minutes at 13,000g to remove any residual ethanol. The column was 
transferred to a new 1.5ml eppendorf and 50µl of nuclease free water pippetted 
directly onto the membrane and left to stand for 2 minutes at room 
temperature. Samples were centrifuged at 13,000g for 1 minute to elute RNA. 
For all RNA samples a second DNase step was performed at this stage to ensure 
removal of any contaminating DNA. The TURBO DNA-free™ kit (Ambion, Life 
Technologies, UK) was use as per the manufacturers guide. RNA was aliquoted 
into 5µl samples and stored at -80°C until required. 
2.8.2 RNA quantity and quality 
RNA concentration was measure on the nanodrop ND 1000 (Thermo Scientific, 
UK), and quality assessed using the Bioanalyser 2100 (Agilent, UK). PCR was also 
performed on RNA samples to confirm absence of DNA contamination. 
 
Figure 2-10: Bioanalyser 2100 total RNA readout. 
Bioanalyser 2100 total RNA readout showing two prominent peaks (16S and 23S RNA), 
which are used as an indicator of RNA isolation and purity. If RNA is degraded these peaks 
decrease in size and shift to the left. 
 
2.8.3 RNA vs. RNA Microarray 
Microarray technology was used to look at gene expression differences in mutant 
strains. Microarrays used were designed and printed at the Bacterial Microarray 
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group at St. Georges Hospital, London (Bµg@S). Probes printed onto the 
microarray slide were designed based on the genome sequenced strain TIGR4 
(Tettelin et al., 2001), representing all 2236 open reading frames, a further 117 
probes were added to represent unique genes seen in the R6 genome sequence 
(Hoskins et al., 2001), array version SPv1.1.0. 
On each microarray slide was a Cy3 labelled control sample (always T4 RNA) 
used as a baseline for expression and a Cy5 labelled sample (RNA of strain 
tested). Microarrays were done in pairs each slide containing the Cy5 labelled 
samples to be compared e.g. T4 vs. Xen35 both Cy5 labelled on separate slides 
(also contains a Cy3 labelled T4 sample). Arrays were performed in triplicate (6 
slides per experiment, 3 per strain) with RNA on each slide being from a 
different biological replica. 
2.8.3.1 Microarray slide preparation 
Microarray slide preparation was performed alongside microarray sample 
preparation. Microarray slides were placed in 0.2µm filtered pre-hybridised 
solution (8.75ml 20x SSC buffer, 250µl 20% SDS, 5ml 100mg/ml BSA, made to 
50ml with sterile distilled water) pre-heated to 65°C. Slides were incubated at 
65°C for 30 minutes before washing in sterile distilled water for 1 minute and 
then in propan-2-ol for a further minute. Slides were centrifuged to remove any 
residual liquid for 5 minutes at 1500g (4K15 centrifuge, Sigma-Aldrich, UK) and 
stored in a dust free box until required. 
2.8.3.2 cDNA synthesis  
All incubations were performed using a Techgene thermal cycler (Bibby 
Scientific, UK). 2µg of total RNA was mixed with 1µl of random primers (Life 
Technologies, UK) and made to 11µl with nuclease free water. Samples were 
incubated at 70°C for 10 minutes and allowed to snap cool on ice. To each 
sample 5µl 5x first strand buffer*, 2.5µl DTT* (100mM), 2.3µl dNTP mix (5mM 
dGTP/ dATP/ dTTP and 2mM dCTP, Life Technologies, UK), 1.7µl Cy3-dCTP/ Cy5-
dCTP (GE Healthcare, Fisher Scientific, UK) and 2.5µl Superscript 11 (200U/µl) 
were added. Samples were incubated at 25°C for 10 minutes followed by 45°C 
for 90 minutes.   
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* Came as a kit with Superscript 11 from Life Technologies, UK.  
Post incubation a Cy3 labelled sample (control) was combined with a Cy5 
labelled sample (test strain) and cDNA sample purified using the MinElute PCR 
purification kit (Qiagen, UK) as per manufacturers guide. Final elution was 
performed in 15.9µl nuclease free water. 14.9µl of sample was mixed with 4.6µl 
of filtered 20x SSC buffer (Ambion, Life Technologies, UK) and 3.5µl of 0.2µm 
filtered 2% SDS (20% sodium dodecyl sulphate, Ambion, Life Technologies, UK). 
Samples were incubated at 95°C for 2 minutes, briefly allowed to cool and then 
pippetted under the raised lifter slip (Erie Scientific Company, USA) covering the 
microarray. Samples were pippetted from the bottom left hand corner of the 
lifter slip and liquid drawn up over the array area via capillary flow action. 
Microarray slides were sealed in hybridization cassettes, submerged in water 
pre-warmed to 65°C and incubated over night in the dark for 16-20 hours in a 
Techne Hybridiser HB-1D (Techne, USA).  
After incubation microarray slides were washed in 65°C pre-warmed wash A 
(20ml 20xSSC, 1ml 20% SDS made to 400ml with sterile distilled water) for 2 
minutes with agitation, allowing the lifter slips to slide off the array slide. Slides 
were subsequently washed in wash B (1.2ml 20xSSC made to 400ml with sterile 
distilled water) for 4 minutes with agitation. Slides were centrifuged to remove 
any residual liquid at 1500g for 5 minutes, and stored in a dust free box until 
scanning.  
2.8.3.3 Microarray analysis 
Microarray slides were scanned using ScanArray Express™ (Packard biosciences, 
Biochip Technologies, Perkin Elmer) and the resulting TIFF (tagged image file 
format) images created used for analysis. TIFF images were imported into 
Bluefuse for microarrays 3.5© (BlueGnome LTD, UK) with control data (Cy3 
labelled) in channel 1 and test strain data (Cy5 labelled) in channel 2. The files 
containing the microarray gridmap were created and provided by BµG@S, this 
(SPv1_1_0_CGH_Gridmap.bcf) automatically removes control spots from the 
analysis in Bluefuse. Further preliminary post processing analysis involved initial 
exclusion of unreliable data due to poor hybridization with a confidence 
estimate of below 0.1. To account for spatial, intensity and dye related effects a 
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“Global Lowess excluding all with text.” normalization step was performed with 
confidence flags set at default. Replicas of each dye swap were combined by 
fusion.  
Further data analysis was performed in Genespring GX 7.3.1 (Agilent 
Technologies, USA). Files created in Bluefuse (Output_fused.xls) for each of the 
three biological replicas were imported into Genespring 7.3.1. Initial 
normalization consisted of a “dye swap” and a “per gene” step.  Statistical 
analysis of RNA expression was performed in Genespring using the statistical 
analysis (ANOVA) tool, performing a 1-way parametric test without assuming 
variances are equal. False discovery rate was set to 0.05 (5% gene false 
discovery rate), and a Benjamini and Hochberg false discovery rate multiple 
testing correction applied. This analysis was used to create lists of genes that 
were statistically differentially regulated between the parent strain and the 
mutant strains. Although in the literature the cutoff for a true change is classed 
a 2 fold or above however all the data was included in the analysis as small 
changes such as a 1.1 fold change would still equate to a 10% change in 
transcript level which may be biologically relevant. This was validated by the 
fact some genes showed low expression changes but were true changes 
confirmed by RT-PCR and were of important cell surface virulence factors.  
Validation of microarray experiments was performed using real time PCR (RT-
PCR). RT-PCR was performed to confirm some of the gene expression changes 
seen from the microarray experiments. The same starting RNA was use as for the 
microarrays so a direct comparison can be made between techniques. For each 
condition RNA was extracted from three biological replicas as for microarrays, 
cDNA synthesis was performed on each replica and each ran as an individual 
sample. Analysis was then performed on the three replicas.  
2.8.4 cDNA synthesis 
For real time PCR cDNA synthesis was performed as described for the 
microarrays however all DNTPs concentrations were 5mM, and the Cy dye was 
replaced with 1.7µl of nuclease free water. Alongside cDNA synthesis a No-RT 
(no reverse transcriptase) control was performed for each cDNA sample, where 
the Superscript 11 was replaced with 2.5µl nuclease free water. All cDNA 
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samples and their No-RT control were diluted 1/50 in nuclease free water and 
stored at -20°C until required. 
2.8.5 RT-PCR  
Real-time PCR was performed using FastStart Universal SYBR green master mix 
(ROX) (Roche, UK). Each sample consisted of 12.5µl of master mix, 1µl of 
forwards and reverse primer mix (10mM working solution), 0.5µl of sample (cDNA 
1/50 dilution or No-RT control etc) and made to 25µl with nuclease free water. 
Samples were run in 0.2ml white 96 well PCR plates (ABgene, Fisher Scientific, 
UK) or 0.2ml white 8-well strips (ABgene, Fisher Scientific, UK), with optically 
clear 8- strip caps (ABgene, Fisher Scientific, UK). All samples were run under 
the same conditions (Table 2-17) unless otherwise stated on a Chromo4™ system 
CFB-3240 (Bio-Rad, USA).  
Temperature Time Cycle number 
50°C 2 minutes 1 cycle 
95°C 10 minutes 1 cycle 
95°C 15 seconds 
55°C 30 seconds 
72°C 30 seconds 
 
40 cycles 
72°C 5 minutes 1 cycle 
Hold 4°C   
72°C- 95°C  Melting curve 
Table 2-17: RT-PCR program information. 
 
2.8.5.1 RT-PCR primers 
gyrA  was used as an internal control to normalize for cDNA synthesis variations  
as its expression shouldn’t vary under different conditions. For each primer pair 
along with the cDNA samples and their corresponding No-RT control a gDNA 
sample was run to ensure the primers amplify and a no-DNA control to ensure 
the master mix was not contaminated with DNA. Primers were designed 
manually against the TIGR4 whole genome sequence (NC_003028). Primers were 
confirmed to not form primer dimers and to form no secondary structure using 
the online primer design tool provided by Sigma Aldrich 
(http://www.sigmaaldrich.com/configurator/servlet/DesignTool), as this may 
give false positives results during RT-PCR by forming DS-DNA that the SYBR green 
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dye would bind to. This would also be corrected for in the No-RT control. All 
primers used for RT-PCR analysis can be seen in Table 2-18. 
Gene Gene 
number 
Primer name DNA sequence 5’-3’ size 
(bp) 
rr01 SP_1633 RR01 RT-F GGGAAAATGCTCTCTGAAT 120 
  RR01 RT-R ACAAGGGCAAACCAATATC  
rr02 SP_1227 RR02 RT-F GGTCGTGAAGCGCTAGAG 106 
  RR02 RT-R TACGAATGGTCTTAGCAACTT  
rr03 SP_0387 RR03 RT-F GACCTCCAAGACGATGTAGA 143 
  RR03 RT-R ATTGCTAAGGTCGCGTCA  
rr04 SP_2082 RR04 RT-F GTGACAAATGGACGGAAG 166 
  RR04 RT-R ATTCATCACTTTTCGCAGA  
rr05 SP_0798 RR05 RT-F GATTTTGCTGGATTTGATGTTGCC 146 
  RR05 RT-R CCGCTCCCAGTTCAAATCCAT  
rr06 SP_2193 RR06 RT-F TGAGTGCTCTGGGAGATGAAACT 148 
  RR01 RT-F         CGCCAAAGATCCTCTATGACG  
rr07 SP_0156 RR07 RT-F GTGGGATATGGAGGTCGTCG 132 
  RR07 RT-R TCCCGAATCATATCAAGCCCT  
rr08 SP_0083 RR08 RT-F GGCAGGTTATCAGGTCTTGG 157 
  RR08 RT-R AGGCTGCTCTGGTGATAAGTA  
rr09 SP_0661 RR09 RT-F CAGGTGCCAGATATCATTT 147 
  RR09 RT-R GACAGCAGACAAGGCATAA  
rr10 SP_0603 RR10 RT-F GTGGCTATGAAACTATTGAGG 120 
  RR10 RT-R GGACTTCTAAGCCGTTGAG  
rr11 SP_2000 RR11 RT-F GCTTCAACCGGATGTAGAG 151 
  RR11 RT-R TTCTGCTCGTATCCACTCC  
rr12 SP_2235 RR12 RT-F CCAATATCATACAAGACAACG 130 
  RR12 RT-R GAGCCACTTCAAATCCCT  
rr13 SP_0526 RR13 RT-F AAAGCACATCATATCATTCC 137 
  RR13 RT-R AGTCCCTTCATCTCTTCATT  
orr SP_0376 ORR RT-F CCAGAAAGAGCAGTATCGG 145 
  ORR RT-R TCGGCTCAATTTTTCTGC  
psrP SP_1772 PsrP RT-F AATGAGTCAGCAGTACTTG 100 
  PsrP RT-R TCGCTGAATTACTTGTAG  
rlrA SP_0461 0461 RT-F CCATCGCAACAGGCTACC 185 
  0461 RT-R                 
TGTGACCCAATCCATACTTCC 
 
rrgA SP_0462 0462 RT-F AACCAGTCCAGCGATAGG 185 
  0462 RT-R                 CTTCTGTCAAGGTGTATGTCC  
rrgB SP_0463 0463 RT-F ATACACCTGTGAACCACCAAG 104 
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  0463 RT-R                 CATTCTATCGCTCCAGTTTGC  
rrgC SP_0464 0464 RT-F GTATCTTCTTTGTTATGGCTCTG 185 
  0464 RT-R             
ATCATCATAGGAATACGAATCATC 
 
srtB SP_0466 0466 RT-F GGTGTCTCGCTTGTATTATCG 86 
  0466 RT-R                 TGTCAGCCTCATCCAACG  
srtC SP_0467 0467 RT-F GTGTCTCGTTATTATTATCGTATTG 91 
  0467 RT-R                 CCTCAAGTTCTGCCTTATCC  
srtD SP_0468 0468 RT-F TCTCGCCTACAATCAACGC 169 
  0468 RT-R               ATAATCTGCTCCCAAATAAACCG  
hyp SP_1914 1914 RT-F TGGCGTGTAGATTTGAAAGTAG 127 
  1914 RT-R                CGTAGACAATTTCCAACAACC  
hyp SP_1915 RT-1915F*N TCAAGCTCTATGAGTTGGAGTC 118 
  1915 RT-R               TTAGGAGGGATTGGTAATGCCG  
Ser/thr 
phosphatase SP_1201 SP_1201 RT-F GCTGGGATGCTGGAAGAC 150 
  SP_1201 RT-R GGACAAACAGATAGCCCCTT  
gyrA SP_1219 gyrA RT-F GCGCGAGCTCTTCCTGATGT 100 
  gyrA RT-R             TATGGGGTTTGTCTGGGGTC  
luxA Xen35_ LuxA RT-F GGAGCATCATTTCACGGAGTTTG 114 
  LuxA RT-R GTGGGAAGAACAATAGCGGCAGT  
luxB Xen35_ LuxB RT-F CAGATAATGGTGTTGTCGGCG 120 
  LuxB RT-R N CTATGCGGACAGGATGATGAGTTG  
luxC Xen35_ LuxC RT-F GTGTTTACCTGCCAATATTGAATGAC 166 
  LuxC RT-R TTTAAGTCACGAATGTATGTCCTGCG  
luxD Xen35_ LuxD RT-F GCCAGAAGAAAACAGCCCAAAGAG 88 
  LuxD RT-R CGCCAGACCAGCAAAATGAT  
luxE Xen35_ LuxE RT-F TGATGATTTGATTTTTTCGAGCG 161 
  LuxE RT-R CCGTAATATTGTCATCTACTTTGTGTGC  
Table 2-18: Primers used for RT-PCR. 
 
2.8.5.2 Analysis RT PCR 
Analysis was performed in Opticom Monitor™ version 3.1. Background was 
subtracted in the software and replicas grouped together with at least two 
replicas used for analysis. Data was analysed using the 2-""CT method (Livak & 
Schmittgen 2001), graphical data represent was performed in Prism version 4.0b 
(GraphPad Software), each bar representing the sample replica means ± 
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standard deviation error bars. Statistical analysis was performed using a 1-way 
ANOVA with a Tukeys testing correction comparing the dCT values (Ct of test 
gene minus Ct of control genes (gyrA)) of the control strain (normally TIGR4) 
against that of the test strain.  
2.9 RNA-seq 
2.9.1 mRNA purification for transcriptomics 
RNA-seq analysis was performed on T4JH and Xen35. Starting total RNA used was 
from the same batch as that used for microarray and RT-PCR, allowing direct 
comparison of the techniques. Starting RNA for each sample was 20µg, ribosomal 
RNA was depleted using the MICROBExpress™ Kit (Ambion, Fisher Scientific, UK) 
as per manufacturers instructions with the following exceptions. Volume used of 
everything was doubled, as the recommended starting RNA concentration is 2-
10µg. Volume of Oligo MagBeads used per sample was 200µl to increase 
efficiency of rRNA binding. And final resuspension volume was decreased to 
16.5µl to obtain a more concentrated mRNA preparation. To confirm rRNA 
depletion samples were run on the Bioanalyser 2100 (Agilent, UK) and 
concentration measures using the nanodrop ND 1000 (Thermo Scientific, UK). 
 
Figure 2-11: Bioanalyser 2100 readout of rRNA depleted total RNA. 
Bioanalyser 2100 readout of rRNA depleted total RNA showing small 16S and 23S RNA 
peaks due to rRNA depletion. mRNA labelled is represented by the prominent peak now the 
most abundant RNA due to rRNA depletion. 
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2.9.2 cDNA synthesis from mRNA 
cDNA synthesis was performed on a starting volume of 2µg of mRNA. Added to 
2µg of mRNA was 1µl (3µg) Random hexamers (Life Technologies, UK) this was 
made to 23µl with RNase free water and incubated at 70°C for 10 minutes. 8µl of 
5x first strand buffer, 4µl 0.1M DTT and 2µl 10mM dNTPs was added and 
incubated at 25°C for 2 minutes. A further 3µl of superscript III was added and 
incubated for 25°C for 10 minutes, 42°C for 90 minutes and 70°C for 15 minutes. 
Added to this reaction on ice was 186µl DNase free water, 60µl 5x second strand 
reaction buffer, 6µl 10mM dNTP mix, 2µl E.coli DNA ligase (10U/µl), 4µl E.coli 
DNA polymerase (10U/µl), 2µl E.coli RNase H (2U/µl) giving a total volume of 
300µl.This was incubated at 16°C for 3 hours. 
300µl of phenol:chlorophorm:isomayl (25:24:1) was added, vortexed for 30 
seconds and centrifuged for 1 minute at 12,000g. The aqueous phase removed to 
a fresh tube and 300µl of chloroform added, vortexed for 30 seconds and 
centrifuged for 1 minute at 12,000g. The aqueous phase was removed into a 
fresh tube and 3µl of Glycogene (10mg/ml, Gene Link, USA) added. 300µl 4M 
ammonium acetate and 300µl of isopropanol were added, and samples mixed via 
inverting 4 times and incubated at 4°C overnight to aid precipitation of cDNA. 
Samples were then centrifuged at 4°C, 12,000g for 30 minutes (1K15 centrifuge, 
Sigma-Aldrich, UK), supernatant carefully removed and pellet rinsed with 500µl 
70% ethanol twice centrifuging in between at 14,000g for 2 minutes and 
discarding supernatant. The pellet was dried at 37°C for 10 minutes and finally 
resuspended in 10µl DNase free water. cDNA concentration and quality was 
measure on the nanodrop ND 1000  and Bioanalyser 2100 respectively. 2µg of 
cDNA was sent from each sample for sequencing. 
2.9.3 Downstream cDNA processing and sequencing 
Pre sequence processing was performed as described in materials and methods 
2.7, by Mrs Julie Galbraith. Paired end RNA-seq was performed using the 
IlluminaGA$$x at the Glasgow Polyomics Facility. 
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Data analysis was performed in CLC Genomics Workbench 4.5.1 (CLC bio, USA) 
T4JH RNA-seq data was assembled to the genome sequence TIGR4 data (NCBI) 
and Xen35 RNA-seq data was assembled to the Xen35 genome sequence 
(Assembled from WGS data by author and Dr Andrea Mitchell). RPKM (reads per 
kilobase of exon model per million mapped reads) values given were used for 
comparison between expression analysis performed by microarray. 
2.10 Western blotting  
2.10.1 Sample preparation 
For all western blots S.pneumoniae strains were grown to OD600m 0.6 in 15ml BHI, 
strains were centrifuged at 4000g for 10 minutes (4K15 centrifuge) and the 
supernatant discarded. The bacterial pellets were then resuspended in 750µl PBS 
and sonicated on ice at 10 microns for four repeats of 30 seconds with 30 
seconds break using a Soniprep 150 sonicator (MSE, UK).  Protein concentration 
in each sample was measured using the Qubit" fluorometer (Life Technologies, 
UK) as per the manufacturers manual. Protein samples being compared were 
normalised to that of the sample with the lowest concentration, samples were 
diluted if required with PBS and NuPAGE" LDS sample buffer (4X) (Novex", Life 
Technologies, UK) added in the appropriate volume. Samples were boiled at 
70°C for 10 minutes.  
2.10.2 SDS-PAGE gels and western blotting 
Samples prepared as above were run on NuPAGE" Novex 4-12% Bis-Tris gels, 15 
well (Life Technologies, UK). Gels were run in XCell SureLock" Mini-Cell tank 
(Life Technologies, UK) for 50-60 minutes at 200V. 5-10µl of sample were run in 
each well along with 5µl of SeeBlue" Plus2 pre-stained standard marker (Life 
Technologies, UK).  Gels were transferred using the iBlot" module and iBlot" 
transfer stack, mini (nitrocellulose) (Life Technologies, UK), transfer was run on 
program 2 as per the manufacturers guide. The membrane was blocked in 3% 
skimmed milk (Marvel, UK) in PBS overnight at 4°C or shaking at 37°C for 1 hour.  
The membrane was then incubated with a 1/4000 dilution of the primary 
antibody* in 3% skimmed milk for 3 hours shaking at 37°C, washed 6x 5 minutes 
in PBS with 0.1% Tween 20 (Sigma-Aldrich, UK). A 1/20,000 dilution of the HRP 
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labelled secondary antibody (Goat Anti-Rabbit IgG HRP linked F(ab)2, GE 
Healthcare, Fisher Scientific, UK) was added and incubated shaking at 37°C for 1 
hour, washed 6x5 minutes in PBS with 0.1% Tween 20 (Sigma-Aldrich, UK). 
Membranes were developed using Immobilon Western Chemiluminescent HRP 
substrate (Millipore, UK) with 18x24cm X-ray film (Kodak, USA).  
* Anti-Rabbit RrgB – Kindly provided by Novartis Vaccines (De Angelis et al. 2011) 
* Anti-Rabbit GroEL (E.coli) pAb (Enzo Life Sciences, UK) 
2.11 Tissue culture 
2.11.1 Maintenance of cells 
HBMEC (Human brain microvascular endothelia cells) were grown in advanced 
RPMI 1640 media (Life technologies, UK) supplemented with 20% FBS (Fetal 
bovine serum (EU approved), Biosera, UK), 2mM L-Glutamine (Sigma Aldrich, 
UK), 1% 100X Penicillin streptomycin solution (Sigma Aldrich, UK), and 1% 
Fungizone" Antimycotic (Gibco", Life Technologies. UK).  
A549 (Human lung epithelial carcinoma cell line, ATCC-CCL-185) cells were 
grown in Hams F12K (Kaighns modification) media (Life Technologies, UK) 
supplemented with 10% FBS, Penicillin streptomycin and Fungizone" as above.  
Detroit 562 (Human Pharyngeal epithelial carcinoma cell line, ATCC-CCL-138) 
cells were grown in Minimal Essential Media Eagle (Sigma-Aldrich, UK) 
supplemented with 10% FBS, 2mM L-glutamine, Penicillin streptomycin and 
Fungizone" as above. 
2.11.2 Growing cells from liquid nitrogen 
When resuscitating cells from liquid nitrogen 1ml aliquots were thawed quickly, 
cells were made up to 10ml with pre-warmed media in a falcon and centrifuged 
at 1000g for 2 minutes (4K15 centrifuge, Sigma-Aldrich, UK). The supernatant 
was then removed and the cell pellet resuspended in 15ml media placed into a 
75cm2 vented flask and grown at 37°C in 5% CO2. The exception to this is the 
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HBMEC cells which once the 1ml vial was thawed were placed immediately into 
15ml pre-warmed media in a 75cm2 vented flask without centrifugation. 
2.11.3 Splitting cells 
Cells were split when they reached 70-80% confluence.  The tissue culture media 
was decanted and roughly 15ml of sterile PBS washed over the cells to remove 
any residual FBS. To digest the cells off the flask 4ml 0.25% Trypsin-EDTA 
(Sigma-Aldrich, UK) was added and incubated for 5 minutes at 37°C. When cells 
were visually detached they were removed into a flacon and made up to 10ml 
with media, centrifuged at 1000g for 2 minutes, supernatant removed and the 
pellet resuspended in 10ml media. The cell suspension was diluted 1/10 in a 
75cm2 vented flask containing fresh media and grown at 37°C in 5% CO2. 
2.11.4 Adherence assay 
For adherence assay all cell lines were grown in the same media as stated in 
section Error! Reference source not found., however the penicillin 
streptomycin solution and fungizone" was removed. All adherence assays were 
performed in 24 well microtitre plates. For adherence assays the protocol for 
splitting cells was followed however the bacterial suspension produced was used 
to seed the correct number of tissue culture cells into the 24 well plates. Cell 
numbers from the bacterial suspension were first counted using a 
haemocytometer and the volume containing 2x105 viable cells seeded into each 
well and made to 1ml with media. The plates were incubated at 37°C in 5% CO2 
for 48 hours (cells confluent) and could then be used for the adherence assay. 
Prior to seeding the HBMEC cells into the 24 wells plates the plates were 
incubated overnight with a fibronectin solution to allow the cells to adhere. 
150µl of 1mg/ml fibronectin from bovine plasma (Sigma-Aldrich, UK) was added 
to 10ml of sterile PBS, 200µl of this solution was added to each well of the 24 
well plate and incubated overnight at 37°C in 5% CO2. The fibronectin solution 
was then removed and stored at 4°C, the solution can be used twice. 
To begin adherence assay 1ml of S.pneumoniae at 107 CFU/ml are seeded in to a 
single well containing tissue culture cells. The volume of glycerol stock 
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containing the required number of bacteria was calculated using Equation 2-1. 
The required volume was centrifuged at 13,000g for 3 minutes (113 centrifuge) 
the supernatant discarded and the bacterial pellet resuspended in 1ml tissue 
culture media. The assay was incubated at 37°C in 5% CO2 for 2 hours. Each 
strain per assay was performed in duplicate and each assay run in triplicate. 
After two hours 100µl of media was removed from each well, samples from wells 
containing the same strain (two wells per assay) are pooled and serial dilutions 
made and viable count performed as stated in materials and methods 2.1.1. The 
CFU/ml is calculated using Equation 2-1 giving the number of non-adherent cells. 
The remaining media is removed and the cells washed 3 times with 1ml PBS, 
200µl of 0.25% Trypsin-EDTA added to each well to detach the cells and the 
plate incubated at 37°C for 10 minutes. 800µl of 0.0125% Triton-X-100 (Sigma-
Aldrich, UK) in PBS was then added to each well to lyse the tissue culture cells. 
200µl was removed from each well into a 96 well plate from each individual 
well. Serial dilutions of these were created as described previously and neat to 
10-5 dilutions plated onto BAB plates. The CFU/ml is then calculated from this 
giving the number of adherent bacteria, from this an average of the two 
duplicate wells is calculated. Percentage adherence is then calculated by adding 
the non-adherent and adherent CFU/ml values together and from this calculating 
the percentage of adherent from the total. Graphical presentation and 
statistical analysis was performed in Prism version 4.0b (GraphPad Software). 
Data presented was normalized to that of the wild type strain (100%), so 
percentage adherence was calculated relative to this. Error bars on graphs 
represent the standard error of the mean from three replicas. Statistical analysis 
was performed using a one-way ANOVA with Tukey’s multiple comparison test. 
2.12 Electron microscopy 
2.12.1 Sample preparation 
Samples for electron microscopy were taken from 1ml frozen S.pneumoniae 
glycerol stock. Stocks were first defrosted and 500µl centrifuged at 4000g for 5 
minutes (113 centrifuge, Sigma-Aldrich, UK), supernatant removed and the 
pellet washed once in an equal volume of 0.2µm filtered 1x PBS, supernatant 
was removed and the pellet resuspended in 100µl 0.2µm filtered 1x PBS. 
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20µl of the prepared bacterial suspension were pippetted onto glow discharge 
poly-lysine coated nickel grid and incubated at room temperature for 15 minutes 
to allow bacterial attachment. Grids were then placed sample side down onto 
20µl droplets of 1% PFA (paraformaldehyde, Sigma-Aldrich, UK) in 1X PBS on 
Nescofilm (VWR Jencons) to fix cells and left for 30 minutes at room 
temperature. All further washed mentioned were performed via placing the grids 
sample side down on 20µl droplets of the solution on Nescofilm.  Grids were then 
washed 5x for 2 minutes in 0.2µm filtered 1xPBS followed by 3x 5 minute washes 
in 0.2% BSA (Albumin from bovine sera, Sigma-Aldrich, UK) in 1xPBS.  Any excess 
liquid was removed using filter paper. The grid was then placed sample side 
down onto 20µl droplets of a 1/10 dilution of the primary antibody (Anti-Mouse 
RrgB, see section 2.18) in 0.2% BSA PBS, and incubated at room temperature for 
1 hour. Grids were then washed 6x 5 minutes in 0.2% BSA PBS, and any excess 
liquid removed. Grids were then placed onto 20µl of a 1/20 dilution of the 
secondary antibody (Goat-anti-Mouse IgG (H&L) gold conjugate (10nm particles), 
Aurion, Holland) in 0.2% BSA PBS and incubated at room temperature for 1 hour. 
Grids were subsequently washed 6x 5 minutes in 0.2% BSA PBS, then 5x 2 
minutes in 0.2µm filtered 1xPBS. Cells were then fixed again in 1% PFA for 30 
minutes at room temperature. Grids were washed 6x 2 minute washes in 0.2µm 
filtered 1xPBS followed by 6x 5 minute washes in 0.2µm filtered distilled water. 
Any residual liquid was removed using filter paper and finally grids stained for 20 
seconds with 0.5% aqueous uranyl acetate (Sigma-Aldrich, UK) (made in distilled 
water). Residual uranyl acetate was removed using filter paper and grids allowed 
to dry at room temperature for 10 minutes.  
2.12.2 Viewing samples 
Grids were viewed between x5000 and x16,000 magnification on a LEO 912 
Transmission Electron Microscope.  
2.13 Fluorescence activated cell sorting (FACS) 
2.13.1 Sample preparation 
S.pneumoniae strains were grown to OD600nm 0.6 in 5ml BHI. Cultures were 
centrifuged at 4000g for 5 minutes (4K15 centrifuge), and bacterial pellet 
Chapter 2 
 
115 
resuspended in 1ml 2% paraformaldehyde (Sigma-Aldrich, UK) and incubated at 
room temperature for 1 hour to fix the cells.  Cells were centrifuged at 4000g 
for 5 minutes (113 centrifuge) and resuspended in 1ml buffer 1 (0.2µm filtered 
1x PBS, 1% BSA) (Sigma-Aldrich, UK), and blocked at 4°C over night.   
For antibody staining 100µl of fixed bacterial suspension was centrifuged at 
4000g for 5 minutes (113 centrifuge, Sigma-Aldrich, UK) and resuspended in 
500µl buffer 2 (0.2µm filtered 1x PBS, 1% BSA, 0.05% Tween 20) (Sigma-Aldrich, 
UK), 1µl of each primary antibody* (1/500 dilution) was added and incubated at 
room temperature for 1 hour. Cells were washed once (buffer 2) and then 
resuspended in 500µl buffer 2. 1µl of each secondary antibody** was added and 
incubated for 1 hour in the dark at room temperature.  Cells were washed three 
times in 500µl buffer 2 and then resuspended in 500µl buffer 1.  
* Anti-Mouse RrgB polyclonal (Made in house, see section 2.18) 
* Anti-Rabbit Type Serum 4 (Statens Serum Institute, Denmark) 
** Goat Anti-Rabbit IgG (H&L chain specific) Allophycocyanin (APC) conjugate 
(Southern Biotech, USA). 
** Goat Anti-Mouse IgG (% chain specific) Fluorescein (FITC) Conjugate (Southern 
Biotech, USA). 
2.13.2 Running fluorescence activated cell sorting 
Samples were diluted 1:1 in buffer 1 and run on a FACScalibur flow cytometer 
(BD biosciences, USA), samples were acquired in CellQuest-Pro software (BD 
biosciences, USA). FACS settings were as follows: the primary parameter was set 
as the forwards scatter (FSC), voltage set at E00 on a log scale, side scatter 
(SSC) voltage was set at 587 on a linear scale, FL1 voltage was set at 624 on a 
log scale and FL4 voltage was set at 682 on a log scale. The threshold was set at 
0 and no compensation was required. FACS analysis was performed in FlowJo 
9.4.10 for Macintosh (Tree Star, USA). Cells were gated initially on being capsule 
positive (APC+) and then this population gated on selecting RrgB positive (FITC+) 
and RrgB negative populations. Percentage RrgB positive and negative 
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populations were compared between parent and mutant strains. Cell populations 
throughout this study refer to these gates.  
2.13.3 Fluorescence activated cell sorting controls 
FACS controls were performed to confirm no cross reactivity between the two 
antibodies. This was performed by using the Anti-rabbit capsule antibody with 
the Anti-mouse FITC secondary and the Anti-mouse RrgB antibody with the Anti-
rabbit APC secondary. This was also confirmed by staining a T4NO1 bacterial 
population with the single antibody pairs alone and confirmed they gave the 
same percentage positive and negative populations. FACS analysis was also 
confirmed in all cases by visually assessing the samples using fluorescence 
microscopy.  
Based on the unstained T4NO1 population data the values for the capsule 
positive (FL4) and RrgB positive (FL1) gates were set. For capsule positive cells 
anything above 101 log FL4 were classed as capsule positive, during fluorescence 
microscopy no events were observed to be APC positive and not be a bacterial 
cell. For RrgB positive cells anything above 121 log FL1 were classed as RrgB 
positive and anything below this negative for RrgB. All values referring to 
different cell population throughout this study refer to these gates. 
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Figure 2-12: FACS controls swapping the secondary antibodies. 
FACS was performed on T4NO1 and T4!rrgB. T4NO1 was run as an unstained sample, 
stained with a anti-mouse RrgB/ anti-rabbit APC, stained with a anti-rabbit capsule/ anti-
mouse FITC or stained with a anti-mouse RrgB/ anti-mouse FITC and anti-rabbit capsule/ 
anti-rabbit APC. T4!rrgB was stained with anti-mouse RrgB/ anti-mouse FITC and anti-rabbit 
capsule/ anti-rabbit APC antibody combinations. (A) Shows histograms of the capsule 
positive population of T4NO1 and the negative controls showing no APC positive cells. 
Histograms/ polychromatic plot show negative (left) and positive (right) capsule 
populations. (B) Shows the capsule stained populations being gated on for being RrgB 
positive in T4NO1, and the negative controls being negative for FITC (RrgB). Histograms/ 
polychromatic plot show negative (left) and positive (right) RrgB populations in each strain. 
 
Strain FL4- (%) FL4+ (%) 
T4NO1 0 100 
T4 anti-CAP FITC 100 0.01 
T4 anti-RRGB APC 99.9 0.07 
T4NO1 unstained 99.9 0.1 
 
Strain FL1- (%) FL1+ (%) 
T4NO1 12.1 87.9 
T4 anti-CAP FITC 98 2 
T4 anti-RRGB APC 100 0.04 
T4"rrgB 98.4 1.6 
T4NO1 unstained 100 0.006 
Table 2-19: Percentage APC and FITC positive cells in FACS control samples. 
(A) Shows the percentage APC (FL4) positive and negative cells in T4NO1 samples 
unstained or stained with different antibody combinations. (B) Shows the percentage FITC 
(FL1) positive and negative cells in T4NO1 samples unstained or stained with different 
antibody combinations and T4!rrgB. FACS analysis was performed in FlowJo. 
!"
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From the control FACS data the secondary antibody was swapped for one that 
should not bind to the primary antibody (Figure 2-12). This confirmed in most 
instances that both the antibodies were unable to cross react with another 
antibody or cellular components (Table 2-19). Based on the gates however there 
may be a small amount of cross reactivity between the capsule antibody and the 
FITC antibody with the cells stained with this antibody combination showing 2% 
of events FITC positive. Alternatively the FITC antibody may bind weakly to 
some other cellular component irrespective of the capsule antibody binding. The 
pilus knockout strain T4&rrgB also showed 1.6% of cells positive for FITC when 
stained with both antibody pairs, however fluorescence microscopy confirmed 
T4&rrgB cells to be negative for FITC and therefore could potentially be very 
weak FITC positive cells undetectable by fluorescence microscopy. This finding 
must be kept in mind when looking at FACS data analysis.  
FACS controls were also performed with the single antibody pairs to confirm that 
using the double antibody staining simultaneously didn’t alter the results (Figure 
2-13). The capsule stained population of T4NO1 from the single stained and 
double stained cells gave the same number of cells positive for the capule (Table 
2-20). The RrgB populations in T4NO1 with the single and double stained 
populations were roughly 2% different, this can be seen from the histogram as an 
increase in the unstained RrgB population (left hand side) in the single stained 
T4NO1 sample and can likely be put down to the fact this is where the events 
would be that weren’t cells, as with this sample there is no way of selecting the 
cells from the debris as APC staining was not performed and this is likely the 
cause of this difference (Table 2-20). Corroborated by the fact the T4NO1 
double stained population showed roughly 2% of event were unstained for the 
capsule and were therefore not cells. 
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Figure 2-13: FACS controls staining T4NO1 with single antibody pairs 
FACS was performed on T4NO1. T4NO1 was run as a sample stained with the two antibody 
pairs anti-mouse RrgB/ anti-mouse FITC and anti-rabbit capsule/ anti-rabbit APC or with 
each antibody pair singly. (A) Shows histograms of the capsule positive (APC) population of 
T4NO1 with the double and single antibody staining and the single RrgB stained population 
negative for APC positive cells. Histograms/ polychromatic plot show negative (left) and 
positive (right) capsule populations. (B) Shows the capsule stained populations being gated 
on for being RrgB positive in T4NO1, and the single RrgB and capsule antibody stained 
T4NO1 sample gated on also. Histograms/ polychromatic plot show negative (left) and 
positive (right) RrgB populations in each strain. 
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Strain FL4+ (%) FL4- (%) 
T4NO1 98.3 1.7 
T4 anti-CAP 98 2 
 
Strain FL1- (%) FL1+ (%) 
T4NO1 12.1 87.9 
T4 anti-RrgB 14.9 85.1 
Table 2-20: Percentage APC and FITC positive cells in FACS single antibody pair control 
samples. 
(A) Shows the percentage APC (FL4) positive and negative cells in T4NO1 samples stained 
with both or a single antibody pair. (B) Shows the percentage FITC (FL1) positive and 
negative cells in T4NO1 samples stained with both or a single antibody pair. FACS analysis 
was performed in FlowJo. 
 
2.13.4 Fluorescence microscopy 
10µl of antibody stained bacteria preparation was pippetted onto a 76x22mm 
glass slide (Menzel Gläser, Germany) and a 22x22mm glass cover slip (Menzel 
Gläser, Germany) placed over the sample. Samples were heated for 60 minutes 
at 50°C to fix the sample. All fluorescence microscopy images were taken at X40 
and X100 magnification using a Zeiss AxioscopeM1 fluorescence microscope with 
the correct filters. Images were analysed in Volocity software 6.0.1 (Perkin 
Elmer). Images were arranged in Adobe Photoshop elements 10. 
2.14 Measuring bioluminescence over time. 
To follow bioluminescence over time, 1x106 CFU of S.pneumoniae were added in 
20µl volumes to a black F96 MicroWell™ plate (Nunc, Fisher Scientific, UK) 
containing 180µl BHI, each strain was tested in triplicate. Luminescence was 
measured on a FLUOstar OPTIMA (BMG) taking readings every 20 to 30 minutes 
for roughly 10 hours. Graphical presentation was performed in Prism version 4.0b 
(GraphPad Software), each data point representing the mean of the triplicate 
luminescence reading. 
#"
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2.15 Preparation of T4!spxB samples with addition of 
hydrogen peroxide 
The volume of culture grown will vary depending on the downstream technique 
being used e.g. FACS/ western blotting. Cultures of T4"spxB were grown in BHI 
to OD600nm 0.3 and then 10µl/ml of Hydrogen peroxide 30% w/v AnalaR 
NORMAPUR" (VWR, UK) added from 1/10 (contains 9mM), 1/25 (contains 3.6mM) 
and 1/50 (contains 1.8mM) dilutions. Higher concentrations were used at roughly 
20mM but all T4"spxB bacteria were killed by this concentration. Samples were 
grown to OD600nm 0.6 and processed according to the technique being used. 
2.16 Hydrogen peroxide assay 
Hydrogen peroxide assay was performed on some strains to look at their ability 
to produce hydrogen peroxide. S.pneumoniae cultures were grown to OD600nm 0.6 
in BHI, 180µ of culture were added in triplicate to a 96 well flat bottom plate. 
To this 20µl of 3mg/ml ABTS (2,2 azinobis (3-ethylbenzthiazolinesulfonic acid) 
diammonium salt, Sigma-Aldrich, UK), 0.2mg/ml HRP (Peroxidase from 
horseradish Type II, Sigma-Aldrich, UK) in a 0.1M sodium phosphate buffer pH7.0 
was added. The assay was left to develop for 30 minutes at 37°C followed by 
centrifugation at 1500g for 3 minutes (4K15 centrifuge). 100µl from each well 
was removed and placed into a fresh well. Absorbance was measured using a 
spectrophotometer at 540nm (FLUOstar OPTIMA, BMG). Hydrogen peroxide 
standards were used as a positive control by making serial dilutions of Hydrogen 
peroxide 30% w/v AnalaR NORMAPUR" (VWR, UK) in BHI. From this a standard 
curve was generated in Microsoft Excel plotting known hydrogen peroxide 
concentrations against the absorbance (Figure 2-14). From this the concentration 
of Hydrogen peroxide produced from pneumococcal strains was obtained. 
Graphical presentation of hydrogen peroxide assay data was performed in Prism 
version 4.0b (GraphPad Software). Data presented was the hydrogen peroxide 
(mM) produced from each strain tested, obtained from averaging a triplicate 
absorbance value and from this value using the standard curve below to give the 
amount of H2O2 produced in mM. No statistical analysis was performed. 
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Figure 2-14: Hydrogen peroxide assay standard curve 
Standard curve of known hydrogen peroxide concentrations and absorbance values 
obtained when usied in a hydrogen peroxide assay. Graph used throughout the thesis to 
calculate hydrogen peroxide concentration produced by pneumococcal strains. 
 
2.17 In Vivo experiments 
All animal experiments were performed in 6-8 week old MF1 outbred mice 
(Harlan, UK). 
2.17.1 Animal passage 
Prior to challenge S,pneumoniae strains were intraperitoneally passaged through 
MF1 outbred mice (Harlan, UK). To ensure the correct dosing glycerol stocks 
were viable counted giving the CFU/ml (materials and methods 2.1.1). From the 
CFU/ml a calculation was performed (Equation 2-2) giving the volume containing 
2.5x106 CFU/dose (1x107 CFU/ml). The dosage volume is 200µl/ mouse, the 
amount of inoculum prepared will vary depending on the number of mice 
infecting. 
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Equation 2-2: Equation used to calculate the volume required from glycerol stocks for 
intraperitoneal passage of S.pneumoniae strains through MF1 mice.  
*0.5 is the amount in ml of inoculum you wish to prepare (in this case 0.5ml). 
**1x107 as stated above is the concentration /ml you wish the inoculum to be. 
***Dose in ml containing the number of bacteria required to give 1x107 CFU/ml in 0.5ml, the 
volume is made up to the required volume (0.5ml) with 1x PBS. 
 
2.17.1.1 Standard inoculum preparation 
Glycerol stocks were thawed and centrifuged at 13,000g for 3 minutes (113 
centrifuge, Sigma-Aldrich, UK) to pellet the bacteria, supernatant removed and 
the pellet resuspended in an equal volume of sterile PBS. From this the 
calculated volume of glycerol stock required was removed into a new sterile 
eppendorf and made to the correct volume with PBS.  
2.17.1.2 Challenge 
MF1 mice were infected via the I.P route with 2.5x106 CFU in 200!l, at 6 hours 
post infection mice were culled via terminal exsanguination under general 
anesthetic and death confirmed via cervical dislocation. Blood obtained was 
placed into 20ml BHI and incubated overnight at 37°C. 1ml of overnight culture 
was then place in 50ml BHI plus 20% FBS (Fetal bovine serum, Life Technologies, 
UK) and grown at 37°C to OD600nm 0.6, 1ml aliquots were made and stored at -
80°C.  
2.17.1.3 Viable counting of S.pneumoniae frozen standard inoculum 
For counting of bacterial SI (standard inoculum) at least 24 hours post freezing 
three x 1ml vials were thawed per strain at 37°C for 3 minutes. SI were 
centrifuged at 13,000g for 3mins (113 centrifuge, Sigma-Aldrich, UK), 
supernatant removed and the pellet resuspended in 1ml PBS. Each vial was then 
viable counted (materials and methods 2.1.1), and from the three vials an 
 
0.5* x 1x107**  = N 
 
N divide by CFU/ml of glycerol stock = dose in ml*** 
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average CFU/ml was calculated. This value was used to calculate the dosage for 
challenge experiments. 
2.17.2 In vivo challenge intranasal (I.N) 
For intranasal challenge mice were infected with 5x106 CFU in 50!l, 25µl given 
into each nostril. To calculate the dosage Error! Reference source not found. 
was used as for the IP passage, 1.5ml of inoculum was made per strain as 20 
mice were infected per strain. 
2.17.2.1 Preparation of inoculum 
A vial of SI per strain was thawed at 37°C for 3 minutes. SI was centrifuged at 
13,000g for 3mins (113 centrifuge, Sigma-Aldrich, UK), supernatant removed and 
the pellet resuspended in 1ml PBS. The volume required containing the correct 
number of bacteria as calculated from Error! Reference source not found. was 
moved to a new sterile 5ml bijoux. This volume was then made up to 1.5ml with 
PBS giving a final concentration of 1x108 CFU/ml. Prior to inoculation the 
inoculum was viable counted (materials and methods 2.1.1) to confirm the 
correct dosing this is also performed post animal inoculation to account for any 
death/growth of the bacteria in this period of time. 
2.17.2.2 T4 vs. Xen35 vs. T4P2 
20 MF1 mice were infected I.N per strain (T4NO1/ Xen35/ T4P2). Mice were split 
into four groups of 5, 24 hour group, 48 hour group, 72 hour group and a survival 
group. 24 hours post inoculation the 24 hour group mice were sacrificed and 
lungs, brain, nasal wash and blood removed for bacterial enumeration. The same 
was done at 48 hours for the 48 hour group and at 72 hours for the 72 hour 
group. If mice became sick before this period of time they were culled and time 
of death noted. The survival group was left until the mice became sick or culled 
at the end of the experiment 100 hours post inoculation. 
For enumeration of bacterial counts from blood and nasal wash viable counting 
was performed as previously described, for blood dilutions of 10-1 to 10-6 were 
created and plated onto BAB, as described in section 2.1.1. For nasal wash 
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dilutions of 10-1 to 10-5 were created and plated onto BAB along with the neat 
wash, CFU/ml for both was calculated using Equation 2-1.  
Enumeration of bacterial counts from organs varied slightly. Upon removal from 
mice the lungs and brain were placed into 3ml PBS. The weight of the PBS was 
measured prior to and post addition of the organ to obtain the exact weight of 
the organ, allowing us to work out the CFU/ gram of tissue. The organs in PBS 
were homogenized followed by viable counting of the homogenate, dilutions 10-1 
to 10-5 were created and plated onto BAB along with the neat homogenate. The 
CFU/ml was calculated for each organ using Equation 2-1 and then this used to 
calculated the CFU/gram of tissue as seen in Equation 2-3. 
 
Equation 2-3: Equation used for calculating the bacterial burden in mouse organs from 
animal challenge experiments.  
*3 indicated volume of PBS organ placed in. 
** O indicated organ weight, calculated from subtracting the PBS weight from that of the 
organ and PBS together. 
 
2.17.2.3 Analysis 
Graphical presentation and statistical analysis was performed in Prism version 
4.0b (GraphPad Software). CFU/ml data for nasal wash and blood were used to 
compare colonization and bacteremia between different strains. CFU/gram of 
tissue was used for lungs and brain to compare the organ bacterial load between 
strains. Comparisons were made at time points 24/ 48 and 72 hours. Statistical 
analysis was performed using a non-parametric Mann-Whitney two sample rank 
test, significance P<0.05. This statistical test was also used for comarison of the 
percentage weight loss of the mice over time. Survival of mice infected with 
different strains was compared using a Kaplain meier survival curve and analysed 
using a Log-rank Test (P<0.05). 
CFU/ml x 3* = T (total CFU/organ) 
 
T x O** = CFU/gram of tissue 
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T4NO1 and Xen35 animal inoculations were performed by Mr Ryan Ritchie and Dr 
Kirsty ross. Processing was performed by Mr Ryan Ritchie, Dr Kirsty Ross, Dr Carol 
McInally and author. For T4P2 all inoculations and processing was performed by 
author. 
2.17.3 IVIS imaging 
Mice infected with Xen35 or T4P2 were imaged for 5 minutes while under 
general anesthetic using the IVIS spectrum CCD camera (Xenogen corporation, 
USA). All images were displayed using the same settings in Living image 4.0 
software (Xenogen corporation, USA), to allow comparison between images and 
strains. Images allowed visualization of progression of pneumococcal disease in 
vivo. 
Help was supplied throughout by Mr Ryan Ritchie for animal imaging. 
2.18 RrgB antibody production 
2.18.1 Cloning rrgB into pET-33b  
A partial fragment of the rrgB gene encoding amino acid 40-600 (to remove cross 
reactivity with other pilins) was cloned into pET-33b at restriction sites BamHI 
and HindIII. pET-33b was initially isolated using the QIAprep miniprep kit 
(QIAGEN), digested with the stated restriction enzymes for 3 hours at 37°C and 
then purified using the Wizard® SV gel and PCR clean up system (Promega). rrgB 
was amplified using primers in Table 2-21, with the primers incorporating the 
required restriction sites at the end of the PCR product, the PCR product was 
purified using the Wizard® SV gel and PCR clean up system (Promega) followed 
by restriction digest with the required enzymes as above, followed by a further 
purification and ligation into plasmid (materials and methods 2.2.7).  
Transformation was performed as described into XL1-Blue cells and sample 
plated onto LB agar containing 100µg/ml kanamycin. Positive colonies were 
screened for by PCR using T7 and RrgBR-Ab primers and confirmed by sequencing 
(Table 2-21).  
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pET-33bRrgB plasmid was then purified using the QIAprep miniprep kit (QIAGEN) 
and transformed into BL21(DE3) chemically competent cells, and transformants 
screened for as above. This strain was used for protein expression. 
 
Figure 2-15: Plasmid map of pET-33bRrgB. 
Plasmid map of pET-33bRrgB from CLC Genomics Workbench 4.5.1. Constructed via 
cloning part of rrgB encoding amino acid 40-600 at restriction sites BamHI and HindIII using 
primers in Table 2-21. 
 
Gene Gene 
number 
Primer 
name 
DNA sequence 5’-3’ Size 
(bp) 
rrgB SP_0463 RrgBF AATGGGTCGGGATCCGCATAAACTATTGGCAACAGAT 1731 
  RrgBR-Ab AGTGCGGCCGCAAGCTTTTAATAAGAAGTTGCAGTGACTTC  
  Pet T7 TAATACGACTCACTATAGGG  
Table 2-21: Primers used for cloning of rrgB into pET33b. 
Primers and related information used for cloning and confirmation of insertion of rrgB into 
pET33b for protein expression and purification. Dark Blue nucleotides indicate region of the 
primer specific to the gene being amplified. Red indicates the stop codon incorporated at 
the end of the rrgB gene sequence. Light blue and green represent BamHI and HindIII 
restriction site respectively. 
 
2.18.2 RrgB protein purification 
2.18.2.1 Expression 
BL21(DE3) pET33bRrgB was grown in 10ml LB overnight containing 100µg/ml 
kanamycin. The starting culture in the morning was inoculated into 1 liter of LB 
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containing 100µg/ml kanamycin and cells were grown at 37°C, 220rpm until 
OD600nm 0.8 was reached, IPTG (Melford, UK) was added to a final concentration 
of 1mM and cells grown at 30°C, 220rpm for a further 4 hours. Culture was then 
centrifuged at 4000g for 40 minutes (Beckman" J-6B centrifuge) supernatant 
decanted and pellets stored at -20°C until purification.  
2.18.2.2 Purification 
Cell pellet was resuspended in 50ml PBS, Benzamidine and DNase 1 added 
(Sigma-Aldrich, UK) and sonicated on ice with rotation for 4x 30 seconds with 1 
minute in between each at 84% amplitude. Samples were further centrifuged for 
45 minutes at 4°C at 17,000g (4K15 centrifuge), pellet discarded and supernatant 
filtered using a 0.2µm filter and placed in a fresh falcon tube. 
Due to the addition of 6 Histidines at the C-terminal of RrgB in pET33b the Initial 
purification step consisted of Nickel affinity chromatography. A 1ml HisTrap HP 
(GE Healthcare, Fisher Scientific, UK) nickel affinity column was charged by 
running through 5ml of 0.2M nickel solution (benchtop peristaltic pump, 
masterflex C/L). Sample was then looped through the column for 30 minutes 
using a benchtop peristaltic pump, leaving the protein bound to the column. To 
elute the protein off the column 15ml of elution buffer was run through the 
column using a peristaltic pump and fractions collected on ice manually. Elution 
buffer consisted of dilutions made of a 0.5M NaCl and 0.5M imidazole pH7.4 
solution made with PBS, giving final solution concentrations of 0.03125M, 
0.0625M, 0.125M, 0.175M, 0.25M and 0.5M. Buffers were run through the column 
as above starting with the lowest concentration. As the buffer concentration 
increases imidazole displaced the bound protein, all collected fractions were run 
on a SDS gel (Figure 2-16). Fractions 0.175M, 0.125M and 0.0625 were pooled and 
purified further by anion exchange chromatography. Samples were dialysed 
overnight at 4°C and buffer exchanged into in 20mM Tris-HCl pH7.4.  
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Figure 2-16: Coomassie stained gel of nickel affinity chromatography elution fractions 
during RrgB purification. 
Boxed are the three fractions containing the 64kDa RrgB protein, three fractions were 
pooled and taken forward to anion exchange. Left is size in kDa of bands from the 
SeeBlue"  Plus2 pre-stained ladder. 
 
To begin anion exchange 20ml anion exchange starter buffer (20mM Tris-Hcl 
pH8.0) was run through a HiTraP™ Capto™Q column followed by the pooled 
dialysed protein fractions for 30 minutes to allow protein to bind. Column was 
transferred to the ÄKTAprimer plus (GE Healthcare, Fisher Scientific, UK) and an 
anion exchange protocol performed eluting protein in fractions using a gradient 
of anion exchange elution buffer ranging from 0- 1M NaCl (20mM Tris-HCl pH8.0). 
Following anion exchange fractions were run on a SDS gel (Figure 2-17) and 
fractions 14-19 pooled, dialysed overnight at 4°C in PBS. Purified protein was 
used for antibody production (2.18.3). 
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Figure 2-17: Coomassie stained gel of anion exchange chromatography elution fractions 
during RrgB purification. 
Boxed are the six fractions containing the 64kDa RrgB protein, these fractions were pooled 
and used for later experiment. Left is size in kDa of bands from the SeeBlue"  Plus2 pre-
stained ladder. 
 
2.18.3 Antibody production 
Anti-RrgB antibody was made via vaccinating five MF1 mice with purified RrgB 
protein. Mice were vaccinated subcutaneously with 10µg of purified RrgB protein 
emulsified in 50µl of Freunds adjuvant incomplete (Sigma-Aldrich, UK) made to 
100µl with PBS, on three occasions, with two week intervals between each 
vaccination. Two weeks after the final vaccination mice were culled via terminal 
exsanguination under general anesthetic and death confirmed by cervical 
dislocation. The blood was transferred to sterile 1.5ml eppendorfs and stored at 
4°C overnight for the blood to clot and then spun at 13,000g for 10 minutes at 
4°C (1K15 centrifuge, Sigma-Aldrich, UK), the clear sera was removed into fresh 
1.5ml eppendorfs and pooled from all 5 mice. The antibody specificity for RrgB 
was tested by western blotting and subsequently used for all FACS experiments. 
Vaccination and bleeds were performed by Dr Kirsty Ross. 
  
 
 
 
 
 
 
 
 
3 Virulence gene regulation by two-component 
signal transduction systems 
Chapter 3 
 
132 
3.1 Aims of this chapter 
In S.pneumoniae there are 13 TCS and one orphan response regulator (ORR) 
(Lange et al., 1999), described in chapter 1.7.1.1. The aim of the work 
described in this chapter is to assess virulence gene regulation by TCS (two-
component signal transduction systems), determined via microarray analysis of 
single TCS mutants. As well as looking at virulence factors regulated by these 
systems in these single knockouts the expression levels of all the other RR of TCS 
pairs were evaluated elucidating whether there is potential cross regulation 
between the systems and whether a hierarchy exists. Initial experiments were 
performed on a rr08 and rr09 knockout constructed in TIGR4 assessing the global 
expression changes seen upon their deletion. Further analysis was performed 
looking at what effects removal of both systems has to global expression 
changes. 
Interestingly deletion of six TCS (TCS03, TCS05, TCS06, TCS08, TCS09 and TCS10) 
in the pneumococcus have shown to cause changes in the expression of the 
pneumococcal pilus. To further assess the potential interactions between TCS a 
knockout was constructed in rr06, and from this construction of a number of 
double mutants (T4&rr086 and T4&rr096) and a triple mutant (T4&rr0986) 
performed. As all single mutants have been shown to regulate the pilus, in these 
mutants the expression levels of the whole pilus islet was evaluated by RT-PCR, 
to illuminate further any potential cross regulation between the systems. FACS 
analysis was also performed on all strains to assess potential changes in 
expression of the pilus at the population level. Due to time limitations no 
mutants were constructed in TCS10, TCS05 and TCS03. Adherence capabilities of 
these TCS mutants were also assessed to different cell lines to try and pinpoint 
where these TCS may be important in vivo, during pneumonia, meningitis or 
colonisation.  
Studies performed on TCS are often performed in different parental strains and 
under different laboratory conditions, which can make it hard to compare 
between their functions reported in the literature. TCS have been shown to 
regulate different genes in different strains and under different growth 
conditions, therefore this study enables clear comparisons to be made with 
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regards to what genes are commonly regulated by RR09 and RR08 under the 
same conditions and how these systems may interact with one another. 
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3.2 Genes regulated by RR08 
Initial analysis was performed on T4&rr08 to assess gene regulation by this TCS 
and its regulation of other transcription regulators including other TCS. A total 
of 57 genes were differentially regulated in T4&rr08 compared to T4JH, (Table 
3-1). When increasing the P value to P<0.1 a total of 131 genes were 
differentially regulated (data not shown). 
Gene Description Abbrev 
Fold 
change 
SP_0043  Competence factor transport protein comB 1.8 
SP_0044  Phosphoribosylaminoimidazole-succinocarboxamide purM 15.5 
SP_0048  Glycinamide ribonucleotide transformylase purN 17.0 
SP_0049  vanZ protein vanZ 15.6 
SP_0050  phosphoribosylamine purH 14.5 
SP_0051  Hypothetical protein  14.0 
SP_0053  Phosphoribosylaminoimidazole carboxylase purE 14.4 
SP_0055  Hypothetical protein  4.3 
SP_0271  Ribosomal protein S12 rpsL 1.2 
SP_0288  Xanthine/ uracil permease protein  6.9 
SP_0409  Hypothetical protein  4.6 
SP_0461  Transcriptional regulator rlrA 2.1 
SP_0462  Cell surface anchor family protein rrgA 1.9 
SP_0626  Branched chain amino acid transport system  1.4 
SP_0703  Hypothetical protein  2.1 
SP_0785  Hypothetical protein  2.1 
SP_0786  ABC transporter  2.0 
SP_0802  ATP dependant DNA helicase  1.1 
SP_0820  ATP dependant Clp protease clpE 1.2 
SP_0825  5,10-methylene tetrahydrofolate dehydrogenase folD 1.1 
SP_0918  Spermidine synthase speE 1.4 
SP_1225  VicX protein vicX 1.7 
SP_1226  Histidine kinase 02 hk02 1.7 
SP_1227  Response regulator 02 rr02 1.6 
SP_1228  A/G specific adenine glycosylase  2.6 
SP_1269  Choline kinase  1.3 
SP_1357  ABC transporter  1.4 
SP_1368  PSR protein psr 1.8 
SP_1369  Prephenate dehydratase pheA 2.0 
SP_1370  Shikimate kinase aroK 1.9 
SP_1371  3-phosphoshikimate 1- carboxyvinyltransferase aroA 1.8 
SP_1501  ABC transporter  1.5 
SP_1527  ABC transporter aliB 3.3 
SP_1552  Cation efflux pump mntE 1.2 
SP_1587  Oxalate: formate antiporter  6.6 
SP_1626  Ribosomal protein S15 rspO 1.5 
SP_1697  ATP dependant DNA helicase recG 1.4 
SP_1699  Phosphopantetheinyl transferase acpS 1.4 
SP_1701  Phospho-2-dehydro-3-deoxyheptonate aldolase aroG 1.5 
SP_1709  GTP binding protein engA 1.3 
SP_1802  Hypothetical protein  2.3 
SP_1804  General stress protein 24  2.4 
SP_1814  Tryptophan biosynthesis trpC 2.1 
SP_1862  Hypothetical protein  1.5 
SP_1871  Iron ABC transporter fecE 3.6 
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SP_1978  Diaminopimelate decarboxylase lysA 1.7 
SP_1986  Hypothetical protein  1.8 
SP_1987  ABC transporter, ATP binding protein  1.7 
SP_1988  Immunity protein, putative  1.9 
SP_2072  Glutamate amidotransferase guaA 4.1 
SP_2077  Transcriptional repressor, putative argR 1.2 
SP_2078  Aminoacyl-tRNA synthetase argS 1.4 
SP_2095  5-formyltetrahydrofolate cyclo-ligase family  1.4 
SP_2105  Hypothetical protein  1.9 
SP_2167  L-fuculose kinase fucK 5.3 
SP_2194  ATP dependant Clp protease  1.4 
SP_2201  Choline binding protein D cpbD 1.9 
Table 3-1 : Table of genes differentially regulated in T4&rr08 
Table shows genes differentially regulated in T4&rr08 compared to its parent T4JH (P<0.05). 
Fold change represents that seen in T4&rr08 compared to T4JH, red showing genes up 
regulated in T4&rr08 and blue are those that are down regulated. 
 
Genes that are regulated by RR08 include a number of the genes present on the 
pilus islet, which are up regulated in T4&rr08 including the rlrA regulator. A 
number of genes involved in purine biosynthesis (SP_0044/ SP_0048/ SP_0050/ 
SP_0053) and the virulence factor cbpD are also up regulated upon RR08 
deletion. The transcriptional repressor argR is down regulated in T4&rr08, which 
may be responsible for some of the genes that are differentially regulated in 
T4&rr08, discussed later. A number of ABC transporter including one for iron, a 
PTS system, and a manganese efflux pump are also all differentially regulated in 
the knockout. Interestingly both rr02 and hk02 are up regulated in T4&rr08, 
which suggest RR08 is a repressor of this TCS. Alternatively TCS02 expression 
could be modulated indirectly by RR08 as deletion of rr08 could cause a stress 
on the cell which induces expression of this gene.  
RR02 is part of TCS02 which is also referred to as vicRK, micAB, yycFG and 
walRK, this system was shown to be differentially regulated by microarray 
analysis of T4&rr08. So RT-PCR analysis was performed to confirm this change 
and the expression levels of all the other RR were also evaluated (Figure 3-1), as 
subtle changes may not have been identified by microarray analysis. RT-PCR 
analysis confirmed there is a trend towards an increase in expression of rr02 in 
T4&rr08 however this was not statistically significant, perhaps due to the small 
change, and would need further validation. Interestingly a statistically 
significant down regulation of rr01 was observed by RT-PCR, which was not 
observed during microarray analysis suggesting RR08 positively regulates this 
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TCS. Although some of the other RR including rr07, rr09 and rr12 look to show a 
small down regulation these were not statistically significant. With regards to 
the other genes shown to regulate the pilus there seems to be no expression 
change in the TCS known to regulate the pilus (rr03, rr05, rr06, rr10). RT-PCR 
analysis and microarray analysis also did not show any other genes shown to 
regulate the pilus to be differentially regulated by RR08, other than that of 
mntE. However MntE is unlikely to modulate pilus expression through its direct 
binding to the islet, so RR08 may act through direct binding to the pilus islet. A 
summary of the major genes regulated by RR08 can be seen in Figure 3-2, 
including virulence factors, transcription regulators and groups of genes showing 
a big expression difference in T4&rr08. 
 
Figure 3-1: RT-PCR graph of response regulator expression in T4&rr08. 
Graph shows RT-PCR of all the pneumococcal response regulators in T4&rr08. Fold change 
represents that T4&rr08 compared to T4JH. Each bar represents the average of three 
replicas (three biological replicas) and errors bars the standard deviation. Statistical 
analysis was performed by a 1-way ANOVA with a Tukeys testing correction comparing the 
dCt values of the control strain (TIGR4) to the test strain (T4&rr08), * P<0.05. 
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Figure 3-2: Summary of genes regulated by RR08 
Summary of genes regulated by RR08 has been compiled from microarray and RT-PCR 
data. Arrow represents RR08 positively regulating the gene and a bar represent RR08 
repression of the gene. Values indicate the fold change of the gene observed during 
microarray analysis or RT-PCR in T4&rr08. 
 
3.3 Genes regulated by RR09 
Further microarray analysis was performed on T4&rr09, which has also previously 
been shown to regulate the pneumococcal pilus. A total of 43 genes were shown 
to be differentially regulated between T4&rr09 and its parent strain T4JH, 
shown in Table 3-2. When increasing the P value to P<0.1 a total of 87 genes 
were shown to be differentially regulated between the two (data not shown). 
Gene Description Abbrev 
Fold 
change 
SP_0047  Phosphoribosylaminoimidazole synthetase purM 11.8 
SP_0048  Glycinamide ribonucleotide transformylase purN 11.5 
SP_0055  Hypothetical protein  2.2 
SP_0117  Pneumococcal surface protein A pspA 2.3 
SP_0287  Xanthine/ uracil permease protein  4.2 
SP_0290  Dihydrofolate synthetase folC 2.4 
SP_0409  Hypothetical protein  3.6 
SP_0415  Enoyl-CoA hydratase phaB 1.4 
SP_0461  Transcriptional regulator rlrA 4.6 
SP_0463  Cell surface anchor family protein rrgB 5.1 
SP_0464  Cell surface anchor family protein rrgC 6.4 
SP_0648  Beta-galactosidase bgaA 3.8 
SP_0715  Lactate oxidase lctO 2.2 
SP_0862  Ribosomal protein S1 rpsA 1.2 
SP_0868  Hypothetical protein  1.7 
SP_0875  Lactose phosohotransferase system repressor lacR 15.2 
SP_0876  Phosphofruktokinase fruB 14.0 
SP_0877  PTS system, fructose specific fruA 13.4 
SP_1225  VicX protein vicX 1.5 
SP_1501  ABC transporter  1.3 
SP_1578  Hypothetical protein  1.6 
SP_1675  ROK family protein glk 2.1 
SP_1676  N-acetyl neuraminate lyase npl 2.5 
SP_1677  Hypothetical protein  2.6 
SP_1682  ABC transporter  3.2 
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SP_1708  Hypothetical protein  3.0 
SP_1724  Sucrose-6-phosphate hydrolase scrB 12.7 
SP_1801  Hypothetical protein  2.6 
SP_1803  Hypothetical protein  2.7 
SP_1804  General stress protein 24  2.8 
SP_1853  Galactokinase galK 6.1 
SP_1884  Trehalosse PTS system treP 3.5 
SP_1895  Sugar ABC transporter msmG 10.8 
SP_1896  Sugar ABC transporter msmF 10.5 
SP_1897  Sugar ABC transporter msmE 10.4 
SP_1898  Alpha-galactosidase aga 12.5 
SP_1922  Hypothetical protein  2.0 
SP_1924  Hypothetical protein  2.3 
SP_1925  Hypothetical protein  2.3 
SP_1967  Hypothetical protein  1.2 
SP_2063  lysM domain containing protein  1.6 
SP_2107  4-alpha-gluconotransferase malM 1.7 
SP_2150  Ornithine carbamoyltransferase argF 3.8 
Table 3-2 : Table of genes differentially regulated in T4&rr09 
Table shows genes differentially regulated in T4&rr09 compared to its parent T4JH (P<0.05). 
Fold change represents that seen in T4&rr09 compared to T4JH, red showing genes up 
regulated in T4&rr09 and blue are those that are down regulated. 
 
No TCS were differentially regulated in a rr09 knockout strain as determined by 
microarray analysis. However RT-PCR was performed to assess the expression 
levels of all the other RR incase as seen in T4&rr08 some were differentially 
regulated yet not detected by microarray analysis. RT-PCR analysis of rr 
expression in T4&rr09 showed a potential down regulation of rr01, rr07 and rr08 
suggesting RR09 acts as a positive regulator of these TCS (Figure 3-3). However 
none were found to be statistically significant.  
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Figure 3-3: RT-PCR graph of response regulator expression in T4&rr09. 
Graph shows RT-PCR of all the pneumococcal response regulators in T4&rr09. Fold change 
represents that T4&rr09 compared to T4JH. Each bar represents the average of three 
replicas (three biological replicas) and errors bars the standard deviation. No statistical 
difference was observed. 
 
A summary of the genes regulated by RR09 can be seen below in Figure 3-4. 
Encompassing virulence factors, transcription regulators and groups of genes 
showing a big expression difference in T4&rr09. When comparing this to what 
genes are regulated by RR08 we see a number of similarities, both repress the 
expression of the pilus islet and genes involved in purine biosynthesis. They 
potentially both regulate RR01 to a similar level (not significant difference in 
T4&rr09) and RR09 may positively regulate RR08, however again this difference 
was not seen as significant. 
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Figure 3-4: Summary of genes regulated by RR09 
Summary of genes regulated by RR09 has been compiled from microarray and RT-PCR 
data. Arrow represents RR08 positively regulating the gene and a bar represent RR09 
repression of the gene. Values indicate the fold change of the gene observed during 
microarray analysis or RT-PCR in T4&rr09. 
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3.4 Genes differentially regulated in T4&rr098 
To try and understand further the potential cross regulation of these TCS a 
double knockout was constructed and microarray analysis performed on this 
strain. A total of 122 genes were differentially regulated in the double knockout 
compared to the parent strain T4JH, shown in Table 3-3. When increasing the P 
value to P<0.1 a total of 327 genes are differentially regulated (data not shown). 
Gene Description Abbrev 
Fold 
change 
SP_0004  GTP dependant nucleic acid binding protein engD 1.3 
SP_0044  Phosphoribosylaminoimidazole-succinocarboxamide purM 13.1 
SP_0048  Glycinamide ribonucleotide transformylase purN 12.3 
SP_0049  vanZ protein vanZ 12.3 
SP_0050  phosphoribosylamine purH 9.3 
SP_0051  Hypothetical protein  13.1 
SP_0053  Phosphoribosylaminoimidazole carboxylase purE 9.8 
SP_0054  Phosphoribosylaminoimidazole carboxylase purK 11.1 
SP_0055  Hypothetical protein  3.1 
SP_0056  Adenylosuccinate lyase purB 2.2 
SP_0063  PTS system IID component  2.5 
SP_0064  PTS system IIA component  2.0 
SP_0066  Aldolase-1 epimerase  2.0 
SP_0099  Hypothetical protein  1.5 
SP_0107  LysM domain containing protein  2.3 
SP_0199  Cardiolipin synthetase cls 1.5 
SP_0201  Hypothetical protein  1.6 
SP_0258  Hypothetical protein  1.9 
SP_0259  Hypothetical protein ruvB 1.2 
SP_0288  Hypothetical protein  6.5 
SP_0290  Dihydrofolate synthetase folC 2.1 
SP_0341  Hypothetical protein  1.3 
SP_0409  Hypothetical protein  4.0 
SP_0419  Enoyl-(acyl-carrier protein) reductase fabK 1.4 
SP_0422  3-oxacyl-(acyl-carrier protein) synthase II fabF 1.3 
SP_0461  Transcriptional regulator rlrA 4.4 
SP_0462  Cell surface anchor family protein rrgA 3.6 
SP_0464  Cell surface anchor family protein rrgC 2.9 
SP_0467  Sortase srtC 4.1 
SP_0468  sortase srtD 2.8 
SP_0487  Hypothetical protein  1.4 
SP_0626  Branched chain amino acid transport system   1.6 
SP_0627  Hypothetical protein  1.3 
SP_0657  Ribonuclease BN, putative  1.2 
SP_0688  UDP-N-acetly muramoylalanine- D-glutamate ligase murD 1.2 
SP_0689  
Undecaprenyldiphospho-muramoylpentapeptide 
beta-N-acetylglucosaminyltransferase 
murG 
1.1 
SP_0703  Hypothetical protein  1.6 
SP_0720  ABC transporter ATP binding protein  1.3 
SP_0742  Hypothetical protein  2.2 
SP_0746  ATP dependant clp protease clpP 1.3 
SP_0784  Glutathione reductase  1.4 
SP_0785  Hypothetical protein  2.3 
SP_0786  Hypothetical protein  2.2 
SP_0787  Hypothetical protein  2.0 
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SP_0790  Hypothetical protein  1.2 
SP_0811  Transposase family protein  1.2 
SP_0820  ATP dependant Clp protease clpE 1.4 
SP_0835  Purine nuceloside phosphorylase deoD 1.3 
SP_0898  Transcriptional repressor, degenerate  1.2 
SP_0966  Adherence and virulence protein A pavA 1.1 
SP_1018  Thymidine kinase tdk 1.2 
SP_1023  acetyltransferase  1.3 
SP_1026  Hypothetical protein  1.8 
SP_1070  Hypothetical protein  1.4 
SP_1103  Hypothetical protein  1.4 
SP_1107  Ribosomal protein L27 rpmA 1.3 
SP_1114  ABC transporter, ATP binding protein  1.2 
SP_1119  Glyceraldehyde-3-phosphate dehydrogenase gapdh 1.6 
SP_1160  Lipoate protein ligase  1.7 
SP_1161  Acetoin dehydrogenase, E3 component  1.5 
SP_1162  Dihydrolipoamide acetyltransferase  1.5 
SP_1163  Acetoin dehydrogenase, E1 component  1.5 
SP_1225  VicX protein vicX 1.7 
SP_1226  Histidine kinase 02  1.6 
SP_1227  Response regulator 02  1.8 
SP_1228  A/G specific adenine glycosylase  2.4 
SP_1231  Phoshpopantothenoylcystein decarboxylase  1.6 
SP_1232  Hypothetical protein  1.7 
SP_1249  Guanosine 5’-monophosphate oxido reductase  2.3 
SP_1299  Ribosomal protein L31 type B rpmE2 1.3 
SP_1356  chlorohydrolase Atz 2.0 
SP_1357  ABC transporter, ATP binding/permease protein.  1.7 
SP_1369  Prephenate dehydratase  1.9 
SP_1371  3-phosphoshikimate 1-carboxyvinyltransferase  1.8 
SP_1393  Putative membrane protein pstA 1.6 
SP_1396  Phosphate transporter, ATP binding protein pst 1.3 
SP_1415  Glucosamine-6-phosphate isomerase nagB 1.9 
SP_1427  U32 family peptidase  1.6 
SP_1428  Hypothetical protein  1.5 
SP_1501  Amino acid ABC transporter, ATP binding protein  1.6 
SP_1509  F0F1 ATP synthase gamma subunit alpG 1.1 
SP_1526  ABC transporter authentic frameshift  3.5 
SP_1527  Oligopeptide ABC transporter aliB 3.7 
SP_1532  Authentic frameshift   1.5 
SP_1535  Hypothetical protein  1.3 
SP_1554  tRNA CCA-pyrophosphorylase  1.5 
SP_1572  Starved cell/ iron storage peroxide induced protein dpr 1.4 
SP_1584  Transcriptional repressor codY 1.3 
SP_1587  Oxalate formate antiporter  2.1 
SP_1626  Ribosomal protein S15 rpsO 1.3 
SP_1697  ATP dependant DNA helicase recG 1.4 
SP_1701  Phospho-2-dehydro-3-deoxyheptonate aldolase  1.5 
SP_1708  Hypothetical protein  2.9 
SP_1749  GTP binding protein yqeH 1.1 
SP_1772  Cell wall surface anchor family protein psrP 1.3 
SP_1802  Hypothetical protein  3.1 
SP_1804  General stress protein 24  3.4 
SP_1941  Competence damage inducible protein A cinA 1.3 
SP_1978  Diaminopimelate decarboxylase  1.7 
SP_1983  Ribulose-3-phosphate epimerase  1.4 
SP_1985  Dimethyladenosine transferase ksgA 1.5 
SP_1987  ABC transporter, ATP binding protein  1.9 
SP_1988  Immunity protein, putative  2.0 
SP_2039  Hypothetical protein sapR 1.6 
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SP_2065  MATE efflux family protein  1.6 
SP_2066  Threonine synthase  1.5 
SP_2071  Hypothetical protein  2.0 
SP_2072  Glutamine amidotransferase  3.3 
SP_2073  ABC transporter, ATP binding/permease protein  1.4 
SP_2075  ABC transporter, ATP binding/permease protein  1.6 
SP_2091  
NADH dependant glyceraldehyde-3-phosphate 
dehydrogenase 
gpsA 
1.2 
SP_2095  5-formyltetrahydrofolate cyclo-ligase family  1.3 
SP_2105  Hypothetical protein  1.8 
SP_2148  Arginine deiminase  3.3 
SP_2167  L-fuculose kinase fucK 3.0 
SP_2193  Response regulator 06 cbpS 1.4 
SP_2194  ATP dependant Clp protease  1.7 
SP_2196  ABC transporter, ATP binding protein  1.4 
SP_2198  ABC transporter, permease protein  1.5 
SP_2199  Hypothetical protein  2.1 
SP_2218  Rod shape determining protein mreC 1.2 
SP_2238  rRNA large subunit transferase  1.9 
Table 3-3 : Table of genes differentially regulated in T4&rr098 
Table shows genes differentially regulated in T4&rr098 compared to its parent T4JH 
(P<0.05). Fold change represents that seen in T4&rr098 compared to T4JH, red showing 
genes up regulated in T4&rr098 and blue are those that are down regulated. 
 
RT-PCR analysis was performed to assess the expression levels of the other RR 
after deletion of both rr08 and rr09 (Figure 3-5). Not surprisingly a down 
regulation of rr01 is observed in T4&rr098 as this has already been seen in 
T4&rr08, however this down regulation is more than the fold change observed in 
T4&rr08, which may indicate the change in rr01 expression observed in T4&rr09 
although not significant may be a true change and in the double knockout the 
increased difference is due to the effect of both of these systems. In the double 
knockout a similar down regulation of rr07 to that observed in T4&rr09 alone is 
seen, although again in T4&rr09 this was not significant it may indicate this is a 
true change and suggests RR09 alone acts to regulate RR07. In the double 
knockout rr02 expression was increased to a level similar to that observed in 
T4&rr08 alone as measured by microarray, but in T4&rr098 the increased 
expression of rr02 was not validated by RT-PCR. rr06 was shown to be up 
regulated by microarray analysis in T4&rr098 however again this was not 
validated by RT-PCR. Interestingly in T4&rr098 statistically significant expression 
changes are observed in a number of the other RR that were not seen in the 
single mutants alone, including down regulation of rr04, rr05 and rr13. A direct 
comparison between rr expression differences via RT-PCR in T4&rr08, T4&rr09 
and T4&rr098 can be seen in appendix II. 
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Figure 3-5: RT-PCR graph of response regulator expression in T4&rr098. 
Graph shows RT-PCR of all the pneumococcal response regulators in T4&rr098. Fold 
change represents that of T4&rr098 compared to T4JH. Each bar represents the average of 
three replicas (three biological replicas) and errors bars the standard deviation. Statistical 
analysis was performed by a 1-way ANOVA with a Tukeys testing correction comparing the 
dCt values of the control strain (TIGR4) to the test strain (T4&rr098), * P<0.05, ** P<0.01, *** 
P<0.001. 
 
 
Figure 3-6: Summary of genes regulated by RR09 and RR08 alone or together. 
Summary of genes regulated by RR09 and RR08 has been compiled from microarray and 
RT-PCR data. Arrow represents positively regulated genes and bars represent genes 
repressed. Values indicate the fold change of the gene observed during microarray analysis 
or RT-PCR in T4&rr098. Genes present to either side represent genes regulated by RR09 
and RR08 alone, genes below represent genes regulated by both RR09 and RR08 shown 
from differential regulation upon deletion of both. 
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A summary of the genes regulated by RR08 or RR09 alone and genes regulated by 
both is shown in Figure 3-6. The genes regulated encode virulence factors, 
transcription regulators and includes groups of genes showing a big expression 
difference in T4&rr098. A large number of these changes include genes that are 
not differentially regulated in the single knockout mutants alone. This suggests 
that single knockout mutants can be compensated for by the other systems, in 
the double knockout this cannot happen. 
Direct comparison of the genes regulated by each single mutant and double 
mutant by microarray analysis can be seen in Figure 3-7. Comparisons were 
performed on both the P<0.05 (Figure 3-7) and P<0.1 (appendix V) gene lists 
from each experiment. From this it is clear only a small proportion of genes are 
commonly differentially regulated in all three strains, 7 genes P<0.05 and 22 
genes P<0.1 (appendix V). The majority of these genes show similar expression 
levels in all three knockout mutants suggesting RR08 and RR09 (not significant) 
both regulate these genes equally, perhaps through a common gene regulated by 
both. For instance RR01, which is controlled by RR08 and RR09 and may 
therefore control a common set of genes. However the pilus expression in the 
single RR08 mutant is lower than that of the single RR09 and double mutant. 
Alternatively these systems may respond to a common stress which cannot occur 
when either is deleted leading to differential expression of a common set of 
genes. 
In most instances it is clear that both RR act independently of each other and 
regulate their own set of genes. Only a quarter to half of the genes differentially 
regulated in the single RR09 mutant were seen to also be differentially regulated 
in the double mutant. This was slightly higher in the RR08 single mutant with 
two thirds of the genes regulated in the single mutant seen to also be 
differentially regulated in the double mutant. The fact a large number of genes 
are differentially regulated in the double mutant that are not observed in either 
of the single mutant alone would however suggest they both may converge on 
some of the same pathways and perhaps compensate for the deletion of the 
other. Deletion of both leads to a large collection of genes being differentially 
regulated, with roughly two thirds of all the genes differentially regulated in 
T4&rr098 not seen to be differentially regulated in either of the single mutants. 
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Figure 3-7: Venn diagram of gene commonly regulated by rr08 and rr09 in T4JH. 
Venn diagrams were compiled from our gene expression data of T4&rr08, T4&rr09 and 
T4&rr098. (A) Compares the gene list In Table 3-1, Table 3-2 and Table 3-3 (P<0.05). 
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3.5 TCS regulation of the pneumococcal pilus 
To further assess how TCS may interact with one another, a further set of RR 
mutants were constructed. A deletion mutant of rr06 in T4JH was constructed 
and subsequently transformed into the other RR mutants creating a total of 
seven mutants, the three described previously and T4&rr06, T4&rr096, T4&rr086 
and T4&rr0986. All of the systems chosen have previously been shown to 
regulate the pneumococcal pilus. These mutants were used to assess potential 
cross regulation of these systems via evaluating their effect on pilus islet 
expression.  
Analysis was performed on all mutants comparing the expression level of the 
pilus islet genes by RT-PCR, including the transcription regulator (rlrA), the 
three pilins (rrgA, rrgB, rrgC) and the three sortases (srtB, srtC, srtD). FACS 
analysis was performed to assess the expression of the pilus at the population 
level. To allow systematic evaluation of the effect of each deletion to the 
double and triple mutants the analysis has been split into three sections, 
comparing T4&rr06, T4&rr08, T4&rr086 and T4&rr0986, then T4&rr06, T4&rr09, 
T4&rr096, T4&rr0986, and finally T4&rr08, T4&rr09, T4&rr098 and T4&rr0986.  
3.5.1 Regulation of the pilus in T4!rr06, T4!rr08, T4!rr086 and 
T4!rr0986 
RT-PCR analysis of pilus expression in T4&rr06 showed a decrease in pilus 
expression compared to T4JH (Figure 3-8), this is contrary to its role as a 
repressor stated in the literature. Possible reasons for this will be discussed 
later. In this study, RR06 acts as a positive regulator of the pilus islet. T4&rr08 
pilus expression shows a small increase in pilus expression compared to T4JH, 
validating what is observed via microarray analysis. Interestingly in the double 
mutant (T4&rr086) there is a large increase in pilus expression, which would 
suggest that RR06 acts as a repressor in this instance. Further to this deletion of 
RR09 in T4&rr086 (T4&rr0986) led to a drop in pilus expression to that of levels 
similar to T4&rr08, suggesting in this case RR09 acts as a positive regulator of 
the pilus. 
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Figure 3-8: RT-PCR graph of pilus expression in T4&rr06, T4&rr08, T4&rr086 and T4&rr0986. 
Graph shows RT-PCR of the whole pilus islet (rlrA, rrgA, B, C, srtB, C, D) in T4&rr06, 
T4&rr08, T4&rr086 and T4&rr0986. Fold change represents that of T4&rr06, T4&rr08, 
T4&rr086 and T4&rr0986 compared to T4JH. Each bar represents the average of three 
replicas (three biological replicas) and errors bars the standard deviation. 
 
FACS analysis performed on these mutants showed variation in the level of pilus 
positive cells in a growing population rather than increased levels on a single cell 
(Figure 3-9, Table 3-4). Analysis confirmed the decrease in pilus expression in 
T4&rr06 with only 4% of cells positive for RrgB on the cell surface compared to 
20.5% of that of the parent T4JH, this was also seen via fluorescence microscopy 
(Figure 3-14).  
T4&rr08 had an increase in 17% of RrgB positive cells compared to T4JH. There is 
likely no difference in the amount of pili on single cells with the RrgB positive 
peak lying directly above that of T4JH suggesting a similar fluorescence intensity 
of RrgB positive cells (similar levels of pili), fluorescence microscopy confirmed 
the increase in pili positive cells shown inFigure 3-14.  
T4&rr086 had 57% of RrgB positive cells within a growing population confirmed in 
Figure 3-14, this is 37% more than in T4JH, 20% higher than T4&rr08 and 53% 
higher than T4&rr06. Interestingly by FACS analysis there is only one large peak 
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compared to that of the normal double peak showing clear RrgB positive and 
negative populations. This larger peak is also shifted to the left suggesting a 
decrease in fluorescence intensity of the RrgB positive cells compared to T4JH 
and the other mutants. This suggests deletion of both RR06 and RR08 causes the 
cells to lose the ability to regulate the amount of pili on the cell surface, as well 
as that at the population level. 
Further deletion of RR09 in T4&rr086 caused the pilus expression to drop. With 
T4&rr0986 showing only 27% of cells to be RrgB positive shown in Figure 3-14, 
this is only 7% higher than that of T4JH. In this mutant we again see two distinct 
peaks representing that of RrgB positive and negative populations, with the 
positive population of a similar fluorescence intensity to T4JH and T4&rr08. 
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Figure 3-9: FACS analysis of RrgB surface expression in T4&rr06, T4&rr08, T4&rr086 and 
T4&rr0986. 
FACS was performed on T4JH, T4&rr06, T4&rr08, T4&rr086, T4&rr0986 and T4!rrgB. (A) 
Shows histograms of the capsule positive populations selected for from samples stained 
with a capsule antibody, population used for further analysis. (B) Shows the capsule stained 
populations being gated on for being RrgB positive, histograms/ polychromatic plot show 
negative (left) and positive (right) RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4JH 79.5 20.5 
T4"rr06 95.9 4.1 
T4"rr08 63.1 36.9 
T4"rr086 42.8 57.2 
T4"rr0986 73.1 26.9 
T4"rrgB 98.4 1.6 
Table 3-4: Percentage RrgB positive cells in a T4&rr06, T4&rr08, T4&rr086 or T4&rr0986 
population from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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3.5.2 Regulation of the pilus in T4!rr06, T4!rr09, T4!rr096 and 
T4!rr0986 
The RT-PCR data for T4&rr06 and T4&rr0986 is that already discussed in section 
3.5.1, with an increase in pilus expression observed in T4&rr0986 and a decrease 
seen in T4&rr06 (Figure 3-10). This data confirms the findings observed by 
microarray analysis for T4&rr09, as all the pilus islet genes are statistically up 
regulated in this strain. Deletion of RR09 in T4&rr06 creating T4&rr096 shows a 
drop in expression compared to T4&rr09 but an increase compared to T4&rr06, 
with expression levels of the pilus islet now only marginally higher than that of 
T4JH. Further deletion of RR08 in T4&rr096 causes little difference in the 
expression levels of the pilus islet compared to T4&rr096.  
 
Figure 3-10: RT-PCR graph of pilus expression in T4&rr06, T4&rr09, T4&rr096 and 
T4&rr0986. 
Graph shows RT-PCR of the whole pilus islet (rlrA, rrgA, B, C, srtB, C, D) in T4&rr06, 
T4&rr09, T4&rr096 and T4&rr0986. Fold change represents that of T4&rr06, T4&rr09, 
T4&rr096 and T4&rr0986 compared to T4JH. Each bar represents the average of three 
replicas (three biological replicas) and errors bars the standard deviation. 
 
FACS analysis was performed comparing the RrgB surface exposure of these TCS 
mutants (Figure 3-11, Table 3-5). As already discussed a T4&rr06 knockout shows 
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only 4% of cells positive for RrgB on the cell surface. Upon deletion of RR09 we 
know from earlier that we see an increase in pilus expression and this 
corresponds to an increase in the number of cells expressing RrgB on the cells 
surface compared to T4JH. 91% of cells upon RR09 deletion contain pili on the 
surface (confirmed by fluorescence microscopy,Figure 3-14), this is 70% more 
than that of T4JH. Interestingly there is one large peak similar to T4&rr086, 
suggesting an inability to regulate the cell surface constituents. However the 
RrgB positive peak lies above that of T4JH, T4&rr096 and T4&rr0986 suggesting 
the amount of pili on the single cells is similar, and there is not large shift to the 
left as observed with T4&rr086. 
Deletion of RR06 in T4&rr09 causes a large drop in the number of pili positive 
cells with only 28% of cells pili positive in T4&rr096 (Figure 3-14). Again there 
are two peaks representing RrgB positive and negative populations. Further 
deletion of RR08 in T4&rr096 has little effect on the number of pili positive cells 
with 27% of cells positive for RrgB on the cell surface. The fact there is only 1% 
difference between T4&rr096 and T4&rr0986 may suggest that without the 
presence of RR06 and RR09 RR08 is unable to perform its role in regulating pilus 
expression. 
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Figure 3-11: FACS analysis of RrgB surface expression in T4&rr06, T4&rr09, T4&rr096 and 
T4&rr0986. 
FACS was performed on T4JH, T4&rr06, T4&rr09, T4&rr096, T4&rr0986 and T4!rrgB. (A) 
Shows histograms of the capsule positive populations selected for from samples stained 
with a capsule antibody, population used for further analysis. (B) Shows the capsule stained 
populations being gated on for being RrgB positive, histograms/ polychromatic plot show 
negative (left) and positive (right) RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4JH 79.5 20.5 
T4"rr06 95.9 4.1 
T4"rr09 9.3 90.7 
T4"rr096 71.8 28.2 
T4"rr0986 73.1 26.9 
T4"rrgB 98.4 1.6 
Table 3-5: Percentage RrgB positive cells in a T4&rr06, T4&rr09, T4&rr096 or T4&rr0986 
population from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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3.5.3 Regulation of the pilus in T4!rr08, T4!rr09, T4!rr098 and 
T4!rr0986 
The RT-PCR data has already been described above in sections 3.5.1 and 3.5.2 
for pilus islet expression of T4&rr08, T4&rr09 and T4&rr0986, this data compares 
the pilus expression in these strains and T4&rr098 (Figure 3-12). Interestingly 
pilus expression in T4&rr098 is lower than that of T4&rr09, which was not clear 
from microarray analysis, and higher than that of T4&rr08. Therefore deletion of 
rr08 in T4&rr09 causes a decrease in pilus expression. Deletion of RR06 in 
T4&rr098 causes a further drop in pilus expression, which is at a similar level to 
that of T4&rr08. 
 
Figure 3-12: RT-PCR graph of pilus expression in T4&rr08, T4&rr09, T4&rr098 and 
T4&rr0986. 
Graph shows RT-PCR of the whole pilus islet (rlrA, rrgA, B, C, srtB, C, D) in T4&rr08, 
T4&rr09, T4&rr098 and T4&rr0986. Fold change represents that of T4&rr08, T4&rr09, 
T4&rr098 and T4&rr0986 compared to T4JH. Each bar represents the average of three 
replicas (three biological replicas) and errors bars the standard deviation. 
 
FACS analysis on T4&rr08, T4&rr09 and T4&rr0986 has already been described 
above in sections 3.5.1 and 3.5.2. T4&rr098 pilus expression level as already 
shown by RT-PCR is in between that of T4&rr08 and T4&rr09. FACS analysis 
confirmed this with 56% of cells positive for RrgB on the cell surface in T4&rr098 
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compared to T4&rr08 (37%) and T4&rr09 (91%) (Figure 3-13, Table 3-6). Deletion 
of RR08 in T4&rr09 restored the two clear populations (RrgB positive and 
negative). Similar pili positive cell numbers were observed in T4&rr086 (57%). 
However only one large peak was observed during FACS analysis, which was not 
seen in T4&rr098. This can also be observed via fluorescence microscopy shown 
in Figure 3-14. 
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Figure 3-13: FACS analysis of RrgB surface expression in T4&rr08, T4&rr09, T4&rr098 and 
T4&rr0986. 
FACS was performed on T4JH, T4&rr08, T4&rr09, T4&rr098, T4&rr0986 and T4!rrgB. (A) 
Shows histograms of the capsule positive populations selected for from samples stained 
with a capsule antibody, population used for further analysis. (B) Shows the capsule stained 
populations being gated on for being RrgB positive, histograms/ polychromatic plot show 
negative (left) and positive (right) RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4JH 79.5 20.5 
T4"rr08 63.1 36.9 
T4"rr09 9.3 90.7 
T4"rr098 44 56 
T4"rr0986 73.1 26.9 
T4"rrgB 98.4 1.6 
Table 3-6: Percentage RrgB positive cells in a T4&rr08, T4&rr09, T4&rr098 or T4&rr0986 
population from FACS analysis.  
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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Figure 3-14: Fluorescence microscopy of TCS mutants  
One representative images of fluorescently labelled TCS mutants used for FACS analysis. 
Cells were stained for the presence of RrgB (FITC) and the capsule (APC). Scale bars above 
represent, T4JH-140µm, T4&rr06 - 140µm, T4&rr08 - 210µm and T4&rr09 - 140µm. The same 
representative image will be used throughout this study for each strain, more images with 
can be seen in appendix I. 
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Figure 3-15: Fluorescence microscopy of TCS mutants  
One representative images of fluorescently labelled TCS mutants used for FACS analysis. 
Cells were stained for the presence of RrgB (FITC) and the capsule (APC). Scale bars above 
represent, T4JH-140µm, T4&rr086 - 22µm, T4&rr096 - 14µm, T4&rr098 - 140µm and 
T4&rr0986 - 140µm. The same representative image will be used throughout this study for 
each strain, more images with can be seen in appendix I. 
 
With regards to the pneumococcal pilus being regulated at the population level, 
currently only one gene has been shown to modulate this function, which is 
RrgA. RrgA has been shown to bind directly to RlrA through a protein-protein 
interaction and modulate RlrAs ability to positively regulate the pilus islet. Upon 
deletion of rrgA almost all cells within a growing population are shown to 
contain pili on the cell surface (Basset et al., 2011, Basset et al., 2012). All of 
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the TCS have been shown to modulate the pilus at the population level, 
therefore direct comparisons were made between the expression levels of rrgA 
and rlrA of all TCS mutants, shown in Figure 3-16. This RT-PCR data has already 
been shown previously in sections 3.5.1, 3.5.2 and 3.5.3 along with the 
expression of the other genes present on the islet. This graph provides a direct 
comparison between the rrgA and rlrA expression levels in all of the TCS 
mutants. This data may indicate if the regulation at the population level of the 
pilus by TCS is through modulating the expression levels of rlrA and rrgA. 
However it must be kept in mind that RNA for RT-PCR was isolated from all the 
bacterial cells present in a growing population, and therefore this analysis gives 
the average expression of these genes in the whole population, which must vary 
from cell to cell as FACS analysis has shown in all mutants different numbers of 
pili positive and negative cells. 
 
Figure 3-16: RT-PCR graph of rlrA and rrgA expression in TCS mutants 
Graph shows RT-PCR of rlrA and rrgA in all the TCS mutants. The data represented here is 
that already seen in previous graphs, this graph provides a direct comparison of rlrA and 
rrgA levels in all TCS mutants. Fold change represents that of T4&rr08, T4&rr09, T4&rr098 
and T4&rr0986 compared to T4JH. Each bar represents the average of three replicas (three 
biological replicas) and errors bars the standard deviation. Statistical analysis was 
performed by a 1-way ANOVA with a Tukeys testing correction comparing the dCt values of 
the control strain (TIGR4) to the test strain (TCS mutant), * P<0.05, **P<0.01, ***P<0.001. 
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With regards to the TCS modulating the rlrA and rrgA levels this seems to be the 
case for T4&rr086, which shows a much higher level of rlrA relative to rrgA. This 
may be why there is a large increase in pili positive cells in this strain. Other 
strains show a similar pattern such as T4&rr096 and T4&rr0986 which show 
moderately higher expression levels of rlrA relative to rrgA. This is not the case 
for T4&rr08 and T4&rr098 however as the difference in the expression of both 
genes is small. T4&rr06 has a clear drop in both rlrA and rrgA expression levels, 
the decrease in rrgA expression is higher than rlrA so is likely not modulated via 
the repression of the islet through binding of RrgA to RlrA. Interestingly T4&rr09 
shows very similar expression levels of rlrA and rrgA yet shows the biggest 
increase in pili positive cells, with 91% of cells pili positive in T4&rr09. This 
suggests RR09 modulates its activity by an alternative means than through 
changing the expression levels of rrgA and rlrA. The phenotype of almost all 
cells being pili positive in T4&rr09 is similar to that of the rrgA knockout noted 
in the literature. Therefore RR09 may act to modulate in some way the protein-
protein interaction of RlrA and RrgA. 
3.5.4 Expression of other RR in TCS mutants 
RT-PCR analysis was also performed on TCS mutants to assess whether deletion 
of any RR altered the expression levels of any of the others, focusing on rr06, 
rr08 and rr09. This may give an indication if one of the studied RR regulates 
another, modulating pilus expression through regulation of another.  
RT-PCR analysis showed no variation in rr06 expression in T4&rr08, T4&rr09 and 
T4&rr098 (Figure 3-17), this data has already been seen for T4&rr08, T4&rr09 
and T4&rr098, but below directly compares this on the same graph. rr08 
expression was slightly lower in T4&rr09 and T4&rr096 however neither were 
statistically significant perhaps due to the small change, but as this is seen in 
both mutants this could be a true change and RR09 may positively regulate rr08 
expression. rr09 expression is slightly lower in T4&rr08 suggesting RR08 may 
regulate rr09 expression, however this was not seen in T4&rr086, and neither 
were noted to be statistically different. 
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Figure 3-17: RT-PCR graph of RR expression in TCS mutants. 
Graph shows (A) RT-PCR of rr06 expression in T4&rr08, T4&rr09 and T4&rr098, (B) RT-PCR 
of rr08 expression in T4&rr06, T4&rr09 and T4&rr096, (C) RT-PCR of rr09 expression in 
T4&rr06, T4&rr08 and T4&rr086. Fold change represents that of the TCS mutant compared to 
T4JH. Each bar represents the average of three replicas (three biological replicas) and 
errors bars the standard deviation. No statistical difference was observed. 
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3.6 Adherence assay analysis of TCS mutants 
All RR mutants were tested for their ability to adhere to different cell lines. A 
number of the TCS have been shown to regulate pneumococcal virulence factors 
and adhesins, which affect adherence. None of the genes required for capsule 
biosynthesis were shown to be differentially regulated in T4&rr08, T4&rr09 and 
T4&rr098 ascertained through microarray analysis. Therefore it is assumed 
variation in capsule levels would not be the cause of any changes in adherence 
in these strains, which has been shown to alter the cell surface exposure of 
adhesins (Sanchez et al., 2011). The capsule level was not evaluated in T4&rr06, 
T4&rr086, T4&rr096 and T4&rr0986. In the double and triple mutants there is 
also no data which may indicate if surface adhesins other than the pilus are 
differentially regulated in these strains which may alter adhesion. RR06 is known 
to also regulate CbpA and PspA therefore we assume these factors may also 
modulate changes in adhesion in T4&rr06 (Standish et al., 2005,  Standish et al., 
2007). In T4&rr08 no known cell surface adhesins were shown to be differentially 
regulated other than the pilus. In T4&rr09 PsaA was shown to be down regulated 
which may alter adherence. Finally In T4&rr098 the adhesin PsrP was down 
regulated 1.3 fold and PavA was up regulated 1.1 fold. 
Adherence assay analysis showed clear difference in adherence capabilities upon 
deletion of a number of the TCS (Figure 3-18). Strains with a deletion of rr09 
showed the biggest increase in adherence compared to T4JH to all cell lines, 
with the biggest increase seen in T4&rr09 and T4&rr098. In this instance this 
would correspond to the strains producing the highest amount of pili shown the 
highest adherence. It would perhaps in this instance be expected that T4&rr086 
would also show an increased adherence. However, this was not the case and 
this strain showed a trend towards a reduced adherence to HBMEC and A549 
cells and a trend towards an increase in adherence to D562 cells, however these 
differences were not significant. Deletion of RR08 alone showed a trend towards 
a small reduction in adherence to all cell lines, however again this was not 
significant compared to T4JH. 
Deletion of RR06 showed no difference in adherence to HBMEC cells, however 
roughly a 5 fold increase in adherence to A549 and D562 cells was observed 
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compared to T4JH, but this is not significant. As we see a reduced level of pili in 
T4&rr06 this is clearly not causing the altered adherence and is likely due to 
another surface protein differentially expressed in T4&rr06, for instance CbpA.  
We see no significant difference in adherence between T4&rr09 and T4&rr098, 
suggesting RR08 deletion in T4&rr09 does not significantly alter adherence. 
However there is a significant difference in adherence of T4&rr096 and 
T4&rr0986 compared to T4&rr09 and T4&rr098, suggesting deletion of RR06 in 
these strains causes the decrease in adherence. Similar adherence capabilities 
are observed between T4&rr0986 and T4&rr096, which show similar levels of pili 
expressed on the cell surface. 
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Figure 3-18: Adherence of TCS mutants to different cell lines. 
Adherence of TCS mutant strains was assessed to HBMEC (A), A549 (B) and (C) Detroit 562 
cell lines. Data is represented as percentage adherence relative to that of T4JH (100%, 
dashed line), each bar is an average of three replicas except for all HBMEC data and 
T4&rr09, T4&rr086, T4&rr098 Detroit 562 data which is an average of two repeats, the error 
bars represent the standard error of the mean. Statistical analysis was performed using a 1-
way ANOVA with a Tukeys testing correction, for (A) and (C) * P<0.05, ** P<0.001, for (B) * 
P<0.05, ** P<0.01. * above the bar represent statistical significance compared to T4JH (not 
represented as a bar on the graphs). 
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3.7 Discussion 
It must initially be noted that the mutants evaluated within this chapter have 
not been complemented to confirm the phenotype observed in these mutants is 
not due to accumulation of genetic changes at an alternative point within the 
genome. However with regards to the alterations in pilus expression all three RR 
evaluated have been linked in the literature to regulation of this virulence factor 
and therefore we assume this is due to true regulation by the TCS. Further the 
gene expression data for RR09 mutant matches that observed in the literature, 
indicating these changes are due to the RR09 deletion. To fully confirm all 
changes complementation of all mutants needs to be performed. 
A number of the genes regulated by RR08 in our microarray experiments 
confirmed what was already known from the literature about genes regulated by 
this system. This system causes repression of the pneumococcal pilus as a 
deletion mutant showed increased expression of the pilus islet genes (Song et 
al., 2009). Our microarray data showed no similarities to that of genes 
differentially regulated in a HK08 mutant constructed in R6, which suggested a 
role of RR08 in cellobiose metabolism (Mckessar & Hakenbeck, 2007). This may 
be due to strain specific regulation of genes via this system, as observed in other 
systems. However in the McKessar study genes classed to be differentially 
regulated had to show a change in expression of 3 fold or above. This cut off has 
not been applied to our data sets and therefore genes differentially regulated in 
this strain below the threshold may show similarities to our data. As this study 
evaluated a HK kinase mutant rather than a RR mutant this may also be why 
there are few similarities. 
One of the genes differentially regulated in T4&rr08 is that of argR (SP_2077) 
which in D39 has been shown to regulate a number of genes involved in arginine 
metabolism (Kloosterman & Kuipers, 2011). In the Kloosterman & Kuipers study a 
single knockout of argR showed no similarities between genes regulated by argR 
and RR08. However deletion of another ArgR type regulator ahrC (SP_1203) 
creating D39&argR&ahrC shared a number of similarities to that of genes 
regulated by RR08 in this study, including purM, purN, vanZ, purH and aliB. In 
D39&argR&ahrC bgaA is differentially regulated which has previously been shown 
to be regulated by RR08 (Song et al., 2009). Although ahrC was not differentially 
Chapter 3 
 
166 
regulated in our study it may be that in TIGR4 ArgR regulates these genes alone. 
However, this would need further study.  
RR08 in TIGR4 positively regulates rr01. Microarray analysis also indicated RR08 
regulates RR02 which is repressed by RR08. However this was not shown to be 
significant via RT-PCR. With regards to RR01 no studies have been performed to 
assess what genes are regulated alone by this system and so we cannot attribute 
any of the expression changes observed in T4&rr08 to that of differential 
expression of this gene. 
RR02 was repressed by deletion of RR08 in TIGR4. When comparing the genes 
regulated by RR02 to that seen in T4&rr08 there were very few similarities 
perhaps due to experiment being performed in different parent strains (R6 and 
JNR7/87) which may again suggest RR02 acts in a strain dependant manner (Ng 
et al., 2005, Mohedano et al., 2005). Both of these studies show RR02 plays a 
clear role in fatty acid metabolism of which none of the genes required for this 
are differentially regulated in T4&rr08. This may indicate that the change in rr02 
expression in T4&rr08 is not a true change. Alternatively perhaps the fact RR02 
is the only system which is indispensible means that its regulation is controlled 
tightly and small changes in its expression are compensated for. 
Other than the pilus islet RR08 has been shown to negatively regulate cbpD a 
putative murein hydrolase shown to play a role in competence induced cell lysis 
(Kausmally et al., 2005). Deletion of cbpD in TIGR4 causes a reduced ability to 
colonise the nasopharynx in an infant rat model and showed a slightly reduced 
adherence to Detroit 562 cells (Gosink et al., 2000). A RR08 knockout in TIGR4 
has previously been shown to be attenuated upon intranasal infection (Throup et 
al., 2000). However no other studies have analysed the in vivo role of RR08. 
Adherence to D562 cells and HBMEC cells showed a trend towards a reduced 
adherence in T4&rr08, however again this was not statistically significant.  
One of the other genes shown to be up regulated in T4&rr08 is mntE a 
manganese efflux pump, which has been linked to altered pilus expression, with 
a T4&mntE strain when grown in high manganese concentrations showing 
increased expression of the pilus islet genes (Rosch et al., 2010). There are a 
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number of other similarities between the expression changes in T4&mntE and 
T4&rr08 including in both cbpD, SP_1501 and SP_2095 are up regulated and fucK 
is down regulated. From this it could be hypothesised that HK08 responds to 
external manganese levels and modulates its cellular content by regulating 
mntE. Deletion of RR08 causes an increase in expression of mntE, which would 
correspond with RR08 acting as a repressor of mntE. Variations in magnesium 
concentrations in vivo could correspond to being present in a certain niche 
where lower levels of pili are required and this islet is repressed alongside mntE 
by RR08. 
Genes regulated by RR09 in this study again confirmed what was already known 
about genes regulated by RR09. This includes an up regulation of the pilus islet 
genes, genes involved in purine biosynthesis and down regulation of a general 
stress protein, beta-glalctosidase, pspA (adhesin) and a ABC transporter 
(SP_1895-1897) (Hendriksen et al., 2007).  
One transcription regulator showing a large down regulation of 15 fold in a RR09 
mutant is that of lacR (lactose phosphotransferase system repressor). 
Interestingly this was opposite to that seen in the Hendriksen study, which 
showed an up regulation of this gene in a RR09 deletion mutant (Hendriksen et 
al., 2007). lacR is known to act as a repressor of genes required for lactose 
uptake and catabolism. However little data is available in the pneumococcus as 
to what genes may be differentially regulated when lacR is deleted and 
therefore its contribution to the gene expression changes observed in T4&rr09 
cannot be evaluated (Zeng et al., 2010). Other than lacR there is no differential 
regulation of genes in T4&rr09 that are linked to lactose metabolism. The reason 
for this may be due to the fact there are two lacR genes in S.pneumoniae, that 
of SP_0875 differentially regulated in this study and that of SP_1182, which is 
located next to a large number of genes important for lactose metabolism. This 
is not the case for SP_0875 and perhaps this lacR gene is redundant, or its 
reduced expression is compensated for by the other lacR gene (SP_1182). 
In T4&rr09 no other TCS were shown to be statistically differentially regulated. 
However rr01, rr07 and rr08 looked to be marginally down regulated. Indication 
these may be true changes have come from the fact rr01 and rr07 are shown to 
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be statistically differentially regulated in T4&rr098, which cannot be fully 
accounted for due to the rr08 mutant. Further rr08 expression levels are also 
down regulated in T4&rr096 to a similar level as in T4&rr09, which is not due to 
the rr06 deletion, and may indicate RR09 positively regulate RR08 at the 
expression level. This may account for why some of the genes are commonly 
regulated by RR09 and RR08. As mentioned earlier little is known about RR01 
and what genes are regulated by this system, however if this is a true change it 
seems to be positively regulated by both RR08 and RR09 to a similar level. rr07 
may also be positively regulated by RR09, this system is also one of the other 
systems that has not been evaluated with regards to what genes it regulates and 
would likely contribute to regulating some of the large number of genes 
differentially regulated in T4&rr09, but which ones are unknown. 
RR09 has also been shown to positively regulate the choline binding protein 
PspA, as in T4&rr09 pspA expression is reduced. This virulence factor is highly 
immunogenic which is why it is a candidate protein to include in a protein based 
pneumococcal vaccine and has been shown to interfere with complement 
activation and can bind lactoferrin (Talkington et al., 1991, Hammerschmidt et 
al., 1999, Tu et al., 1999, Briles et al., 1996). Currently none of the genes shown 
to be regulated by RR09 have been implicated in regulating pspA and therefore 
this TCS may regulate this gene through binding directly to its promoter region. 
There is a large increase in the adherence capability of T4&rr09 to all cell lines 
compared to its parent. The only virulence factor that is up regulated in this 
strain is that of the pneumococcal pilus so it is assumed this is the reason for the 
increased adherence. Looking at the cell surface adhesins expression in T4&rr08, 
T4&rr09 and T4&rr098 there seems to be no pattern of reduced expression of 
one cell surface adhesin while there is an increase in expression of the pilus. 
Once the genes regulated by the single systems alone were evaluated it allowed 
estimation of how these systems may interact with regards to the gene they 
regulate and the potential for each to compensate for the deletion of the other 
through the use of a double mutant. Comparison of the gene regulated by each 
system and the double mutant via microarray analysis were done using a venn 
diagram. From this it seemed that the systems when deleted alone generally 
regulated their own set of genes as only a small number of genes were shown to 
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be commonly differentially regulated in both the single and double mutants. 
This includes rr07, which in the double knockout shows similar expression levels 
to that of the single RR09 mutant, which would indicate this decreased 
expression is due to regulation by RR09 alone.  
22 genes (P<0.1) were shown to be commonly regulated in all three microarray 
experiments. In most instances the expression differences of the genes in this 
group compared to T4JH were similar in all three knockout strains. This would 
suggest that in terms of regulating these genes both systems play an equal role. 
With perhaps both systems regulating the same gene, which regulates these 
common genes, for example RR01. Although if this was the case it would be 
expected in the double mutant that the change in expression of these genes 
would be equal to the sum of both of the expression changes seen in each of the 
single mutants. Alternatively there is evidence upon deletion of rr09 that rr08 is 
down regulated so genes found to be similar between the two mutants may be 
due to the fact RR09 deletion has a knock on effect on rr08 expression levels. 
Regulation in this way is summarised in Figure 3-19 using the repression of the 
genes involved in purine biosynthesis as an example.  
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Figure 3-19: Hypothetical mode of regulation of common genes by RR08 and RR09. 
Diagram represents a potential mode of how RR09 and RR08 regulate the same gene., using 
the regulation of purine biosynthesis genes as an example. Arrows represents positively 
regulated genes and bars represent genes repressed. Hypothesis is based on RR09 
positively regulating rr08 and RR08 positively regulating rr09. 
 
If this was the case it would be expected that genes regulated by RR09 would 
include all the genes regulated by RR09 alone and all the genes shown to be 
regulated by RR08. Yet only a small number of genes are shown to be commonly 
regulated by the two systems. Further the expression of the pilus islet showed 
the regulation is more complex as deletion of both rr09 and rr08 results in a 
phenotype which shows expression levels between that of the single mutants. 
These systems must to some extent interact with one another as deletion of 
both TCS leads to a large number of genes being differentially regulated that are 
not seen in the single mutants alone. In the double mutant a total of 210 genes 
(P<0.1) were not differentially regulated in either of the single mutants. The 
fact deletion of both leads to a totally new collection of genes being 
differentially regulated would suggest that deletion of both singly is 
compensated for by the other systems. Whether this would occur upon deletion 
of two different RR would give an indication if this is common or RR09 and RR08 
are both important TCS.  
However another explanation for this observation may be that deletion of both 
systems puts a stress on the cell, or alters in some way the surrounding 
environment, which leads to the differential expression of the genes which are 
not shown to be differentially regulated by the single systems alone. The large 
number of genes shown to be differentially regulated in the double mutant are 
likely due to the differential expression of rr04, rr05 and rr13 in the double 
mutant which are not seen to be differentially regulated in the single mutants.  
codY is one of the genes differentially regulated in the double mutant but not in 
the single mutants. codY is a global regulator of genes that are important for 
adaptation to different nutritional environments. In T4&rr098 there is only one 
gene shown to be regulated by codY in D39 that is also regulated in the double 
RR mutant, this is that of dpr (SP_1572) a starvation induced protein (Hendriksen 
et al., 2008). These two genes are both down regulated in the double RR mutant 
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to similar levels. However it has been shown that codY cannot be deleted and in 
the above study genome changes had accumulated in the strain to counteract 
this harmful deletion, shown via whole genome sequence (Caymaris et al., 
2010). Due to this some of the genes shown to be regulated by codY in this study 
may not fully represent its true function. This latter paper links codY function 
with potentially playing a role in altering competence therefore suggesting some 
regulation of RR12 and potentially having an interaction with ritR (ORR). 
However there was not statistical differential regulation of these systems in 
T4&rr098 (Caymaris et al., 2010).  
Microarray analysis in the double mutant showed an increase in the expression of 
rr02 however this was not confirmed by RT-PCR. Yet in T4&rr098 a number of 
genes involved in fatty acid biosynthesis (P<0.1) were differential regulated 
shown via microarray analysis, which are known to be regulated by RR02 
(Mohedano et al., 2005). However due to the number of regulators that are 
changed in the double mutant its not unlikely that this may have come about 
due to one of these. For this reason the genes regulated by each of these 
systems will not be discussed further with regard to their likely contribution to 
the genes differentially regulated in T4&rr098. In regards to rr06 this like rr02 
was shown to be up regulated by microarray however this was not confirmed by 
RT-PCR. 
In the double mutant along with some RR there are also virulence factors that 
are differentially regulated that are not observed in the single mutants alone, 
including psrP and pavA. pspA was not observed to be differentially regulated in 
the double mutant at all yet cbpD which was differentially regulated in T4&rr08 
is observed in the P<0.1 gene list of the double mutant. psrP (pneumococcal 
serine rich repeat protein) is found in the genome downstream of a large number 
of glycosyltransferase which function to glycosylate this protein, none of these 
were differentially regulated in the double mutant bar psrPs adjacent gene 
SP_1771, and therefore whether this is a true change would require further 
validation.  
psrP has been shown to be important for biofilm formation and lung infection, 
with it able to bind to keratin 10 on lung epithelial cells (Sanchez et al., 2010, 
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Shivshankar et al., 2009). PsrP was down regulated in T4&rr098 so wouldn’t 
contribute to the increased adherence to all cell lines observed in this strain, 
with the highest to that of A549 cells. Although not significant there is a trend 
towards a lower adherence in T4&rr098 compared to T4&rr09 to HBMEC and 
D562 cells, this correlates well with the lower number of pili expressing cells in 
the double mutant compared to the single. 
With regards to expression of pavA in the double mutant there is only a small 1.1 
fold increase in the expression of this gene, this was not further validated by RT-
PCR and may not be a true change. This fibronectin binding protein has been 
shown to be essential for virulence in D39 in a mouse model of bacteraemia 
(Holmes et al., 2001). Upon deletion of PavA in a serotype 35A and R800 strain a 
large reduction in adherence and invasion of A549 and HBMEC cells is observed, 
this may in part account for the increased adherence of the double mutant to 
these cell lines as pavA is marginally up regulated in this strain. However this 
would not account for the increased adherence in the single rr09 mutant, which 
shows similar adherence to the double mutant. 
We can clearly see that these systems interact with one another from the data 
obtained in this study, yet this is just looking at one aspect (gene expression 
changes). For a clearer picture on how they interact more information is 
required about the genes that are directly regulated by each RR, which has only 
been assessed for RR05 on a large scale (Halfman et al., 2007), which evaluated 
the promoters that RR05 directly bound to through its DNA binding domain. 
Another key feature elucidated in this paper is that of the role of RR in 
regulation of small non-coding RNAs, which would not be picked up by our 
microarrays. Information about whether there is potential for the RR to interact 
with each other at the protein level may further add to the complexity, but 
more likely is the potential of one HK to phosphorylate multiple RR. Another key 
to understanding these systems is what the extracellular stimulus to which they 
respond. This is known to be CSP for HK12 and BLP for HK13 yet this is still 
unknown for all the other systems, (de Saizieu et al., 2000, Pestova et al., 
1996). This is vital to understand during infection where these systems might be 
activated.  
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Further studies to try and understand potential communication between these 
systems was using the expression of the pilus genes to give an indication of their 
interactions, as the systems chosen were all able to alter pilus expression. This 
was performed by assessing the expression level of all seven genes on the pilus 
islet in the mutant strains relative to T4JH. FACS analysis was used to determine 
the RrgB expression within a population of these mutants, as recent studies have 
indicated within a growing population pili negative and positive cells exist 
(Basset et al., 2011, De Angelis et al., 2011). To date only RrgA has been shown 
to modulate this function through forming a protein-protein interaction with 
RlrA, preventing it from positively regulating the islet, upon deletion of rrgA 
almost all bacterial cells are pili positive (Basset et al., 2011, Basset et al., 
2012). This analysis will show in these TCS mutants whether the altered pili 
expression is due to increases in pili on a single cells or increased numbers 
containing the pilus, or perhaps both. 
Contrary to the published role of TCS06 in pilus regulation our data showed RR06 
to act as a positive regulator of the operon rather than that of a repressor 
(Rosch et al., 2008). The most likely reason for this is that studies performed by 
Rosch were performed in a HK06 mutant rather than a RR06 mutant which is 
used in this study (Rosch et al., 2008). In an earlier study when assessings TCS06 
role in virulence deletions of HK06 or RR06 showed opposite effect with regards 
to virulence, it is therefore possible different genes are regulated upon deletion 
of RR06 or HK06, which may be linked to the fact RR06 can be phosphorylated by 
an alternative kinase (StkP) (Standish et al., 2005, Agarwal et al., 2012). 
Alternatively this could also be due to variations in the growth conditions under 
which both experiments were performed, with TCS06 acting as a repressor of the 
pilus islet upon growth in C+Y media when grown to mid log (Rosch et al., 2008), 
and TCS06 acting as a positive regulator of the operon when grown in BHI to 
OD600nm 0.6 (this study). Variations in growth conditions of a T4&rr09 strain have 
been shown to alter whether RR09 acts as a repressor or activator of the pilus 
islet (Hendriksen et al., 2007). In our study all three RR have also shown to act 
both as repressors and positive regulators of the pilus islet depending on the 
presence of the other RR and this may be why we see variations in the RR 
function when grown under different conditions as variations in the activity of 
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other interacting TCS are occurring. The role of the three RR in the presence of 
others is summarised in Table 3-7. 
Strain RR remaining RrgB positive cells Repressor/ activator 
T4JH RR06, RR08, 
RR09 
20% N/A 
T4&rr06 RR08, RR09 4% RR06 activator (dec exp comp T4JH) 
T4&rr08 RR06, RR09 37% RR08 repressor (inc exp comp T4JH) 
T4&rr09 RR06, RR08 91% RR09 repressor (inc exp comp T4JH) 
T4&rr086 RR09 57% RR08 repressor (inc exp comp T4&rr06) 
RR06 repressor (inc exp comp T4&rr08) 
T4&rr096 RR08 28% RR09 repressor (inc exp comp T4&rr06) 
RR06 activator (dec exp comp T4&rr09) 
T4&rr098 RR06 56% RR09 repressor (inc exp comp T4&rr08) 
RR08 activator (dec exp comp T4&rr09) 
T4&rr0986 NONE 27% RR06 activator (dec exp comp T4&rr098) 
RR08 neither (no diff comp T4&rr096) 
RR09 activator (dec exp comp T4&rr086) 
Table 3-7: Summary table of RR function 
Summary table of findings in this study. Showing strain, which RR are still present after 
deletion, the amount of RrgB positive cells within a growing population and whether in each 
strain the RR acts as a repressor or activator of the pilus operon. Dec = decrease, inc= 
increase, exp= expression, comp = compared to. 
 
One initial hypothesis taken from this data is that RR08 does not modulate the 
altered pilus expression observed upon its deletion in T4JH via direct binding to 
the rlrA promoter. Indication this is the case is that deletion of RR08 in T4&rr096 
(T4&rr0986), causes no difference in pilus expression and no change in the 
number of pili positive cells within a population compared to T4&rr096. However 
upon deletion of RR08 in T4&rr09 or T4&rr06 mutants alone there is a decrease 
and increase in pilus expression and pili positive cells observed respectively. This 
may suggest RR08 regulates alterations in pili via both RR09 and RR06, however 
this is likely not at the expression level as there is no observed difference in rr06 
and rr09 expression in T4&rr08. 
Even in the triple RR mutant there is still an increased pilus expression with an 
increase of roughly 6% more pili positive cells compared to T4JH, this confirms 
there are other factors than these three RR interacting to alter pilus expression 
under the conditions of our experiment. This may suggest that factors 
competatively bind to the pilus islet promoters, and deletion of RR08, RR09 and 
RR06 allows binding of other factor, however whether RR09 and RR08 bind 
directly to the islet is still unknown. 
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The single RR09 mutant alone causes a large increase in the number of pili 
positive cells within a population with 91% of cells pili positive upon its deletion. 
In this strain the ability to distinguish between positive and negative cells is lost 
with one large peak seen via FACS rather than the two clear positive and 
negative populaitons seen in T4JH.  
As already noted RR06 in our studies acts as a positive regulator of the pilus islet 
as upon its deletion there is a decrease in pilus expression as well as a decrease 
in the number of pili positive cells (4%). However when rr06 is deleted in 
T4&rr08 there is an increase in pili expression. Interstingly FACS analysis of 
T4&rr086 again showed one single peak rather than the two positive and 
negative populations. This could either indicate that RR09 is non-functional in 
T4&rr086 or in the rr09 knockout the alterations in pilus expression is due to 
RR08 and RR06 being non-functional in T4&rr09. Another interesting finding is 
that upon deletion of rr06 or rr09 in T4&rr08 the same phenotype is observed 
with 56% and 57% of cells being pili positive in T4&rr098 and T4&rr086 
respectively.  
It has been shown that modulation of the number of pili positive cells at the 
population levels occurs through a protein-protein interaction of RlrA and RrgA 
(Basset et al., 2011, Basset et al., 2012). RrgA once bound to RlrA prevents it 
binding to the promoters of the pilus islet and positively regulating its 
expression. All the TCS tested in this study have been shown to alter pilus 
expression at the population level and this may be through modulating the 
expression levels of rrgA realtive to rlrA. T4&rr086 shows a large increase in 
expression of rlrA relative to rrgA, which may account for why over double the 
number of T4&rr086 cells contain pili on the surface relative to T4JH. Both 
T4&rr0986 and T4&rr096 also show marginally higher expression levels of rlrA 
relative to rrgA. However this is not the case for T4&rr098 and T4&rr08 which 
have slighlty lower rlrA levels relative to rrgA. Most surprisingly rrgA and rlrA 
expression levels are almost identical in T4&rr09 yet this strain showed the 
largest increase in the number of pili positive cells within the population. 
Therefore RR09 must act to modulate pilus expression at the population level by 
another means.  
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From this data a model of how these systems regulate the pilus and therfore 
interact has not been constructed as no data it available yet as to whether RR08 
and RR09 bind directly to the rlrA promoter. A further limiting factors is in this 
study only three of the genes known to affect pilus expression are being 
assessed, yet data is available to show RR03, MgrA and MerR bind directly to the 
rlrA promoter modulating its activity(Rosch et al., 2008, Hemsley et al., 2003). 
Further RR10 and RR05 alter pilus expression upon their deletion either directly 
or indirectly through another factor (Haas et al., 2004, Sebert et al., 2002). 
Regulation at the population level of pili has also been observed in S.pyogenes 
but how this is modulated is yet to be discovered. It may be that TCS in this 
species are also important in this function (Nakata et al., 2009). In this instance 
however the link has been made to the conditions under which this phenomenon 
is modulated, with varying pili levels observed when grown at different 
temperatures. It is likely in the pneumococcus that some form of environmental 
cue is also modulating this regulation and this function as shown in this study is 
through the regulation by TCS. 
It perhaps seems unnecessary for these RR to all act on the pilus islet, however 
in vivo this is likely not the case. Our experiments are performed upon growth in 
BHI media, which contains all the nutrients required for growth. In vivo in 
different niches (lungs, nasopharynx, brain, blood) different nutrients will be 
limited and it is likely under these conditions there would be variations in the 
regulation of the pilus by these RR. It being the case that one TCS is able to 
recognise presence in the nasopharynx, and alter pilus expression accordingly, 
one may sense being in the lungs and modulate pilus expression etc. Currently 
the external stimulus that activates these TCS is unknown and requires further 
study.  
More recent data has indicated that response regulators are not always 
phosphorylated by their cognate HK on an aspartate residue. Two pneumococcal 
response regulators RitR (ORR) and RR06 are also phosphorylated by StkP 
(serine/ threonine protein kinase). Although RitR has no cognate HK, RR06 does. 
RR06 phosphorylation by StkP is on a threonine residue and has been shown to 
alter its binding capacity for target genes, when aspartate is not phosphorylated 
(Agarwal et al., 2012), this has also been seen in other bacterial species (Lin et 
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al., 2011). StkP in the pneumococcus contains four extracellular PASTA domains 
which in penicillin binding proteins have been shown to bind to unlinked 
peptidoglycan (Gordon et al. 2000, Maurer et al. 2012). The PASTA domains in 
StkP have been shown to bind to synthetic peptidoglycan, which activates the 
kinase which then functions to phosphorylate protein targets (Maestro et al. 
2010, Beilharz et al. 2012). The fact StkP phosphorylates RR06 may suggest this 
kinase is also able to modulate the cell surface constituents as this RR has been 
shown to regulate three key pneumococcal adhesins (pilus, PspA, CbpA) (Rosch 
et al. 2008, Standish et al., 2005,  Standish et al., 2007). 
This may indicate a more complex scenario of how RR modulate gene expression 
by being able to modulate genes in more that two forms. RR could be found in a 
non phosphorylated state, phosphorylated on an aspartate residue or 
phosphorylated on a threonine residue, with in each form a different set of 
genes can be regulated due to the conformational change of the DNA binding 
domain. It could perhaps be envisaged that phosphorylation on both sites at the 
same time could create another conformation, regulating another set of genes. 
There is currently no data available which directly compares phosphorylation on 
different sites and how this may alter gene regulation.  
We can summarise from this study that all three RR do interact with each other, 
whether that be competing for the same binding site or forming some protein-
protein interaction with one another etc, currently it is not know which and 
would require further study. Binding of two response regulators to each other 
has not been observed, but HK from two different TCS pairs can act in this way 
to impede autophosphorylation (Vincent et al., 2010). RR08 seems to require 
either RR06 or RR09 to function properly, as RR08 shows no functionality when 
both are deleted. Upon deletion of RR06 or RR09 in a T4&rr08 mutant we see the 
same resulting phenotype, suggesting RR08 is required in some way to modulate 
their function. Deletion of RR09 alone causes a phenotype where the amount of 
pili positive cells is deregulated, we also see this upon deletion of RR08 and 
RR06, this again may suggest RR09 requires RR06 or RR08 to modulate its 
function and in T4&rr086 RR09 has a reduced function.  
Genes regulated by these systems are often important for virulence confirmed 
by our adherence assay data, this data has also given an indication on potential 
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niche specific regulatory functions of these RR. The highest increase in 
adherence to all cell lines was observed upon deletion of RR09. With the highest 
increase seen in T4&rr09 and T4&rr098, with no statistical difference between 
the percentage adherences of the two strains to all cell lines. The highest 
increase in the adherence of the RR09 mutant strains was observed to A549 cell 
lines suggesting a role of this RR in pneumonia, perhaps modulating the levels of 
adhesins required in certain environments. 
T4&rr09 has been shown to have a reduced virulence upon intranasal infection, 
with a reduced ability to disseminate to the blood (Hendriksen et al., 2007). 
Perhaps an inability to regulate the pilus hinders translocation to the blood 
where you would perhaps require fewer surface adhesins. Other adhesins were 
also differentially regulated in T4&rr09 from our microarray data including pspA 
in T4&rr09 and psrP in T4&rr098, however both were down regulated and 
therefore wouldn’t contribute to the increased adherence.  
In T4&rr096 and T4&rr0986 there is a drop in adherence to all cell lines 
compared to T4&rr09 and T4&rr098 however there is a trend towards a higher 
adherence than that of T4JH, yet not significant. The drop correlates with that 
of decreased pilus expression with both strains showing 26-27% pili positive cells 
within a population, both show similar adherence capabilities to all cell lines 
with no significant difference between the two.  
Deletion of RR08 has shown an increase in adherence to A549 cells after 
incubation for 3 hours and a reduced adherence to D562 cells post 3 hours 
incubation (Song et al., 2009), no difference was observed post 1 hour 
incubation. In the adherence assays reported here bacteria were incubated with 
cells for 2 hours and no statistical difference in adherence of T4&rr08 compared 
to T4JH to all cell lines was seen. There is a trend towards a reduced adherence 
to HBMEC cell lines however this was not significant. There is an increase in 
expression of the pilus in T4&rr08 so you would perhaps expect to observe an 
increased adherence in this strain however this is not the case.  
Adherence assay data of T4&rr086 showed no statistical difference in adherence 
to all cell lines compared to T4JH, with its adherence capabilities similar to that 
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of T4&rr08. There is a trend towards an increase in adherence to D562 cells 
however this is not significant. The large increase in pili positive cells in 
T4&rr086 would be expected to cause a marked increase in adherence, but 
although more cells contain pili on the surface there are less pili per cell as 
indicated by a shift to the left of the FITC peak via FACS analysis. This could 
indicate the pili are shorter, or perhaps just fewer pili per cell and therefore are 
unable to bind as efficiently. T4&rr08 has been shown to be attenuated using 
intranasal infection models (Throup et al., 2000), however no other studied have 
analysed the in vivo role of RR08. 
The decreased expression of the pneumococcal pilus in T4&rr06 was not 
associated with reduced adherence to all cell lines. A reduced adherence was 
observed to D562 and A549 cells in a RR06 mutant constructed in D39 and R6 
background (Standish et al., 2005, Ma & Zhang, 2007). Whole genome expression 
analysis was not performed on our T4&rr06 mutant, however that of published 
data showed another important virulence factor cbpA is regulated by RR06 and 
may be affecting adherence (Standish et al., 2005, Ma & Zhang, 2007). Deletion 
of RR06 in D39 caused a increase colonisation phenotype in a in vivo mouse 
model and showed an increased ability to cause lung infection, this was shown 
not to be due to CbpA and D39 does not contain the pilus and is therefore not 
due to this, which could be due to other virulence factors also regulated by 
RR06, such as PspA (Standish et al., 2005, Standish et al., 2007). Upon deletion 
of HK06 in TIGR4 no virulence defect was observed in a pneumonia mouse model 
(Rosch et al., 2008). 
The facts in all RR mutants we see variations at the population level in pilus 
expression rather than at the single cell level (bar in T4&rr086 where we see 
variations in both) would suggest these systems may act as quorum sensing 
systems. With the set environmental stimulus e.g. Mn2+ concentration upon 
reaching a certain level causes activation of the TCS. Cells in the proximity of 
the set external stimulus will therefore have activated TCS and for example up 
regulate cellular pili levels and the cells further away will contain no pili. During 
in vitro growth you would perhaps not expect much variation in the external 
environment conditions with regards to metabolite proximity to certain cells, 
however metabolites produced by some bacterial cells and not others may 
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provide this external stimulus e.g. exogenous H2O2 levels. A number of other TCS 
in the pneumococcus are regulated by quorum sensing (ComDE, BlpHR), which 
recognise levels of an external peptide, which upon reaching a critical level 
activates the TCS (de Saizieu et al., 2000, Pestova et al., 1996). Further study 
into the external stimulus activating the TCS would help to confirm or refute this 
hypothesis. 
  
 
 
 
 
 
 
 
 
4 Xen35 
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4.1 Aim of this chapter 
Xen35 is a bioluminescent serotype 4 S.pneumoniae strain, used for studying 
disease progression in vivo. This strain enables users to visually track disease 
progression in a mouse model of pneumonia, septicaemia and meningitis. 
However this strain has been genetically manipulated to enable this trait yet has 
not been fully characterised to show no other genotype and phenotype changes 
have occurred upon genetic manipulation. Preliminary experiments using Xen35 
showed some clear differences in phenotypic traits compared to TIGR4 therefore 
in this chapter Xen35 is fully evaluated in regards to genotype and phenotype 
changes compared to is parent TIGR4. 
Preliminary experiments indicated Xen35 was less virulent than TIGR4. Initial 
whole genome sequencing was performed on Xen35 to deduce any genetic 
changes in this strain lying outwith the known lux insertion site, and confirmed 
positioning of this insertion. Gene expression changes were also analysed using 
microarray, RT-PCR and RNA-seq analysis. There were noticeable amount of 
genomic and expression changes, including those of some key virulence factors 
in the pneumococcus.  
To further evaluate changes in one of these virulence factors, the pneumococcal 
pilus, western blotting and FACS analysis was performed to see if differences 
seen by microarray correspond to that of changes at the protein level. Finally to 
further assess the potential impact of all these changes on virulence MF1 mice 
were infected with Xen35 and TIGR4 and both of their abilities to cause disease 
determined. 
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4.2 Background 
Bioluminescence is produced by a chemical reaction that occurs in living 
organism resulting in the emission of energy in the form of light (see reviews 
Engebrecht & Silverman., 1984, Meighen., 1991). A wide variety of organism in 
nature are able to do this, including fungi, fish, squid and most importantly here 
bacteria. Five genes encode the required proteins needed for the 
bioluminescence reaction. LuxA and LuxB form the luciferase enzyme 
heterodimer required for catalysing the bioluminescence reaction. LuxC, LuxD 
and LuxE form a multienzyme fatty acid reductase complex, composed of a 
reductase, transferase and a synthetase respectively. These enzymes are 
required for the synthesis of the aldehyde substrate required during the 
bioluminescence reaction. These five genes are common to all species that 
bioluminesce however the substrate of the reactions can vary (see reviews 
Engebrecht & Silverman., 1984, Meighen., 1991). A common feature of all 
bioluminescence reactions is that of the requirement of oxygen for the reaction 
to occur. Other regulatory genes are also often found in a number of species 
however these are not vital for the reaction. The bioluminescence reaction itself 
consists of oxidisation of reduced flavin mononucleotide (FMNH2) and a long 
chain aldehyde (RCHO) producing light, flavin mononucleotide (FMN), fatty acids 
(RCOOH) and water shown below in Equation 4-1. 
FMNH2 + RCHO + O2   '   FMN + H2O + RCOOH + Light (490nm) 
Equation 4-1: Equation of bioluminescence reaction. 
 
This chemistry can be used as a scientific tool by using the lux genes as reporter 
genes in vitro and in vivo (Engebrecht et al., 1985, Contag et al., 1995, Jenkins 
et al., 2003). Xen35 the bioluminescent version of S.pneumoniae strain TIGR4 
(Tettelin et al., 2001). Xen35 is one of a number of S.pneumoniae Xen strain 
constructed by Xenogen Corporation. These Xen strains have been used widely in 
the pneumococcal field to assess virulence and disease progression of different 
strains, strains tissue tropisms and in vivo gene expression (Orihuela et al., 2003, 
Orihuela et al., 2004).  
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The first Xen strain constructed was that of a serotype 2 strain D39 (Xen7) 
(Francis et al., 2001). This strain was constructed via placing the lux genes 
(luxA-E) amplified from Photorhabdus luminescens (formerly known as 
Xenorhabdus luminescens) upstream of a kanamycin resistance cassette into a 
plasmid flanked by two S.aureus transposon (Tn4001) inverted repeats, this 
plasmid (pAUL-A Tn4001 luxABCDE KmR) also contained the transposon gene 
required for excision of this region (Francis et al., 2001). The lux gene 
configuration luxABCDE was previously altered from that of luxCDABE naturally 
seen in P.luminescens, and the ribosome binding site altered for use in gram 
positive pathogens (Francis et al., 2000). Upon transformation of pAUL-A Tn4001 
luxABCDE KmR Into the naturally competent S.pneumoniae strain D39 the 
transposon flanked lux genes were excised from the plasmid and randomly 
integrated into the D39 genome. Transformants were selected using kanamycin. 
As no promoter was placed upstream of the lux genes in the plasmid 
transformants were screened using an ICCD camera for high bioluminescence 
indicating the insertion of the lux genes downstream of a promoter, creating 
Xen7. Xen7 genomic DNA was then isolated and transformed into a number of 
other S.pneumoniae strains constructing a collection of S.pneumoniae 
bioluminescent strains that can be used for in vivo analysis of disease 
progression (Francis et al., 2001, Orihuela et al., 2003). This technology allowed 
integration into the genome of the lux genes whereas previous studies expressed 
the lux genes on a plasmid. Using chromosomal integration increases the length 
bioluminescence can be followed as no antibiotic selection is required unlike 
with the plasmid based method (Francis et al., 2000). 
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4.3 Xen35 whole genome sequence 
4.3.1 Genome sequence 
Preliminary virulence analysis showed Xen35 was less virulent that TIGR4. 
Therefore whole genome sequencing was performed on Xen35 to assess any 
genome changes other than the lux insertion found in this strain compared to 
TIGR4, which may alter virulence. Sequence reads were reference assembled to 
the TIGR4 genome sequence data available at NCBI (NC_003028). A de novo 
assembly, assembling the sequence reads against themselves was also 
performed. Upon reference assembly of the sequence reads there were a total 
of 18 low coverage regions, where the sequence data was either of too low 
quality, sequence reads did not assemble due to variation within the region 
between the two strains, or this region was not present in Xen35. All of these 
low coverage regions were analysed further by Sanger sequencing to confirm 
changes in these regions. The de novo assembly created 271 contigs of which 
contig 48 contained the lux genes (unable to align to the TIGR4 sequence). The 
de novo assembly enabled further assessment of the low coverage regions, as 
divergent regions in Xen35 would assemble. SNP and indel analysis was also 
performed on the reference assembly. A total of 243 changes (SNPs/insertions/ 
deletions) were seen in Xen35 when compared to TIGR4, all of which can be seen 
in appendix III. This includes 8 deletions (Table 4-1), 15 insertions (Table 4-2) 
and 220 SNPs. Of theses SNPs 139 are located in intergenic regions or 
synonymous, but 81 lead to 73 amino acid changes in 34 genes (Table 4-3).  
Gene Function Position 
TIGR4 
Position 
Xen35 
NT Outcome 
SP_0200
/ 0201 
SP_0200 Competence-
induced protein Ccs4. 
SP_0201 Hypothetical 
protein 
188293 188292-
188293 
 
C SP_0200 removal of stop 
codon. 
SP_0201 frame shift. 
Premature stop codon. 
INT 
SP_0296
-0297 
 273379 273378-
273379 
G  
SP_0491 Hypothetical protein 469288 469286-
469287 
C Frameshift. Removal of stop 
codon 
INT 
SP_1029
 972510 972509-
972510 
T  
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-1030 
SP_1732 Serine/Threonine protein 
kinase. 
1634948
-
1635163 
1634951
-
1634952 
 216bp deletion between 
amino acid repeats 
TQIVLTVAKKA/ 
TQIVLTVAKKV, removing 
PASTA domain 3. 
INT 
SP_1851
-1852 
 1759031 1758820
-
1758821 
A  
SP_1920 MarR family 
transcriptional regulator. 
1829756 1837438
-
1837439 
 
T Frameshift. Premature stop 
codon. 
SP_1920 As above. 1829840 
 
1837521
-
1837522 
A Frameshift. Premature stop 
codon. 
Table 4-1: Deletions in Xen35 compared to TIGR4. 
INT refers to changes observed in intergenic regions. 
 
Gene Function Position TIGR4 Position Xen35 NT Outcome 
SP_0206 Hypothetical 
protein 
192436-192437 192435 C Frameshift, removal 
of stop codon. 
INT SP_0630-
0631 
 597325-597326 597324 G  
INT SP_0885-
0886 
 834922-834923 834923 C  
INT SP_1053-
1054 
 991106-991107 991106 C  
INT SP_1199-
1200 
 1132344-
1132345 
1132346 G  
INT SP_1199-
1200 
 1132391-
1132392 
1132394 G  
SP_1715 Hypothetical 
protein 
1618515-
1618516 
1618519 G Frameshift. 
Premature stop 
codon. 
INT SP_1775-
1776 
 1113285-
1113286 
1113286 C  
INT SP_1776-
1777 
 1695199-
1695200 
1694988 T  
INT SP_1777-
1778 
 1696085-
1696086 
1695875 C  
INT SP_1928-
1929 
 1835757-
1835758 
1843439-
1843440 
AT  
INT SP_1928-
1929 
 1835782-
1835783 
1843466-
1843489 
24b  
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p 
INT SP_1928-
1929 
 1835840-
1835841 
1843548 A  
SP_2076 Authentic 
frameshift 
1985218-
1985219 
1992927 G Frameshift, removal 
of frameshift. 
INT 2105-
2106 
 2016331-
2016332 
2024041 G  
Table 4-2: Insertions in Xen35 compared to TIGR4 
INT refers to changes observed in intergenic regions. 
 
Gene Function Position 
TIGR4 
Position 
Xen35 
Amino acid 
TIGR4 
Amino 
acid 
Xen35 
Origin 
(D39/ 
TIGR4) 
SP_0148 ABC transporter, 
substrate binding 
protein. 
146055 146055 Leu (TTG) Phe (TTC) D39 
SP_0272 30S ribosomal protein 
S7. 
247805 247805 Lys (AAA) Glu (GAA) D39 
SP_0715 Lactate oxidase 681177 681176 Gly (GGA) Stop 
(TGA) 
Neither 
SP_0730 Pyruvate oxidase 695462 695461 Glu (GAG) Stop 
(TAG) 
Neither 
SP_0784 Glutathione reductase. 737108 737107 Cys (TGC) Arg (CGC) D39 
SP_0807  Septation ring 
formation regulator 
EzrA. 
762843 762842 Gln (CAA) Lys (AAA) Neither 
SP_0904 Hypothetical protein. 857447 857447 Asn (AAC) Thr (ACC) Neither 
SP_0927 LysR family 
transcriptional 
regulator. 
880600 880600 Ala (GCT) Val (GTT) Neither 
SP_1166 MATE efflux family 
protein. 
1101585/
1101586 
1101585
/110158
6 
Arg (CGT) Ala (GCT) D39 
SP_1190 Tagatose 1,6- 
diphosphate aldolase. 
1127020 1127022 Val (GTT) Leu (CTT) D39 
SP_1190 As above. 1127021 1127023 Cys (TGC) Trp (TGG) D39 
SP_1343 Prolyl oligopeptide 
family protein. 
1267219/
1267220 
1267222
/ 
1267223 
Thr (ACG) Ser (AGC) D39 
SP_1715 Hypothetical protein 1618223 1618226 Glu (GAA) Gly (GGA) D39 
SP_1733 Phosphatase, putative. 1636745 1636533 Ala (GCT) Gly (GGT) Neither 
SP_1891 ABC transporter, 
oligopeptide binding 
1796273 1796062 His (CAT) Tyr (TAT) Neither 
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protein AmiA. 
SP_1908 Single stranded DNA 
binding protein. 
1822699 1822488 
 
Ala (GCT) Val (GTT) Neither 
SP_1908 As above. 1822817 1822606 Leu (TTG) Met (ATG) D39 
SP_1909 Short chain 
dehydrogenase/ 
reductase family 
oxidoreductase. 
1823433/ 
1823434 
1823222
/ 
1823223 
Gln (CAG) Arg (AGG) D39 
SP_1910 Hypothetical protein. 1823880 1823669 Leu (CTC) Phe (TTC) D39 
SP_1910 As above. 1823968/ 
1823969 
1823757
/ 
1823758 
Thr (ACT) Ile (ATA)  D39 
SP_1910 As above. 1824141 1823930 Thr (ACA) Ser (TCA) D39 
SP_1910 As above. 1824220 1824009 Asp (GAT) Glu (GAA) D39 
SP_1910 As above. 1824264 1824053 Asp (GAT) Asn (AAT) D39 
SP_1911 Putative thioredoxin 1824391/ 
1824393 
1824180
/ 
1824182 
Glu (CAA) Asp (GAC) Neither 
SP_1911 As above. 1824588 1824377 Ser (AGC) Gly (GGC) D39 
SP_1911 As above. 1824609 1824398 Ile (ATT) Leu (CTT) D39 
SP_1913 Authentic frameshift. 1825256 1825045 Ser (AGT) Gly (GGT) D39 
SP_1914 Hypothetical protein 1825712 1825501 Ile (CTA) Thr (ACT) D39 
SP_1914 As above. 1826142 1825931 Leu (CTC) Ile (ATC) D39 
SP_1915 Hypothetical protein 1826478/ 
1826479 
1834161
/ 
1834162 
Ala (GCA) Val (GTT) D39 
SP_1915 As above. 1826503 1834186 Asn (AAT) Ser (AGT) D39 
SP_1915 As above. 1826525 1834208 Ser (TCT) Leu (GCT) D39 
SP_1916 PAP2 family protein. 1827142 1834825 Asp (GAT) Asn (AAT) D39 
SP_1916 As above. 1827352 1835035 Cys (TGT) Arg (CGT) D39 
SP_1916 As above. 1827368 1835051 Ser (AGC) Arg (AGA) D39 
SP_1918 ABC transporter, ATP 
binding protein. 
1828094 1835777 Pro (CCG) Ser (TCG) D39 
SP_1918 As above. 1828115 1835798 Arg (CGT) Cys (TGT) D39 
SP_1918 As above. 1828142 1835825 Arg (AGA) Gly (GGA) D39 
SP_1919 ABC transporter, 
permease protein. 
1828907 1836590 Leu (CTC) Phe (TTC) D39 
SP_1919 As above. 1829040/
1829041 
1836723
/182902
4 
Leu (TTG) Stp (TAA) D39 
SP_1919 As above. 1829231 1836914 Ile (ATC) Val (GTC) D39 
SP_1919 As above. 1829312 1836995 Ser (TCA) Pro (CCA) D39 
SP_1919 As above. 1829318 1837001 Arg (CGT) Cys (TGT) D39 
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SP_1919 As above. 1829335 1837018 Gly (GGC) Asp (GAC) D39 
SP_1919 As above. 1829383 1837066 Thr (ACG) Met (ATG) D39 
SP_1919 As above. 1829537 1837220 Ser (TCC) Pro (CCC) D39 
SP_1919 As above. 1829561 1837244 Ser (TCG) Pro (CCG) D39 
SP_1919 As above. 1829587 1837270 Glu (GAA) Gly (GGA) D39 
SP_1920 MarR family 
transcriptional 
regulator. 
1829980 1837661 Pro (CCT) Ser (TCT) D39 
SP_1920 As above. 1830130 1837811 His (CAC) Tyr (TAC) D39 
SP_1923 Pneumolysin. 1832174 1839855 Asn (AAT) Asp (GAT) D39 
SP_1924 Hypothetical protein. 1833393 1841074 Tyr (TAC) His (CAC) D39 
SP_1927 IS1381, transposase 
OrfA 
1834935 1842616 Tyr (TAT) Asp (GAT) D39 
SP_1927 As above. 1834962 1842643 Ala (GCA) Thr (ACA) Neither 
SP_1927 As above. 1835012 1842693 Ile (ATA) Met (ATG) D39 
SP_1928 IS1381, transposase 
OrfB 
1835482/ 
1835483 
1843163
/ 
1843164 
Gly (GGT) Asp (AAT) Neither 
SP_1928 As above. 1835507 1843188 Cys (TGT) Tyr (TAT)  D39 
SP_1928 As above. 1835558 1843239 Ala (GCT) Val (GTT) Neither 
SP_1928 As above. 1835629 1843310 Glu (GAA) Lys (AAA) D39 
SP_1928 As above. 1835657 1843338 Tyr (TAT) Cys (TGT) Neither 
SP_1928 As above. 1835699 1843380 Ile (ATT) Ser (AGT) D39 
SP_1930 Hypothetical protein 1836482 1844190 Leu (CTC) Phe (TTC) D39 
SP_1931 Hypothetical protein 1836923 1844631 Glu (GAA) Val (GTA) D39 
SP_1931 As above. 1836993 1844701 His (CAT) Tyr (TAT) D39 
SP_1931 As above. 1837074 1844782 Pro (CCT) Ser (TCT) D39 
SP_1933 Hypothetical protein. 1837534 1845242 Stp (TGA) Gly (GGA) Neither 
SP_1933 As above. 1837543 1845251 Val (GTT) Ile (ATT) Neither 
SP_1933 As above. 1837602 1845310 Ile (ATT) Thr (ACT) Neither 
SP_1934 Hypothetical protein. 1838778 1846486 Tyr (TAT) His (CAT) D39 
SP_1934 As above. 1838873 1846581 Gly (GGG) Ala (GCG) D39 
SP_1934 As above. 1839074 1846782 Leu (TTG) Ser (TCG) D39 
SP_1935 Hypothetical protein 1839292 1847000 Gly (GGA) Val (GTA) Neither 
SP_1935 As above. 1839298 1847006 Ala (GCA) Val (GTA) D39 
Table 4-3: SNPs causing amino acid changes in Xen35 genes compared to TIGR4 
 
Using the table above the major genome changes have been compiled into Table 
4-4, consisting of genes that contain frameshifts due to insertions or deletions or 
contain amino acid changes leading to introduction of a premature stop codon. 
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Or includes genes that contain large deletions which may alter the functionality 
of the resulting protein. Although SNPs leading to single amino acid changes in 
the resulting protein may have a severe effect on the proteins function these 
have not been further validated with regards to their effect in Xen35 due to 
their shear number. 
Gene Function Change Outcome 
SP_0200/ 
0201 
SP_0200 -Competence-
induced protein Ccs4. 
SP_0201 Hypothetical protein 
C deletion SP_0200 removal of stop codon. 
SP_0201 frame shift. Premature stop 
codon. 
SP_0206 Hypothetical protein C insertion Frameshift, removal of stop codon. 
SP_0491 Hypothetical protein C deletion Frameshift. Removal of stop codon 
SP_0715 Lactate oxidase (LctO) SNP (G>T) Amino acid change, Glycine > stop. 
SP_0730 Pyruvate oxidase (SpxB) SNP (G>T) Amino acid change, Glutamine > 
stop. 
SP_1715 Hypothetical protein G Insertion Frameshift. Premature stop codon. 
SP_1732 Serine/Threonine protein 
kinase. (StkP) 
216bp deletion Removal of PASTA domain 3 
between amino acid repeats 
TQIVLTVAKKA/ TQIVLTVAKKV,  
SP_1914 Hypothetical protein luxA-E 
insertion 
Gene loss of function 
SP_1919 ABC transporter, permease 
protein. 
SNP (TG>AA) Amino acid change, Leucine > stop 
SP_1920 MarR family transcriptional 
regulator. 
T and A 
deletion 
Frameshift. Premature stop codon. 
SP_2076 Authentic frameshift G Insertion Frameshift, removal of frameshift. 
Table 4-4: Genome changes in Xen35 resulting in loss of function of the protein encoded or 
proteins containing large in frame deletions. 
Table compiling the changes in Xen35 that cause the gene encoded protein to become non-
functional or to likely cause a reduced function. 
 
Included in Table 4-4 is the gene encoding the eukaryotic like serine/ threonine 
protein kinase, a global regulator of gene expression in S.pneumoniae, which 
contains a deletion of 216bp (72 amino acid) (Saskova et al., 2007). This deletion 
still leaves the protein in frame so whether this affects the functionality of StkP 
is unknown. It appears that the deletion has occurred between two identical 10 
amino acid repeats (TQIVLTVAKK) present at the end of the second and third 
PASTA (penicillin binding protein and serine threonine kinase associated) 
domains respectively. Which have been shown to play a role in sensing the 
external environment and relaying this information to the N-terminal kinase 
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domain (Biol et al., 2002). SP_1914 is non-functional as this is the gene into 
which the lux genes were inserted (Figure 4-1). Interestingly both the pyruvate 
oxidase and lactate oxidase which function under aerobic growth conditions 
contain amino acid changes creating a premature stop codon in both genes 
(Taniai et al., 2008). Gene alignments of spxB and lctO from Xen35 to other 
genome sequenced S.pneumoniae strains available at NCBI showed this amino 
acid change is not common, not being seen in any other strains (data not 
shown). SpxB has been shown to be an important virulence factor in 
S.pneumoniae producing hydrogen peroxide as a by-product of its enzymatic 
reaction, and is important for intraspecies competition in the nasopharynx 
(Pericone et al., 2000).  
Of the changes seen in Xen35 a large proportion were located around the lux 
gene insertion, summarised in Table 4-5. Due to this each change was mapped as 
to whether it corresponded to that seen in the corresponding gene in D39 
(NC_008533). Xen35 was constructed via transformation of Xen7 (D39) genomic 
DNA into TIGR4. Therefore it was hypothesised that along with the lux gene 
insertion a large proportion of the genes surrounding the lux insertion in Xen7 
were also recombined into TIGR4 to make Xen35. This seemed to be the case as 
170 out of 194 of the gene changes seen surrounding the lux insertion 
corresponded to the changes of a D39 gene rather than a TIGR4 gene. There 
were a few exceptions to this, which may be due to some variation of the TIGR4 
strain Xen35 was constructed in compared to the genome sequenced TIGR4 
strain (Tettelin et al., 2001). Or potential variations in the D39 strain Xen7 was 
constructed in compared to that of the genome sequenced strain (Lanie et al., 
2007). Figure 4-2 shows the region surrounding the lux genes (17kb), which was 
also recombined into TIGR4 creating Xen35.  
Change  Surrounding lux insertion Rest of the Genome 
SNPS 189 31 
Insertions 3 12 
Deletions 2 6 
Table 4-5: Location of genome changes seen in Xen35 
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Figure 4-1: Schematic diagram of the lux gene insertion site in Xen35 
Diagram showing the lux insertion site in Xen35, constructed in CLC genomics workbench. LuxA-E are the five genes required for the bioluminescence 
reaction which are inserted into SP_1914 in Xen35. 
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Figure 4-2: Schematic diagram showing region recombined into Xen35 from Xen7 (D39) 
Diagram shows whole region SP_1908-1935 in Xen35 that now contains Xen7 (D39) alleles rather than TIGR4, which spans roughly 17kb not including the 
lux genes. Boxed in purple is the lux genes. Diagram was constructed in CLC genomics workbench. 
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The rest of the genome changes lying outwith the lux insertion site were also 
mapped to the D39 genome sequence. A number of these changes were also 
shown to be in D39, which could indicate multiple recombination events 
occurring during a single transformation, which has been shown can occur 
(Croucher et al., 2012). However it could also be from genome variations in the 
Xen35 TIGR4 parent to that of the genome sequenced strain, which is likely the 
case for the in frame deletion in StkP. PCR was performed and this deletion was 
shown not to be present in Xen7, which contains the full length StkP(data not 
shown). The only other explanation would be this deletion has occurred in Xen35 
over time in the laboratory. The SNP causing the loss of function of SpxB is also 
not present in Xen7, as Xen7 produced similar levels of hydrogen peroxide to 
TIGR4 (Figure 4-3). 
4.3.2 Hydrogen peroxide production of Xen35 
Due to the noted SNP in spxB in Xen35, a hydrogen peroxide assay was 
performed on this strain to confirm the resulting SpxB protein was non-
functional. SpxB produces over 90% of the cells H2O2 as a by-product of its 
enzymatic reaction therefore it would be expected to see severely reduced 
levels of H2O2 in Xen35 compared to T4JH (Pericone et al., 2000). The presence 
of hydrogen peroxide leads to a colour change to purple visualised in the assay. 
This assay was also performed on all the other Xen strains created. This included 
Xen7 (serotype 2, D39), Xen9 (serotype 19, HUS-TMBIG), Xen10 (serotype 3, 
A66), Xen11 (serotype 19, Ef3030), Xen12 (serotype 14, 140301) and Xen34 
(serotype 23, 230401). This assay will assess if reduced H2O2 production is a 
common feature of all the Xen strains, which is brought about due to the 
insertion of the lux genes or expression of the lux genes. These strains were 
compared to T4JH as we did not have their parent strains available for 
comparison. 
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Figure 4-3: Hydrogen peroxide production of Xen strains 
Each strain was represented in triplicate in the Hydrogen peroxide assay. (A) The graph 
gives the hydrogen peroxide production in mM of each strain calculated using a standard 
curve of known hydrogen peroxide concentrations (See Figure 2-14), the dotted line 
represent the limit of detection. (B) Shows visually the assay performed in a 96 well plate 
with each strain represented in triplicate. 
 
Hydrogen peroxide assay confirmed the lack of H2O2 production in Xen35 and 
therefore the fact that SpxB is non-functional in this strain. Although there is 
only a small decrease in Xen35 H2O2 production compared to T4JH, visually it is 
clear there is no H2O2 produced by Xen35 (Figure 4-3). The other Xen strains all 
produce H2O2 and therefore this SNP in Xen35 spxB is clearly not a common 
feature in all Xen strains. The fact this is not the case in Xen7 would also 
indicate this change did not come from this strain during production of Xen35. 
This SNP in Xen35 likely arose from the original TIGR4 strain Xen35 was 
constructed in. 
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4.4 Expression changes in Xen35 
4.4.1 Microarray analysis of Xen35 
Due to the large number of genome changes seen in Xen35 gene expression 
changes were assessed to deduce the downstream effect these genome changes 
may have in Xen35. For this microarray analysis was performed on Xen35 
compared to T4JH.  
A total of 33 genes were differentially regulated between Xen35 and T4JH 
(P<0.05) shown in Table 4-6. When increasing the P value to P<0.1 a total of 65 
genes were differentially regulated (data shown in appendix IIII). Although not 
within our designated P<0.05 cut off this list is referred to as it may contain 
genes that show true expression changes, for instance it may include genes that 
are contained within the same operon of genes in the P<0.05 list.  
Included in the genes that were differentially regulated is that encoding the 
pilus backbone protein (rrgB), and a number of glycosyltransferases, which 
function to glycosylate a large surface protein know as the pneumococcal serine 
rich repeat protein (PsrP). psrP was shown to be differentially regulate in the 
P<0.1 gene list. Both are important for virulence in S.pneumoniae contributing 
to adherence and biofilm formation respectively (Hemsley et al., 2003, Sanchez 
et al., 2010). rlrA, rrgA and rrgC were also shown to be differentially regulated 
in the P<0.1 list. Also Included were a number of transcriptional regulators and a 
HK (hk06) of a TCS pair, the RR (rr06) was also differentially regulated in the 
increased P value list (P<0.1). The lactate oxidase (lctO) was shown to be down 
regulated in Xen35, however from the genome sequence data we know this gene 
encodes a truncated protein.  
Interestingly the genes surrounding the lux insertion were both highly up 
regulated in Xen35. SP_1914 a hypothetical protein is non-functional due to the 
lux insertion, however the adjacent gene SP_1915 also encoding a hypothetical 
protein still remains functional (contains a number of SNPs). SP_1915 located 
downstream to SP_1914 is up regulated over 100 fold in Xen35. The surrounding 
genes were not differentially regulated and therefore we hypothesise the 
promoter driving the expression of the lux genes lies downstream of SP_1915. 
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Due to their huge up regulation it is likely the lux genes interruption of SP_1914 
altered some regulatory unit causing the huge up regulation of both SP_1914 and 
SP_1915. Both protein are of unknown function and therefore the effect of this 
to virulence of Xen35 is unknown.  
Gene Description Abbrev Fold 
change 
SP_0095  Hypothetical protein  2.9 
SP_0107  LysM domain containing protein  3.3 
SP_0202  Anaerobic ribonucleoside triphosphate reductase nrdD 1.5 
SP_0463  Cell wall surface anchor family protein rrgB 13.7 
SP_0663 Hypothetical protein  1.8 
SP_0715  Lactate dehydrogenase lctO 2.3 
SP_0726  Phosphomethylpyrimidine kinase thiD 2.8 
SP_1159  Tyrosine recombinase (chromosome seg) xerS 1.4 
SP_1427  U32 family peptidase  1.7 
SP_1464  Acetyltransferase  1.3 
SP_1468  Pyridoxal biosynthesis lyase pdxS 2.4 
SP_1546  Hypothetical protein  2.1 
SP_1572  Non-heme containing ferritin  1.9 
SP_1587  Oxalate formate antiporter  4.6 
SP_1757  Hypothetical protein  5.4 
SP_1764  Glycosyltransferase family protein  5.9 
SP_1765  Glycosyltransferase family protein  2.5 
SP_1766  Glycosyltransferase family protein  4 
SP_1767  Glycosyltransferase family protein  3.8 
SP_1769 Glycosyltransferase family protein, authentic frameshift.  4.2 
SP_1861  Choline transporter proV 1.7 
SP_1862  Hypothetical protein  2.1 
SP_1863 MarR family transcriptional regulator marR 2.2 
SP_1895 Sugar ABC transporter, permease protein  5 
SP_1898  Alpha-galactosidase aga 5 
SP_1914  Hypothetical protein  66.1 
SP_1915  Hypothetical protein  185.6 
SP_2010  Penicillin binding protein 2A PBP 2A 1.1 
SP_2057  Hypothetical protein  1.4 
SP_2106  Glycogen phosphorylase family protein  1.7 
SP_2185  Hypothetical protein  1.7 
SP_2192  Sensor Histidine kinase hk06 1.6 
SP_2195  Transcriptional regulator  ctsR 1.5 
Table 4-6: Genes differentially regulated in Xen35 compared to T4JH 
Table shows genes differentially regulated in Xen35 compared to T4JH (P<0.05). Fold 
change represents that seen in Xen35 compared to T4JH, red showing genes up regulated 
in Xen35 and blue are those that are down regulated. 
 
4.4.2 Real time PCR validation of microarray analysis 
RT-PCR (Real-time PCR) was performed on a number of genes shown to be 
differentially regulated in Xen35 to confirm changes seen by microarray analysis. 
Of the genes included were the whole pneumococcal pilus islet (SP_0461-64/ 
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SP_0466-68), PsrP (SP_1772) and the two hypothetical proteins surrounding the 
lux insertions (SP_1914/ SP_1915). 
 
Figure 4-4: RT-PCR graph of pilus islet genes, psrP and SP_1914/15 expression in Xen35 
Graph shows RT-PCR of the whole pilus islet (rlrA, rrgA, rrgB, rrgC, srtB, srtC, srtD), psrP, 
SP_1914 and SP_1915 in Xen35. Fold change represents that of Xen35 compared to TIGR4. 
Each bar represents the average of three replicas (three biological replicas) and errors bars 
the standard deviation. Statistical analysis was performed by a 1-way ANOVA with a Tukeys 
testing correction comparing the dCt values of the control strain (T4JH) to the test strain 
(Xen35), * P<0.01, **P<0.001. 
 
Gene Microarray RT-PCR 
SP_0461 (rlrA) 6.3 12.8 
SP_0462 (rrgA) 13.3 28.1 
SP_0463 (rrgB) 13.7 16.2 
SP_0464 (rrgC) 7.1 12.6 
SP_0466 (srtB) 2.4 11.8 
SP_0467 (srtC) 2.0 7.5 
SP_0468 (srtD) 1.8 5.6 
SP_1914 66.1 59.7 
SP_1915 185.6 96.3 
SP_1772 (psrP) 4.3 6.3 
Table 4-7: Comparison of expression changes of the pilus islet genes, psrP, SP_1914 and 
SP_1915 in Xen35 from microarray (P<0.05/ P<0.1) and RT-PCR analysis. 
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Table shows fold changes in gene expression of the whole pilus islet, psrP, SP_1914 and 
SP_1915 in Xen35 compared to T4JH. Fold changes show that from microarray data and 
those from RT-PCR analysis. 
 
RT-PCR for the selected genes confirmed the changes seen by microarray 
analysis. RT-PCR was performed on the same RNA preparations that microarray 
analysis was performed on so variations between the two experimental 
techniques could also be assessed. Microarray seemed to slightly underestimate 
the down regulation of the pneumococcal pilus in Xen35, showing a decrease in 
28-5.5 fold in the different genes required for pilus assembly. RT-PCR also 
showed the huge difference in the genes surrounding the lux insertion is a true 
change. The up regulation of psrP was also confirmed. 
Due to their being such a large change in the expression of the pneumococcal 
pilus RT-PCR was performed on some of the genes known to regulate the 
pneumococcal pilus. This includes TCS shown to all be repress expression of the 
pilus genes (Hendriksen et al., 2006, Rosch et al., 2008, Song et al., 2009). rr06 
was also shown to be differentially expressed in Xen35 by microarray (P<0.1). 
This will assess whether they may be causing this decrease in pilus expression 
seen in Xen35.  
 
Figure 4-5: RT-PCR graph of TCS expression in Xen35 
Graph shows RT-PCR of rr03, rr06, rr08 and rr09 in Xen35. Fold change represents that of 
Xen35 compared to TIGR4. Each bar represents the average of three replicas (three 
biological replicas) and errors bars the standard deviation. No statistical difference was 
observed. 
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Gene Microarray RT-PCR 
SP_0387 (rr03) 1.2 1.9 
SP_2193 (rr06) 1.6 2.2 
SP_0083 (rr08) 1.4 1.1 
SP_0661 (rr09) 1.8 1.6 
Table 4-8: Comparison of expression changes of TCS in Xen35 from microarray and RT-PCR 
analysis. 
Table shows fold changes in gene expression of rr03, rr06, rr08 and rr09 in Xen35 compared 
to TIGR4. Fold changes show that from microarray data and those from RT-PCR.  
 
RT-PCR performed on the four TCS known to regulate the pneumococcal pilus 
showed three of them were up regulated in Xen35, however none were classed 
as statistically significant (Table 4-8, Figure 4-5). rr06 was shown to be up 
regulated by RT-PCR (not significant) and by microarray analysis. Whether this 
may contribute to the altered pilus expression would require further study. 
4.4.3 RNA-seq analysis of expression changes in Xen35 
RNA-seq analysis was also performed on Xen35 compared to T4JH. mRNA 
purification was performed on the same total RNA preparation used for 
microarray analysis and RT-PCR analysis and therefore is directly comparable. No 
statistical analysis has been performed on this data set to date so comparison is 
performed using the RPKM (reads per kilobase of exon model per million mapped 
reads) expression values assigned in CLC genomics workbench. Only a few chosen 
genes are shown below in Table 4-9. This gives an indication of the expression 
levels of both genes in the two strains and from this the fold change is 
calculated. 
Gene RPKM 
Xen35 
RPKM 
TIGR4 
Fold 
change 
RNA-seq 
Fold 
change 
Microarray 
Fold 
change RT-
PCR 
SP_0461 (rlrA) 3.33 38.6 11.6 6.3 12.8 
SP_0462 (rrgA) 11.17 249.34 22.3 13.3 28.1 
SP_0463 (rrgB) 41.22 612.78 14.9 13.7 16.2 
SP_0464 (rrgC) 41.34 671.84 16.3 7.1 12.6 
SP_0466 (srtB) 4.58 40.56 8.9 2.4 11.8 
SP_0467 (srtC) 10.32 57.22 5.5 2.0 7.5 
SP_0468 (srtD) 11.35 60.25 5.3 1.8 5.6 
SP_1772 (psrP) 21.07 4.63 4.6 4.3 6.3 
SP_0387 (rr03) 92.64 99.76 1.1 1.2 1.9 
SP_2193 (rr06) 304.3 239.65 1.3 1.6 2.2 
SP_0083 (rr08) 53.1 102.04 1.9 1.4 1.1 
SP_0661 (rr09) 56.36 129.27 2.3 1.8 1.6 
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Table 4-9: Comparison of expression changes of the pilus islet, psrP and TCS in Xen35 from 
microarray, RT-PCR and RNA-seq analysis. 
Table shows fold changes in gene expression of the pilus islet (rlrA, rrgA, rrgB, rrgC, srtB, 
srtC, srtD), psrP, rr03, rr06, rr08 and rr09 in Xen35 compared to TIGR4. Fold changes show 
that in Xen35 from microarray, RT-PCR and RNA-seq analysis.  
 
Initial comparisons were performed looking at the pilus islet genes expression 
which showed as for the microarray and RT-PCR a decrease in pilus islet 
expression in Xen35, with the fold change values being similar to both RT-PCR 
and microarray analysis. This was also the case with psrP, which also showed an 
up regulation in the RNA-seq data corresponding to that shown by microarray 
and RT-PCR analysis. Analysis of the four TCS shown to play a role in pilus 
regulation by RNA-seq showed some variations to the data obtained by 
microarray and RT-PCR analysis. rr03 and rr09 expression shown by RNA-seq 
analysis was opposite to that shown by RT-PCR and microarray, perhaps 
confirming that these are not true changes and would need further validation. 
rr08 showed a down regulation in Xen35 by RNA-seq analysis however RT-PCR 
showed no difference. rr06 still showed a small up regulation in Xen35 during 
RNA-seq analysis. Due to the small fold changes in the TCS it is hard to validate 
if this is a true change due to variation within the techniques used. 
4.5 Changes in pilus expression in Xen35 
To further confirm this decrease in pilus expression in Xen35 western blotting 
was performed to assess if this correlates to a decrease in protein levels. And 
FACS analysis was performed to assess the spread of the pilus in the population 
level. 
4.5.1 Western blot analysis of Xen35 
Western blot analysis was used to determine the amount of pilus backbone 
protein (RrgB) in Xen35 and T4JH. Western blot analysis was performed on 
samples prepared at varying ODs (OD600nm 0.2/ 0.6 and 1.0) to assess any 
variation in the pilus at different ODs. Analysis showed a clear decrease in the 
amount of RrgB in Xen35 compared to T4JH at all ODs (Figure 4-6). There does 
seem to be some variation at the different ODs with the biggest difference in 
RrgB expression seen at OD600nm 0.6. There is likely some variation in the fold 
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changes stated due to variations in the technique, however at all ODs it is clear 
there is a large decrease in RrgB expression in Xen35 compared to T4JH. 
 
Figure 4-6: Western blot of Xen35 RrgB expression compared to TIGR4. 
Western blotting analysis was performed on TIGR4, Xen35 at varying ODs (OD600nm 0.2/ 0.6/ 
1.0) and T4!rrgB looking for RrgB protein levels in all (!-RrgB antibody). Equal protein 
loading was confirmed by equal expression of GroeL (!-GroeL antibody), normalised 
against in analysis. Western blotting quantification was performed using ImageJ with fold 
changes in RrgB expression in Xen35 compared to TIGR4 boxed below the strain, analysis 
was performed comparing the Xen35 OD sample to that of its corresponding TIGR4 same 
OD sample. Left hand side numbers represent the size in kDa of proteins run to the same 
point. 
 
It has recently been shown that the pneumococcal pilus in a population is not 
distributed evenly between cells. Within a growing population a number of cells 
are positive for the pilus and some negative (Basset et al., 2011, De Angelis et 
al., 2011). It was therefore important to evaluate in Xen35 if the decrease in 
pilus expression correlated with a decrease in pili on single cells or if the 
number of cells expressing the pilus were fewer than T4JH. 
4.5.2 FACS and fluorescence microscopy analysis of Xen35 
FACS analysis was performed initially by staining a fixed bacterial population 
grown in BHI (OD600nm 0.6) with a anti-rabbit capsule antibody specific for the 
serotype 4 capsule and co-staining with a anti-mouse RrgB antibody. Samples 
were then stained with a anti-rabbit APC conjugate and a anti-mouse FITC 
conjugate antibody. This left the bacterial cells stained positive for the capsule 
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(APC+), which were gated on to confirm events acquired were that of the 
bacterial population. This capsule stained population was then gated on for 
being RrgB positive (FITC+) or RrgB negative (FITC-).  
FACS performed to look at the change in pilus expression at the population level 
was performed on Xen35 and two TIGR4 strains, T4JH used for all experiments to 
date and T4NO1 a strain taken only a single passage from the original genome 
sequenced strain (Tettelin et al., 2001, Aaberge et al., 1995). Both strains were 
used as we do not have access to the parent strain of Xen35 (Figure 4-7). We 
know from the Xen35 genome sequence data there is a degree of variability 
between different strains and likely strains of the same serotype. We thought it 
important then to confirm the same pilus expression in the two TIGR4 strains 
with T4JH being used for microarray, RT-PCR, RNA-seq, western blotting 
experiments and T4NO1 being used as the reference for the genome sequence 
data. 
FACS analysis performed on Xen35 showed that only 5.5% of the population were 
positive for the pneumococcal pilus (Table 4-10). This showed that rather than a 
decrease in pili present on a single cell there are fewer cells that contain the 
pilus on their cell surface. 
With regards to the TIGR4 strains, interestingly there is a big difference in the 
number of cells expressing the pilus on the cell surface. T4NO1 showed 88% of 
cells positive for the pilus however T4JH only showed 20.5% of the cells 
expressing the pilus (Table 4-10), which is similar to the 30% seen in TIGR4 in 
published data (Basset et al., 2011). The reasons for this difference in these two 
strains will be discussed in section 4.8. Due to this it was decided that all future 
experiments would be performed using T4NO1 (the strain the original genome 
sequence was performed on) (Tettelin et al., 2001, Aaberge et al., 1995).  
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Figure 4-7: FACS analysis of RrgB surface expression in Xen35 
FACS was performed on Xen35, T4NO1, T4JH and T4!rrgB. (A) Shows histograms of the 
capsule positive populations selected for from samples stained with a capsule antibody, 
population used for further analysis. (B) Shows the capsule stained populations being gated 
on for being RrgB positive, histograms/ polychromatic plot show negative (left) and positive 
(right) RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4NO1 12.1 87.9 
T4JH 79.5 20.5 
Xen35 94.7 5.35 
T4!rrgB 98.4 1.6 
Table 4-10: Percentage RrgB positive cells in a Xen35 population from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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Fluorescence microscopy confirmed all changes seen during FACS analysis as 
seen in Figure 4-8. T4NO1 showed the majority of cells contain the pilus and this 
is present over the whole cell, this is also the case for T4JH however a smaller 
number of cells have the pili. Xen35 showed a number of cells with pili present 
all over the cell surface but some also contained just a small region on the cells 
where pili were present. No T4!rrgB cells were observed to be RrgB positive by 
fluorescence microscopy shown in Figure 4-8. Further representative fluorescent 
microscopy images can be seen in appendix I. 
 
Figure 4-8: Fluorescence microscopy of Xen35. 
One representative image of fluorescently labelled T4NO1, T4JH, T4"rrgB and Xen35 used 
for FACS analysis. Cells were stained for the presence of RrgB (FITC) and the capsule 
(APC). Scale bars above represent, T4NO1-9µm, T4"rrgB - 140µm, T4JH - 140µm and Xen35 
- 140µm. The same representative image will be used throughout this study for each strain, 
more images can be seen in appendix I. 
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4.6 Electron microscopy analysis of Xen35 
Electron microscopy was performed on Xen35 to evaluate mainly any obvious 
structural changes in the pilus, but also any changes in cell morphology, which 
may give a hint as to whether StkP in Xen35 is non-functional. StkP mutants have 
been shown to affect cell division forming longer cells with multiple septa 
(Giefing et al., 2008). Microscopy was performed using a !-RrgB primary 
antibody with a 10nm gold particle conjugate secondary antibody. This labelled 
the length of the pilus shaft with gold particles. Microscopy was also performed 
on T4NO1. T4!rrgB was used to confirm absence of the pilus and no cross 
reactivity of the antibody to any other surface proteins. Images were taken 
between 4000x and 16000x magnification. 
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Figure 4-9: Electron microscopy of T4NO1, Xen35 and T4!rrgB. 
Electron microscopy images of T4NO1 (A), Xen35 (B) and T4!rrgB (C). Cells were stained 
using a !-RrgB antibody and a secondary 10nm gold conjugate antibody. Cells were 
visualised at 4000-16000x magnifications. 
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Electron microscopy further confirmed that T4!rrgB contains no pili on the 
surface, and the gold conjugate antibody did not cross react with any other 
bacterial surface component (Figure 4-9). Images of Xen35 cells showed that 
some cells did express the pneumococcal pilus on the surface as shown by FACS 
however a large majority did not. One of the Xen35 cells visualised showed an 
elongated morphology with multiple septa along the length suggesting this cell is 
unable to divide properly. Which may indicate StkP in this strain is non-
functional or has a reduced functionality (Figure 4-9). The majority of T4NO1 
cells contained pili on the surface with often more than one pilus coming from 
the same cell. However some had no pili. These structures reach a long way 
from the cell surface in T4NO1. In Xen35 the pili appear shorter, however when 
performing electron microscopy fewer Xen35 cells were observed on the nickel 
grid and therefore these cells imaged may not be representative of a normal 
Xen35 population. More experiments would have to be performed to assess the 
length of pili in Xen35 cells compared to T4NO1. 
4.7 Analysis of virulence of Xen35  
Due to the huge genome changes, expression changes and changes in the surface 
expression of the pilus we wanted to assess difference in virulence of Xen35 
compared to T4NO1. 
4.7.1 Adherence assay analysis of Xen35 
Initial experiments were performed assessing the ability of Xen35 to adhere to 
different cell lines. Chosen cell lines included HBMEC cells (human brain 
microvascular endothelial cells), A549 cells (Human lung epithelial carcinoma 
cells line) and D562 cells (Detroit 562, Human pharyngeal carcinoma cell line), 
used to mimic meningitis, pneumonia and colonisation respectively. The 
pneumococcal pilus has been shown to aid adherence to A549 cells (Hemsley et 
al., 2003). psrP has also been shown to be important for pneumonia and aids 
adherence to A549 cells (Shivshankar et al., 2009). SpxB has been shown to be 
important for colonisation and is non-functional in Xen35 (Pericone et al., 2000). 
All these factors likely affect the virulence of Xen35. 
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Figure 4-10: Adherence of Xen35 to different cell lines. 
Adherence of Xen35 was assessed to HBMEC, A549 and Detroit 562 cell lines. Data is 
represented as percentage adherence relative to that of T4NO1 (100%, dashed line), each 
bar is an average of three replicas and the error bars represent the standard error of the 
mean. Statistical analysis was performed using a 1-way ANOVA with a Tukeys testing 
correction, no statistical difference was observed.  
 
Adherence of Xen35 to all cells lines showed a trend towards an increase 
compared to T4NO1, however none were significant. With the highest trend 
towards an increase seen to the A549 cells, this is likely due to the increased 
expression of psrP. It is possible psrP is also able to aid adherence to other cells, 
and may also contribute to the trend towards an increase in adherence observed 
to HBMEC and D562 cells also. 
4.7.2 In vivo analysis of Xen35 
Virulence was also assessed in vivo using a mouse model of infection. For this 
MF1 mice were infected intranasally with 5x106 cfu/50µl with either Xen35 or 
T4NO1 (already animal passaged). 20 mice were infected per bacterial strain and 
mice split into four groups, 24hour time point, 48hour time point, 72hour time 
point and survival. At each time point the mice in each group were culled and 
nasal wash, blood, lung and brain bacterial counts enumerated. If mice got sick 
before their time point they were culled and time of death noted. The survival 
group were culled if sick or culled at the end of the experiment at 96 hours post 
inoculation. 
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Initial analysis was performed comparing the survival of mice infected with both 
strains using a Kaplan-meier survival curve. This analysis was performed only on 
the 5 mice of the survival group of each strain. From this it is clear T4NO1 is 
more virulent than Xen35 showing a statistically significant increase in survival 
time with mice infected with Xen35 (Figure 4-11). The average survival time of 
mice infected with T4NO1 was 43 hours whereas the mice infected with Xen35 
had an average survival time of 76 hours. 
Over the course of the experiment the weight of the mice was noted as this can 
be used to assess disease progression. Percentage weight loss of mice infected 
with T4NO1 or Xen35 was compared at different time points over the course of 
the experiment. Data showed at all time points mice infected with T4NO1 had a 
statistically significant higher percentage weight loss than mice infected with 
Xen35 (Figure 4-11). This suggests disease progression in T4NO1 is quicker than 
in Xen35. To assess at what point during infection Xen35 is attenuated bacterial 
count from the brain, lung, blood and nasal wash of each mouse were compared 
to that of T4NO1 at varying time points. 
 
Figure 4-11: Survival and weight loss of mice infected with Xen35 
(A) Shows percentage survival of mice infected with T4NO1 or Xen35 over time, statistical 
analysis was performed using a logrank Test, ** P<0.01. ** above the strain indicated a 
statistical difference compared to Xen35. (B) Shows percentage weight loss of mice infected 
with either Xen35 or T4NO1. Statistical analysis was performed using a non-parametric 
Mann-Whitney two sample rank test, **P< 0.01 and ***P<0.001. 
 
Comparison of bacterial counts in body organs and fluids were performed 
comparing the four groups stated above against each other. Dotted lines on the 
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graphs represent the limit of detection, if no counts were observed in the 
organs/ bodily fluids the limit of detection value was ascribed. It must be taken 
into account when analysing this data that the mice in each group did not 
necessarily die at the same time, for instance for the 72 hour group all T4NO1 
infected mice were culled between 31-66 hours post inoculation (mice were too 
sick) and these counts are represented in the 72 hour graph, whereas the Xen35 
72 hour group were culled between 55- 72 hours. This is less so the case at 
earlier time points, at 24 hours all the mice of both groups were culled at the 
same time, and therefore this data is a good direct comparison of disease 
progression. For the 48 hour group all Xen35 infected mice were culled at this 
time point however T4NO1 infected mice were culled between 31-48 hours.  
Comparison of bacterial counts at different time points showed a statistically 
significant difference in nasal wash bacterial counts at 24 hour and survival time 
points (Figure 4-12). This suggests perhaps Xen35 is unable to colonise as well as 
T4NO1 in mice. This could be due to the decrease in pilus expression (although 
this has not been validated in vivo) or due to the non-functional SpxB. There is a 
trend towards lower bacterial counts in the lungs at 24 hours in Xen35 infected 
mice, however not significant (Figure 4-12). At later time points there is a trend 
towards higher numbers of bacteria counts in Xen35 infected mice in the lungs, 
perhaps due to up regulation of PsrP which is known to play a role in biofilm 
formation and pneumonia (although this has not been validated in vivo). 
Bacterial counts in the brain of mice infected with either strain seem to be fairly 
similar at all time points with no statistical difference between them. However 
analysis of tail vein bleeds at the 24 hours time point showed a statistical 
significant decrease in the bacterial number in the blood of Xen35 infected mice 
when comparing all 20 mice infected per strain (data not shown). This again is 
perhaps due to the decreased number of bacteria able to colonise in Xen35 
infected mice causing a lag in the time taken for invasive disease to be initiated. 
Xen35 infected mice were imaged at each time point to visually assess disease 
progression shown in (Figure 4-13). 
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Figure 4-12: Bacterial counts in organs and bodily fluids of MF1 mice infected with Xen35 or 
T4NO1. 
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Bacterial counts were enumerated from brain, lungs, nasal wash and blood of mice infected 
with either Xen35 or T4NO1. Counts were enumerated from 5 mice for each strain over 
varying time points, graph (A) represent the 24 hour post infection time point, (B) 48 hours, 
(C) 72 hours and (D) the survival time point. Statistical analysis was performed using a non-
parametric Mann-Whitney two sample rank test, *P< 0.05. 
 
 
Figure 4-13: Images of mice infected with Xen35 
Images of mice infected with Xen35 over time showing in vivo infection in the lungs and 
abdomen of some mice. Images were acquired using the IVIS spectrum in vivo imaging 
system, imaging for 5 minutes for each image. Hours above the images indicate that of the 
time elapsed since inoculation. Numbers to the side indicate the mice numbers in each 
group. If mice are not present in the image they have been culled. 
 
4.8 T4NO1 and T4JH genome sequence 
Whole genome sequence analysis was also performed on T4NO1 and T4JH to 
assess any genome changes between these strains and that of the genome 
sequenced strain (NC_003028). One clear phenotypic change noticed between 
T4NO1 and T4JH is that in a growing population 88% of T4NO1 cells contain pili 
(RrgB) on the cells surface whereas only 20.5% contain pili on the cell surface in 
T4JH. This difference may be due to a genetic difference between the strains. 
Only preliminary data is currently available for the genome sequence data of 
these strains, which includes reference assembling the sequence reads of both 
strains to the available genome sequence (NC_003028), followed by SNP and 
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indel testing and assessing if there are any low coverage regions. This analysis 
was performed by Dr Andrea Mitchell. The changes observed have currently not 
been confirmed by other methods.  
4.8.1 T4NO1 
Preliminary whole genome sequence changes in T4NO1 compared to the genome 
sequence data available at NCBI (NC_003028) can be seen in Table 4-11. T4NO1 
was taken only a single passage from that of the genome sequence strain 
(NC_003028) and therefore few genome changes would be expected. Only three 
changes were observed, one indel, one SNP and one region of low coverage. Only 
one change was located in a gene, which was a SNP in comF. However this did 
not result in an amino acid change and probably does not alter the genes 
function. The region of low coverage was located in the intergenic region 
between SP_1199 and SP_1200. This region was also found to contain a number 
of changes in Xen35. It may be that this region is a mutational hotspot and 
readily accumulates changes, as an indel in this region is also seen in T4JH 
(Table 4-12). Alternatively there may have been mistakes in the assembly of the 
original genome sequence and these changes are common to all TIGR4 strains. 
The final indel was located in an intergenic region located between SP_1045 and 
SP_1046, again the function of this change is not known. 
Gene Information Position 
TIGR4 
Variant  In Xen35? 
INT SP_1045-
1046 
 985056 Indel T  No 
INT SP_1199-
1200 
  Low 
coverage 
 Likely, Xen35 contains 
4 Indel/ SNPS in this 
region 
SP_2207 ComF 2127997 SNP G>T (no aa 
change) 
No 
Table 4-11: Preliminary whole genome sequence changes in T4NO1. 
 
4.8.2 T4JH 
Preliminary whole genome sequence changes of T4JH compared to the genome 
sequence data available at NCBI (NC_003028) can be seen in Table 4-12. A total 
of five indels and three SNPs were observed in this strain. Interestingly six of 
these changes are also observed in Xen35, which may indicate these are 
Chapter 4 
 
 
217 
mutational hotspots. The majority of these changes are found in intergenic 
regions however two are located in genes. This includes the indel in SP_0206, 
which results in removal of the stop codon, this is also seen in Xen35. This gene 
is a hypothetical protein and its function is currently unknown. There are no 
genome changes in any of the genes known to regulate the pilus islet, which may 
account for the differences in expression of the pilus at the population level in 
T4NO1 and T4JH. However there is a SNP in the pilus anchor protein (rrgC) which 
has been shown to be present at the base of the pilus (El Mortaji et al., 2012). 
Currently no structure is available for RrgC so if this amino acid change (His>Tyr) 
would alter its function is unknown. The change occurs at aa 20 and is present in 
the N-terminal of the protein so would not effect the cell wall sorting signal or 
the LPXTG variant (VPDTG) motif required for sortase recognition. This data may 
suggest that like RrgA, RrgC plays a role in modulating expression of the pilus 
islet. Perhaps through a protein- protein interaction with one of the other pilus 
proteins (Basset et al., 2011, Basset et al., 2012).  
Gene Information Position 
TIGR4 
Variant  Amino acid 
change 
In 
Xen35? 
SP_0206 Hypothetical 
protein 
192436 Indel C  Yes 
SP_0464 RrgC- pilus 
anchor protein 
443333 SNP C>T His>Tyr (aa 
20) 
No 
INT SP_0482-
0483 
 463630 SNP G>A  Yes 
INT SP_0496-
0497 
 476406 SNP G>T  Yes 
INT SP_1199-
1200 
 1132344 Indel G  Yes 
INT SP_1359-
1360 
 1282011 Indel G  No 
INT SP_1777-
1778 
 1696086 Indel C  Yes 
INT SP_2105-
2106 
 2016331 Indel G  Yes 
Table 4-12: Preliminary whole genome sequence changes in T4JH. 
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4.9 Discussion 
In this study the phenotype and genotype changes in the bioluminescent strain 
Xen35 used to study in vivo disease progression was assessed. This strain showed 
a decrease in virulence compared to T4NO1, with mice infected with Xen35 
showing an increased survival time to those infected with T4NO1. Corresponding 
to decreased counts in the nasal wash at 24 hours and survival time points and a 
slower disease progression indicated by a reduced percentage weight loss 
compared to mice infected with T4NO1. Contrary to this a trend towards an 
increase in Xen35 adherence capabilities to A549, D562 and HBMEC cells was 
observed, however this was not significant. This could indicate not an inability 
of Xen35 to adhere in vivo but a decreased ability to disseminate through the 
host.  
One of the key phenotype changes observed in Xen35 was the large decrease in 
the presence of the pneumococcal pilus on the cell surface. Recent findings have 
shown that the pneumococcal pilus expression is regulated at the single cell 
level with a number of cells within a growing population being negative for the 
pilus (Basset et al., 2011, De Angelis et al., 2011). Xen35 only contains 5.5% of 
cells in a growing population positive for the pilus on the cell surface compared 
to that of 30% in TIGR4 stated in the literature, and 20.5% in T4JH and 88% in 
T4NO1. In S.pyogenes the ability to modulate pili at the population level is 
linked to disease state (Nakata et al., 2009). The fact we see almost an inability 
for Xen35 to modulate the pilus at the population level may give an indication as 
to why the strain in less virulent than the wild type. The regulation of this 
phenomenon is tightly controlled with a number of TCS regulating it suggesting 
in the pneumococcus it is also an important regulatory mechanism for survival 
and virulence.  
To assess the contributions of any genome changes in Xen35 causing this 
decrease in virulence/ pilus expression genome sequencing was performed. 
Whole genome sequencing of Xen35 showed a large number of genome changes. 
Xen35 was constructed via transformation of Xen7 genomic DNA (bioluminescent 
version of D39, serotype 2) into TIGR4. In Xen35 along with the lux gene 
insertion (into SP_1914) a large region surrounding these genes in Xen7 was also 
recombined into TIGR4. This left these genes in Xen35 that of a D39 allele rather 
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than a TIGR4 allele. Although the majority of these changes were synonymous a 
number caused amino acid changes in the resulting protein, whether this would 
affect the functionality of the protein is unknown. Genes in different strains 
have been shown to act in a strain specific manner so this is definitely possible 
(Blue & Mitchell., 2003). Also due to this recombination event two genes 
(SP_1919/ SP_1920) are non-functional in Xen35 due to frameshifts present in 
the D39 alleles. These genes encode a component of an ABC transporter and 
transcriptional regulator respectively. Neither gene has been studied for their 
effect on virulence and therefore their role in Xen35 is unknown. Of the genes 
recombined in with the lux insertion some have been implicated to play a in role 
in virulence including SP_1909, SP_1913, SP_1923 and SP_1931. SP_1913 
although being up regulated in the blood of infected mice contains an authentic 
frameshift in TIGR4 and therefore is unlikely to play a role in virulence changes 
in Xen35 (Orihuela, et al., 2004). SP_1923 encodes the pneumococcal toxin 
pneumolysin (ply) which has been shown to be important for lung infection, ply 
contains 1 amino acid change in Xen35, however this change likely doesn’t alter 
ply function (Hava & Camilli, 2002). SP_1909 was shown to be up regulated in 
the CSF of infected rabbits and therefore may play a role in meningitis however 
this gene was not found to be important in replication during meningitis. This 
gene also contains only a single amino acid change and again is unlikely to cause 
the virulence differences in Xen35 (Orihuela et al., 2004, Molzen et al., 2011). 
SP_1931 has been shown to be important for bacterial replication during 
meningitis increasing in expression over time, three amino acid changes are 
observed in this gene and again seems unlikely to cause the huge changes in 
virulence seen in Xen35 (Molzen et al., 2011). 
Xen35 is widely used to assess the virulence of TIGR4 in vivo and assess genes in 
TIGR4 important to virulence (Orihuela et al., 2003, Orihuela et al., 2004). 
However due to genotype and phenotype changes this perhaps is not the best 
model. This also shows the importance of proper characterisation of strains 
genetically manipulated and importance of designing mutants ensuring 
recombination events only introduce the desired mutations. With the increasing 
accessibility of genome sequencing and genome sequence data it is becoming 
easier to assess whole genome changes in mutants and whether SNPs etc may be 
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introduced due to allele variations between strains, when producing identical 
mutations in different serotypes. 
A number of genome changes in Xen35 were also located outside of the 
recombination region, although fewer than that seen in this region. Some of 
these changes could also be mapped to that of what would be seen in D39, 
indicating perhaps multiple recombination events during a single transformation 
(Croucher et al., 2012). This could also indicate variation in the original TIGR4 
strain used to construct Xen35 (we do not have access to this strain for 
comparison) to that of the available TIGR4 genome sequence data (Tettelin et 
al., 2001). Some of these changes are located in genes important for virulence. 
This included an in frame deletion of the 3rd PASTA domain of the serine/ 
threonine protein kinase, which was not seen in Xen7 and therefore likely came 
from the TIGR4 parent of Xen35. There were also SNPs causing introduction of 
premature stop codons in SpxB and LctO. The spxB SNP was also not from Xen7 
shown by the fact Xen7 produces similar levels of hydrogen peroxide as T4JH, 
whereas Xen35 produces none. These findings would also indicate variation not 
only between different serotypes but that of the same strains. The Xen35 parent 
TIGR4 seems to contain changes not seen in the TIGR4 strain that was genome 
sequenced.  
This is also validated by some of our data concerning the surface expression of 
pili on two TIGR4 strains (T4JH and T4NO1). Both show in a growing population 
variations in the amount of cells positive for the pilus backbone protein on the 
cell surface. Although not confirmed this is likely due to a SNP present in rrgC in 
T4JH which is not seen in T4NO1. There are further genome changes observed in 
T4JH which are not present in T4NO1 which further validates the idea that the 
“same strain” can be genetically different. In this instance the changes lead to 
differentially regulation of a key virulence factors which may alter virulence. 
However in this study the virulence of T4JH and T4NO1 were not directly 
compared. 
Of the gene changes observed outwith the lux insertion region a number have 
been shown to play a role in virulence. The genes only containing amino acid 
changes include SP_0784, SP_0807, SP_0927, SP_1343 and SP_1891 will not be 
discussed further as their function is likely not perturbed (Hava & Camilli, 2002, 
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Molzen et al., 2011, Orihuela et al., 2004). A number of genes however do 
contain changes that make them non-functional and have shown a role in 
virulence, including SP_0200, SP_0201, SP_0206, SP_0730, SP_1715, SP_1732 and 
SP_2076. There is a deletion in SP_200/ SP_201 in Xen35, the same deletion lies 
in the region where both genes overlap causing removal of the stop codon in 
SP_0200 and introduction of a premature stop codon in SP_0201. This change is 
seen in the D39 genome sequence data however shows one larger gene 
encompassing SP_0200 and half of SP_0201 (SPD_0186). Both of these genes 
were down regulated in the CSF of infected rabbits in TIGR4, and SP_0200 was 
up regulated on contact to D562 cells suggesting a role of SP_0200 in adherence. 
SP_0206 contains an insertion in Xen35 causing a frameshift, again in D39 a gene 
is annotated encompassing SP_0206 and part of SP_0207 (SPD_0191). SP_0206 is 
up regulated in a mouse model of bacteraemia in TIGR4 so this deletion may 
contribute to an attenuation of Xen35 invasion into the blood. Although data was 
not shown, discussed was a statistical decrease in bacterial counts in the blood 
taken form the tail veins of mice infected with Xen35 24 hours post inoculation. 
SP_1715 a component of an ABC transporter contains an insertion creating a 
frameshift, this gene has been noted to play a role in lung infection and 
meningitis (Hava & Camilli, 2002, Molzen et al., 2011). SP_2076 contains an 
insertion, this gene is non-functional in TIGR4 however this insertion removes 
the authentic frameshift restoring its function in Xen35, this gene is important 
for lung infection in TIGR4 (Hava & Camilli, 2002). 
SP_1732 encoding StkP as stated earlier contains an in frame deletion of the 
third PASTA domain in the N-terminal of the protein. As the protein is still in 
frame we cannot assess the impact in Xen35 or this change. StkP has been shown 
to be important for virulence in a bacteraemia and pneumonia models of 
infection. However Xen35 does not seem attenuated during lung infection and 
therefore perhaps the deletion in StkP does not perturb its function (Echenique 
et al. 2004, Hava & Camilli, 2002, Saskova et al. 2007). The role of the deletion 
in StkP is discussed further in chapter 5 and therefore will not be covered here. 
The SNP causing the introduction of a premature stop codon in SpxB may also 
affect virulence of Xen35. SpxB has been widely studies showing a role in phase 
variation with cells non-functional in SpxB showing only opaque colonies, a trait 
seen with Xen35 (data not shown). This gene has been shown to play a role in 
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colonisation and to a lesser extent a role in replication in the lungs and 
translocation to the bloodstream (Orihuela et al, 2004, LeMessurier et al, 2006). 
This gene is also important for competing in the nasopharynx with other 
coloniser and does this through production of hydrogen peroxide as a by-product 
of its enzymatic reaction (Pericone et al., 2000). The role of SpxB in Xen35 will 
be discussed later in this study in chapter 6 and so will not be covered further 
here. 
Microarray analysis was performed on Xen35 comparing it to TIGR4 to assess the 
expression changes in this strain. A number of the genes shown to be 
differentially regulated have been shown to play a role in virulence and 
therefore may contribute to the decrease in virulence of Xen35 in vivo. Of these 
genes SP_0095, SP_0726, SP_0663, SP_1861 and SP_1898 have been shown to be 
important during lung infection (Hava & Camilli, 2002). SP_0107, SP_0202 and 
SP_1587 show increased expression in the blood of infected mice and SP_1572 
decreased expression. SP_1468 and SP_1587 show increased expression in the 
CSF of infected rabbits and SP_1572 and SP_1863 showed a decreased expression 
(Orihuela, et al., 2004). The two genes surrounding the lux insertion SP_1914 
and SP_1915 were not shown to be important for virulence from the large scale 
virulence screens or in vivo expression experiments. These genes have however 
been shown to be variable between strains not being present in some, this may 
indicate a non vital role of these genes in the pneumococcus, and we assume 
from this are not causing the decrease in virulence in vivo of Xen35 (Silva et al., 
2006). Interestingly two important virulence factors in the pneumococcus were 
differentially regulated in Xen35. Up regulation of psrP (pneumococcal serine 
rich repeat protein) and down regulation of the pneumococcal pilus was 
observed in Xen35. 
psrP although only present in roughly 50% of clinical isolates is an important 
virulence factor in the pneumococcus (Mun et al., 2010). This gene is up 
regulated 4-6 fold in Xen35 along with its surrounding glycosyltransferases. 
These genes are found on a large 37kb islet whose presence has been associated 
with pneumonia causing clinical isolates (Sanchez et al., 2011, Obert et al., 
2006) . PsrP has been shown to be important for biofilm formation with biofilms 
showing a hyper adhesive phenotype to A549 and D562 cell lines (Sanchez et al., 
2011). With PsrP able to bind directly to keratin 10 on lung epithelia cells (Rose 
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et al., 2008, Shivshankar et al., 2009). Although only confirmed at the 
expression level we assume this increase in expression of psrP in Xen35 
correlates with that of surface expressed protein, as Xen35 shows an increased 
biofilm formation (data not shown) and shows a trend towards an increased 
adherence to A549 cells. A psrP homologue in Group B streptococci has been 
shown to adhere to and aid penetration of the blood brain barrier (Barrier et al., 
2009). Although no current data shows association of psrP with meningitis in the 
pneumococcus this could be why a trend towards an increased adherence to 
HBMEC cells is observed in Xen35. 
The pneumococcal pilus another major virulence factor is down regulated 15-25 
fold in Xen35. The pneumococcal pilus is encoded on a 14kb islet containing 7 
genes, a positive regulator of the operon (rlrA), three pilins rrgA, rrgB and rrgC 
and three sortases srtB, srtC and srtD (Hava & Camilli, 2002). The Hava & 
Camilli study showed rlrA and srtD were important during lung infection. Later 
studies also implicated the pilus in playing a role in colonisation and 
bacteraemia, as a non piliated TIGR4 strain was out competed in a pneumonia, 
colonisation and bacteraemia model of infection (Barocchi et al., 2006). The 
pilus knockout strain also showed an increased survival time compared to its 
parent (Barocchi et al., 2006). The pilus has also been shown to aid in adherence 
to A549 cells. In Xen35 a trend towards an increased adherence to all cell lines is 
observed, which would not be expected due to the decrease in pilus expression, 
however this is likely the cause of psrP which may be able to compensate for the 
decrease in pilus. In vivo analysis did however show a statistical decrease in 
nasal wash counts of Xen35 infected mice compared to T4NO1 at 24 hours and 
survival time points and may be due to this decrease in pilus. The decrease in 
pilus was confirmed as a decrease in the number of cells expressing the pilus on 
the cell surface and therefore in vivo you could envisage fewer Xen35 bacterial 
cells being able to adhere in the nasopharynx upon inoculation, which causes a 
lag in disease progression. Xen35 infected mice showed an increased survival 
time to that of T4NO1 infected mice mimicking the increased survival data of 
the non piliated TIGR4 strain published.  
Due to the large number of genome and expression level changes in Xen35 it is 
hard to pinpoint the exact culprit of this decreased virulence or if this is 
multifaceted. To start to narrow down on the factors contributing to the altered 
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phenotype of Xen35 we further studied the single contribution of a number of 
genes to the most prominent phenotypic change in Xen35 (the decrease in pilus 
expression). This includes evaluating the role of StkP, SpxB and LctO in pilus 
regulation, which are discussed in later chapters. Another potential contributor 
to this altered pilus expression is the high expression of the lux genes and the 
potential metabolic burden this places on the bacterial cell. The effect this has 
on pilus expression is also evaluated in chapter 7. 
  
 
 
 
 
 
 
 
 
5 Studying the role of StkP in virulence gene 
regulation. 
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Aim of this chapter 
Eukaryotic like serine/threonine protein kinases have been discovered in a 
number of bacteria, which function as an alternative signalling system than the 
highly abundant TCS, described in chapter 1.7.2. The aim of the work described 
in this chapter was to examine the potential role of the pneumococcal serine/ 
threonine protein kinase (StkP) in virulence gene regulation, specifically focusing 
on regulation of the pneumococcal pilus. Serine/threonine protein kinases are 
known to regulate pili in other species (Panichkin et al. 2006). The genome 
sequence data of strain Xen35 showed an in frame deletion within the stkP gene. 
Further Xen35 has been shown to have a decrease in pilus expression at the 
transcript and protein level. In this chapter the potential contribution of the 
deletion in StkP to the decrease in pilus expression seen in Xen35 is evaluated.  
Initial experiments performed were on a knockout of stkP constructed in T4NO1. 
To look at genome wide changes in gene expression microarray analysis was 
performed followed by RT-PCR to confirm microarray findings on a number of 
genes of interest. Specifically looking for changes in pilus expression, western 
blots were performed on T4!stkP to assess any changes in RrgB levels, followed 
by FACS analysis to assess the expression of the pilus in the population as a 
whole. 
As the deletion in stkP in Xen35 is an in frame deletion the stkP knockout is not 
necessarily representative of this change in Xen35. To elucidate the 
functionality of the in frame deletion in Xen35 stkP, both alleles from Xen35 and 
T4NO1 were cloned into T4!stkP at an alternative region in the genome under 
the control of a strong promoter (P2). Western blotting and FACS was then 
performed on these strains (T4!stkP"ST/ T4!stkP"XST) investigating pilus 
expression, to see how the different alleles are able to complement T4!stkP. 
The role of StkP in adherence in T4NO1 was also assessed and the contribution of 
the pneumococcal pilus to this validated. Potential variation in adherence to 
different cell lines was also assessed (HBMEC/ A549/ D562). 
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5.1 Background 
In the pneumococcus there is a single serine/threonine protein kinase (StkP) 
making it an easy model to study their function (Yeats et al. 2002, Echenique et 
al. 2004). StkP is highly conserved between pneumococcal strains and although 
not indispensible clearly plays an important role in survival and virulence 
(Giefing et al. 2008). The pneumococcal StkP is a global regulator of gene 
expression (Saskova et al. 2007). Null mutants show a decreased ability to 
survive under stressful conditions (heat/ osmotic/ oxidative and acid stress) 
(strain dependant)(Saskova et al. 2007), a reduced transformation efficiency and 
a decrease in virulence in vivo in a bacteraemia and pneumonia model of 
infection (Echenique et al. 2004, Saskova et al. 2007).  
StkP directly regulates genes via phosphorylation of target proteins on a serine 
or threonine residue (Novakova et al. 2005). StkP is known to phosphorylate a 
number of pneumococcal protein including two pneumococcal response 
regulators (RR06, RitR) (Novakova et al. 2010, Novakova et al. 2005, Agarwal et 
al. 2012, Ulijasz et al. 2009).  
Structurally StkP contains a N-terminal kinase domain joined by a hydrophobic 
linker to a C-terminal extracellular domain (Yeats et al. 2002, Pallova et al. 
2007). The extracellular domain consists of four PASTA domains (penicillin 
binding protein and serine threonine kinase associated domain), which function 
as a extracellular sensor domain (Maestro et al. 2010). PASTA domains in PBPs 
function to recognise the amount of unlinked peptidoglycan and regulate via 
their transpeptidase domain the amount of cross linking (Gordon et al. 2000, 
Maurer et al. 2012). This is also thought to be the case in StkP with the PASTA 
domains shown to be able to bind to synthetic peptidoglycan and #-lactam 
antibiotics (Maestro et al. 2010, Beilharz et al. 2012). The PASTA domains have 
also been shown to be important for localisation of StkP to the cell septum 
(Beilharz et al. 2012, Giefing et al. 2010).  
StkP functions as a dimer in vivo and is found in the genome adjacent to its 
cognate protein phosphatase which dephosphorylates proteins phosphorylated by 
the kinase, forming a signalling couple (Pallova et al. 2007, Ulijasz et al. 2009). 
In the pneumococcus PhpP also affects gene regulation indirectly through 
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altering the phosphorylation state of key regulatory proteins, which has been 
shown for RR06 and RitR (Agarwal et al. 2012, Ulijasz et al. 2009). PhpP also 
regulates a number of important pneumococcal surface proteins and genes 
involved in cell wall biosynthesis (cbpA, pspA, lytA, ftsZ, enolase etc) (Agarwal 
et al. 2012).  
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5.2 Gene expression changes seen in T4!stkP 
5.2.1 Microarray analysis of T4!stkP 
Microarray analysis was performed comparing expression changes in T4!stkP to 
its parent strain (T4NO1). StkP is already known to be a global regulator of gene 
expression as a StkP knockout made in strain CP1015 showed a large number of 
genes to be differentially regulated (Saskova et al. 2007). However other global 
gene regulators (TCS) are known to function in a strain specific manner 
(Hendriksen et al. 2007). Therefore we thought it important to perform 
microarray analysis on a stkP knockout in TIGR4, as this is the background strain 
of Xen35. This will also give an indication if StkPs regulation is strain specific 
like PhpPs. 
When performing microarray analysis on T4!stkP a total of 32 genes were 
differentially regulated, shown in Table 3-2. Microarray analysis indicates StkP 
likely regulates the biosynthesis of certain cells wall components in TIGR4. In 
T4!stkP genes involved in lipoteichoic acid biosynthesis and incorporation of 
choline into the cell wall components were up regulated. Further SecY the major 
component of the SecYEG translocase was down regulated in T4!stkP, implying a 
role of StkP in regulation of protein translocation onto the cell surface. This 
translocase is required for transport of the pilins to the cells surface therefore 
StkP may modulate cell surface pili levels through modulating protein 
translocation. The serine protease htrA was also up regulated in T4!stkP 
functioning to maintain protein quality under conditions of cellular stress and is 
known to play a role in virulence. A number of sugar transporters were also 
differentially regulated and a number of ribosomal proteins were down 
regulated. Although a smaller number of genes were statistically differentially 
regulated than in CP1015 when increasing the P value cut off to 0.1 (10% genes 
false positive) a total of 188 genes were differentially regulated. Some of these 
genes are likely true differences. Included in this list was some of the genes that 
encode the pneumococcal pilus (data not show).
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Gene Description Abbrev 
Fold 
change 
SP_0209  
50S ribosomal protein L3. Binds 3’ end 23S rRNA, nucleates 
assembly of 50S subunit. rplC 1.5 
SP_0213  
30S ribosomal protein S19. complexes with S13 that binds 
strongly to 16S rRNA. rpsS 1.6 
SP_0218  30S ribosomal protein S17, involved in translation fidelity.  rpsQ 1.4 
SP_0230  Forms heterotrimeric complex in the membrane. secY 1.5 
SP_0282  PTS system mannose specific, IID component. manN 1.5 
SP_0283  PTS system mannose specific, IIC component. manM 1.5 
SP_0284  PTS system mannose specific, IIAB component. manL 1.6 
SP_0645  PTS system IIA component, putative.  1.8 
SP_0742  Hypothetical protein.  1.3 
SP_0801  Hypothetical protein.  1.3 
SP_1000  Thioredoxin family protein  1.2 
SP_1164  
Acetoin dehydrogenase E1 component, alpha subunit, 
putative. acoA 1.3 
SP_1260  Copper homeostasis protein cutC 1.4 
SP_1274  Phosphorylcholine metabolism. licD2 1.5 
SP_1356  Chlorohydrolase trzA 1.8 
SP_1462  Hypothetical protein.  1.9 
SP_1599  Mediates pseudouridylation at the tRNA anticodon region. truA 1.6 
SP_1646  Metallo-beta-lactamase superfamily protein.  1.31 
SP_1734  rRNA methyltransferase. rsmB 6.2 
SP_1735  
Modifies the free amino group of the aminoacyl moiety of 
methionyl-tRNA. fmt 4.9 
SP_1736  Primosome assembly protein. priA 3.9 
SP_1803  Hypothetical protein.  1.5 
SP_1884  Trehalose PTS system, IIABC component.  5.2 
SP_1972 Hypothetical protein.  1.4 
SP_1994 Aminotransferase. alaT 1.4 
SP_2086 Phosphate ABC transporter, permease protein. pstA 1.4 
SP_2096 M20/ M25/ M40 family peptidase. hipO 1.3 
SP_2106 Glycogen phosphorylase family protein. malP 1.6 
SP_2107  4-alpha-glucanotransferase. malM 1.6 
SP_2175  Incorporate D-alanine into Lipoteichoic acid. dltB 1.2 
SP_2239  Serine protease. htrA 2.2 
 Table 5-1 : Table of genes differentially regulated in T4!stkP 
Table shows genes differentially regulated in T4!stkP compared to its parent T4NO1 
(P<0.05). Fold change represents that seen in T4!stkP compared to T4NO1, red showing 
genes up regulated in T4!stkP and blue are those that are down regulated. 
 
When comparing the T4!stkP gene expression changes to that of Xen35, only 1 
gene was found to be common to both (SP_2106) (Figure 5-1), However this gene 
was up regulated in !stkP (+1.6) and down regulated in Xen35 (-1.7). This means 
that the gene expression changes seen in Xen35 are likely not due to inactivation 
of StkP.  
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Figure 5-1: Venn diagram of gene expression changes in T4!stkP and Xen35. 
Venn diagram showing genes commonly regulated in T4!stkP compared to Xen35. Diagram 
shows only 1 gene common to both evaluated from strains individual gene expression 
changes compared to their parent strains. 
 
5.2.2 StkP regulates genes in a strain specific manner 
Microarray analysis was performed in strain CP1015!stkP (Saskova et al. 2007). 
StkPs cognate phosphatase has been shown to regulate genes in a strain specific 
manner. Therefore this may also be the case for StkP. Using already published 
data we compared our microarray data to that of the published data using a 
venn diagram (Figure 5-2) to see if many genes were commonly differentially 
regulated between the two strains. Although different methodologies were used 
between the two studies it could give an indication if genes regulated were 
similar. When comparing the data sets only 3 genes were common between the 
two strains (SP_0742/ SP_1462/ SP_1803). To ensure there were not a large 
number of genes similar that just missed our statistical test we increased the P 
value cut off to 0.1 and compared this data set to that of CP1015!stkP (Saskova 
et al. 2007). 188 genes came out in our P<0.1 list (data not shown) (10% are 
potential false positives). When comparing this gene list to that of the published 
data only 11 genes were found to be common between the two (appendix VI). 
Although a number of genes were commonly regulated between the two strains, 
comparatively to the total number of genes differentially regulated the number 
is small. This gives a good indication that StkPs regulation is also strain specific. 
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Figure 5-2: Venn diagram of gene commonly regulated by StkP in T4NO1 and CP1015. 
Venn diagrams were compiled from our gene expression data in T4!stkP and that of already 
published data in CP1015. (A) Compares the gene list In Table 3-2 (P<0.05) to that of 
published CP1015 gene lists, showing only 3 genes commonly regulated by StkP.  
 
5.2.3 Real-time PCR validation of microarray analysis 
RT-PCR (Real-time PCR) was performed on a number of genes to confirm findings 
from the microarray. Although not in the list above a number of the genes 
encoding the pneumococcal pilus (SP_0461-63/ SP_0466) came out in the gene 
list with an increased P value (P<0.1). We therefore decided to perform RT-PCR 
on the whole pilus islet to see if this was a true difference.  
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Figure 5-3: RT-PCR graph of pilus expression in T4!stkP 
Graph shows RT-PCR of the whole pilus islet (rlrA, rrgA, B, C, srtB, C, D) in T4!stkP. Fold 
change represents that of T4!stkP compared to T4NO1. Each bar represents the average of 
three replicas (three biological replicas) and errors bars the standard deviation. Statistical 
analysis was performed by a 1-way ANOVA with a Tukeys testing correction comparing the 
dCt values of the control strain (TIGR4) to the test strain (T4!stkP), * P<0.01. 
 
Gene Microarray RT-PCR 
SP_0461 (rlrA) 2.0 1.8 
SP_0462 (rrgA) 1.7 2.7 
SP_0463 (rrgB) 1.4 1.2 
SP_0464 (rrgC) 1.4 1.2 
SP_0466 (srtB) 1.7 1.8 
SP_0467 (srtC) 1.3 1.8 
SP_0468 (srtD) 1.2 1.3 
Table 5-2: Comparison of expression changes of the pilus islet in T4!stkP from microarray 
and RT-PCR. 
Table shows fold changes in gene expression of the whole pilus islet in T4!stkP compared 
to T4NO1. Fold changes show that from microarray data and those from RT-PCR. 
 
The RT-PCR of the pilus islet genes in T4!stkP is shown in Figure 5-3. rrgA 
expression in T4!stkP was the only gene showing a statistically significant 
increased expression. rlrA, srtB and srtC showed a trend towards an increase in 
expression in the StkP deletion mutant, however this was not significant. rrgB, 
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rrgC and srtD although potentially showing a very small increase in expression, 
this again was not significant. Expression values from microarray analysis and 
RT-PCR were compared in Table 5-2, showing good correlation between both 
techniques. 
StkP has been shown to directly interact with a number of TCS altering their 
phosphorylation states and therefore their conformation and ability to bind to 
target genes. Again although not in the list above some of the TCS were shown 
to be differentially regulated in the P<0.1 gene list (rr05, rr06, rr10, rr13). RT-
PCR analysis was performed on all the response regulator of the TCS to see if 
deleting StkP affected their expression.  
 
Figure 5-4: RT-PCR graph of TCS expression in T4!stkP 
Graph shows RT-PCR of all the known TCS in S.pneumoniae in T4!stkP. Fold change 
represents that of T4!stkP compared to T4NO1. Each bar represents the average of three 
replicas (three biological replicas) and errors bars the standard deviation. No statistical 
difference was observed. 
 
Gene Microarray RT-PCR 
SP_1633 (rr01) 1.2 1.2 
SP_1227 (rr02) 1.2 1.3 
SP_0387 (rr03) 1.0 1.4 
SP_2082 (rr04) 1.0 1.0 
SP_0798 (rr05) 1.6 1.2 
SP_2193 (rr06) 1.3 1.3 
SP_0156 (rr07) 1.4 1.0 
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SP_0083 (rr08) 1.0 1.1 
SP_0661 (rr09) 1.4 1.2 
SP_0603 (rr10) 1.2 1.4 
SP_2000 (rr11) 1.2 1.5 
SP_2235 (rr12) 1.0 1.8 
SP_0526 (rr13) 1.2 1.2 
SP_0376 (orr) 1.1 1.2 
Table 5-3: Comparison of expression changes of TCS in T4!stkP from microarray and RT-
PCR. 
Table shows fold changes in gene expression of all the TCS in T4!stkP compared to T4NO1. 
Fold changes show that from microarray data and those from RT-PCR. Genes highlighted in 
red are up regulated in T4!stkP and those in blue down regulated. 
 
The changes in the expression of the TCS are very subtle with no fold change 
over 2 (Figure 5-4). Of the four TCS that were shown to be differentially 
expressed by microarray analysis, three showed similar expression levels by RT-
PCR (rr06, rr10, rr13) (Table 5-3), although none of the changes were 
significant. rr05 when performing RT-PCR showed a change in the opposite 
direction to that seen in the RT-PCR and therefore is not a true change. 
Interestingly rr12 upon RT-PCR seemed to show a trend towards a decreased 
expression although again this was not significant, and was not seen as 
significantly differentially regulated in either P<0.05/ P<0.1 lists during 
microarray analysis.  
5.3 Changes in pilus expression in T4!stkP 
To try and confirm any changes in pilus expression in the T4!stkP strain western 
blotting was performed using an antibody against the pilus backbone protein 
(RrgB) to see if there was a noticeable change at the protein level. FACS was 
also performed to deduce changes in the population of pilus expression. And 
finally electron microscopy performed to note any obvious changes in the 
structure or localisation of the pilus in T4!stkP. 
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5.3.1 Western blot analysis of T4!stkP 
 
Figure 5-5: Western blot of T4!stkP RrgB expression compared to T4NO1. 
Western blotting analysis was performed on T4NO1, T4!stkP and T4!rrgB looking for 
expression of RrgB in all strains ($-RrgB antibody). Equal protein loading was confirmed by 
equal expression of GroeL ($-GroeL antibody), normalise against in analysis. Western 
blotting quantification was performed using ImageJ with fold changes in RrgB expression 
compared to T4NO1 boxed below the strain. 
 
Western blotting analysis showed no difference between T4NO1 and T4!stkP in 
RrgB expression. The high molecular weight ladder of the pilus visually looks 
more abundant in T4!stkP compared to T4NO1, however on analysis taking into 
account the loading control GroeL a slight decrease in RrgB in T4!stkP was 
noted.  
5.3.2 FACS and fluorescence microscopy analysis of T4!stkP 
FACS (fluorescence activated cell sorting) was performed to further validate 
changes seen by western blotting. As well as looking at RrgB abundance it will 
show the number of cells in the population that are RrgB positive. Cells were 
initially stained using an antibody against the capsule (APC), this population was 
gated on and from this cells positive for the pilus gated on (FITC). Confirmation 
of the data seen by FACS analysis was performed via studying the same sample 
using fluorescence microscopy, visually confirming the FACS findings. 
Chapter 5 
 
237 
 
 
Figure 5-6: FACS analysis of RrgB surface expression in T4!stkP 
FACS was performed on T4!stkP, T4NO1, T4!stkP!rrgB and T4!rrgB. (A) Shows 
histograms of the capsule positive populations selected for from samples stained with a 
capsule antibody, population used for further analysis. (B) Shows the capsule stained 
populations being gated on for being RrgB positive, histograms/ polychromatic plot show 
negative (left) and positive (right) RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4NO1 12.1 87.9 
T4!stkP 0.628 99.4 
T4!stkP!rrgB 98.3 1.66 
T4!rrgB 98.4 1.6 
Table 5-4: Percentage RrgB positive cells in a T4!stkP population from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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Figure 5-7: Fluorescence microscopy of T4!stkP. 
One representative image of fluorescently labelled T4NO1, T4!rrgB and T4!stkP used for 
FACS analysis. Cells were stained for the presence of RrgB (FITC) and the capsule (APC). 
Scale bars above represent, T4NO1- 9µm, T4!rrgB - 140µm, T4!stkP - 210µm and 
T4!stkP!rrgB - 140µm. The same representative image will be used throughout this study 
for each strain, more images can be seen in appendix I. 
 
FACS clearly showed a difference in RrgB at the population level in T4!stkP 
compared to T4NO1. As already seen in a T4NO1 population when grown in BHI 
88% of the cells are positive for the pneumococcal pilus. When removing StkP 
there is an increase of roughly 10% of cells containing the pilus on the cell 
surface (Figure 5-6). In StkP 99.4% of a growing population contain the 
pneumococcal pilus on the cell surface, suggesting a total loss of ability to 
regulate the amount of the pilus being placed onto the cell surface (Figure 5-6). 
Visually from the FACS histograms there is a total loss in T4!stkP of the 
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population seen on the left hand side representing the pilus negative cells (RrgB 
negative), which can be seen in T4NO1. 
Confirmation of RrgB positive cells is performed via fluorescence microscopy on 
the same samples used during FACS analysis. The intensity of the RrgB positive 
population in T4!stkP and T4NO1 were similar and therefore the amount of pili 
on a single cell in T4!stkP is similar to that of T4NO1 (Figure 5-7). Fluorescence 
microscopy of T4!stkP showed no cells were pili negative (FITC-) and therefore 
we assume 100% of T4!stkP cells contain pili on the cell surface. Both the RrgB 
knockouts show roughly a 1.6% positive RrgB population however this was not 
confirmed via fluorescence microscopy (Figure 5-7) and Is likely an artefact of a 
small amount of non specific binding of the "-RrgB or "- Mouse FITC antibody.  
5.3.3 Electron microscopy analysis of T4!stkP 
Electron microscopy was performed on T4!stkP to evaluate mainly any potential 
structural changes in the pilus but also any changes in cell morphology already 
observed in strains when deleting StkP. Microscopy was performed using a "-
RrgB primary antibody with a 10nm gold particle conjugate secondary antibody, 
with pili shown by gold particles labelled along the length of the shaft. 
Microscopy was also performed on T4!stkP!rrgB to further confirm absence of 
the pilus and no cross reactivity to any other surface proteins. Images were 
taken between 4000x and 10000x magnification (Figure 5-8). 
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Figure 5-8: Electron microscopy of T4!stkP and T4!stkP!rrgB. 
Electron microscopy images of T4!stkP (A) and T4!stkP!rrgB (B). Cells were stained using 
a "-RrgB antibody and a secondary 10nm gold conjugate antibody. Cells were visualised at 
4000-10000x magnifications. 
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With regards to pili on T4!stkP cell surface the images clearly show pili on all 
cells. The number varies from cell to cell with some containing one and others 
numerous. The projections coming from the cells are not all labelled along the 
whole pilus shaft compared to T4NO1, which could indicate a change in 
structure at these regions, which hinders the binding of the RrgB antibody. This 
could occur through increased RrgA pilin numbers along the RrgB shaft however 
this has not been validated. These projections are confirmed to be pili as 
microscopy of T4!stkP!rrgB do not show any of these structures (Figure 5-8). 
There is no discernable difference in the localisation of the pili between the WT 
train and T4!stkP. 
T4!stkP was visualised via EM in large clumps (Figure 5-8), which was noticeably 
different to T4NO1 and T4!stkP!rrgB, which formed small clumps/ chains or no 
clumps respectively. This implicates a role for the pilus in the clumping of 
T4!stkP. The inability of T4!stkP to divide properly probably also plays a role in 
clumping. Elongated cells with numerous septa and cells with a bulging 
appearance can be seen in T4!stkP due to the cells inability to divide properly, 
a phenotype already noted in the literature. However this phenotype varies with 
some cells appearing to divide normally and show a regular shape like T4NO1.  
5.4 Role of StkP in adherence 
Adherence assays were performed to study the role of StkP in adherence. PhpP 
has already been shown to play a strain specific role in adherence and therefore 
as its function is coupled to that of StkP it would be expected that StkP will also 
alter adherence. Adherence assays were performed on three cell lines to assess 
if genes regulated by StkP are important at a specific niche. As FACS has 
indicated an increase in the pilus in T4!stkP at the population level, the role of 
pilus in adherence of T4!stkP was also elucidated. For this adherence assays 
were also performed on strain T4!stkP!rrgB and T4!rrgB. 
5.4.1 Adherence assay analysis of T4!stkP 
Adherence assays showed StkP affects adherence, with a statistical increase 
seen to all cell lines in T4!stkP (Figure 5-9). However deletion of the pilus (RrgB) 
in T4!stkP causes the increase in adherence to be lost, dropping the adherence 
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capabilities to that similar to T4!rrgB and T4NO1. The biggest increase in 
adherence of T4!stkP is observed to A549 cells (1500%). Upon deletion of the 
pilus (RrgB) there is a large drop in adherence to levels similar to the WT strain. 
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Figure 5-9: Adherence assay of T4!stkP to different cell lines. 
Adherence of strains T4NO1, T4!stkP, T4!stkP!rrgB and T4!rrgB was assessed to HBMEC 
(A), A549 (B) Detroit 562 (C) cell lines. Data is represented as percentage adherence relative 
to that of T4NO1 (100%, dashed line), each bar is an average of three replicas and the error 
bars represent the standard error of the mean. Statistical analysis was performed using a 1-
way ANOVA with a Tukeys testing correction, * P<0.05/ ** P<0.001/ *** P<0.0001. * above the 
bar represent statistical significance compared to T4NO1 (not represented as a bar on the 
graphs). 
 
!"
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5.5 Studying the functionality of PASTA domains in pilus 
regulation.  
As described previously the C-terminal sensor domain of StkP consists of four 
PASTA domains. In Xen35 the third PASTA domain has been deleted. This still 
leaves StkP in frame but the functionality of the resulting StkP protein is not 
known. To study the functionality of Xen35 StkP this stkP allele and T4NO1 stkP 
allele were cloned into plasmid pC2LSD P2, placing stkP under the control of the 
strong P2 promoter (pCP2 ST/ pCP2 XST). Once transformed into T4!stkP this 
left the stkP alleles in the genome between genes SP_1885/ SP_1887 along with 
the P2 promoter (T4!stkP#ST/ T4!stkP#XST). Both strains were tested for their 
ability to complement T4!stkP in regards to its altered pilus expression. For this 
western blotting for RrgB was performed as well as FACS to see if there were 
changes in the population as a whole expressing the pilus. Adherence assays 
were also performed to see if complementation of T4!stkP alters the strains 
ability to adhere to HBMEC and A549 cells. 
5.5.1 Western blot analysis of T4!stkP complements 
Western blotting again showed no difference between T4NO1 and T4!stkP likely 
due to detection limits of western blotting. However differences in RrgB 
expression could clearly be seen in T4!stkP#ST and analysis showed a 2 fold 
decrease in RrgB expression compared to T4NO1 (Figure 5-10). T4!stkP#XST also 
showed a decrease in RrgB expression of 1.2 fold compared to T4NO1 (Figure 
5-10). This gives an indication that StkP from T4NO1 has increased activity than 
StkP from Xen35, and therefore the third PASTA domain is important in StkP 
signalling. 
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Figure 5-10: Western blot of T4!stkP complements RrgB expression compared to T4!stkP 
and T4NO1. 
Western blotting analysis was performed on T4NO1, T4!stkP, T4!stkP#ST, T4!stkP#XST 
and T4!rrgB analysing expression of RrgB in all strains ("-RrgB antibody). Equal protein 
loading was confirmed by equal expression of GroeL ("-GroeL antibody), normalise against 
in analysis. Western blotting quantification was performed using ImageJ with fold changes 
in RrgB expression compared to T4NO1 boxed below the strain. 
 
5.5.2 FACS and fluorescence microscopy analysis of T4!stkP 
complements. 
FACS analysis was also performed on the complement strains to see how pili 
were distributed throughout the population. FACS analysis clearly showed a large 
reduction in pilus expressing cells in T4!stkP#ST with only 26% of cells 
remaining pilus positive compared to 100% of T4!stkP and 88% of T4NO1 cells 
(Figure 5-11/ Table 5-5). The majority of T4!stkP#ST RrgB positive cells also 
seem to show a large reduction in the amount on a single cells, with just small 
single pilus positive regions visualised in most cases (Figure 5-12). The exact 
locality is hard to assess and would require a more sensitive technique. This 
however may indicate StkP is regulating the positioning of the pilus on the cell 
surface. However there is not shift to the left of the pilus positive population in 
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T4!stkP#ST observed via FAC, which would indicate that the pili positive cells 
have a lower fluorescent intensity (less pili) than the other strains tested. 
In T4!stkP#XST there was also a decrease in the population of pilus expressing 
cells with only 51% of cells being pilus positive. Indicating Xen35 StkP has 
roughly half the functionality of T4NO1 StkP containing all four PASTA domains. 
These cells similarly compared to T4NO1 and T4!stkP show in the majority of 
cases pili spread all over the cell surface (Figure 5-12) 
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Figure 5-11: FACS analysis of RrgB surface expression in T4!stkP complements. 
FACS was performed on T4!stkP, T4NO1, T4!stkP#ST, T4!stkP#XST, T4!rrgB. (A) Shows 
histogram of the capsule positive populations selected for from samples stained with a 
capsule antibody, population used for further analysis. (B) Shows the capsule stained 
populations being gated on for being RrgB positive, histograms/ polychromatic show 
negative (left) and positive (right) RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4NO1 12.1 87.9 
T4!stkP 0.628 99.4 
T4!stkP#ST 74 26 
T4!stkP#XST 48.7 51.3 
T4!rrgB 98.4 1.6 
Table 5-5: Percentage RrgB positive cells in a T4!stkP population from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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Figure 5-12: Fluorescence microscopy of T4!stkP#ST and T4!stkP#XST. 
One representative image of fluorescently labelled T4NO1, T4!rrgB, T4!stkP, T4!stkP!rrgB, 
T4!stkP#ST and T4!stkP#XST used for FACS analysis. Cells were stained for the presence 
of RrgB (FITC) and the capsule (APC). Scale bars above represent, T4NO1- 9µm, T4!rrgB - 
140µm, T4!stkP - 210µm, T4!stkP#XST - 9µm and T4!stkP#XST - 9µm. The same 
representative image will be used throughout this study for each strain, more images can be 
seen in appendix I. 
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5.5.3 Adherence assay analysis of T4!stkP complements 
Due to the clear differences seen in pilus expression in T4!stkP#ST and 
T4!stkP#XST adherence assays were performed on these strains to HBMEC and 
A549 cells (Figure 5-13).  
Adherence assay data clearly showed a reduced adherence to both cells lines of 
both strains with complemented StkP. T4!stkP#ST showed the biggest statistical 
decrease in adherence with adherence to both cell lines dropping to nearly that 
of T4NO1. T4!stkP#XST showed a trend towards a drop in adherence compared 
to T4!stkP, although this was not statistically significant. This data further 
validates StkPs role in regulation of the pneumococcal pilus and its importance 
in adherence to different cell lines. With the pneumococcal pilus in this strain 
being a large contributing factor to adherence to different cell types.  
This data also confirms the importance of the four PASTA domains in StkP as 
complementation of T4!stkP with StkP with only three PASTA domains was 
unable to complement the mutant to the same level as the full length StkP. Why 
this may be the case is discussed further in section 5.6. 
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Figure 5-13: Adherence assay of T4!stkP complements to different cell lines. 
Adherence of strains T4NO1, T4!stkP, T4!stkP!rrgB, T4!stkP#ST, T4!stkP#XST and 
T4!rrgB was assessed to HBMEC (A), A549 (B) cell lines. Data is represented as percentage 
adherence relative to that of T4NO1 (100%, dashed line), each bar is an average of three 
replicas and the error bars represent the standard error of the mean. Statistical analysis was 
performed using a 1-way ANOVA with a Tukeys testing correction, * P<0.05. * above the bar 
represent statistical significance compared to T4NO1 (not represented as a bar on the 
graphs). 
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5.6 Discussion 
StkP has already been shown to be a global regulator of gene expression 
(Saskova et al. 2007), our data also indicates that this is the case with 32 genes 
differentially regulated in a stkP deletion mutant constructed in T4NO1 (P< 
0.05). When decreasing the stringency of analysis a total of 188 genes were 
differentially regulated (P<0.1). Comparison of these gene lists with genes 
known to be regulated by StkP in CP1015 showed very few were commonly 
regulated between the two strains, indicating a strain specific role in regulation 
of StkP (Saskova et al. 2007). This phenomenon has been shown for alternative 
signalling systems (TCS) and has recently been shown for StkPs cognate 
phosphates (PhpP) (Blue et al. 2003, Hendriksen et al. 2007, Agarwal et al. 
2012). 
Some of the genes shown to be differentially regulated in T4!stkP were those of 
genes involved in choline metabolism. Phosphorlycholine is an essential part of 
the two teichoic acids (TA (Lipoteichoic acid, teichoic acid)) present in the cell 
wall of the pneumococcus (Tomasz 1967b, Brundish & Baddiley 1968). Removal 
of choline in growth media results in the hindrance of pneumococcal growth 
showing altered chain formation, loss of transformability and no autolysis 
(Tomasz 1967a). Choline metabolism is controlled by two main operons lic1 and 
lic2. lic1 operon consists of 5 genes licABC involved in choline uptake and tarI/J 
involved in ribitol formation. lic1 was not shown to be differentially regulated in 
T4!stkP (Kharat & Tomasz 2006, Baur et al. 2009). lic2 consists of 3 genes licD1/ 
licD2 involved in attachment of phosphorylcholine to TA and tacF involved in 
transport of TA across the membrane (Damjanovic et al. 2007). licD2 has been 
shown to directly affect the amount of choline present in the cell wall with a 
deletion mutant containing a 50% reduction of the amount of choline in the cell 
wall (Zhang et al. 1999). licD2 (P<0.05) and licD1 (P<0.1) were up regulated on 
deletion of stkP, implicating a role of StkP in regulation of the amount of choline 
in the cell wall components. S.pneumoniae contains a number of important 
virulence factors, which are dependant on the presence of choline in the cell 
wall for cell surface attachment (Yother & White 1994, Hakenbeck et al. 2009). 
These choline binding proteins include a number of adhesins and virulence 
factors (CbpA, PspA etc) and autolytic enzymes (LytA-D, CbpD) important for 
cell division and autolysis (Gillespie et al. 1997, Hakenbeck et al. 1983, De Las 
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Rivas et al. 2002). Altering the amount of cell wall choline will likely effect the 
abundance of these proteins on the cell surface, determining if they attach or 
are released into the supernatant (Hakenbeck et al. 1983). The alterations in 
some of these proteins potentially affected by variations in cell surface choline 
composition corresponds to the phenotypes changes seen when deleting StkP. 
T4!stkP shows reduction in competence, a phenomenon noted upon growth in 
choline limited media (Tomasz 1967a, Regine Hakenbeck et al. 1983). StkP 
mutants show a deficiency in ability to divide a phenotype associated to that of 
a LytB mutant, which may correlate in T4!stkP with decreased amounts of LytB 
on the cell surface (Tomasz 1967a, Hakenbeck et al. 1983). Along with choline 
incorporation into the cell wall dltB was also up regulated in T4!stkP, which is 
important for LTA biosynthesis (Poyart et al. 2001).  
Although TCS CiaRH was not shown to be regulated at the transcript level by 
StkP other data indicates a potential interaction of StkP and RR05 potentially 
through phosphorylation as seen with StkP for RR06 and RitR (Agarwal et al. 
2012, Ulijasz et al. 2009). A study in 2007 evaluated the direct interaction of 
CiaR with the promoters of its target genes, which showed a number of 
similarities to the genes seen to be differentially regulated in T4!stkP (Halfmann 
et al. 2007). Of these common genes included were manM/ manM and manL 
which function as a mannose phosphotransferase system (Cochu et al. 2003),  
malM and malP encoding enzymes involved in maltosaccharide metabolism 
(Nieto et al. 1997). Interestingly the lic1 operon was regulated by CiaR whereas 
we saw differences in the lic2 operon, and finally the serine protease htrA and 
parB (P<0.1) involved in chromosomal segregation (Halfmann et al. 2007, Minnen 
et al. 2011). From this the hypothesis would be that StkP may also phosphorylate 
CiaR affecting its binding capacity to these promoter regions causing the changes 
in gene expression seen in T4!stkP. For the genes that are know to be regulated 
by CiaR and were not shown in our !stkP gene list, it could be that these were 
not regulated by CiaR in a TIGR4 background. 
Along with potentially regulating the attachment of the cell surface proteins to 
the cell wall our data indicates a potential role of StkP in translocation of 
proteins onto the cell surface. In T4!stkP secY was also differentially regulated, 
which function as a transmembrane pore vital for protein translocation across 
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the cell membrane. Other members of the translocase secE and secG were not 
differentially regulated and normally function on a 1:1:1 ratio with secY. secA 
which functions as a protein chaperone was also not differentially regulated 
(Dalal & Duong 2011). However if this is the case it indicates another level at 
which StkP Is able to regulate the content of the cell surface. Interestingly 
recent data has shown that during exponential growth SecY localises to the cell 
septum at the point where active peptidoglycan synthesis is occurring (Tsui et 
al. 2011). StkP has already been shown to localise to the midcell and partakes in 
sensing the cell wall peptidoglycan (Giefing et al. 2010, Maestro et al. 2010). 
Therefore a role could be envisaged for StkP to act in conjunction with SecY 
regulating at the expression level the amount of SecY available for protein 
translocation and therefore the amount of proteins translocated.  
Another component shown to interact with the Sec translocase is HtrA a serine 
protease that works in conjunction with SecA (chaperone for proteins being 
directed to the SecYEG translocase) (Tsui et al. 2011). HtrA is thought to act 
here as quality control for the proteins targeted to the translocase and cell 
surface. HtrA also localises to the cell septum along with SecA and SecY (Tsui et 
al. 2011). htrA is up regulated in T4!stkP indicating a requirement for protein 
degradation. 
High temperature requirement A (HtrA) protein has been extensively studied in 
the pneumococcus, functioning as a temperature induced serine protease 
(Ibrahim et al. 2004a), and in other streptococci has been shown to alter the 
expression of some cell surface proteins (S. Biswas & I. Biswas 2005). HtrA 
activity is more evident upon increased temperature and has been shown to help 
the cell survive environmental stresses (Ibrahim et al. 2004a). HtrA has been 
shown to be an important virulence factor showing increased survival in a mouse 
pneumonia and bacteraemia model (Ibrahim et al. 2004b, Ibrahim et al. 2004a). 
A phenotype of decreased competence associated with HtrA is one that is also 
seen in T4!stkP (Sebert et al. 2005, ). In T4!stkP an increase in HtrA expression 
is observed, which may correlate to a decrease in competence (Sebert et al. 
2005). This could potentially be the cause of the decrease in competence in 
T4!stkP.  
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htrA is found adjacent to parB in the genome and they are likely expressed as a 
single operon. ParB has recently been shown to be involved in chromosomal 
segregation upon replication recruiting condensing to the pneumococcal oriC 
(Minnen et al. 2011). This gene is also up regulated in T4!stkP (P<0.1), as StkP 
has been shown to be involved in cell division its not unlikely that it may also 
regulate proteins involved in chromosome segregation as cell division and DNA 
segregation would likely be required to work in unison. 
We did not study further the affect of the StkP deletion on the presence of 
choline and choline binding proteins on the cell surface. As the pneumococcal 
pilus was differentially regulated in the increased P<0.1 list we studied further 
changes in this virulence factor in T4!stkP. RT-PCR was performed and 
confirmed an expression change in rrgA, however expression of the other genes 
on the pilus islet were not shown to be statistically significant. Western blotting 
for the pilus backbone protein (RrgB) showed no discernable change in T4!stkP 
RrgB levels. However FACS analysis looking for the presence of RrgB on the cell 
surface showed roughly a 10% increase in the number of cells containing the 
pilus in T4!stkP. If there was a true decrease in expression of secY you would 
perhaps expect a decrease in proteins on the cell surface, including RrgB. 
However perhaps such a small fold change is too small to see a large change in 
phenotype. This increase in pilus shown by FACS was confirmed by fluorescence 
microscopy and corresponded to 100% of T4!stkP cells having pili on their cell 
surface. Therefore StkP seems to regulate whether individual cells produce pili 
at the population level, which could also be the case for a number of other 
surface proteins regulated by StkP. StkP cognate phosphatase has shown to 
regulate a number of cell surface components, as they work as a pair, StkP 
therefore likely affects oppositely the expression of these surface proteins. 
Implicating a global role for StkP in regulation of cell surface components, 
however none of these surface proteins showed expression change from our 
microarray analysis.  
A recent finding has shown that the pneumococcal pilus is regulated at the 
population level, with within a population two cell types existing, high pilus 
expressing cells and low pilus expressing cells. As of the moment no genes lieing 
outwith the pilus islet have been characterised as altering at the population 
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level the amount of pili that are seen on the cell surface in a growing population 
(Basset et al. 2011, De Angelis et al. 2011). Between the two populations no 
expression differences were observed indicating changes in the cell that are 
expression independent (De Angelis et al. 2011). Further studies showed that 
this phenotype is modulated via RrgA through its binding to RlrA (Basset et al., 
2011, Basset et al., 2012). However there is a large increase in rrgA expression 
in T4!stkP relative to the expression of rlrA therefore it is unlikely StkP 
modulates its regulation at the population level through altering levels of these 
two proteins. StkP has been shown to phosphorylate RR06. RR06 has also been 
shown to repress the expression of the pneumococcal pilus as in a deletion 
mutant of HK06 an increase in expression of the pilus islet is observed (Rosch et 
al. 2008). RR06 could potentially be the factor modulating the expression of the 
pilus at the population level in T4!stkP.  
StkP cognate partner PhpP has been shown to regulate genes that affect 
adherence to D562 cells in a strain specific manner. Here we show that StkP in 
T4NO1 also regulates adherence to different cell types. The contribution of the 
pneumococcal pilus to this increased adherence phenotype in T4!stkP was also 
evaluated. The role of StkP in adherence varied between all three cell lines, 
with the biggest increase in adherence seen to A549 cells with an increase of 
1500% compared to T4NO1, HBMEC cells showed an increase of 700% and D562 
cells 250%. In HBMEC cells it is clear this increased adherence phenotype is due 
to the increase in the pneumococcal pilus in T4!stkP, as upon deletion of the 
pilus (RrgB) the adherence phenotype is reverted to that of T4!rrgB. This 
phenotype is seen for all cell lines, as deletion mutants of RrgB in T4!stkP are 
no longer able to adhere to the same level and reverts to the level of adherence 
of T4!rrgB. However in A549 cells there is potentially another unknown factor 
contributing to the increased adherence to this cell line as upon deletion of the 
pilus (RrgB) the strain does not fully revert to that of T4!rrgB and has a similar 
adherence to the WT strain. D562 cells showed the smallest increase in 
adherence in T4!stkP perhaps indicating a less important role of the pilus in 
colonisation to that of pneumonia and meningitis.  
Considering there is only a 10% increase in the number of cells containing the 
pilus in T4!stkP the huge increase in adherence seems disproportionate relative 
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to T4NO1. However due to the most recent structure of the pneumococcal pilus 
it has been shown that RrgA is also able to multimerise and form branches of 
adhesins (RrgA) coming from varying positions along the RrgB backbone shaft (El 
Mortaji et al., 2012). As there was a clear increase in rrgA expression and likely 
corresponding protein expression we could hypothesis that as well as the 
increased amounts of RrgB present in the population on the cell surfaces, these 
cells may contain increased amounts of branched RrgA molecules, further 
increasing the adhesive capabilities of the cells. RrgA has also been associated 
with increased biofilm formation and may promote bacterial cell to cell 
attachment in T4!stkP (Muñoz-Elías et al. 2008). Therefore increasing the 
number of cells adherent during the adherence assays, not only through those 
that are directly associated with the tissue culture cells but also through 
bacteria- bacteria interactions. Upon deletion of RrgB this removes the 
backbone at which RrgA anchors itself to and likely depletes RrgA adhesive 
capabilities by removing the length at which RrgA can reach beyond the cell 
wall. Indications that this may be the case was shown by immunogold labelling 
of pili in T4!stkP visualised by electron microscopy. With pili from T4!stkP not 
always being labelled along the whole length of the RrgB shaft compared to that 
seen in T4NO1, this could indicate an inability for the antibody to efficiently 
reach the RrgB backbone due to other proteins blocking them (RrgA). However 
this could also be a staining problem and would need to be validated further. 
To evaluate the role of the deletion of the 3rd PASTA domain in the Xen35 stkP 
allele we looked at its potential role in regulation of the pneumococcal pilus. 
StkP regulates the pneumococcal pilus however this is opposite to what we 
would expect to see if this deletion was causing the huge decrease in pilus 
expression seen in Xen35. However the exact effect the deletion of the 3rd 
PASTA domain has on StkP in Xen35 is not know. To study this T4!stkP was 
complemented with stkP amplified from T4NO1 (Four PASTA domains) and Xen35 
(three PASTA domains), and both alleles were put under the control of a strong 
promoter (P2) in T4!stkP. This resulted in the over expression of these 
complemented StkP alleles in T4!stkP. It is assumed these alleles were 
expressed to the same level in the two strains as they were constructed using 
the same plasmid, this is currently being validated via western blot for StkP, to 
Chapter 5 
 
257 
confirm similar expression levels. The role of these different StkP alleles 
functionality was then assessed for their ability to effect pilus expression.  
These experiments further confirmed that StkP regulates the pneumococcal pilus 
as western blotting showed a clear decrease in RrgB when T4!stkP was 
complemented with both alleles. However there was a marked difference in the 
amount of RrgB between both T4!stkP#ST and T4!stkP#XST. T4!stkP 
complemented with T4 StkP showed a higher reduction in RrgB than that 
complemented with Xen35 StkP, implying that Xen35 StkP has a reduced 
functionality and that the 3rd PASTA domain is important for downstream 
signalling.  
FACS performed on these complemented strains also showed that these changes 
in protein expression are at the population level. With T4!stkP#ST now only 
showing 26% of the population are positive for the pneumococcal pilus compared 
to 51% of T4!stkP#XST to 100% of T4!stkP. Further studies would need to be 
performed on these strains to elucidate the downstream gene causing these 
changes seen in the pilus. Fluorescence microscopy of T4!stkP#ST cells also 
seemed to show a decrease in the amount of pili on each cell compared to that 
of T4!stkP#XST, T4!stkP and T4NO1. To see if StkP also affects the localisation 
of the pilus electron microscopy would have to be performed on T4!stkP#ST. 
Yet from this we can say StkP clearly also regulates the amount of pili on a 
single cell as well as that in the population. Maintaining heterogeneity within a 
bacterial population is important to allow bacterial survival, the fact StkP 
modulates this function fits in with the idea that these systems sense the 
external environment and modulate responses to the outside accordingly. With 
StkP in each bacterial cell acting according to the environment within which it is 
present in this instance modulating expression changes depending on the levels 
of unlinked peptidoglycan on the cell surface. StkP has also been shown to 
interact with a TCS, which may be the downstream system which modulated the 
change in pilus expression directly.  
Adherence assay were performed on both complement strains using A549 and 
HBMEC cells. The adherence seen to both cell lines correlated directly to the 
amount of pili positive cells, with T4!stkP#ST showing a large reduction in 
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adherence to both cell lines. However this was still higher than that of T4!rrgB 
and T4!stkP!rrgB due to 26% of cells still containing the pilus. T4!stkP#XST also 
showed a trend towards a decrease in adherence to both cell lines compared to 
T4!stkP (no significant difference). Yet this was still higher than T4!stkP#ST 
due to 51% of cells containing the pilus. 
The importance of PASTA domains with regards to the functionality of StkP have 
been elucidated in Beilharz et al 2012. Mutants constructed removing the PASTA 
domains were no longer able to localise to the cell septum (Where WT StkP 
localises too), with mutants containing only the kinase domain or 
transmembrane and kinase domain showing a cytoplasmic and membrane 
localisation pattern respectively (Beilharz et al. 2012). When replacing the four 
PASTA domains of StkP with the Three PASTA domain of PrkC (B.subtilis) StkP no 
longer localised to the cells septum indicating that the PASTA domains are 
species specific with regards to their substrate binding (Beilharz et al. 2012). 
Which in this instance is to unlinked peptidoglycan, as blocking these moietys 
with vancomycin lead to delocalisation of StkP from the midcell (Beilharz et al. 
2012). The consequence of the removal of the PASTA domains not only affects 
StkP localisation but also that of its cognate phosphatase, which localised to the 
midcell along with StkP in a WT cell, however upon StkP deletion PhpP is only 
seen in the cytoplasm and therefore requires StkP to function properly (Beilharz 
et al. 2012). The outcome of this leads to alterations in the protein 
phosphorylation levels of the targets of StkP and PhpP, which has been shown to 
be modulated through StkP activity. Beilharz et al 2012 showed blocking the 
activity of StkP via incubating cells with vancomycin (binds to the substrate of 
StkP) lead to reduced phosphorylation of protein targets, however incubating 
cells with ampicillin which binds to the PASTA domains (mimics peptidoglycan 
substrate) hyperphosphorylation of StkP protein targets is observed. Some of 
StkPs protein targets are that of cell division proteins (FtsA and DiviVA) which is 
why when StkP is deleted an altered cell morphology is observed, as deletion of 
StkP alters the localisation of these cell division proteins which also colocalise at 
the cell septum with StkP (Beilharz et al. 2012). 
As we observed some cells that had an elongated cell morphology for Xen35 we 
assume this is due to the deletion of the third PASTA domain within StkP, which 
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is likely a consequence of alteration in the localisation of StkP and cell division 
protein to their correct cellular positions. Interestingly Beilharz et al 2012 also 
showed that this elongated morphology is selected against and multiple passages 
show fewer cells with this morphology, which may be why not all Xen35 cells 
showed this altered morphology (Beilharz et al. 2012). Further as we know the 
deletion of PASTA domains alters StkP localisation and interaction with its 
protein targets, its likely this is also the cause of the altered pilus expression 
observed in the mutants. RR06 has been shown to regulate the pilus and is a 
protein target of StkP, its therefore likely that deletion of the third PASTA 
domain affects the level of phosphorylation of this protein target altering its 
activity (Agarwal et al. 2012). 
StkP clearly plays a multifaceted role in gene regulation and is already know to 
affect the expression of a large number of genes, and phosphorylate a number of 
other proteins. In this study we also show a potential role of StkP in regulation 
of protein translocation through the cell membrane and incorporation of some of 
these proteins onto the cell wall via regulation of choline abundance in the cells 
wall TA. Both of these phenomenon fit in with StkPs role in regulation and 
sensing of cell wall components, however require further study for validation. A 
role of StkP regulating genes at the population level has also been envisaged, a 
mode of regulation only recently touched upon in the pneumococcal field. Our 
studies have also shown that StkP regulates the pneumococcal pilus which has 
not been shown before and we further validated the importance of the PASTA 
domains in downstream gene regulation. More studies are required for further 
confirmation of exactly how the deletion of the third PASTA domain affects StkP 
functionality.  
  
 
 
 
 
 
 
 
 
6 Studying the role of oxidative stress on pilus 
expression
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6.1 Aim of this chapter 
The aim of the work described in this chapter is to investigate the potential role 
of the pneumococcal pyruvate oxidase (SpxB) and lactate oxidase (LctO) in pilus 
gene regulation. The genome sequence data of Xen35 a bioluminescent strain 
used to track in vivo disease progression contained SNPs in both of these genes, 
causing the introduction of a premature stop codon, resulting in truncated 
proteins. Xen35 showed a clear reduction in the expression of the pneumococcal 
pilus and in this chapter the contribution of these mutations to this phenotype is 
assessed.  
Initial experiments were performed to assess the pilus expression in a SpxB and 
LctO mutant constructed in T4NO1. For this RT-PCR, western blot analysis and 
FACS analysis was performed to look at the expression of RrgB in both strains. 
This analysis was also performed using a double mutant. The expression of the 
whole pilus islet was assessed in all strains. Adherence assays were also 
performed to evaluate the role of these genes in adherence and if this is niche 
specific as SpxB is thought to play an important role during colonisation. 
Both genes are involved in growth under aerobic conditions so we sought to 
assess pilus expression in a wild type strain when grown aerobically and 
anaerobically. The enzymatic reactions catalysed by both SpxB and LctO lead to 
production of hydrogen peroxide as a by-product. Therefore the effect of 
hydrogen peroxide alone on pilus expression was evaluated. For all western 
blotting and FACS analysis was performed.  
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6.2 Background 
Both SpxB and LctO play a role in energy production in a bacterium that contains 
no tricarboxylic acid cycle or electron transport chain (Hoskins et al., 2001, 
Tettelin et al., 2001). spxB encodes a pyruvate oxidase which functions to 
convert pyruvate from glycolysis to acetyl phosphate, which is eventually 
converted by acetate kinase to acetate to produce ATP (Pericone et al., 2003). 
The reaction catalysed by SpxB occurs during aerobic growth producing 85% of 
the cells acetyl phosphate with hydrogen peroxide produced as a by-product 
(Pericone et al, 2003). spxB deletion mutants show reduced levels of ATP 
production (Pericone et al., 2003). lctO encoding a lactate oxidase has not been 
as extensively studied as SpxB. LctO converts the lactate normally seen as a 
dead end product of fermentation back to pyruvate which can then be processed 
by the pyruvate oxidase to acetyl phosphate and eventually ATP (Taniai et al., 
2008, Udaka et al., 1959).  
Both genes work in a concerted manner under aerobic growth conditions with 
1/4th of pyruvate converted by SpxB to acetyl phosphate resulting in ATP 
production (Taniai et al., 2008, Liu et al., 2012). The remaining pyruvate is 
converted to lactate via lactate dehydrogenase, which acts as a reservoir until 
the lactate oxidase converts the lactate back to pyruvate resulting in an end 
product of ATP production (Taniai et al., 2008). This has been hypothesised to 
maximise ATP production under aerobic growth. Both enzymes are flavoproteins 
and produce hydrogen peroxide as a by-product of their enzymatic reaction, 
with SpxB being the main contributor to the high hydrogen peroxide levels 
produced by the pneumococcus (0.5-2mM) (Liu et al, 2012, Taniai et al., 2008, 
Pericone et al, 2003). Hydrogen peroxide is an important virulence factor in the 
pneumococcus, as already discussed in section 1.6.10. 
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Figure 6-1: Pathway of glucose metabolism in S.pneumoniae 
(Modified from Taniai et al., 2008) Boxed in blue is the two enzymes discusses in this 
section. Boxed in pink is the hydrogen peroxide produced as a by-product of said 
enzymatic reactions 
 
Changes in a number of different genes have been linked to phase variation, 
including mutations in SpxB (Weiser et al., 1994, Pericone et al., 2000, Ramos-
Montañez et al., 2008). For more information see section 1.5.4. 
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6.3 Role of SpxB and LctO in pilus regulation 
To assess the role that SpxB and LctO play in pilus regulation two knockout 
mutants were constructed. A spxB mutant was constructed using a transposon 
insertion based method and a lctO mutant constructed using a splice overlap PCR 
method to replace the whole gene. Both mutants were constructed in T4NO1. 
The spxB mutant was constructed using a spectinomycin resistance cassette and 
the lctO mutant using a kanamycin resistance cassette. Use of different 
selection markers allowed construction of a double knockout creating 
T4!spxB!lctO. 
6.3.1 Microarray analysis of T4!spxB 
Initial experiments assessed the expression changes in T4!spxB, in an attempt to 
attribute the gene expression changes seen in Xen35 to this deletion. For this 
microarray analysis was performed on T4!spxB compared to T4NO1.  
Gene Description Abbrev 
Fold 
change 
SP_0413  Aspartate kinase  1.3 
SP_0461  Transcription regulator, putative rlrA 2.1 
Table 6-1 : Table of genes differentially regulated in T4!spxB 
Table shows genes differentially regulated in T4!spxB compared to its parent T4NO1 
(P<0.05). Fold change represents that seen in T4!spxB compared to T4NO1, red showing 
genes up regulated in T4!spxB and blue are those that are down regulated. 
 
Microarray analysis showed only two genes differentially regulated between 
T4NO1 and T4!spxB (Table 3-2). Neither of these genes were differentially 
regulated in Xen35 as measured by microarray analysis (P<0.05). However when 
increasing the P value to 0.1 two genes were commonly down regulated in Xen35 
and T4!spxB (SP_0461 and SP_0462), of which both encode components of the 
pneumococcal pilus. This gives an indication the non-functional SpxB in Xen35 
may contribute to the decreased pilus expression. However it is likely not the 
only cause as only a 2 fold decrease in rlrA expression is observed in T4!spxB 
compared to a decrease of 6 fold in Xen35 shown by microarray analysis. 
Microarray analysis performed on a spxB mutant in a R6 strain showed 21 genes 
differentially regulated compared to its parent (Ramos-Montañez et al., 2008). 
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6.3.2 Real-time PCR analysis of pilus islet and TCS expression in 
T4!spxB, T4! lctO and T4!spxB! lctO 
RT-PCR analysis was performed to confirm the change in rlrA expression 
observed in T4!spxB by microarray analysis, as well as any expression changes 
seen in the rest of the pilus islet. RT-PCR analysis was also performed on 
T4!lctO and T4!spxB!lctO knockout strains to assess if LctO also affects pilus 
expression and if removal of both lead to a similar pilus expression level as 
observed in Xen35 (Figure 5-3). 
 
Figure 6-2: RT-PCR graph of pilus expression in T4!spxB, T4! lctO and T4!spxB! lctO. 
Graph shows RT-PCR of the whole pilus islet (rlrA, rrgA, B, C, srtB, C, D) in T4!spxB, 
T4! lctO and T4!spxB! lctO. Fold change represents that of stated mutant compared to 
T4NO1. Each bar represents the average of three replicas (three biological replicas) and 
errors bars the standard deviation. Statistical analysis was performed by a 1-way ANOVA 
with a Tukeys testing correction comparing the dCt values of the control strain (TIGR4) to 
the test strain (T4!spxB, T4! lctO and T4!spxB! lctO), * P<0.05, **P<0.001. 
 
RT-PCR analysis confirmed the difference in pilus expression seen in T4!spxB, 
showing roughly a 2-3 fold statistical decrease in expression of all the genes 
encoded on the pilus islet shown in Figure 5-3. RT-PCR showed perhaps a small 
drop in expression of some of the pilus islet genes in T4!lctO compared to 
T4NO1 however this was not the case for the sortase enzymes and only the 
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reduced expression of rrgC was shown to be statistically significant (Figure 5-3). 
T4!spxB!lctO showed a similar statistical decrease in pilus expression compared 
to that of T4!spxB. RT-PCR was also performed on some of the RR of the TCS 
pairs that have been shown to alter pilus regulation in the pneumococcus, to try 
and attribute pilus expression changes to that of varied expression of the RR 
(Figure 5-4). 
 
Figure 6-3: RT-PCR graph of TCS expression in T4!spxB, T4! lctO and T4!spxB! lctO 
Graph shows RT-PCR of rr03, rro6, rro8 and rr09 TCS in T4!spxB, T4! lctO and 
T4!spxB! lctO. Fold change represents that of the stated mutant compared to T4NO1. Each 
bar represents the average of three replicas (three biological replicas) and errors bars the 
standard deviation. No statistical difference were observed. 
 
RT-PCR of some of the TCS shown to alter pilus regulation were all slightly up 
regulated in T4!spxB and T4!spxB!lctO, however none were statistically 
significant. T4!lctO also showed no statistical difference in expression of any of 
the TCS RR. Due to none of the changes being significant it is unlikely any of 
these TCS contribute to the altered pilus expression in these strains. 
To further confirm changes in pilus expression western blot analysis was 
performed on all strains comparing the total amount of RrgB (Figure 5-10). FACS 
analysis was also performed to assess the distribution of the pilus on the cell 
surface of the bacterial population (Figure 5-6).  
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6.3.3 Western blot analysis of T4!spxB, T4! lctO and 
T4!spxB! lctO 
Western blot analysis was performed on T4!spxB, T4!lctO and T4!spxB!lctO to 
assess the total amount of RrgB. Western blotting showed differences in the 
expression of RrgB in T4!spxB, T4!lctO and T4!spxB!lctO (Figure 5-10). 
T4!spxB!lctO showed a 1.9 fold decrease in RrgB levels compared to T4NO1 and 
T4!spxB showed a 1.4 fold decrease. T4!lctO showed a small decrease of 1.1 
fold. These finding correlate well with the RT-PCR values. 
 
Figure 6-4: Western blot of T4!spxB, T4! lctO and T4!spxB! lctO RrgB expression 
compared to T4NO1. 
Western blotting analysis was performed on T4NO1, T4!spxB, T4! lctO, T4!spxB! lctO and 
T4!rrgB looking for expression of RrgB in all strains ("-RrgB antibody). Equal protein 
loading was confirmed by equal expression of GroeL ("-GroeL antibody), normalise against 
in analysis. Western blotting quantification was performed using ImageJ with fold changes 
in RrgB expression compared to T4NO1 boxed below the strain. Left hand side numbers 
represent the size in kDa of proteins run to the same point. 
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6.3.4 FACS and fluorescence microscopy analysis of T4!spxB, 
T4! lctO and T4!spxB! lctO 
To further analyse the difference in pilus expression in these strains FACS 
analysis was performed to assess within a growing population the number of cells 
positive for RrgB on the cell surface and therefore pilus positive. 
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Figure 6-5: FACS analysis of RrgB surface expression in T4!spxB, T4! lctO and 
T4!spxB! lctO 
FACS was performed on T4!spxB, T4! lctO, T4!spxB! lctO, T4NO1 and T4!rrgB. (A) Shows 
histograms of the capsule positive populations selected for from samples stained with a 
capsule antibody, population used for further analysis. (B) Shows the capsule stained 
populations being gated on for being RrgB positive, histograms/ polychromatic plot show 
negative (left) and positive (right) RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4NO1 12.1 87.9 
T4!spxB 80.1 19.9 
T4!lctO 43.1 56.9 
T4!spxB!lctO 81 19 
T4!rrgB 98.4 1.6 
Table 6-2: Percentage RrgB positive cells in T4!spxB, T4! lctO and T4!spxB! lctO 
 populations from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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Figure 6-6: Fluorescence microscopy of T4!spxB, T4! lctO and T4!spxB! lctO. 
One representative image of fluorescently labelled T4!spxB, T4! lctO and T4!spxB! lctO 
used for FACS analysis. Cells were stained for the presence of RrgB (FITC) and the capsule 
(APC). Scale bars above represent, T4NO1- 9µm, T4!rrgB - 140µm, T4!spxB - 210µm, 
T4! lctO - 140µm and T4!spxB! lctO - 210µm. The same representative image will be used 
throughout this study for each strain, more images can be seen in appendix I. 
 
FACS analysis on T4!spxB, T4!lctO and T4!spxB!lctO showed clear differences 
in the cell surface exposure of RrgB at the population level compared to T4NO1 
(Figure 5-6). There was a large decrease in the number of RrgB positive cells in a 
growing population of T4!spxB and T4!spxB!lctO both showing only 19-20% RrgB 
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positive cells compared to that of 88% in a T4NO1 population (Table 6-2). 
Although there was a difference in RrgB expression seen via western blot there 
seems to be roughly the same number of cells positive for RrgB in T4!spxB and 
T4!spxB!lctO. Interestingly there was also a large drop in the number of cells 
positive for RrgB in T4!lctO showing 57% of a growing population positive 
compared to that of 88% of T4NO1 (Table 6-2). As there is only a small drop in 
RrgB levels in T4!lctO this would suggest that the reduced pili expression at the 
population level is not due to this and may be due to another factor, such as 
reduced protein export to the cell surface. The fact that almost the same 
percentage of RrgB positive cells is observed in T4!spxB!lctO and T4!spxB 
would suggest that knocking out lctO has no effect on T4!spxB. And therefore 
the decrease in the RrgB positive cells in T4!lctO is likely due to a knock on 
effects of this deletion to the SpxB catalysed reaction. 
Variations in pilus expression via FACS analysis was visualised using fluorescence 
microscopy of T4!spxB, T4!lctO and T4!spxB!lctO shown in Figure 6-6. 
Due to clear change in the pilus expression at the population level in T4!spxB, 
T4!lctO and T4!spxB!lctO we wanted to assess the adherence capabilities to 
different cell lines which may show potential roles of SpxB and LctO in tissue 
tropisms during infection. 
6.4 Role of SpxB and LctO in adherence 
6.4.1 Adherence assay analysis of T4!spxB, T4! lctO and 
T4!spxB! lctO 
Adherence assays were performed on three different cell lines HBMEC, A549 and 
Detroit 562 cells to mimic the blood brain barrier, lung and nasopharynx 
respectively. This assay was performed to assess the adherence capabilities of 
T4!spxB, T4!lctO and T4!spxB!lctO.  
The adherence assay data shows that T4!spxB and T4!spxB!lctO have reduced 
adherence capabilities to all cell lines compared to T4NO1. With the largest 
decrease being to HBMEC cells, showing approximately a 90-95% reduction in 
adherence compared to that of T4NO1. This level of adherence is similar to a 
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non pilated strain (Figure 5-9). Interestingly T4!lctO also showed a reduced 
ability to adhere to all cell lines compared to T4NO1 (Figure 5-9). The decrease 
in adherence was similar to that of T4!spxB and T4!spxB!lctO to A549 and D562 
cells, with no statistical difference in the adherence capabilities of the three 
strains. Adherence of T4!lctO to HBMEC cells however was statistically different 
to that of T4!spxB and T4!spxB!lctO suggesting SpxB plays a more important 
role in meningitis, corroborating the ability of transparent variants to cross the 
blood brain barrier more efficiently (Ring et al., 1998). This difference in the 
adherence to HBMEC cells correlates well with the number of pilus positive cells 
within the bacterial populations, with T4!lctO showing a higher adherence than 
that of T4!spxB and T4!spxB!lctO as it contains 30-40% more pili positive cells.  
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Figure 6-7: Adherence assay of T4!spxB, T4! lctO and T4!spxB! lctO to different cell lines. 
Adherence of strains T4NO1, T4!spxB, T4! lctO and T4!spxB! lctO, T4!rrgB was assessed 
to HBMEC (A), A549 (B) Detroit 562 (C) cell lines. Data is represented as percentage 
adherence relative to that of T4NO1 (100%, dashed line), each bar is an average of three 
replicas except that of T4!spxB, T4! lctO and T4!spxB! lctO HBMEC data and T4! lctO D562 
data which is an average of two repeats, the error bars represent the standard error of the 
mean. Statistical analysis was performed using a 1-way ANOVA with a Tukeys testing 
correction, * P<0.05/ ** P<0.001. * above the bar represent statistical significance compared 
to T4NO1 (not represented as a bar on the graphs). 
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6.5 Variation in pilus expression under different growth 
conditions 
Due to the fact that there is a differences in the expression of the pilus in 
T4!spxB, T4!lctO and T4!spxB!lctO which contain knockouts in genes important 
during aerobic growth, pilus expression under both aerobic and anaerobic growth 
conditions were evaluated. T4NO1 was either grown statically under aerobic 
conditions at 37°C or statically anaerobically at 37°C in an anaerobic cabinet. 
Samples were processed for western blotting or FACS analysis. 
6.5.1 Western blot analysis of T4NO1 grown anaerobically 
Initial western blot analysis comparing cellular levels of RrgB under the two 
conditions showed a clear decrease (2.6 fold) in the amount of RrgB when T4NO1 
was grown anaerobically compared to aerobically (Figure 6-8).  
 
Figure 6-8: Western blot of T4NO1 RrgB expression when grown aerobically or 
anaerobically. 
Western blotting analysis was performed on T4NO1 when grown under aerobic (T4NO1) or 
anaerobic (T4 AN) conditions looking for expression of RrgB ("-RrgB antibody). Equal 
protein loading was confirmed by equal expression of GroeL ("-GroeL antibody), 
normalised against in analysis. Western blotting quantification was performed using ImageJ 
with fold changes in RrgB expression compared to T4NO1 grown aerobically boxed below 
the strain. Left hand side numbers represent the size in kDa of proteins run to the same 
point. 
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6.5.2 FACS and fluorescence microscopy analysis of T4NO1 
grown anaerobically 
FACS analysis was performed to assess if the decrease in pilus under anaerobic 
conditions is due to that of a reduction in the amount of pili on a single cell or if 
there is a reduction in the number of cells expressing the pilus.  
Analysis showed that unlike the reduction at the population level of pili positive 
cells in T4!spxB, T4!lctO and T4!spxB!lctO, T4NO1 grown under anaerobic 
conditions shows around a 1% increase in pilus positive cells and therefore this 
cannot account for the decrease in expression seen via western blotting (Figure 
6-9,Table 6-3). FACS data does however show a clear shift to the left in the FITC 
pilus positive population grown under anaerobic conditions, suggesting a 
decrease in the amount of pili on a single cell. No change in the pilus at the 
population level was confirmed by fluorescence microscopy as seen in Figure 
6-10. 
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Figure 6-9: FACS analysis of RrgB surface expression in T4NO1 grown anaerobically. 
FACS was performed on T4 AN, T4NO1 and T4!rrgB. (A) Shows histograms of the capsule 
positive populations selected for from samples stained with a capsule antibody, population 
used for further analysis. (B) Shows the capsule stained populations being gated on for 
being RrgB positive, histograms/ polychromatic plot show negative (left) and positive (right) 
RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4NO1 12.1 87.9 
T4 AN 11.3 88.7 
T4!rrgB 98.4 1.6 
Table 6-3: Percentage RrgB positive cells in a T4 AN population from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
 
Chapter 6 
 
277 
 
Figure 6-10: Fluorescence microscopy of T4NO1 grown anaerobically. 
One representative image of fluorescently labelled T4NO1, T4!rrgB and T4NO1 grown under 
anaerobic conditions used for FACS analysis. Cells were stained for the presence of RrgB 
(FITC) and the capsule (APC). T4NO1- 9µm, T4!rrgB - 140µm and T4AN - 14µm. The same 
representative image will be used throughout this study for each strain, more images can be 
seen in appendix I. 
 
6.6 Role of H2O2 in pilus expression 
One of the common features of the enzymatic reactions catalysed by SpxB and 
LctO is that both produce hydrogen peroxide as a by-product, although to 
varying levels. To confirm this we performed a hydrogen peroxide assay on 
T4!spxB, T4!lctO and T4!spxB!lctO using T4NO1 and Xen35 as positive and 
negative controls respectively (Figure 6-11). 
6.6.1 Hydrogen peroxide production of T4!spxB, T4! lctO and 
T4!spxB! lctO 
Hydrogen peroxide levels were significantly reduced in T4!spxB compared to 
T4NO1 with no visible hydrogen peroxide production after 30 minutes. However 
after 24 hours we can see that T4!spxB can produce hydrogen peroxide but this 
is at a much slower rate. SpxB clearly produces the majority of the cellular 
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hydrogen peroxide however some is still produced by LctO as T4!lctO also shows 
a reduction in hydrogen peroxide levels compared to T4NO1 after 30 minutes. 
Xen35 shows no hydrogen peroxide production after 24 hours due to it containing 
a non-functional SpxB and LctO. This is also the case for T4!spxB!lctO showing 
no hydrogen peroxide production after incubation for 24 hours. 
 
Figure 6-11: Hydrogen peroxide assay of T4!spxB, T4! lctO and T4!spxB! lctO strains 
Each strain was represented in triplicate in the Hydrogen peroxide assay. (A) The graph 
gives the hydrogen peroxide production in mM of each strain calculated using a standard 
curve of known hydrogen peroxide concentrations (See Figure 2-14), the dotted line 
represent the limit of detection. Hydrogen peroxide production above 9mM could not be 
accurately measured therefore a maximum value of 9mM was assigned. (B) Shows visually 
the assay performed in a 96 well plate with each strain represented in triplicate after 30 
minutes incubation at 37°C. (C) Shows visually the assay performed in a 96 well plate with 
each strain represented in triplicate after 24 hour incubation at room temperature. 
 
Due to hydrogen peroxide production being a common factor altered in both of 
these mutants the role of hydrogen peroxide alone on the expression of the 
pneumococcal pilus was assessed. A culture of T4!spxB, which has a severely 
reduced rate of hydrogen peroxide production, was grown and hydrogen 
peroxide added back in at varying concentrations.  
6.6.2 Western blot analysis of T4!spxB grown with exogenously 
added H2O2 
To assess any variation in pilus expression upon addition of exogenous hydrogen 
peroxide western blot analysis (Figure 6-12) and FACS analysis (Figure 6-13) was 
performed on these samples. The H2O2 concentrations added to the growing 
bacterial cultures are noted in the figures as the dilutions used which were made 
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from a 30% H2O2 solution. The final concentrations for each dilution was 9mM 
(1/10 dilution), 3.6mM (1/25 dilution) and 1.8mM (1/50 dilution). Higher 
concentrations were tested however this killed the bacterial cells. The lowest 
concentration is likely similar to the normal levels of exogenous H2O2 produced 
by the cell (0.5-2mM) (Pericone et al., 2003). 
 
Figure 6-12: Western blot of T4!spxB RrgB expression when grown in the presence of 
varying concentrations of H2O2. 
Western blotting analysis was performed on T4!spxB when grown in the presence of 
varying concentrations of H2O2 looking for expression of RrgB ("-RrgB antibody). Equal 
protein loading was confirmed by equal expression of GroeL ("-GroeL antibody), 
normalised against in analysis. Western blotting quantification was performed using 
ImageJ. Left hand side numbers represent the size in kDa of proteins run to the same point. 
 
Western blot analysis clearly showed an increase in pilus expression when adding 
exogenous hydrogen peroxide to a growing culture of T4!spxB, shown in Figure 
6-12. However this was not dose dependant as the highest concentration showed 
only a 1.1 fold increase In pilus expression, this may be due to toxic effects by 
H2O2 on the cells limiting growth. This was certainly the case at higher 
concentrations with cells dying (data not shown). However this could also be due 
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to variation in the western blotting technique. Upon further analysis of lower 
concentrations we may begin to see a dose dependent increase of pili with 
increasing amounts of hydrogen peroxide, however this was not assessed.  
6.6.3 FACS and fluorescence microscopy analysis of T4!spxB 
grown with exogenously added H2O2 
FACS analysis confirmed findings seen by western blot showing an increase in 
pilus positive cells (Figure 6-13). However there is only an increase by roughly 
10% of pilus positive cells compared to T4!spxB and is therefore still much lower 
than the parent T4NO1 (Figure 6-13). It may be the case that other factors in 
T4!spxB are altering pilus expression. Or addition of exogenous hydrogen 
peroxide does not compensate for the loss of endogenous hydrogen peroxide, 
which would likely be higher in T4NO1. We also see an increase via FACS in the 
percentage of RrgB positive cells in the 1.10 H2O2 concentration sample, which 
showed no increase in RrgB levels by western blot analysis. This may suggest that 
the lower dilutions (1/25 and 1/50) contain higher levels of cellular RrgB but are 
unable to transport it to the cell surface. 
Key points 
• Addition of H2O2 to a growing T4!spxB culture increases the cellular 
amount of RrgB. This is not dose dependant at the concentrations used 
here, likely due to the toxic effects on the cell at the higher 
concentrations. 
• Although cellular RrgB levels increase, addition of H2O2 is unable to fully 
modulate the RrgB levels present on the cell surface. Perhaps via protein 
export which may be limited in T4!spxB due to reduced ATP levels. 
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Figure 6-13: FACS analysis of RrgB surface expression in T4!spxB plus H2O2 
FACS was performed on T4NO1, T4!spxB, T4!rrgB and T4!spxB grown in the presence of 
varying concentrations of H2O2. (A) Shows histograms of the capsule positive populations 
selected for from samples stained with a capsule antibody, population used for further 
analysis. (B) Shows the capsule stained populations being gated on for being RrgB positive, 
histograms/ polychromatic plot show negative (left) and positive (right) RrgB populations in 
each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4NO1 12.1 87.9 
T4!spxB 80.1 19.9 
T4!spxB 1.10 H2O2 70.8 29.2 
T4!spxB 1.25 H2O2 70.3 29.7 
T4!spxB 1.50 H2O2 70.9 29.1 
T4!rrgB 98.4 1.6 
Table 6-4: Percentage RrgB positive cells in a T4!spxB population grown in the presence of 
H2O2 from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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Figure 6-14: Fluorescence microscopy of T4!spxB grown in the presence of H2O2. 
One representative image of fluorescently labelled T4NO1, T4!rrgB, T4!spxB and T4!spxB 
grown in the presence of varying concentrations of H2O2, samples used for FACS analysis. 
Cells were stained for the presence of RrgB (FITC) and the capsule (APC). T4NO1- 9µm, 
T4!rrgB - 140µm, T4!spxB - 210µm, T4!spxB 1:10 - 14µm, T4!spxB 1:10 - 9µm and 
T4!spxB 1:50- 22µm. The same representative image will be used throughout this study for 
each strain, more images can be seen in appendix I. 
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6.7 Discussion 
It must initially be noted that the mutants analysed within this chapter were not 
complemented which is required to ensure the phenotype observed in the 
mutants strains is due to the deletion of the gene removed and not due to 
accumulation of other genetic changes. However we can assume the alterations 
to the levels of hydrogen peroxide is a true consequence of the gene deletions as 
their known function in the literature is enzymes that produce hydrogen 
peroxide as a by-product of the reaction. As we have been able to link the levels 
of hydrogen peroxide to pilus levels it’s likely the gene deletions cause the 
altered pilus expression, but to fully confirm this complementation is required. 
SpxB and LctO both play a role in energy production under aerobic conditions 
(Tettelin et al., 2001). Both are non-functional in the strain Xen35 which shows a 
reduced virulence and reduced expression of the pilus. SpxB alone has been 
shown to be important in the ability of the pneumococcus to colonise, replicate 
in the lungs and translocate to the blood (Orihuela et al., 2004, Spellerberg et 
al., 1996, Ramos-Montañez et al., 2008, Regev-Yochay et al., 2007). This lack of 
SpxB is therefore likely to be one of the reasons for the reduced virulence in 
Xen35. However, other virulence factors are also altered in this strain and the 
reasons for this reduced virulence is likely multifaceted. 
As pilus expression in Xen35 was reduced the contribution of both LctO and SpxB 
to this decrease was assessed. Western blot analysis and RT-PCR showed a 
decrease in pilus expression in the spxB knockout. This was not the case for the 
lctO knockout. FACS analysis of the knockout strains T4!spxB showed only 20% of 
cells were now RrgB positive compared to 88% of the parent strain. Interestingly 
T4!lctO also showed a reduction in the percentage of RrgB positive cells with 
now only 57% positive for RrgB compared to its parent, however no difference in 
the total cellular amount of RrgB was observed. 
The double knockout T4!spxB!lctO showed a similar number of RrgB positive 
cells to that of the single spxB knockout and therefore it was concluded that the 
effects seen on the pilus expression in the lctO knockout are likely via having a 
knock on effect on SpxB functionality. This could occur as SpxB and LctO work in 
a concerted manner in the pneumococcus, similar to that for S.mutans (Liu et 
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al., 2012, Taniai et al., 2008). Under aerobic conditions only 1/4th of pyruvate is 
converted to acetyl phosphate and the rest converted to lactate. If lactate 
oxidase is non-functional then the lactate cannot be converted back to pyruvate, 
which may be followed by a reduced activity of SpxB as there is less substrate 
available for its enzymatic reaction (Taniai et al., 2008). In contrast in a SpxB 
knockout there is no pyruvate converted to acetyl phosphate, which presumably 
explains the more severe phenotype in the SpxB knockout.  
Due to the dependence of pilus expression on SpxB it is predicted that a product 
of the SpxB reaction may cause the changes in pilus expression. One of these 
products is acetyl phosphate which is produced from pyruvate via SpxB. This 
reaction produces 85% of the cells acetyl phosphate (Pericone et al., 2003). 
Acetyl phosphate has been shown to act as a phosphate donor for 
phosphorylation of response regulators of TCS pairs. As a number of TCS regulate 
the pilus in the pneumococcus, this could be responsible for the altered pilus 
expression (McCleary & Stock, 1994). However if this was the case there should 
be global expression changes upon deletion of SpxB (as noted in Ramos-Montañez 
et al., 2008). However this is not the case in our data or in published data and 
therefore is likely not the cause. Phosphorylation of RR by small phosphate 
containing molecules has also been shown to be limited to prevent in vivo cross 
talk between the systems (Boll & Hendrixson, 2011).  
The end product of the reaction catalysed by SpxB followed by acetate kinase is 
ATP, vital for cell survival (Ramos-Montañez et al., 2010). The functionality of 
LctO during aerobic metabolism is thought to maximise ATP production (Taniai 
et al., 2008). Upon deletion of SpxB there is a severe reduction in ATP 
production. However some is still produced via conversion of pyruvate to acetyl 
Co-A via pyruvate formate lyase followed by conversion to acetyl phosphate via 
phosphotransacetylase. This production of ATP is at a much slower rate than 
that produced in a cell with a functional SpxB (Pericone et al., 2003,  Ramos-
Montañez et al., 2008). ATP is vital for a large number of cellular processes, so 
reduced amount may reduce the overall fitness of the growing cells. Although 
the assembly of the pneumococcal pilus by sortase enzymes is not energy taxing 
on the cell, the secretion of proteins to the cell surface is ATP dependent and 
therefore protein translocation may be reduced in a cell with reduced ATP levels 
(Lill et al., 1989, Economou & Wickner, 1994). This may account for why we see 
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no expression change in pilus expression in T4!lctO yet a clear reduction in the 
number of cells expressing the pilus on the cell surface compared to the parent. 
Another common feature of both of these enzymes is the fact they both produce 
hydrogen peroxide as a by-product of their reactions. H2O2 is an important 
molecule produced by the pneumococcus as it is able to kill off other colonising 
bacterial inhabitants of the upper respiratory tract (Pericone et al., 2000, 
Mcleod & Gordon, 1922). H2O2 production however is a double edged sword 
eventually producing deleterious effects on the pneumococcus which does not 
produce a catalase enzyme (Tettelin et al., 2001). As both SpxB and LctO 
function under aerobic conditions we wondered if H2O2 production under these 
conditions acts as a signal to being in the nasopharynx where the bacterium 
would require up regulation of the cell surface adhesins to aid colonisation. 
To assess the effect of hydrogen peroxide alone on the reduced pilus phenotype 
western blot and FACS analysis was performed assessing whether addition of 
exogenously added H2O2 restores pilus expression in T4!spxB. Addition of 
hydrogen peroxide clearly caused an increase in pilus expression with this 
corresponding to an increase in the number of cells positive for the pilus by 
roughly 10%. However this was still much lower than the T4NO1 level of 88% 
positive cells. As previously noted the ability to modulate pilus expression at the 
population level has been linked in S.pyogenes to changes in temperature which 
are thought to signal to the bacterium where it is present within the host. It may 
be that in the pneumococcus hydrogen peroxide is the environmental cue which 
signals to the bacterium that it is present in the nasopharynx where increased 
adhesive capabilities are required, which is modulated by the pilus. As TCS have 
been shown in this study to modulate the expression of the pilus at the 
population level we can hypothesise that this is likely the environmental signal 
which activates one of the TCS known to modulate pilus expression. 
The lack of complete recovery of pilus expression to the WT level could be due 
to other factors also playing a role. Alternatively it could be that hydrogen 
peroxide given exogenously is unable to restore the level of endogenous H2O2 
normally produced within the cell. 
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The changes seen upon addition of hydrogen peroxide to a growing culture 
suggests this alone is able to alter cellular functions. We did not assess the 
mRNA expression level of the pilus after addition of H2O2 but increased amounts 
of protein were seen via western blot. With regards to H2O2 or another ROS 
(reactive oxygen species) acting as a signalling molecule this could be the case 
as this has been observed in plants, animals and bacteria (see reviews Stone & 
Yang, 2006 and Lushchak, 2011). Some proteins are able to sense changes in 
oxidative stress (ROS levels) and alter gene expression by either being oxidised 
directly by ROS or indirectly affected through reaction with another protein that 
has an altered confirmation due to interaction with ROS. The levels of 
intracellular ROS can be modulated by the large number of enzymes used to 
break down these molecules such as catalases and peroxidises etc (Mishra & 
Imlay, 2012). 
There are a number of bacterial proteins directly modified by ROS including the 
well studied OxyR transcriptional regulator of E.coli which is oxidised by H2O2 
directly on a cystein residue altering its confirmation and therefore its binding 
efficiency for target DNA molecules (Toledano et al., 1994, Storz et al., 1990). 
In B.subtilis no homolog for OxyR exists but there are two other peroxide sensing 
proteins OhrR and PerR. OhrR homologues can also be seen in a number of other 
bacteria including S.aureus, E.faecalis, P.aeruiginosa and Agrobacterium 
tumefaciens (Chen et al., 2006, Giard et al., 2001, Ochsner et al., 2001, 
Chuchue et al., 2006). OhrR a member of the MarR family of transcription 
regulators doesn’t recognise H2O2 but organic hydroperoxides (ROOH), and 
regulates the expression of ohr a thiol peroxide which catalyses their conversion 
to a less harmful alcohol (Fuangthong & Helmann, 2002, Panmanee et al., 2002).  
PerR homologues have also been seen in a number of bacteria including 
S.aureus, S.pyogenes, Campylobacter jejuni, Streptomyces reticuli, 
Streptomyces coelicolor and Borrelia burgdorferi (Horsburgh et al., 2001, King 
et al., 2000, Van Vliet et al., 1999, Ortiz de Orué Lucana & Schrempf, 2000, 
Hahn et al., 2000, Boylan et al., 2003). PerR a metallo protein is a member of 
the ferric uptake regulator family, which contains two metal binding sites. One 
that binds zinc (structurally required) and another which binds either iron or 
magnesium which regulate its function. Fe2+ or Mn2+ when bound act to retain 
binding of PerR to its target DNA (Herbig & Helmann, 2001). PerR like OxyR 
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responds to H2O2 levels resulting in the metal dependant catalysed oxidation of a 
histidine residue in PerR resulting in the release of the metal ion and release of 
PerR from DNA (J.-won Lee & Helmann, 2006). This oxidation is dependent on 
production of a hydroxyl radical via the Fenton reaction.  
Interestingly PerR in S.pyogenes has been associated with alterations in pilus 
expression (Grifantini et al., 2011). Addition of hydrogen peroxide to a WT strain 
of S.pyogenes causes an increase in the expression of the genes required for 
pilus expression and assembly, of roughly 3-7 fold. This increase in pilus 
expression is also observed in one of the sortase genes after deletion of perR. 
This would give an indication that recognition of hydrogen peroxide levels by 
bacteria can lead to alterations in cell surface components. S.pyogenes is found 
in the pharynx causing minor throat infections but can also cause serious soft 
tissue infections. In the pharynx S.pyogenes has been shown to adhere to human 
tonsil epithelium and it was hypothesised here would require increased levels of 
pili which would be augmented by sensing by PerR of increased levels of ROS 
(Abbot et al., 2007). Interestingly as discussed in the Rosch study (2008) the 
promoter lying upstream of rlrA shows high homology to PerR binding sites in 
other Streptococci, with only a single mismatch between the two (Brenot et al., 
2005, Rosch et al., 2008). Currently no homologues of PerR have been found in 
S.pneumoniae and perhaps this pathogen has evolved another means to respond 
to ROS. With ROS acting as a key signal to being present in the nasopharynx 
where regulation of cell surface adhesins is required.  
Although not associated with PerR increasing levels of hydrogen peroxide have 
been associated with increase pili expression in the pneumococcus (Rosch et al., 
2010). This was observed in a mutant defective in a manganese efflux pump 
MntE (SP_1552), causing increases in intracellular manganese. Manganese has 
been shown to affect oxidative stress response, and perhaps in this strain 
alterations in this causes accumulation of H2O2 which in turn alters expression of 
the pilus (Mcallister et al., 2004, Tseng et al., 2002). SodA (Superoxide 
dismutase) in the pneumococcus converts superoxide radicals to H2O2, this 
enzyme is manganese dependant and therefore increased levels of intracellular 
manganese may lead to increase activity of SodA and resulting H2O2 production 
(Yesilkaya et al., 2000).  
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The role of manganese in pilus regulation was also further confirmed in two 
studies where deletions of psaR resulted in increased expression of the pilus islet 
genes (Johnston et al., 2006, Hendriksen et al., 2009). PsaR is a transcription 
regulator which directly regulates a number of genes on the psa operon, 
including those coding for a manganese ABC transporter present (PsaA, PsaB and 
PsaC). Deletion of PsaR causes an increase in pilus expression, with low Mn2+ 
concentrations associated with high pilus expression and high Mn2+ associated 
with low pilus expression. This is contrary to that seen with high intracellular 
Mn2+ associated with high pilus expression however it is clear manganese directly 
or indirectly affects pilus expression. PsaD also present on the psa operon is 
thought to function in the breakdown of H2O2 which is why deletion mutants 
show a reduced resistance to oxidative stress (Cha & Kim, 1996, Novak et al., 
1998, Johnston et al., 2004, Tseng et al., 2002). However this gene has its own 
promoter and is not regulated by PsaR and therefore is likely not modulating 
H2O2 levels which is causing the altered pilus expression in the PsaR mutant 
(Johnston et al., 2006, McAllister et al., 2004, Hendriksen et al., 2009).  
merR which has previously been shown to modulate pilus expression was shown 
to be up regulated in the Hendriksen study (2009) (in a PsaR deletion mutant). 
However MerR was shown to act as a repressor of the islet and the pilus genes 
were up regulated in this study, so is likely not the reason for this change (Rosch 
et al., 2008, Hendriksen et al., 2009). psaD is also present on the psa operon 
which encodes a putative thiol peroxide (Novak et al., 1998). Although the 
Hendriksen (2009) study did not observe any expression changes in spxB or lctO 
in the PsaR mutant strain. Deletion mutants in psaA have shown to effect the 
expression of both spxB and lctO (Ogunniyi et al., 2010). This study however was 
performed in a non piliated strain (D39) and therefore its effect on pilus 
expression is unknown. If this was also the case in TIGR4 there could be subtle 
change in SpxB and LctO levels in the PsaR mutants in the Hendriksen (2009) and 
Johnston (2006) studies which account for the changes in pilus expression 
(Johnston et al., 2006, Hendriksen et al., 2009). Both of these studies did not 
assess the H2O2 levels produced in the PsaR mutants. 
However in this study we have not assessed whether it is H2O2 directly altering 
pilus expression or if it may be due to a breakdown product of H2O2. H2O2 itself 
has a short half life and is rapidly degraded by the Fenton reaction into hydroxyl 
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radicals and a hydroxide ion (Imlay et al., 1988). The effect of break down 
products of H2O2 on pilus regulation could be assessed further by growing 
T4!spxB not only with H2O2 but also with iron chelators to block the Fenton 
reaction or hydroxyl radical scavenger. We would assume that this may be the 
case as roughly 30 minutes passed after addition of H2O2 to the growth media 
before samples were collected.  
The deletion of SpxB has been linked to the ability of the pneumococcus to 
phase vary, with a single bacterial population consisting of two colony types that 
of transparent and opaque (Weiser et al., 1994). Transparent colony types have 
been associated with having a 2.1-3.8 increase in amounts of cell surface 
teichoic acid compared to opaque types, showing increase ability to colonises 
the nasopharynx (Kim & Weiser, 1998, Weiser et al., 1994). Whereas opaque 
phenotype is associated with a 1.2-5.6 fold increase in the amount of capsule on 
the cell, having an increased virulence during invasive disease and decreased 
ability to be phagocytosed due to the increased levels of the capsule (Kim & 
Weiser, 1998, Kim et al., 1999). Along with this a number of variations in the 
levels of surface proteins has been noticed between the two phenotypes with 
increased levels of PspA seen in opaque variant and decreased levels of LytA, 
PpmA and CbpA (Kim & Weiser, 1998, Weiser et al., 1996, Overweg et al., 2000). 
Increased levels of LytA and CbpA, both choline binding proteins may be due to 
increased levels of teichoic acid in transparent variants and therefore 
phosphorylcholine levels creating more anchoring points for these proteins. 
PpmA (proteinase maturation protein A) is also thought to aid protein maturation 
on the cell surface and therefore may regulate the abundance of proteins on the 
cell surface. PpmA has also been shown to play a role in colonisation during 
infection (Cron et al., 2009).  
Our microarray data measuring expression differences between T4NO1 and 
T4!spxB did not show any of these genes to be differentially regulated but 
whether there were differences in protein levels was not assessed. The fact we 
see difference in a number of surface proteins in the two phenotypes and the 
fact the transparent phenotype is better equipped during colonisation fits with 
our data, as the T4!spxB mutant shows only opaque variants (data not shown), 
and has reduced levels of the pilus on the cell surface (Ramos-Montañez et al., 
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2008). Currently no literature has made a link between phase variation and pilus 
expression which may be in part due to the fact the majority of studies assessing 
cell surface constituents in phase variants is performed in non piliated strains. 
Clearly if there are changes in the capsule levels in T4!spxB etc this may effect 
the surface exposure of levels of the pilus and skew the FACS data (Sanchez et 
al., 2011). However microarray analysis did not indicate differential expression 
of any of the capsule genes and FACS analysis did not indicate there was an 
increase in the fluorescence intensity of the capsule stained population, which 
would be expected if capsule levels were increased in the strains studied. 
Another variation that may be affecting the cell surface constituents is that 
caused by differences in the cell membrane fluidity. This has also been shown to 
vary between opaque and transparent phenotypes with a lower degree of 
unsaturated fatty acids seen in opaque variants compared to transparent (Aricha 
et al., 2004). Variations in the fatty acid saturation of the cell membrane alters 
membrane fluidity which is important for bacterial adaptation under varying 
environmental conditions. The ability to regulate the membrane fluidity is called 
homeoviscous adaptation (Sinensky, 1974). Membrane fluidity can affect the 
functionality of proteins within the cell membrane including those involved in 
cell signalling and transport (Lee, 2004). In the pneumococcus variations in the 
cell membrane fatty acid saturation and H2O2 have been directly linked 
(Pesakhov et al., 2007). FabF an enzyme involved in the fatty acid synthesis is 
oxidised directly by hydrogen peroxide on a cystein residue which inhibits its 
activity (Benisty et al., 2010).  
This may link in to why we see upon addition of H2O2 to a growing culture of 
T4!spxB increased levels of pilus on the cell surface. Hydrogen peroxide addition 
may alter the membrane permeability and directly effect the translocation of 
proteins through the membrane or alter functionality of proteins retained in the 
cell membrane that have signalling capabilities. Six pneumococcal TCS have 
been shown to regulate the pneumococcal pilus, perhaps their signalling 
functionality is altered upon variation in the membrane fluidity. In the 
pneumococcus a link between membrane fluidity and variation in surface 
exposed protein has not been directly assessed and would require further study. 
Interestingly addition of exogenous H2O2 in a SpxB mutant strain was unable to 
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revert the membrane fatty acid composition to that of the WT strain, suggesting 
this does not complement to the full extent the levels of endogenous hydrogen 
peroxide levels (Pesakhov et al., 2007). This as discussed earlier, may be why we 
only see a slight increase in pilus expression in T4!spxB upon addition of 
exogenous hydrogen peroxide. 
Contradictory to our hypothesis when grown under anaerobic conditions we did 
not see a similar effect on pilus expression to that of the T4!spxB mutant. Pilus 
expression was reduced suggesting an important role in colonisation, however 
upon FACS analysis T4NO1 grown anaerobically showed a decrease in the amount 
of pili on the surface of a single cell. Whereas in T4!spxB and T4!lctO we 
observed a reduction at the population level in the total number of cells positive 
for pili on the cell surface. H2O2 production has been shown to be reduced to 
almost nothing in pneumococci grown under anaerobic conditions, likely due to 
reduced activity of SpxB and LctO (Pesakhov et al., 2007). Growth under 
anaerobic conditions has also been shown to have altered membrane fatty acid 
saturation due to varying levels of H2O2 production (Pesakhov et al., 2007). 
However the change in fatty acid composition of the membrane during growth 
anaerobically was more subtle than the huge shift seen upon deletion of SpxB 
and therefore these differences may account for the differences observed in our 
data (Pesakhov et al., 2007).  
The fact that we see variations in adherence upon deletion of SpxB is not 
surprising with its role in colonisation is clearly noted in the literature 
(Spellerberg et al., 1996, Weiser et al., 1996). T4!spxB showed a statistical 
decrease in adherence to all cell lines compared to T4NO1, which would suggest 
a multifaceted role in virulence, which is also clear from the literature. Being 
important for ATP production within the bacterial cell it would be expected to 
be the case. T4!spxB!lctO also showed a statistical decrease in adherence to all 
cell lines compared to T4NO1, this was to a similar level as that of T4!spxB.  
Interestingly T4!lctO also showed a statistically reduced adherence to all cell 
lines compared to T4NO1. No in vivo data is available in the literature assessing 
the bacterial fitness when this gene is deleted, however due to similar 
adherence capabilities to T4!spxB we would expect it to play some role in 
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virulence. However its role in meningitis is perhaps less than that of T4!spxB as 
it showed a statistical increase in adherence to HBMEC cells compared to 
T4!spxB and T4!spxB!lctO. This difference correlated well with the differing 
amount of surface exposed RrgB/ pili, again suggesting an important role of the 
pilus in meningitis. This was also observed when looking at StkP variants 
expressing different surface levels of RrgB/pili (Chapter 5). 
In conclusion we have shown that both SpxB and LctO alter the expression of the 
pneumococcal pilus at the population level. Microarray data looking at 
expression differences in T4!spxB did not give an indication of any other genes 
that may be affected by this deletion and cause the decrease in expression of 
the pneumococcal pilus. With regards to our initial question of what contribution 
these deletions make in Xen35 to the reduced pilus expression, we can conclude 
from this data they likely cause some of the decreased pilus expression. 
However the pilus expression seen in Xen35 is still lower than that of T4!spxB 
showing 5.5% and 20% cells positive for RrgB on the surface within a population, 
respectively. This may suggest there are other factors contributing to the 
reduced pilus expression in Xen35. However it is hard to compare between the 
two strains as we do not know the level of expression of the pilus in the parent 
TIGR4 strain Xen35 was constructed in. This could be similar to T4JH which 
showed only 20.5% of cells positive for RrgB on the cell surface and in that case 
would equate to around 75% reduction in pilus expressing cells in Xen35, a value 
that would be similar to that when comparing between T4NO1 and T4!spxB. 
No genome or expression changes were observed in Xen35 in either mntE, psaA, 
psaB, psaC and psaR. However microarray data of a MntE mutant grown in the 
presence of high levels of manganese showed some similar expression changes to 
those seen in Xen35, but oppositely expressed (Rosch et al., 2010). This included 
up regulation of SP_515, SP_516, SP_1757, SP_1764-67, SP_1769-71 in Xen35 
which were all down regulated in T4!mntE. SP_0461-64 and SP_0875-77 were up 
regulated in Xen35 and down regulated in T4!mntE. Finally SP_1895-98 and 
SP_1676 were down regulated in both strains. The fact we see no variations in 
genes which function to modulate intracellular manganese levels in Xen35 would 
suggest perhaps another common factor between the two strains is causing the 
common expression changes, which could be due to variations in H2O2 
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production, with none produced in Xen35 and higher levels than the parent 
TIGR4 strain produced in T4!mntE. Further studies would be needed to assess 
whether any genome or expression changes in Xen35 could be altering the ability 
to regulate manganese uptake/ efflux. 
  
 
 
 
 
 
 
 
 
7 Evaluating the potential burden of lux gene 
expression in the pneumococcus 
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7.1 Aim of this chapter 
As seen previously Xen35 shows a reduced pilus expression compared to TIGR4. 
The work described in this chapter evaluates the role of the lux genes insertion 
and expression with regards to potentially contributing to the reduced pilus 
expression in Xen35, and causing a metabolic burden on the bacterial cell.  
To assess this a new collection of bioluminescent S.pneumoniae strains were 
constructed, placing the lux genes at an alternative region in the genome and 
under the control of different strength promoters, including that of the 
promoter driving the lux gene expression in Xen35. Placing the genes at an 
alternative, clearly defined location in the chromosome eliminates the risk of 
effects due to insertion into functional genes e.g. SP_1914 in Xen35. These 
bioluminescent strains were assessed via western blotting to determine the 
effect expression of the lux genes has on pilus expression (RrgB levels).  
One of the constructed strains T4P2 was further characterised by determining 
the effects the lux genes have on whole genome expression changes. For this 
microarray analysis was performed on T4P2 compared to its parent T4NO1. This 
data was compared to the genome expression changes observed in Xen35 to see 
whether common genes are differentially regulated between T4P2 and Xen35. 
And are therefore likely due to the lux genes over expression in both strains. 
Further the expression of the lux genes and pilus genes expression were 
validated in T4P2 relative to Xen35. T4P2 virulence was also evaluated in a 
mouse model of infection and compared to the data obtained for T4NO1 and 
Xen35 virulence. Finally to determine whether expression of the lux genes 
resulted in accumulation of specific genome changes in Xen35, whole genome 
sequence analysis was performed in T4P2. 
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7.2 Background 
As described previously Xen35 is a bioluminescent serotype 4 S.pneumoniae 
strain, used to visualise in vivo disease progression (see section 4.2). Chapter 4 
elucidated the genome changes that were present in this strain however the high 
expression of the lux genes alone remains to be evaluated.  
The bioluminescence reaction can be seen in Figure 4-1. As well as the 
requirement for oxygen the rate limiting step for this reaction is production of 
the long chain aldehyde substrate (RCHO) not normally synthesised within the 
bacterial cell which is catalysed by the luxC-E encoded fatty acid reductase 
complex, which channelling fatty acids from the fatty acid biosynthesis pathway 
to produce the substrate for the luciferase (LuxA/ LuxB) (Boylan et al., 1985, 
Boylan et al., 1989). Initial steps in the synthesis of the aldehyde are catalysed 
by the transferase (luxD), which catalyses the transfer of fatty acyl groups from 
acyl-ACP or acyl-CoA onto water, resulting in a fatty acid (Byers & Meighen, 
1985). The next step involves the synthetase (luxE), which only functions when 
bound to the reductase. The enzyme activates the fatty acid forming a fatty 
acyl-AMP intermediate bound to the enzyme (Boylan et al., 1985, Boylan et al., 
1989). The acyl group is then transferred to the synthetase followed by the 
reductase, which in turn is reduced to give the aldehyde. During the reactions 
catalysed by the synthetase and reductase ATP and NADPH are utilised. The 
reaction equation is shown in Equation 7-1. 
RCOOH + ATP + NADPH   #   NADP + AMP + PPi + RCHO 
Equation 7-1: Reaction catalysed by luxE and luxC 
Reaction catalysed by the synthetase and reductase component of the fatty acid reductase 
complex, producing the aldehyde substrate for the luciferase (LuxA/ LuxB). RCOOH (fatty 
acids), ATP (adenosine triphosphate), NADPH (reduced nicotinamide adenine dinucleotide 
phosphate), NADP (nicotinamide adenine dinucleotide phosphate), AMP (adenosine 
monophosphate), PPi (pyrophosphate), RCHO (long chain aldehyde) 
 
The reaction also required the constant recycling of FMN to its reduced form 
FMNH2, which is performed in luminescent bacteria by flavin reductase, which is 
not encoded on the lux operon (reaction is NAD(P)H dependant) (Jablonski & 
DeLuca, 1977, Michaliszyn et al., 1977). The fact in normally non bioluminescent 
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bacteria we observe bioluminescence suggests this enzyme is also present, likely 
due to the requirement for FMNH2 in a number of other biological processes. 
SP_1627 in S.pneumoniae is homologous to a putative NADH flavin reductase. In 
this instance for FMNH2 production NADH is oxidised reducing FMN giving FMNH2 
and NAD+. The cloning of the lux genes into a bacterium that does not normally 
bioluminesce may pose a metabolic burden to the cell via using ATP for aldehyde 
production and altering the availability of molecules with reducing power, 
required for energy production and redox balance.  
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7.3 Promoter disruption 
Initial experiments were performed to confirm the promoter driving the 
expression of the lux genes in Xen35 it that lying downstream of SP_1915. A 
mutant was constructed in T4NO1 inserting a spectinomycin resistance cassette 
20 nucleotides downstream of the start of SP_1915, using a transposon based 
mutagenesis method. This separated the predicted -10 and -35 sigma70 binding 
recognition sites from that of the start of the SP_1915 gene (Figure 7-1). This 
was initially constructed in a TIGR4 background and then PCR amplified from this 
strain and transformed into Xen35 producing Xen35!19. This insertion enabled 
evaluation of whether this is the promoter driving the expression of the lux 
genes in Xen35.  
To assess the ability of Xen35!19 to bioluminescence bacterial strains were 
inoculated at 1x106 cfu/20µl into 180µl of BHI in a black 96 well plate in 
triplicate, with Xen35 and TIGR4 used as controls. Bioluminescence was 
measured over time in a plate reader taking measurements every 30 minutes 
over a period of approximately 10 hours. Average of the three readings was 
calculated and plotted as shown in Figure 7-2. Insertion of the resistance 
cassette down stream of SP_1915 removed the ability of the strain to 
bioluminesce (Figure 7-2), confirming that this promoter drives the high 
expression of the lux genes in Xen35. 
 
 
 
Chapter 7 
 
299 
 
 
 
 
Figure 7-1: Schematic diagram of transposon insertion in Xen35!19 
Diagram of downstream region of gene XEN35_1915 where its predicted promoter lies (BPROM), red box encircles the predicted -10 box and the blue box 
the -35 box. Blue cross represents the insertion site of the transposon insertion of roughly 1.1kb in size. 
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Figure 7-2: Bioluminescence of Xen35!19 
Graph of bioluminescence of strains Xen35, TIGR4 and Xen35!19 over time. Each point on 
the graph represents the average of a triplicate reading, Readings were taken every 30 
minutes. 
 
7.4 Construction of a new bioluminescent strain 
To assess the metabolic burden that the high expression of the lux genes may 
have on the bacterial cell a collection of bioluminescent strains were 
constructed. Initial experiments performed were to clone the lux genes (luxA-E) 
into plasmid pCEP2 (Guiral et al., 2006), which placed the genes under the 
control of a maltose inducible promoter (pCEP2lux). This plasmid was then 
transformed into T4NO1 and these genes recombined into SP_1886 (IS1167 
element, frameshift). This plasmid was designed to allow chromosomal 
expression of genes and no deleterious effects from affecting adjacent genes, as 
this insertion is into a non-functional element (Figure 7-3).  
Once transformed into T4NO1 the lux gene expression was induced using 
maltose. However no bioluminescence was observed (data not shown). This was 
attributed to the requirement for a strong promoter and the maltose inducible 
promoter was not strong enough to drive expression of all five lux genes. 
Therefore bioluminescence produced by this strain was below the detection limit 
of the plate reader used for analysis. 
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The maltose inducible promoter was therefore swapped for that of alternative 
pneumococcal promoters chosen from high expression of the downstream gene 
shown by RNA-seq analysis, see Table 7-1. Promoter presence was predicted in 
the upstream regions of the highly expressed genes by using the BPROM internet 
tool to detect potential sigma70 binding sites. The promoter present upstream 
of SP_1915 was also chosen as this is the promoter driving the expression of the 
lux genes in Xen35. In some instances the highly expressed gene contained no 
promoter directly upstream and therefore the expression of the surrounding 
genes was gauged to assess whether the gene is contained within an operon. In 
this instance the nearest upstream promoter was chosen as for SP_0236. Site 
directed mutagenesis was performed on pCEP2lux to create a restriction site 
upstream of the maltose inducible promoter to allow excision and replacement 
with the new promoters, which was performed for all chosen promoters. 
Plasmids constructed were then transformed into T4NO1 creating strains T4P1, 
T4P2, T4P3, T4P4 and T4P19. These strains were initially assessed for their 
ability to bioluminesce. 
Promoter Gene 
number 
Gene function RPKM 
expression 
value 
Promoter 5’ 
of gene 
P1 SP_1489 Elongation factor Tu 8,057.38 SP_1489 
P2 SP_2012 GAPDH 5,126.58  SP_2012 
P3 SP_1128 Enolase 3,202.48 SP_1128 
P4 SP_0236 DNA directed RNA 
polymerase alpha 3,178.91 
SP_0232 
P19 SP_1915 Hypothetical protein 34.84 SP_1915 
Table 7-1: Table of promoters used to drive expression of the lux genes 
Table of promoters chosen for cloning into pC2LSD upstream of the lux genes, and 
information regarding their expression in TIGR4. 
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Figure 7-3: Schematic diagram of cloning region in pC2LSD plasmid and recombination site into TIGR4. 
 
 
Chapter 7 
 
303 
 
7.4.1 Bioluminescence of T4P strains 
The different T4P strains were assessed for their ability to bioluminesce, which 
gives an indication of the strength of the promoter placed upstream of the lux 
genes. Bacterial strains were inoculated at 1x106 cfu/20µl into 180µl of BHI in a 
black 96 well plate in triplicate. Bioluminescence was measured over time in a 
plate reader taking measurements every 20 minutes over a period of 10 hours. 
Average of the three readings was calculated and plotted as shown in Figure 7-4. 
 
Figure 7-4: Bioluminescence of T4P strains 
Graph of bioluminescence of Xen35, TIGR4 and the T4P strains over time. Each point on the 
graph represents the average of a triplicate reading, Readings were taken every 20 minutes. 
 
T4NO1 was used as a negative control for bioluminescence measurement and 
Xen35 as a positive control. All T4P1-4 strains showed bioluminescence using the 
plate reader, however to varying extents. T4P2 and T4P3 showed the highest 
bioluminescence, T4P1 showed slightly lower levels and T4P4 bioluminescence 
levels were almost undetectable. When comparing these strains to Xen35 none 
of them were as bioluminescent with T4P3 and T4P2 showing roughly 3-4 times 
less bioluminescence respectively. T4P19 although containing the promoter that 
drives the lux gene expression in Xen35 showed no bioluminescence. This would 
indicate that some of the other genome changes seen in Xen35 effect the 
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activity of this promoter, which is why the bioluminescence is so bright in Xen35 
and other Xen strains.  
7.4.2 Western blot analysis of T4P strains 
Western blot analysis was performed on strains T4P1-4 to assess the effect of lux 
gene expression on RrgB expression, as RrgB levels were severely reduced in 
Xen35. 
 
Figure 7-5: Western blot of T4P strains RrgB expression compared to T4NO1. 
Western blotting analysis was performed on T4NO1, T4P1, P2, P3, P4 and T4!rrgB looking 
for expression of RrgB in all strains (!-RrgB antibody). Equal protein loading was confirmed 
by equal expression of GroeL (!-GroeL antibody), normalise against in analysis. Western 
blotting quantification was performed using ImageJ with fold changes in RrgB expression 
compared to T4NO1 boxed below the strain. Left hand side numbers represent the size in 
kDa of proteins run to the same point. 
 
Expression of the pilus backbone protein (RrgB) showed a large decrease in the 
RrgB levels in all T4P strains, shown in Figure 7-5. All strains showed a decrease 
of 40-280 fold in RrgB pilus protein levels compared to T4NO1. Xen35 was not 
included in the analysis so the relative RrgB levels in these strains and Xen35 
may vary. The fold change observed in these strains is much higher than that 
observed in Xen35. However Xen35 was compared against T4JH and the T4P 
strains were constructed in T4NO1. Pilus expression varies between the two 
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TIGR4 strains with roughly a four fold increase in T4NO1 pilus positive cells 
compared to T4JH, which may account for why a bigger drop in RrgB expression 
is observed in the T4P strains. 
7.4.3 Hydrogen peroxide production of T4P strains 
Levels of hydrogen peroxide were measured to see whether expression of the lux 
genes effects hydrogen peroxide production. In Xen35 there is no hydrogen 
peroxide production due to the SNPs located in spxB and lctO resulting in 
truncated proteins. Both of these protein are important during aerobic growth. 
As both are non-functional in Xen35 this may indicate they were non-functional/ 
had a reduced functionality anyway and therefore mutations were able to 
accumulated in these genes. 
 
Figure 7-6: Hydrogen peroxide production of T4P strains 
Each strain was represented in triplicate in the Hydrogen peroxide assay. (A) The graph 
gives the hydrogen peroxide production in mM of each strain calculated using a standard 
curve of known hydrogen peroxide concentrations (See Figure 2-14), the dotted line 
represent the limit of detection. Hydrogen peroxide production above 9mM could not be 
accurately measured therefore a maximum value of 9mM was assigned. (B) Shows visually 
the assay performed in a 96 well plate with each strain represented in triplicate. 
 
SpxB is functional in the T4P strains shown from Figure 7-6, however all show 
reduced levels of hydrogen peroxide production compared to T4NO1. This may 
suggest SpxB has a reduced function in these strains. However even after 
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deletion of SpxB we did not observe the same level of reduced pilus expression 
that we see in Xen35 and the T4P strains. Therefore there must be another 
factor causing this reduction in pilus expression in the T4P strains and Xen35, 
which is in some way linked to high expression of the lux genes. 
Only one of the T4P strains was chosen for further analysis, so further 
experiments were performed on T4P2. 
7.5 Characterisation of T4P2 
7.5.1 FACS and fluorescence microscopy analysis of T4P2 
Differences seen in pilus expression in T4P2 were further confirmed by FACS 
analysis and fluorescence microscopy. This assessed if the difference in RrgB 
expression is that of a reduction in the RrgB levels on a single cells or that of a 
reduction in the number of pili positive cells within the population as a whole. 
FACS analysis confirmed the reduction in RrgB and like Xen35 this reduction was 
at the population level (Figure 7-7, Figure 7-8), with now only 7.6% of T4P2 cells 
expressing RrgB on their cell surface compared to that of its parent T4NO1 (88% 
RrgB+) (Table 7-2). A population of Xen35 however still contained fewer RrgB+ 
cells (5.4%). As observed for some Xen35 pili positive cells, some T4P2 cells 
contained pili just at set location on the cell and a small number also showed 
pili over the whole cell surface (Figure 7-8). The level of expression of the lux 
genes and pilus islet genes in T4P2 were analysed comparing their expression 
levels to Xen35. 
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Figure 7-7: FACS analysis of RrgB surface expression in T4P2 
FACS was performed on T4P2, T4NO1, Xen35 and T4!rrgB. (A) Shows histograms of the 
capsule positive populations selected for from samples stained with a capsule antibody, 
population used for further analysis. (B) Shows the capsule stained populations being gated 
on for being RrgB positive, histograms/ polychromatic plot show negative (left) and positive 
(right) RrgB populations in each strain. 
 
Strain RrgB- (%) RrgB+ (%) 
T4NO1 12.1 87.9 
T4P2 92.4 7.6 
Xen35 94.7 5.4 
T4!rrgB 98.4 1.6 
Table 7-2: Percentage RrgB positive cells in a T4P2 population from FACS analysis. 
Table shows the percentage RrgB positive and negative cells in a growing bacterial 
population. FACS analysis was performed in FlowJo. 
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Figure 7-8: Fluorescence microscopy of T4P2. 
One representative image of fluorescently labelled T4NO1, T4"rrgB, Xen35 and T4P2 used 
for FACS analysis. Cells were stained for the presence of RrgB (FITC) and the capsule 
(APC). Scale bars above represent, T4NO1-9µm, T4"rrgB - 140µm, T4P2 - 14µm and Xen35 - 
140µm. The same representative image will be used throughout this study for each strain, 
more images can be seen in appendix I. 
 
7.5.2 Lux gene and pilus expression in T4P2 
RT-PCR analysis was performed to measure the expression levels of the lux genes 
(luxA-E) and the pilus islet in T4P2 relative to that of Xen35. 
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Figure 7-9: RT-PCR graph of lux and pilus genes expression in T4P2 
Graph shows RT-PCR of luxA-E and the whole pilus islet (rlrA, rrgA, rrgB, rrgC, srtB, srtC, 
srtD) in T4P2. Fold change represents that of T4P2 compared to Xen35. Each bar represents 
the average of three replicas (three biological replicas) and error bars the standard 
deviation. Statistical analysis was performed by a 1-way ANOVA with a Tukeys testing 
correction comparing the dCt values of the control strain (Xen35) to the test strain (T4P2), * 
P<0.05, **P<0.001. 
 
RT-PCR showed roughly a 3-5 fold decrease in the expression of the lux genes in 
T4P2 compared to Xen35, this correlates well with the difference in 
bioluminescence levels produced between the two strains, shown in Figure 7-4. 
Interestingly this also correlates with an increase in pilus expression of 2-4 fold 
seen in T4P2 compared to Xen35. This would indicate a potential metabolic 
burden on the cell of expressing the lux genes, with higher expression of the lux 
genes resulting in decreased pilus expression. 
7.5.3 Microarray analysis of T4P2 
Microarray analysis was performed on T4P2 to assess whole genome expression 
changes compared to T4NO1, this will also enable evaluation of the contribution 
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of the expression of the lux genes to variations in gene expression in T4P2 and 
Xen35. 
Gene Description Abbrev Fold 
change 
SP_0453 Amino acid ABC transporter, permease protein.  1.2 
SP_0461 Transcriptional regulator, pilus islet rlrA 36.3 
SP_0494  CTP synthase, catalyses amination of UTP to CTP pyrG 1.4 
SP_1071  ABC transporter ATP binding protein.  1.8 
SP_1296 Hypothetical protein  1.5 
SP_1356  Chlorohydrolase, Atz/Trz family protein  2.1 
SP_1500  Amino acid ABC transporter, amino acid binding protein.  1.7 
SP_1501  Amino acid ABC transporter, ATP binding protein.  1.8 
SP_1576  
Homoserine-o succinyltransferase, methionine 
biosynthesis. 
 
1.1 
SP_1578  Hypothetical protein  1.3 
SP_1675  ROK family protein  3.0 
SP_1676  N-acetlyneuraminate lyase  2.8 
SP_1682  Sugar ABC transporter, permease protein  2.8 
SP_1684  PTS system, IIBC component  2.4 
SP_1688  ABC transporter permease protein  4.3 
SP_1816  Anthranilite synthase component II trpG 3.2 
SP_1852  
Galactose-1-phosphate uridylyltransferase, galactose 
metabolism. 
 
3.7 
SP_1874  Ribosomal large subunit pseudouridine synthase  2.2 
SP_1875  Functions during chromosome segregation. scpB 2.0 
SP_1878  CBS domain containing protein  1.9 
SP_1879  Hypothetical protein  2.0 
SP_1880  
Putative deoxyribonucleotide triphosphate 
pyrophosphatase 
 
2.1 
SP_1882  Hypothetical protein  4.1 
SP_1894  Sucrose phosphorylase gtfA 3.0 
SP_1895  Sugar ABC transporter, permease protein rafE 3.0 
SP_1897  Sugar ABC transporter, sugar binding protein rafG 4.4 
SP_2000  DNA binding response regulator rr11 1.8 
SP_2196  ABC transporter, ATP binding protein.  1.6 
Table 7-3: Genes differentially regulated in T4P2 
Table shows genes differentially regulated in T4P2 compared to its parent T4NO1 (P<0.05). 
Fold change represents that seen in T4P2 compared to T4NO1, red showing genes up 
regulated in T4P2 and blue are those that are down regulated. 
 
A total of 28 genes were shown to be differentially regulated between T4P2 and 
T4NO1 shown in Table 7-3. Included in this are a number that have been shown 
to play a role in virulence. SP_0494 and SP_1356 have been shown to play a role 
in meningitis (Molzen et al., 2011). SP_0461, SP_0494, SP_1816 and SP_1879 are 
important for lung infection (Hava & Camilli, 2002). SP_1356 is up regulated 
upon contact with D562 cells, SP_1578, 1852, 1875 and 1878 are up regulated in 
the blood of infected mice and SP_1675 and SP_2196 are up regulated in the CSF 
of infected rabbits (Orihuela et al., 2004). 
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The genes differentially regulated in the T4P2 were compared to those that 
were differentially regulated in Xen35, with common genes likely due to 
expression of the lux genes. A comparison was made between the P<0.05 (Figure 
7-10) and P<0.1 (appendix VII) gene lists from microarray analysis of both strains 
compared to TIGR4. Comparison was performed using a venn diagram. 
 
Figure 7-10: Venn diagram of gene expression changes in T4P2 and Xen35. 
Venn diagram showing genes commonly regulated in T4P2 compared to Xen35. Diagram 
shows only 1 gene (P<0.05) (A) and 16 genes (P<0.1) (B) common to both evaluated from 
strains individual gene expression changes compared to TIGR4. 
 
When comparing gene expression changes between T4P2 and Xen35 only 1 gene 
was commonly regulated in both (P<0.05) SP_1895, a component of a sugar ABC 
transporter. SP_1895 was down regulated in Xen35 and T4P2 5 and 3 fold 
respectively. When comparing the gene lists with an increased P value (P<0.1) 
there were a further 15 genes commonly differentially regulated in the two 
strains shown in appendix VII. Of the genes a number are regulated oppositely in 
the two strains and therefore are likely not genes regulated commonly by the lux 
genes. The genes that were common to both and aren’t oppositely regulated 
include SP_0461-64 (the pilus pilins and transcription regulator), SP_1895-98 
(sugar ABC transporter genes and a alpha galactosidase) and SP_2193 (rr06, 
response regulator). 
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7.5.4 Real-time PCR validation of microarray analysis in T4P2 
Microarray analysis was confirmed by RT-PCR analysis of the genes encoded on 
the pilus islet. Microarray analysis showed a large decrease in pilus expression in 
T4P2 compared to T4NO1. This decrease is larger than that of Xen35, but this is 
due to the fact Xen35 pilus expression was compared to that of T4JH, which 
shows roughly a 4 fold decrease in pilus expression compared to T4NO1. As T4P2 
was constructed in T4NO1 this is the appropriate comparison. 
 
Figure 7-11: RT-PCR graph of pilus expression in T4P2 
Graph shows RT-PCR of the whole pilus islet (rlrA, rrgA, B, C, srtB, C, D) in T4P2. Fold 
change represents that of T4P2 compared to T4NO1. Each bar represents the average of 
three replicas (three biological replicas) and error bars the standard deviation. Statistical 
analysis was performed by a 1-way ANOVA with a Tukeys testing correction comparing the 
dCt values of the control strain (TIGR4) to the test strain (T4P2), * P<0.001. 
 
Gene Microarray RT-PCR 
SP_0461 (rlrA) 36.3 39.9 
SP_0462 (rrgA) 24.9 36.5 
SP_0463 (rrgB) 25.1 47.5 
SP_0464 (rrgC) 23.2 36.8 
SP_0466 (srtB) 5.0 21.3 
SP_0467 (srtC) 9.3 14.7 
SP_0468 (srtD) 13.5 12.3 
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Table 7-4: Comparison of expression changes of the pilus islet in T4P2 from microarray and 
RT-PCR analysis. 
Table shows fold changes in gene expression of the whole pilus islet in T4P2 compared to 
T4NO1. Fold changes show that from microarray data and those from RT-PCR. 
 
RT-PCR further confirmed the down regulation of the pneumococcal pilus in 
T4P2 showing a 35-50 fold down regulation of the genes that encode the pilins 
and the transcriptional regulator and a 10-20 fold down regulation of the sortase 
enzymes (Figure 7-11). Comparison of the pilus islet expression by microarray 
and RT-PCR analysis showed very similar expression levels, confirming this 
change (Table 7-4). 
7.5.5 In vivo analysis of T4P2 
To assess the virulence of T4P2 in vivo a mouse model of infection was 
performed as described previously for T4NO1 and Xen35 (experimental design 
identical to that of Xen35 vs. T4NO1). The data below is that of the T4NO1 and 
Xen35 data already presented above and comparisons made between these data 
sets and T4P2. In this data set statistical analysis was performed comparing 
T4NO1 and T4P2/ Xen35 and T4P2 only as the T4NO1 and Xen35 comparison have 
been assessed earlier in this study.  
Initial analysis was performed looking at the survival of MF1 mice infected with 
T4P2 and the percentage weight loss of these mice over time (Figure 7-12). Mice 
infected with T4P2 had a statistically significantly longer survival time than mice 
infected with T4NO1. However their survival time was similar to that of mice 
infected with Xen35, showing no statistical difference between the two (Figure 
7-12). Percentage weight loss of mice infected with T4P2 was statistically lower 
than that of mice infected with T4NO1 suggesting a slower disease progression in 
this strain compared to T4NO1 (Figure 7-12). Mice infected with Xen35 showed a 
similar percentage weight loss to that of T4P2 infected mice indicating a similar 
disease progression. 
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Figure 7-12: Survival and weight loss of mice infected with T4P2 
(A) Shows percentage survival of mice infected with T4NO1, Xen35 or T4P2 over time, 
statistical analysis was performed comparing T4P2 to T4NO1 or T4P2 to Xen35 using a 
logrank Test, ** P<0.01. ** above the strain indicated a statistical difference compared to 
T4P2. (B) Shows percentage weight loss of mice infected with Xen35, T4NO1 or T4P2. 
Statistical analysis was performed using a non-parametric Mann-Whitney two sample rank 
test, **P< 0.01 and ***P<0.001. 
 
To assess at what point during infection this attenuation of T4P2 is occurring 
enumerated of the bacterial load in the mouse lungs, brain, blood and nasal 
wash over time was performed.  
At 24 hours post infection there seemed to be no statistical difference in counts 
from any organs/ bodily fluids when comparing T4P2 to T4NO1 and Xen35. 
However there is a trend towards lower counts in all compared to T4NO1 except 
the nasal wash (Figure 7-13). At later time points there are some clear 
differences in virulence between T4P2 and T4NO1/Xen35. At 48 hours and 
survival time points there is a statistical difference in bacterial counts in the 
nasal wash, blood and brain of T4P2 infected mice compared to T4NO1, at 72 
hours post infection bacterial counts in the blood and brain were statistically 
lower compared to T4NO1. This may suggest an inability of T4P2 to spread into 
the blood and to the brain. The decrease in colonisation is likely due to the 
decrease in pilus as T4P2 has a functional SpxB confirmed by hydrogen peroxide 
production (Figure 7-6). Interestingly at this time point there was also a 
statistical decrease in bacterial counts in the brain, blood and lungs of T4P2 
infected mice compared to Xen35, suggesting a decrease in virulence of T4P2 
compared to Xen35 (Figure 7-13). T4P2 infected mice were imaged at each time 
point to visually assess disease progression, shown in Figure 7-14. 
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Figure 7-13: Bacterial counts in organs and bodily fluids of MF1 mice infected with Xen35, 
T4NO1 or T4P2. 
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Bacterial counts were enumerated from brain, lungs, nasal wash and blood of mice infected 
with either Xen35, T4NO1 or T4P2. Counts were enumerated from 5 mice for each strain over 
varying time points, graph (A) represent the 24 hour post infection time point, (B) 48 hours, 
(C) 72 hours and (D) the survival time point. Statistical analysis was performed comparing 
T4NO1 to T4P2 or Xen35 to T4P2 using a non-parametric Mann-Whitney two sample rank 
test, *P< 0.05, ** P<0.01. 
 
 
Figure 7-14: Images of mice infected with T4P2 
Images of mice infected with T4P2 over time showing in vivo infection in the lungs and 
abdomen of some mice. Images were acquired using the IVIS spectrum in vivo imaging 
system, imaging for 5 minutes for each. Hours above the images indicate that of the time 
elapsed since inoculation. Numbers to the side indicate the mice numbers in each group. If 
mice are not present in the image they have been culled. 
 
7.6 T4P2 whole genome sequence 
Whole genome sequence analysis was performed on T4P2 to assess whether 
expression of the lux genes leads to accumulation of genetic changes. 
Preliminary whole genome sequence changes of T4P2 compared to the genome 
sequence data available at NCBI (NC_003028) can be seen in Table 7-5. 
Preliminary analysis included reference assembling the sequence reads of T4P2 
to the available genome sequence (NC_003028), followed by SNP and indel 
testing and assessing if there are any low coverage regions. This analysis was 
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performed by Dr Andrea Mitchell. Only three genome changes were observed in 
T4P2 compared to the genome sequenced strain. One of these changes included 
a low coverage region in gene SP_1886, which is where the lux genes have been 
inserted, as these would not align to the TIGR4 genome sequence. A second low 
coverage regions was observed in the intergenic region between genes SP_1199-
SP_1200, this was also observed in the parent strain of T4P2 (T4NO1) so this 
change likely came from this. Finally the indel in the intergenic region between 
SP_1777 and SP_1778 was not observed in T4NO1. Interestingly this change was 
observed in T4JH and Xen35. Whether this change is linked to any biological 
function would require further study. Interestingly there were two genome 
changes in T4NO1 that were not observed in T4P2. 
Gene Information Position 
TIGR4 
Variant  In 
T4NO1? 
INT SP_1199-
1200 
  Low 
coverage 
 Yes 
INT SP_1777-
1778 
 1696086 Indel T  No 
SP_1886 New lux gene 
insertion site 
 Low 
coverage 
 No 
Table 7-5: Preliminary whole genome sequence changes in T4P2 
 
The fact only a small number of genome changes were observed in T4P2 would 
suggest the reason for the reduced pilus expression in this strain is solely due to 
the metabolic burden expression of the lux genes places on the cell. In this 
experiment T4P2 had only been passaged once whereas it could be that some of 
the genome sequence changes in Xen35 were able to accumulate over time if 
passaged multiple times. 
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7.7 Discussion 
To assess the metabolic burden of bioluminescence on the bacterial cells the lux 
genes were placed at a different genomic region (into SP_1886) to that in Xen35 
and expressed at a high level using different pneumococcal promoters. Inserting 
the genes into a different genomic region removes any potential effects to pilus 
regulation the lux insertion site has in Xen35, such as SP_1914 becoming non-
functional and the high expression of SP_1915. The plasmids constructed only 
contained roughly 2kb of pneumococcal DNA required for recombination either 
side of the cloning site, which removed the potential contributions of 
introducing other changes via recombining in large amounts of surrounding DNA, 
which occurred in Xen35 (Guiral et al., 2006). 
Xen35"19 containing a transposon insertion downstream of XEN35_1915 
(SP_1915) confirmed the promoter downstream of SP_1915 was that driving the 
lux gene expression, as no bioluminescence was observed in this strain. The new 
collection of bioluminescent strains produced include T4P19 which contained the 
SP_1915 promoter in front of the lux genes. However this strain showed no 
bioluminescence suggesting this promoter alone is unable to drive the high 
expression of the lux genes. This may indicate disruption in Xen35 of some 
regulatory network surrounding the lux insertion site, which results in the high 
expression of SP_1915. Perhaps though perturbing the function of a repressor of 
this gene via the SNPs/ indels recombined in from Xen7 surrounding the lux 
insertion site. Both SP_1919 and SP_1920 are non-functional in Xen35 due to 
changes recombined in from Xen7, however further study would need to be done 
to assess a potential role of these genes in regulation of SP_1915. 
Bioluminescence produced by all T4P strains was observed however to varying 
levels, with T4P2 and T4P3 showing the highest levels. Yet this was still lower 
than that observed in Xen35. Western blot analysis for expression of the pilus 
backbone protein RrgB showed a large decrease in RrgB levels in all T4P strains 
compared to T4NO1, showing a similar reduction in RrgB levels to that seen in 
Xen35. However the RrgB levels were not directly compared by western blot. 
The fold change observed in RrgB levels compared to T4NO1 correlated well with 
the level of bioluminescence with T4P3 showing the largest decrease in RrgB 
levels and the highest bioluminescence, followed by T4P2, T4P1 and T4P4. 
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T4P19 showed no difference in RrgB levels compared to T4NO1 (data not shown), 
and no bioluminescence. In T4P1-4 hydrogen peroxide levels were reduced by 
around 25%-50% compared to T4NO1, which may suggest a decreased 
functionality of SpxB. 
T4P2 was taken forward for further analysis. RT-PCR comparing the pilus islet 
genes and lux genes expression in T4P2 relative to Xen35 further validated the 
likelihood that the lux gene expression puts a metabolic burden on the bacterial 
cell. Observed was a 3-5 fold reduction of the lux gene expression in T4P2 
compared to Xen35, corroborated by a lower bioluminescence in T4P2 seen on 
the plate reader. Simultaneously T4P2 has a 2-4 fold increase in expression of 
the pilus islet genes compared to Xen35. This would indicate that the expression 
of the lux genes places a metabolic burden on the cell as the lower levels of lux 
gene expression in T4P2 correlates to an increased expression of the pilus islet 
genes. 
Although T4P2 was not complemented to ensure the change in pilus expression is 
due to lux expression we assume that the expression of the lux genes is the 
cause of the phenotypic change and not due to any other genetic changes as all 
mutant strains showed the same phenotype. Further whole genome sequencing 
was performed on T4P2 to show one a very small number of genetic changes had 
occurred in the strain which did not seem to be linked to pilus expression. 
Further analysis by FACS showed as in Xen35, T4P2 had a large decrease in the 
number of cells positive for RrgB on the cell surface, with only 7.6% of cells RrgB 
positive compared to 88% in T4NO1. In T4P2 only 2% more cells were RrgB 
positive than Xen35. For both in the majority of instances pili were only 
observed at set locations on the bacterial cell rather than spread over the whole 
cell as seen in T4NO1.  
To assess genes commonly effected by the lux gene expression comparison of 
the genes differentially regulated in T4P2 and Xen35 were compared. Using both 
the P<0.05 and P<0.1 genes lists a total of 8 genes were shown to be commonly 
regulated including the pilus islet genes rlrA, rrgA, rrgB, rrgC and SP_1895, 
SP_1896, SP_1897, SP_1898 and SP_2193. SP_1895-97 encode an ABC transporter 
enabling growth on raffinose, stachyose and melibiose (Bidossi et al., 2012). 
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SP_1896 and SP_1898 were also shown to be important for lung infection (Hava & 
Camilli, 2002). The response regulator SP_2193 was also commonly regulated in 
both T4P2 and Xen35 and has been shown to regulate the pneumococcal pilus 
and is therefore likely the cause of the decrease in pilus in both strains (Rosch et 
al., 2008). However this difference was not shown to be statistically significant 
by RT-PCR in Xen35 and has not been validated by this method in T4P2. Further 
analysis of the expression of rr06 in the other T4P strains may give a clearer 
indication if this is a common feature of all strains. If this is the case RR06 in 
this instance acts as a repressor of the pilus islet genes, as shown in the 
literature (Rosch et al., 2008). 
How the expression of the lux genes may have such a pronounced effect on the 
bacterial cell is likely due to two factors: through utilisation of ATP for aldehyde 
production and a requirement for large amounts of reducing power for the 
recycling of FMN to FMNH2 (Jablonski & DeLuca, 1977, Boylan et al., 1985). 
Natural bioluminescent bacteria are equipped for this however in normally non 
bioluminescent bacteria expression of the lux genes may lead to depletion of 
ATP levels and altered redox balance, leading to alterations in normal cell 
functioning and virulence. 
The production of energy in the pneumococcus is strictly fermentative via 
glycolysis followed by pyruvate metabolism to lactate, acetate, formate or 
ethanol, with no genes found encoding the required enzymes for the TCA cycle 
of electron transport chain (Hoskins et al., 2001, Tettelin et al., 2001), see 
Figure 7-15. Glycolysis yields two ATP molecules, two NADH molecules and two 
molecules of pyruvate. Pyruvate fermentation follows glycolysis, under both 
anaerobic and aerobic conditions. During fermentation pyruvate is converted to 
lactate via lactate dehydrogenase (NADH dependant), simultaneously NADH is 
converted to NAD+ required for glycolysis. Under aerobic conditions there is a 
shift to mixed acid fermentation resulting in acetate, formate and ethanol 
production rather than lactate (Yesilkaya et al., 2009). During this pyruvate is 
either processed via SpxB (pyruvate oxidase) under aerobic conditions to acetyl 
phosphate followed by conversion to acetate via AckA (acetate kinase). The 
latter reaction producing ATP as a by-product, which contributes to the majority 
of the cells ATP production, ATP levels severely drop upon deletion of SpxB or 
AckA (Ramos-Montañez et al., 2010, Pericone et al, 2003). Alternatively 
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pyruvate is converted to Acetyl CoA and formate via pyruvate formate lyase, 
acetyl CoA can then either be converted to acetyl phosphate by Pta 
(phosphotransacetylase) and processed by AckA, converted to ethanol via 
acetaldehyde CoA/ alcohol dehydrogenase or used as a precursor for fatty acid 
biosynthesis (Yesilkaya et al., 2009). Lactate is not a dead end metabolic 
product in the pneumococcus and under aerobic conditions can be converted 
back to pyruvate via LctO (lactate oxidase), which is thought to enable further 
processing by SpxB and AckA for increased ATP production (Taniai et al., 2008). 
The ability to maintain the redox balance within the cell is vital for proper 
cellular growth and functioning. NADH and NAD+ are required during carbon 
catabolism and the constant recycling between the two factors must be 
maintained. During glycolysis NAD+ is oxidised producing its reduced equivalent 
NADH, which is recycled back to NAD+ during fermentation of pyruvate to lactate 
by lactate dehydrogenase. As described earlier one of the requirements of the 
bioluminescence reaction is the availability of FMNH2 (reduced riboflavin), which 
is oxidised during the reaction giving FMN, recycling between the two via flavin 
reductase is NAD(P)H dependent (Jablonski & DeLuca, 1977, Michaliszyn et al., 
1977). In the pneumococcus the NADH dependant flavin reductase upon 
conversion of FMN to FMNH2 results in NADH oxidation giving NAD+, potentially 
altering the levels of NAD+ relative to NADH.  
Variations in redox balance may affect the functionality of NADH dependant 
enzymes such as NADH oxidase in the pneumococcus. NADH oxidase converts 
oxygen to water helping prevent the toxic effects oxygen may have on the cell 
(Auzat et al., 1999). If this enzyme is unable to function oxygen may be broken 
down into harmful reactive oxygen species such as superoxide anions/hydroxyl 
radicals, causing harm to the bacterial cell. 
Changes in redox balance have been shown to cause variation in gram positive 
and gram negative bacterial metabolism (Bennett & San, 2005, Berrıos-Rivera et 
al., 2002, Ramos et al., 2004, Neves et al., 2002, Vemuri et al., 2006). Over 
expression of a NAD+ dependant formate dehydrogenase from Candida boidinii in 
E.coli, causes an increase in NADH levels, which results in a shift in the final 
carbon catabolite concentrations both under aerobic and anaerobic growth 
conditions (Berrıos-Rivera et al., 2002). In this instance increased levels of NADH 
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caused a shift away from fermentation (lactate production) and resulted in 
increased levels of ethanol and acetate production. Further studies expressing 
NADH oxidase from S.pneumoniae in E.coli resulted in the oxidisation of NADH 
into NAD+ (Vemuri et al., 2006). NADH levels are thought to act as a sensor which 
when NADH levels are high metabolism is directed into acetate production to 
prevent further accumulation of NADH produced from the TCA cycle. Over 
expression of NADH oxidase, results in reduced NADH levels causing a shift to 
glucose metabolism via the TCA cycle. Under these conditions a 70% increase in 
glucose uptake was observed, confirming a clear link between NADH levels and 
glucose metabolism. 
Disruption in catabolism has been shown in the pneumococcus to alter regulation 
of large groups of genes, altering virulence and regulation of virulence factors. 
Deletion of the global regulator of catabolite metabolism CcpA in D39 shows 
altered expression levels of up to 19% of genes in the genome (Carvalho et al., 
2011). Along with differential regulation of genes involved in metabolism, there 
was differential regulation of a number of TCS, transcription regulators (codY), 
psaR the capsule and surface proteins pcpA, nanA and nanB and the lic1 operon 
regulating choline metabolism. The D39 genome does not encode the 
pneumococcal pilus and therefore would not be seen in this study (Lanie et al., 
2007). Virulence studies showed a reduced virulence of ccpA mutants compared 
to their parent strain (TIGR4), with ccpA mutants being out competed in a 
pneumonia and colonisation model of infection (Iyer et al., 2005).  
From this a hypothesis has been drawn where upon expression of the lux genes 
in S.pneumoniae there is a change in the redox balance within the cell, due to 
the requirement for the oxidation of NADH occurring during the production of 
FMNH2. How this may affect the NAD+/NADH balance is unknown. This change 
could lead to an increased shift towards lactic acid fermentation if NAD+ levels 
were increased, as in E.coli upon decreased NAD+ levels there was a shift away 
from fermentation (lactate production). This may be why there is reduced 
hydrogen peroxide production in T4P2 as SpxB has a reduced activity.  
Fermentation resulting in mainly lactate formation occurs to a greater extent 
under anaerobic condition which in the pneumococcus would likely signal being 
present in low oxygen environments, for instance in the blood. Under these 
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conditions you would perhaps need reduced levels of adhesins such as the pilus, 
and variations in redox balance under these conditions may be the trigger for its 
down regulation. The fact we observe up regulation of rr06 in Xen35 and T4P2 
which is known to regulate the pilus would suggest this factor may be causing 
the pilus down regulation in both strains. However currently it is not known 
whether RR06 modulates pilus expression in its phosphorylated or non 
phosphorylated form and therefore the change in expression levels may not 
directly correlate to its ability to regulate the pilus if it is not present in the 
correct form. The external stimulus required for the activation of rr06 is 
unknown and may be via sensing intracellular redox potential. There is some 
evidence to back up this theory as deletion of RR06 in D39 causes a 6 fold 
increase in the expression of a NADPH dependant flavin mononucleotide 
reductase, confirming a link between RR06 expression and redox potential 
(Standish et al., 2007). Redox potential varies depending on the usage of 
different sugars during growth and it could be envisaged during in vivo growth 
different carbon sources are available, with free sugars in short supply, but 
glycoproteins readily available (Philips et al., 2003, Voynow & Rubin, 2009). 
Availability of different sugars could indicate the niche in which the bacterium is 
present via the redox potential of the cell, which in turn leads to regulation of 
virulence factors required for survival within that niche.  
Shifts in metabolism will also affect the ATP pool present within the cell, which 
is required for a large number of cellular processes and cell survival. The 
majority of the ATP produced within the pneumococcus is synthesised under 
aerobic conditions via SpxB and AckA. If metabolism is shifted towards lactate 
fermentation lower ATP amounts will be produced. Coupled to this is the fact 
aldehyde production for the bioluminescence reaction requires ATP, further 
depleting the intracellular ATP stores. Mutations in AckA (acetate kinase) have 
been shown to be unstable and result in spontaneous mutation in SpxB or SpxR 
(SpxB regulator) (Ramos-Montañez et al., 2010). This may be due to the 
requirement for ATP to repair the cellular damage created via H2O2 production, 
as cellular ATP levels are severely reduced in AckA mutants (Ramos-Montañez et 
al., 2010). This may be why we see SNPs in both SpxB and LctO in Xen35 as both 
produce hydrogen peroxide as a by-product of their reactions, and likely reduced 
ATP levels. There is no SNP in spxB or lctO in T4P2, therefore expression of the 
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lux genes which may lead to reduced ATP levels may not be the cause of the SNP 
in spxB and lctO in Xen35. 
One of the TCS known to regulate the pneumococcal pilus (HK03) was shown to 
be down regulated upon deletion of spxB, ackA and pta, however differential 
regulation of this TCS was not observed in Xen35 and T4P2 so is likely not the 
factor causing the pilus repression in these strains (Rosch et al., 2008, Yesilkaya 
et al., 2009). 
The idea that reduced ATP levels are causing this reduced pilus expression in the 
both bioluminescent strain is also supported by data in previous chapters. A SpxB 
mutant showed only 20% pili positive cells compared to 88% in T4NO1 and SpxB 
mutants have been shown to have reduced ATP levels (Pericone et al., 2003). 
The LctO mutant also has reduced pili expression with only 57% of cells pili 
positive, upon deletion of SpxB in this strain the same number of pili positive 
cells as a single SpxB mutant is observed, suggesting the reduced pili phenotype 
in the LctO mutant is acting via knock on effects to SpxB. If LctO functions to 
convert lactate back to pyruvate to be processed via SpxB, in a knockout this 
would not occur and perhaps lead to reduced ATP levels within the cell. If this is 
the case in the bioluminescent strains there must be less ATP available than in 
the SpxB and LctO mutants as both strains have lower number of pili positive 
cells (Xen35 5.4% and T4P2 7.6%). Differential expression of any other surface 
proteins is not observed in both bioluminescent strains, which would suggest the 
pilus alone is dependant on the reduced ATP levels, or resulting from a knock on 
effect this has to the cell. In S.aureus deletion of PknB a serine/threonine 
protein kinase showed a significant alteration in the cellular levels of NADH and 
FMN as well as intermediates required during glycolysis, cell wall biosynthesis 
and fatty acid biosynthesis (Liebeke et al., 2010). As hypothesised for SpxB and 
LctO the mutation seen in StkP in Xen35 may have occurred in this strain due to 
metabolic stresses on the cell, which required a reduction in StkP functionality.  
To validate what is happening in T4P2 and Xen35 with regards to having a 
potentially altered metabolism, metabolomic analysis could be performed, 
which was not done due to time limitations. This would enable validation of 
what the effect the lux genes expression has on levels of different metabolites 
within the cell. This could also be performed on strain T4"SpxB and T4"lctO 
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which would allow us to understand if variations in pilus expression in these 
strains are due to the same effect on metabolism changes or due to variations in 
hydrogen peroxide levels, ATP levels, or both.  
From this it is not surprising a reduced virulence is observed in T4P2 as seen in 
Xen35. T4P2 infected mice showed a statistical increase in survival time 
compared to T4NO1, and a slower disease progression deduced from a 
statistically reduced percentage weight loss compared to T4NO1 at all time 
points. No difference in organ, nasal wash and blood bacterial counts was 
observed at 24 hours post infection when compared to Xen35 and T4NO1, yet at 
48 hours post inoculation and survival time points nasal wash bacterial counts 
were lower compared to T4NO1 and blood and brain counts at 48, 72 and 
survival time points. Interestingly there was also a significant decrease in 
bacterial counts in the brain, lungs and blood at 72 hours post inoculation in 
T4P2 infected mice compared to Xen35. This would indicate Xen35 is more 
virulent than T4P2.  
Interestingly unlike Xen35, T4P2 only contains a small number of genome 
changes compared to its parent T4NO1. One is a SNP in an intergenic region of 
which its function is unknown. This SNP is also found in Xen35 so could be linked 
to changes in pilus expression, however it is also found in T4JH. The other 
change is a region of low coverage, which was expected as this is the insertion 
site of the lux genes (SP_1886) in T4P2. This data further validates that the 
reduced expression of the pilus is due to a metabolic burden placed on the cell. 
It was also hypothesised that the metabolic stress on the cell may promote the 
accumulation of specific SNPs and indels, due to the fact such a large number of 
genome changes were observed in Xen35. This seems not to be the case for T4P2 
however it may be that over time SNPs would accumulate in this strain in genes 
such as SpxB. As the genome sequence of T4P2 was performed on the strain 
taken only a single passage from the original constructed strain, it may be that 
this has not had time to occur. 
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Figure 7-15: Glycolysis and Pyruvate metabolism in S.pneumoniae 
Diagram of glycolysis and pyruvate metabolism in S.pneumoniae, adapted from (Carvalho et 
al., 2011).  
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8.1 Final Discussion 
The key aims of this study were to evaluate genes regulated by some of the key 
signalling systems used by the pneumococcus to adapt to different niches in 
response to external stimuli. This study has hopefully made a contribution to the 
current understanding of how these systems work, what genes they regulate and 
gives examples of external stimuli these systems may respond to. 
One key element to take from this study is the substantiation it provides to show 
the complexity of the signal transduction pathways in the pneumococcus, 
especially with regards to regulation by TCS. In the literature it has already been 
shown that TCS12 and TCS13 are able to converge on the same promoter of an 
ABC transporter and a number of the other systems have been implicated to 
regulate other systems, shown by microarray analysis (Knutsen et al., 2004, 
Mccluskey et al., 2004, Peterson et al., 2004). In this study a similar 
phenomenon was observed between TCS08 and TCS09 where some genes were 
commonly regulated by both but in most instances they regulated their own 
collection of genes. In a double knockout a large number of genes were shown to 
be regulated which were not observed in the single knockouts alone. This could 
indicate the systems are able to compensate for the deletion of the other. 
However, another reason for this may be that deletion of both systems puts a 
stress on the cell which leads to differential expression of these genes. Our 
current data is unable to distinguish between these two phenomenon and further 
study is required to evaluate this.  
Although no clear conclusions can be made about the potential cross regulation 
of these systems and whether a hierarchy exists it is clear these systems are 
connected in some way, whether that be responding to a similar stimulus or 
regulating each other etc. In the literature expression analysis on TCS mutants 
are often performed under different conditions and in different background 
strains. This is the first study to assess the whole genome expression changes in 
more than once mutant and a double mutant. This study only assessed the 
expression changes upon deletion of these TCS and further studies into the genes 
directly regulated by each system, whether these genes are regulated by the RR 
in the phosphorylated or non phosphorylated form, protein-protein interactions 
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of these systems and the external stimulus activating the system need to be 
performed. 
An alternative signalling system was also assessed in this study looking at the 
genes it regulates. The serine/ threonine protein kinase although the only 
signalling system of its type in the pneumococcus is able to interact with the TCS 
(Agarwal et al., 2012, Ulijasz et al., 2009). No differential regulation of the 
pneumococcal RR was observed in a StkP deletion mutant however this system 
has been shown to phosphorylate two of these RR (Agarwal et al., 2012, Ulijasz 
et al., 2009). This further adds another layer of complexity to the regulation of 
genes by both of these systems. The fact deletion of the HK of TCS pairs results 
in a less severe phenotype of a number of systems would suggest these are not 
as vital (Throup et al., 2000). This would also suggest that the RR can function 
without the requirement of phosphorylation by its cognate kinase and is perhaps 
phosphorylated by another means. Although currently only evaluated for two RR 
it may be that all the pneumococcal RR are also phosphorylated by StkP, which 
is able to modulate the binding affinity to certain promoter targets. This could 
allow different groups of genes to be regulated by each system in its different 
forms which would include the non phosphorylated form, the phosphorylation on 
an aspartate residue (typically by the HK), phosphorylation on a threonine (or 
serine) residue (by StkP) and potentially phosphorylation of both at once. 
Evidence this may be the case for other RR has come from this study. Although 
RR05 was not differentially regulated in the StkP knockout, a number of genes 
were shown to be directly regulated by RR05, through the binding of RR05 to the 
upstream promoter regions, which were also differentially regulated in T4!stkP. 
This may also be the case for RR02 as homologues of this RR in S.pyogenes are 
phosphorylated by its serine/ threonine protein kinase (ST-STK) (Agarwal et al., 
2011).  
A further role attributed to StkP in this study is to modulate protein 
translocation to the cell wall. SecY of the SecYEG translocase was down 
regulated in the StkP deletion mutant. Interestingly this resulted in an increase 
in pili on the cell surface so it could be that deletion of StkP results in a 
dysregulation of cell wall constituents. StkP has been shown to localise to the 
cell septum and is important for cell division (Giefing et al. 2010, Maestro et al. 
Chapter 8 
 
331 
2010). Through the use of its extracellular PASTA domains which can bind to 
peptidoglycan it can perhaps sense the presence of cell wall surface components 
and modulate from this the level of protein translocation to the cell surface 
(Beilharz et al. 2012). Interestingly also differentially regulate in the StkP 
deletion mutant was HtrA a serine protease and ParB a chromosomal division 
protein (Ibrahim et al. 2004a, Minnen et al. 2011). HtrA has recently been shown 
to colocalise with SecA (a protein chaperone) to the midcell/ septum during cell 
division. SecA functions as a chaperone for proteins being directed to the 
SecYEG translocase (Tsui et al. 2011). From this data it could be inferred that 
these above protein all function together localising to the midcell/ septum 
during cell division. This protein complex contains StkP which functions to sense 
the changes in the cell wall. Which relays information to the SecA, SecYEG and 
HtrA protein complex, modulating its activity. This complex would be present at 
the midcell/ septum which is the point at which new protein are placed onto the 
cell wall, which is also the site at which new peptidoglycan biosynthesis occurs 
(Tsui et al. 2011). ParB which is also regulated by StkP could also functions 
alongside this complex, as you would expect chromosome segregation to occur 
alongside cell division (Minnen et al. 2011). 
Another key feature elucidated in this study is the potential impact that genome 
changes may have on the bacterial cell with regards to gene regulation and 
regulation of key virulence factors. The new era of affordable genome 
sequencing enables better validation of genetically manipulated strains with 
regards to assessing that they only contain the desired mutation. The genome 
sequence of Xen35 has clearly shown that the genetic manipulation of strains 
can lead to major genome changes depending on how the strain has been 
constructed. This leads to a big issue about strains used in studies that have 
been genetically manipulated and whether along with the desired mutation 
other genome change have also occurred. Perhaps through multiple 
recombination events if transformed with large PCR products or gDNA. In the 
literature there is also evidence that deletion of some genes results in 
accumulation of genomic changes in other genes, which are required to 
counteract the deleterious effect on the cell of the required deletion. This has 
been observed in deletion mutants of AckA (Acetate kinase) which when deleted 
acquires mutations in SpxB or SpxR (Ramos-Montañez et al., 2010). This 
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phenomenon has also been shown to occur in deletion mutants of CodY 
(Caymaris et al., 2010). 
One example of how genetic manipulation of a strain can severely affect its 
phenotype includes Xen35 (the bioluminescent version of TIGR4), which had 
acquired a large number of genetic changes, some in part due to the 
construction of the strain, which highlights the need to ensure when genetically 
manipulating strains that only the desired genetic mutations are introduced. 
Other genetic changes in this strain were likely due to variations in the genome 
of the parent strain Xen35 was constructed in (TIGR4) which can vary as noted 
below. Changes at the genome level in this strain likely contributed to the 
reduced virulence of the strain and the changes in gene expression observed in 
this strain compared to TIGR4. 
However, in this instance the drop in pilus expression observed in Xen35 was not 
due to the genome changes observed and was shown to be due to the over 
expression of the lux genes (genes required for bioluminescence). This also gives 
an insight into the potential effects of expression of foreign genes in a non 
native species, and whether these constructed strains used for in vivo disease 
progression etc can really give a true picture of disease caused by these strains. 
In this instance the expression of these genes resulted in a reduction in the 
expression and level of a key virulence factor the pilus (adhesin) on the cell 
surface in Xen35. Perhaps in the pneumococcus an alternative reporter gene 
should be used for this type of study as expression of and/ or the enzymatic 
reactions catalysed by the lux genes/ LuxA-E respectively alter other biological 
functions within the cell. As no other cell surface virulence factors were shown 
to be commonly differentially regulated in Xen35 and T4P2 it is assumed the 
over expression of the lux genes specifically effects a biological function that is 
linked to how the pilus is regulated, which our current studies did not identify.  
This study also sheds light on the genetic diversity between the supposed same 
strain. Globally TIGR4 a serotype 4 S.pneumoniae strain is used as a laboratory 
standard to enable comparisons between work performed in different 
laboratories. In this study two un-manipulated TIGR4 strains were found to vary 
at the genome level and variations between the two altered expression of a key 
cell surface adhesin. Therefore studies performed in different background 
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strains (TIGR4 etc in different laboratories) may result in different findings if 
genome changes are present that affect the expression of the genes being 
assessed. In this instance it is not known whether the regulation of the pilus islet 
by TCS in T4JH would be effected by the SNP present in RrgC. 
It is assumed that this SNP which causes an amino acid change in RrgC in T4JH is 
the reason for the variations in the level of pilus expression at the population 
level. With T4NO1 showing 88% of cells to be pili positive whereas in T4JH only 
20.5% are pili positive. Why this single amino acid change would cause reduced 
expression of the pilus suggests RrgC also plays a regulatory role in pilus 
expression. It is not known to have any DNA binding functions and therefore may 
modulate expression changes through some sort of protein-protein interaction. 
This type of regulation has been seen for RrgA which binds to RlrA (Basset et al., 
2011, Basset et al., 2012). It may be that RrgC also binds to RlrA or perhaps to 
RrgA modulating its regulatory function. The pneumococcal orphan response 
regulator RitR has been shown to form a protein-protein interaction with PhpP 
(Ulijasz et al., 2009). Therefore perhaps other response regulators are also 
regulated in this manner. The three TCS evaluated in this study have all been 
shown to regulate pilus expression at the population level so perhaps RrgC 
modulates the function of one of these proteins through a protein-protein 
interaction. It may be that the pilus islet itself is temporally regulated as it 
would be unnecessary for the bacteria to produce RrgA and RrgB if there is no 
way to anchor the proteins to the cell wall. Perhaps the SNP in RrgC in T4JH 
renders the protein unable to anchor properly to the cell wall of hinders 
transport to the cell surface at which point there is a checkpoint which initiates 
synthesis of the other pilins. This may be hindered in T4JH which is why there is 
fewer cells at the population level that are pili positive. 
This study has clearly shown that expression of the pilus likely poses a metabolic 
burden on the cell. T4NO1 was originally isolated from a case of IPD, isolated 
from the blood of a 30 year old male from Norway and was found to be highly 
invasive in a mouse model of infection (Aaberge et al., 1995, Tettelin et al., 
2001). This strain was used in these studies only one passage from the original 
strain and therefore likely retained the phenotypic traits of the strain taken 
from the infected male. Whereas T4JH is a lab strain and may perhaps have 
acquired mutations in the pilus islet due to the metabolic burden it places on 
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the cell, which render its unable to express high levels of pili as this trait is not 
required in lab strains. 
As already mentioned these two strains differ in the amount of pili expressed at 
the population level, with T4JH having 20.5% of cells pili positive whereas T4NO1 
has 88% of cells pili positive. This ability to regulate the pilus at the population 
level may be key to why there has been no clear association of strains that carry 
pili with increased incidence of IPD, yet it has been shown that it must convey 
some advantage otherwise strains wouldn’t have it (Moschioni et al., 2008, 
Regev-Yochay et al., 2010). Although strains may have the pilus islet all studies 
assessing its association with strains able to cause IPD do not assess the level at 
which each strain expresses the pilus (Moschioni et al., 2008, Regev-Yochay et 
al., 2010). Which has been shown in this study to vary even between two closely 
related TIGR4 strains. Therefore strains that are able to express the pilus on the 
surface of a larger proportion of cells may be more invasive and are associated 
with higher levels of IPD. No animal data is currently available comparing the 
virulence of T4NO1 and T4JH. Data to support this idea is seen when RR09 is 
deleted in T4JH which results in 91% of cells become pili positive. Adherence 
assay data of this strain shows a large increase in adherence to all cell lines 
tested. Therefore it would be assumed T4NO1 is able to adhere better than T4JH 
as it contains roughly four times more pili on the cell surface and in the host 
perhaps causes a more severe disease. However, more pili does not necessarily 
lead to increased adherence as observed for T4!rr086 which had a similar 
number of pili on the cell surface as T4!rr098 yet showed no increase in 
adherence compared to the parent. This strain however also showed when 
stained with FITC for the pilus a lower fluorescence intensity than that of pili 
positive cells in the WT strain suggesting in this strain there are fewer pili per 
cell or the pili are shorter. 
From this study more factors shown to alter pilus expression have been 
identified including the serine/ threonine protein kinase, pyruvate oxidase and 
lactate oxidase. These add to the six TCS that have been shown to alter pilus 
expression, three transcription regulators and the differential expression 
observed in response to vancomycin stress (Haas et al., 2004, Haas et al., 2005,  
Hendriksen et al., 2007, Hendriksen et al., 2009, Hemsley et al., 2003, Johnston 
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et al., 2006, Rosch et al., 2008, Sebert et al., 2002, Song et al., 2009). Due to 
the large number of genes that regulate this islet it has been concluded that 
pilus expression is probably closely linked to the overall fitness of the cells as a 
number of the genes shown to regulate the pilus are involved in modulating and 
responding to changes in cell wall integrity and energy production. This includes 
StkP, which regulates genes important for cell wall integrity, RR03, (binds 
directly to the rlrA promoter) responds to cell envelope stress, and post 
treatment with vancomycin (induce cell wall stress) the pilus is down regulated 
(Giefing et al., 2010, Haas et al., 2005, Rosch et al., 2008, Suntharalingam et 
al., 2009). The role of LctO and SpxB in pilus regulation supports this idea 
further with regards to pilus regulation being linked to the fitness of the cell. As 
both show reduced pilus expression when they are deleted and both are 
important for energy production during aerobic metabolism, with knockouts of 
SpxB shown to have reduced cellular levels of ATP (Pericone et al., 2003, Taniai 
et al., 2008). This is further validated by the fact the over expression of the lux 
genes also causes reduction in pilus expression which is assumed to lead to 
reduced ATP levels in the cell, however this would need further confirmation. If 
this is the case it may explain why only 30% of strains contain the PI-1 encoded 
islet as some strains may not be able to generate enough energy to maintain all 
the required cellular processes as well as maintain large cell surface structures. 
This may also be the case for other large cell surface proteins such as PsrP, 
which is only present in roughly 50% of strains (Munoz-Almagro et al., 2010). 
The exact function of the pilus in the pneumococcus still remains elusive, 
however it likely plays an important function. In other bacteria functions have 
been assigned to pili which may play a similar role in the pneumococcus. For 
instance pili in S.pyogenes have been shown to aid in resistance to phagocytosis 
and killing by neutrophils (Maisey et al., 2009). During invasive disease 
neutrophils and macrophages have been shown to be key factors in clearance of 
the pneumococcus from the lung (Kadioglu & Andrew, 2004). Neutrophils 
function in one way through release of reactive oxygen species including 
hydrogen peroxide, which have bactericidal effects on bacterial cells (Kadioglu 
& Andrew, 2004). It could therefore be envisaged that the release of hydrogen 
peroxide by neutrophils could induce pilus expression in the pneumococcus, 
which helps protect the bacteria from killing. 
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To conclude, this study has offered a further insight into the complexity of gene 
regulation by signal transduction systems in the pneumococcus. It has offered 
insights into not only the regulatory mechanisms used to modulate gene 
expression but also the potential to regulate protein export. Another key feature 
touched upon is the requirement for a metabolically fit cell and its importance 
in maintaining normal cellular functioning. One major finding to be taken from 
this study is the potential impact of a small number of genetic changes between 
two very closely related strains and how this may have a big impact on the 
phenotype of the strain. This study has hopefully contributed to a better 
understanding of gene regulation in the pneumococcus. 
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Appendices 
Appendices can be found on a CD at the back of this thesis. The contents 
included in this are noted below. 
Appendix I 
Fluorescent microscopy images of capsule and pili stained bacteria, including 3-4 
representative fluorescent images and DIC images of T4NO1, T4JH, Xen35, T4P2, 
T4!stkP, T4!stkP"ST, T4!stkP"XST, T4!spxB, T4!lctO, T4!spxB!lctO, T4!rr06, 
T4!rr08, T4!rr09, T4!rr086, T4!rr096, T4!rr098, T4!rr0986, T4AN and T4!spxB 
grown in the presence of varying hydrogen peroxide concentrations. 
Appendix II 
Graph directly comparing RR expression in T4!rr08, T4!rr09 and T4!rr098, 
deduced from RT-PCR analysis. Expression values are located below in a table 
showing the average fold change in RR expression in the TCS mutants stated 
above. 
Appendix III 
Table summarising all the genome changes in Xen35 compared to the TIGR4 
genome sequence (NC_003028).  
Appendix IIII 
Table of genes differentially regulated in Xen35 compared to T4JH (P<0.1). 
Appendix V 
Venn diagram comparing the genes differentially regulated in T4!rr08, T4!rr09 
and T4!rr098 via microarray analysis when compared to T4JH, comparison was 
performed using the P<0.1 genes lists. A table of the genes found to be 
commonly differentially regulated in all three strains was compiled comparing 
the expression differences. 
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Appendix VI 
Venn diagram comparing the genes commonly differentially regulated in StkP 
mutant strains in a T4NO1 background (this study) and CP1015 (published data) 
via microarray analysis, the data from this study shows a comparison using the 
P<0.1 genes lists. The commonly regulated genes are noted below the diagram. 
Appendix VII 
Venn diagram comparing the genes differentially regulated in Xen35 and T4P2 
via microarray analysis when compared to T4JH and T4NO1 respectively, 
comparison was performed using the P<0.1 genes lists. A table of the genes 
found to be commonly differentially regulated between the two strains was 
compiled comparing the expression differences below. 
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Future work 
With regards to further assessing gene regulation by TCS future work includes 
assessing the genes regulated by each TCS through direct binding of the RR to 
the upstream promoter regions. And assessing whether these RR form any 
protein-protein interactions with each other or other key proteins. Little is 
known about the external stimulus which activates the majority of these systems 
and this knowledge is vital for a better understand of where genes regulated by 
these systems are important in vivo, studies into this are also required. With 
regards to their regulation of the pilus more information is required as to 
whether RR08 and RR09 bind directly on the pilus islet promoters, and whether 
the RR that modulate this activity compete for binding, or bind to different 
promoter sites within the islet. 
To further evaluate the metabolic burden placed on the cell by expression of the 
lux genes metabolomic analysis could be performed. This will evaluate if 
expression of these genes alters levels of a certain metabolites such as ATP, 
which may accounts for the pilus expression changes. This analysis could also be 
performed on Xen35, T4!spxB, T4!lctO and T4!spxB!lctO which may give an 
indication if the reason for the reduced pili expression in all strains is linked to 
alterations of the same factor. 
Other key studies include assessing further the function of the pilus in the 
pneumococcus, whether like in S.pyogenes it is able to protect against death by 
neutrophils. Important studies could also be performed into elucidating whether 
clinical isolates vary in their pili expression at the population level and if this 
correlates with invasive disease potential.  
Further studies need to also be performed to assess whether StkP is also able to 
modulate other cell surface components and whether this is performed via 
regulating protein translocation. If this is the case, whether StkP modulated this 
activity through direct interactions with the SecYEG translocase at the cell 
septum during cell division needs to be evaluated. And further whether this 
potential protein complex also contains HtrA, SecA and ParB.  
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